key: cord-0007082-jmjq98jy authors: nan title: Track 1 – Track 5 date: 2008-05-12 journal: Int J Obes (Lond) DOI: 10.1038/ijo.2008.47 sha: 61c63c5c959c12b0b4c9a85bc8f1fe7f41cecf86 doc_id: 7082 cord_uid: jmjq98jy nan Melanocortin-4 receptor (MC4R) deficiency is the commonest monogenic cause of obesity. However, studies have reported prevalence varying from 1 to 12; penetrance remains elusive with non-obese carriers reported recently and clinical expression variation along the life is also uncertain. We provide a comprehensive molecular and phenotypic characterization of MC4R-induced obesity in a large European population. We sequenced the gene in 2,856 obese individuals and 2,677 non-obese controls and in the families of the mutation carriers. Newly identified missense mutations were functionally characterized. We also provided obesity-related phenotypes, including questionnaire-based appetitive behaviour. Forty-three obese probands (1.46%) and four non-obese controls (0.15%) carried MC4R pathogenic mutations; familial penetrance was 60% for heterozygotes. The longitudinal study of relatives with available data evidenced an age-dependent penetrance (21% at 20years vs. 60% at >40yrs) suggesting MC4R-deficiency as a late-onset obesity disorder. Comparing the 97 carriers with their 81 WT relatives, we observed that the risk of obesity decreased across generations: it is multiplied by 3.4 for children carriers and by 1.7 for adults >52yrs (p=9.6 10 -4 ) but the risk to become obese after 52 when carrying a pathogenic mutation remains significant (p=10 -11 ). In conclusion, our report highlights the importance of genetic diagnosis, particularly for familial background of obesity. Young MC4R-deficient children should benefit an early and very specific follow-up. Indeed, the carriers of the coming generation have a high risk to become obese during childhood but non-penetrant children can not be assured to remain non-obese all along their life; prevention and care should be constant. Is resveratrol a dietary compound which helps to prevent obesity? Szkudelska, K , Szkudelski, T, Nogowski, L Department of Animal Physiology and Biochemistry, August Cieszkowski University of Agriculture, 60-637 Wolynska 35, Poznan, Poland Resveratrol (RSV; 3,5,4'-trihydroxystilbene) is a polyphenol present in many plant species and evincing estrogenic activity. The richest source of this compound is Polygonum cuspidatum and grapes. The interest of RSV has been increased for more than ten years and, during this time, RSV was found to exert numerous beneficial effects including the protection against cardiovascular disease, anticancer properties, inhibition of free radical generation. RSV is able to inhibit insulin secretion and to increase insulin sensitivity. Moreover, RSV appeared to be a modulator of lipid and lipoprotein metabolism, an important regulator of energy balance and a dietary compound reducing metabolic disturbances induced by a high-calorie diet, suggesting its anti-obesity properties. However, the direct influence of RSV on adipocyte functions is unknown. The aim of the experiments was to investigate the effects of RSV on lipolysis and on the antilipolytic action of insulin in rat adipocytes. Cells, isolated from epididymal fat tissue of male Wistar rats, were incubated for 90 minutes with 100 μM RSV and lipolytic factorsepinephrine (0.06, 0.125, 0.25, 0.5 μM) or dibutyryl-cAMP (a direct activator of PKA; 0.06, 0.125, 0.25, 0.5 mM). The lipolysis was evaluated by the measuring of the amount of glycerol released to the incubation buffer. RSV significantly enhanced epinephrinestimulated lipolysis, but did not change lipolysis induced by dibutyryl-cAMP. In the further studies, isolated adipocytes were incubated with epinephrine (0.5 μM) in the presence of insulin (10 nM) and RSV (1, 10 and 100 μM) . It was found that the inhibitory action of insulin on epinephrine-induced lipolysis was attenuated by RSV. Similar effect was demonstrated in adipocytes exposed to epinephrine and H-89 (a direct activator of PKA; 50 μM) -the antilipolytic action of H-89 was diminished in the presence of RSV (1, 10 and 100 μM). The stimulation of epinephrine-induced lipolysis and the attenuation of the antilipolytic action of insulin in adipocytes exposed to RSV seems to be independent on the estrogenic properties of the tested compound since these effects were not alleviated by blockade of intracellular estrogen receptors. Results obtained in the present study revealed for the first time that short-term exposure to RSV enhances adipocyte lipolysis and thereby contributes to reduced lipid accumulation in these cells. The research relating to this abstract is financed by means of the Ministry of Science and Higher Education (2007 to 2009) , research project number: NN 303 3181 33. A growing number of clinical studies validate a relation of insulin resistance and breast cancer in obese patients. We hypothesised that high plasma insulin levels cause aberrant insulin signalling in breast epithelial cells which may be responsible for an increase in cell proliferation, indicative of potential carcinogenesis and increased cancer progression. It was of particular interest to determine any differences of high insulin concentrations in activating the phosphoinositide-3 kinase (PI-3 kinase) pathway or the mitogen-activated protein kinase (MAP kinase) pathway, the latter being linked to increased cell proliferation. We used two cell line models to investigate the carcinogenic (MCF-10A, immortalised breast epithelial cells) and cancer progression (MDA-MB-231, ER-negative breast cancer cells) potential of insulin. Insulin treatment (100 nM, 24 h) increased cell proliferation in MCF-10A cells, but had no cell proliferative effect on MDA-MB-231 cells. Additionally expression of PCNA as marker of proliferation was tested. The use of PI-3 kinase and MAP kinase specific inhibitors (Wortmannin and PD98059, respectively) demonstrated both pathways being responsible for the observed increase in cell proliferation (MCF-10A). Simultaneous treatment with both inhibitors eliminated insulin induced cell proliferation entirely. Phosphorylation of ERK1/2 was examined as specific activity measurement of MAP kinase pathway. Insulin induced higher phosphorylation levels in MCF-10A cells than in MDA-MB-231. These preliminary results suggest that insulin may initiate carcinogenesis of breast epithelial cells by increasing cell proliferation rather than increasing cancer progression of existing tumours. These effects may be mediated by insulin activating both the PI-3 kinase and the MAP kinase signalling pathways. Funding: Research relating to this abstract was supported by NHS Grampian Endowment Trust and Research & Development Initiative, The Robert Gordon University Insulin resistance is a main feature of obesity and type II diabetes. Activity of MAP Kinase family members, including ERK, is increased in adipose tissue from obese and type II diabetic animals and patients. Strong evidences suggest that activation of MAPK is implicated in the down-regulation of insulin signaling and action in insulin resistance state. We have shown that mice lacking ERK1 are resistant to high fat diet induced obesity and protected from insulin resistance due to a decrease in adipogenesis and a higher post-prandial metabolic rate. To investigate the role of ERK1 in the development of insulin resistance in obese mice, we generated leptin-deficient mice (ob/ob) invalidated for ERK1 (ob/ob-erk1-/-). We found that ob/ob-erk1-/-mice remained as obese as ob/ob mice but are not hyperglycemic in the fed state unlike ob/ob mice. Glucose tolerance test and hyperinsulinemic euglycemic clamp showed an improved insulin sensitivity of ob/ob-erk1-/-mice. This phenotype could be explained by a decreased visceral adipose tissue inflammation, known to be implicated in insulin signaling defect, because mRNA expression of inflammatory markers is decreased in adipose tissue of ob/ob-erk1-/-mice. Further, expression of genes coding for Glut4 and lipogenic enzymes is also diminished. In contrast no differences were observed in subcutaneous adipose tissue. We also demonstrated that ob/ob-erk1-/-are protected from liver steatosis with a reduction in liver triglycerides content and a reduction in ACC (acetyl-CoA carboxylase) expression. Our data suggest that the specific targeting of erk1 could be of particular interest to fight obesity and insulin resistance. We evaluated the effect of skeletal muscle mitochondrial uncoupling on energy and glucose metabolism under different dietary challenges. Transgenic HSA-mUCP1 mice with ectopic expression of uncoupling protein 1 in skeletal muscle and wildtype littermates were fed for 3 months semi-synthetic diets with varying macronutrient ratios (energy % carbohydrate:protein:fat): HCLF: (41:42:17), HCHF (41:16:43); LCHF (11:45:44) . Body composition, energy metabolism and insulin resistance were assessed by quantitative NMR, indirect calorimetry, and insulin tolerance test, respectively. Finally, plasma metabolites were measured and gene expression in muscle, liver and white fat determined using real time PCR. In wildtype, both high fat diets led to an increase in body weight and fat. HSA-mUCP1 mice considerably increased body fat on the HCHF diet but stayed lean on the other diets. Irrespective of differences in body fat content, HSA-mUCP1 mice were much more insulin sensitive and had lower insulin levels and liver triglycerides compared to wildtype. Respiratory quotient and gene expression indicated overall higher carbohydrate oxidation of HSA-mUCP1 but a preferential channeling of fatty acids into muscle rather than liver at high fat diets compared to wildtype. Evidence for increased lipogenesis in white fat of HSA-mUCP1 mice suggests an increased energy dissipating substrate cycling. We conclude that skeletal muscle mitochondrial uncoupling does not protect from the development of obesity in all circumstances. Rather it can lead to a "healthy" obese phenotype by preserving insulin sensitivity and a high metabolic flexibility and thus protecting from the development of obesity associated disturbances of glucose homeostasis. Supported by the Deutsche Forschungsgemeinschaft (DFG) Recent data has shown that germ free mice inoculated with gut microbiota from obese diabetic mice gain more fat than mice inoculated with flora from lean mice. However, it is not clear whether gut microbiota is involved in insulin resistance. The aim of this study was to examine the influence of the gut microflora in the pathophysiology of diabetes by modulating the intestinal microbiota of ob/ob diabetic mice using an antibiotic treatment. A 2 week administration of norfloxacin and ampicillin (1g/l each in drinking water) reduced the cecal bacterial DNA concentrations below detection limit, indicating that the number of intestinal bacteria was significantly reduced by the treatment. Similarly, the concentration of plasma lipopolysaccharide from Gram-negative bacteria was also lower in mice receiving antibiotics. In addition, the treated ob/ob mice showed a much improved glycemic control with normalized basal glycaemia, restoration of liver glycogen storage and increased oral glucose tolerance. Elevated plasma adiponectin concentrations in the treated mice supported the beneficial effects of the antibiotic treatment. These benefits were independent of food intake or body weight, since pair-fed mice weighed less but were as insulin resistant as the control animals. Hepatic triglycerides were also lower in the treated mice, and this result was associated with an up-regulation of hepatic fatty acid oxidation gene CYP4a10. In summary, present results indicate that gut microbiota modulation via antibiotics alters the metabolic and inflammatory status associated with insulin resistance, and results in improved glycemic control in obese and insulin resistant ob/ob mice. PPARα can control the expression of metabolism genes in human white adipocytes. Ribet, C 1 , Montastier, E 1 , Bezaire, V 1 , Valle, C 1 , Roussel, B 1 , Mazzucotelli, A 1 , Viguerie, N 1 , Langin, D 1 1 INSERM U858 : Unité de Recherche sur les Obésités, Institut de Médecine Moléculaire de Rangueil, Université Paul Sabatier, Toulouse, France The nuclear receptor PPARα plays a major role in the control of lipid metabolism by regulating the expression of genes of β-oxidation, ketogenesis and peroxisomal oxidation pathways. PPARα is highly expressed in liver and brown fat, tissues with high fatty acid oxidation rates. Surprisingly, PPARα is also expressed in human white adipose tissue, where PPARγ is abundant. Our group has shown that in human mature adipocytes, activation of PPARα with its agonist GW7647 leads to enhanced expression and activity of the glycerol kinase (GyK) gene, probably as a result of direct activation of GyK transcription by PPARα. We further investigated this unexpected role for PPARα in regulation of white adipocyte gene expression. Pangenomic micro-arrays were used to compare mRNA profiles of human mature adipocytes treated with GW7647 or with PPARγ agonist, Rosiglitazone. A one class analysis using SAM software established two lists of 1700 genes whose expressions were significantly modified by BRL or GW7647 treatment (FDR< 5%). A two class paired comparison of these lists, that has been validated by RT-qPCR, yield 80 genes differentially expressed between treatments. Five genes were more expressed when PPARα was activated and the expression of 75 genes was higher with PPARγ agonist. PPARα activation upregulates genes of the β-oxidation pathway and downregulates genes of the glycolytic pathway. To assess the impact of PPARα on adipocyte metabolism, the glycolytic flux and palmitate oxidation are measured in adipocytes where PPARα is either activated by its agonist or silenced using siRNA. This work is part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP, see http://www.hepadip.org/), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme (Contract LSHM- CT-2005-018734) . Sánchez, J, Priego, T, Palou, M, Tobaruela, A, Palou, A, Pico, C. Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics), University of the Balearic Islands (UIB), Palma de Mallorca; and CIBER Fisiopatología Obesidad y Nutrición (CB06/03), Instituto de Salud Carlos III, Spain. We have previously described that neonate rats supplemented with physiological doses of oral leptin during lactation become more protected against overweight in adulthood (Int J Obes 31: 2007) . The purpose of this study was to characterize further the long-term effects on glucose and leptin homeostasis and on food preferences. Neonate rats were supplemented during lactation with a daily oral dose of leptin or the vehicle. We followed body weight and food intake of animals until the age of 15 months, and measured glucose, insulin, and leptin levels under different feeding conditions: ad libitum feeding, 14-h fasting, and 3-h re-feeding after fasting. An oral glucose tolerance test (OGTT) and a leptin resistance test were performed. Food preferences were also measured. Leptin-treated animals were found to have lower body weight in adulthood and to eat fewer calories than their controls. Plasma insulin levels were lower in leptin-treated animals than in their controls under the different feeding conditions, as was the increase in insulin levels after food intake. The homeostatic model assessment for insulin resistance index was significantly lower in leptin-treated animals, and the OGTT also indicated higher insulin sensitivity in leptin-treated animals. In addition, these animals displayed lower plasma leptin levels under the different feeding conditions and were also more responsive to exogenous leptin administration. Leptin-treated animals also showed a lower preference for fatrich food. These observations indicate that animals supplemented with physiological doses of oral leptin during lactation were more protected against obesity and metabolic features of the metabolic syndrome. Adipocytes are now recognized as endocrine cells secreting adipocytokines. In this study, we examined secretion of microvesicles by 3T3-L1 adipocytes. We found that MFG-E8, one of the exosomal proteins was present in the microvesicles and was distributed in the sucrose density fractions with 1.13 to 1.20 g/mL corresponding to those for exosomes. Several integral, cytosolic and nuclear proteins were also identified to be microvesicle components by immunoblotting and proteomic analysis. Unexpectedly, adiponectin was also substantially distributed in the microvesicle fractions. Electron microscopic observation revealed that microvesicles secreted by 3T3-L1 adipocytes exhibited heterogeneity in size and comprised both smaller exosome-like and larger membrane vesicles. MFG-E8-associated adiposomes exhibited binding activity toward phosphatidylserine and apoptotic cells. MFG-E8-adiposomes were down-regulated when cultured in the low glucose medium or cultured in the high glucose medium with antioxidant N-acetyl cysteine, while insulin and TNF-α up-regulated MFG-E8-adiposomes. Moreover, MFG-E8 was highly expressed in the hypertrophic adipose tissue, predominantly in adipocyte fractions, of diet-induced obese C57BL/6 mice. Collectively, it is suggested that microvesicles, especially MFG-E8-associated ones, modulate adipose functions under the redox-and hormone-dependent regulation. Based on the above findings, the adipocyte-derived microvesicles were named adiposomes. Further biological functions of adiposomes will be also discussed. Dietl, P 1 , Brunner, C 2 , Ruiz, PA 1 , Haller, D 1 , Hauner, H 1 , Laumen, H 1 1 Else Kroener-Fresenius-Center for Nutritional Medicine, Technische Universität München, Germany 2 Department of Physiological Chemistry, University Ulm, Germany Chemokine secretion by adipocytes and preadipocytes has been postulated to initiate leukocyte infiltration and might mediate the establishment of obesity-related lowgrade inflammation. The (IFN)gamma-inducible protein 10 (IP-10/CXCL10), a chemokine with chemoattractant properties for various leukocyte subsets, is expressed and secreted in primary mature human adipocytes. Elevated IP-10 serum concentrations correlate positively with the incidence of type 2 diabetes. Aim of this work was to study the mechanism of IP-10 transcriptional regulation in murine 3T3-L1, primary human preadipocytes and adipocytes and to characterize the relative contribution of preadipocytes and adipocytes to IP-10 expression/secretion. In 3T3-L1 cells, IP-10 expression and secretion was significantly regulated by NF-kB as shown by chemical interfering with blockers of different signalling pathways. This was confirmed by specific inhibition of NF-kB activity using stable overexpression of a transdominant mutant of IkB-alpha which was found to completely suppress basal and IL-1beta-induced IP-10 expression. In additional experiments in primary human adipocytes, the critical role of NF-kB for IP-10 expression was confirmed. An interesting observation both in the human and murine system was that adipocytes secrete and express significantly higher levels of IP-10 compared to preadipocytes. In conclusion these data demonstrate a central role for the NF-kB pathway in the regulation of IP-10 in primary human and 3T3-L1 preadipocytes and adipocytes. Furthermore, the results of our study clearly show that adipocytes rather than preadipocytes contribute significantly to obesity-associated elevated IP-10 levels. Future studies should focus on the potential role of this chemokine as a chemoattractant for immune cells in adipose tissue. Funding: Research relating to this abstract was partially funded by the Else Kroener-Fresenius-Stiftung, Bad Homburg, Germany. Oleoyl-estrone (OE) induces a decrease in food intake, and a noticeable decrease in body weight through reduction of body lipids with no concurrent loss of protein. Deep changes in maternal intake affect the pups' growth and can program the metabolism of different tissues in order to develop obesity in adulthood. Lactating dams were treated up to day 15 of lactation with 0.2 mL sunflower oil alone (control and diet-restricted groups) or containing 10μmol/kg/day OE (treated group). After weaning, pups received 4 weeks of standard chow diet (4% lipid) followed by 4 weeks of hyperlipidic diet (22.2% lipid). Pups' perigonadal adipose tissue was obtained from control and treated groups under normal of hyperlipidic diet and used for gene expression analysis with real-time PCR. Male control pups showed a marked decrease in lipogenesis (ACC, LPL), an increase in glycerol production (PEPCK) and a decrease in glucose and fatty acids transport (GLUT 4, FATP 1) after receiving a hyperlipidic diet. OE treated animals with standard diet showed non significant decrease in lipogenesis, a tendency to decrease lipolysis and a decrease in adipocyte differentiation (PPAR 2). After 4 weeks of hyperlipidic diet lipogenesis tended to increase, and lipolysis (HSL), glycerogenesis (PEPCK) and adipocyte differentiation increased. Female OE fed standard diet, showed a decrease in adipose differentiation (PPAR 2) and a decrease in lipid extraction (LPL); whereas in the presence of hyperlipidic diet they showed a decrease in lipid oxidation (CPT1, ACAD(l)) and glycerogenesis (PEPCK). OE treated rats showed a marked resistance to store lipids. This study was supported by grants from the "Fondo de Investigaciones Sanitarias" and "Plan Nacional de Investigación en Biomedicina", from the Government of Spain Comparable adipogenesis of stromovascular cultures from subcutaneous adipose tissue from men with and without type 2 diabetes Tchoukalova YT, Cefalu WT, Smith SR, Ravussin E Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA Studies have reported reduced expression of adipogenic genes in individuals with type 2 diabetes mellitus (T2DM). We here assessed more directly the adipogenic potential (proliferation and differentiation) of cultured stromovascular (SV) cells isolated from subcutaneous abdominal adipose tissue (biopsies) in matched obese men with and without T2DM (n=10 per group, BMI 32.3 ± 4.7, age 58 ± 11, Means ± SD). SV cells (three sets of triplicates) were seeded at 0.3 × 10 4 cells/cm 2 in 96-well plates in DMEM/F-12 with 10% FBS. Nuclear fluorescence (CyQuant kit, Invitrogen) was determined on day 1 and 4 (2 culture sets) and proliferation was calculated as the fold-increase in fluorescence from day 1-4. At confluence, the third culture set was switched to serum-free differentiation medium for 11 days followed by fluorescent staining for lipids (BODIPY) and nuclei (DAPI). The BODIPY-to-DAPI fluorescence ratio was used as an index of differentiation. There was no difference in SV cells proliferation between T2DM and controls: 6.1 ± 2.0 vs. 5.0 ± 2.7 (p = 0.3). Large inter-individual variability in adipocyte differentiation was observed but again there was no difference between groups: 27 ± 20% in T2DM vs. 22 ± 11% in controls (p = 0.6). These results demonstrate that in vitro proliferation and differentiation of adipose tissue-derived SV cells are similar in men with and without T2DM. This suggests that the often reported in vivo impaired adipogenesis in diabetes may be due to different physiological milieu of the adipose tissue rather than intrinsic cellular differences. The excessive development of adipose tissue (AT) is the result of both hypertrophy and hyperplasia of the main cellular component of AT, the adipocytes. Surprisingly, few data are available concerning the identity of the adipocyte precursor cell. Among the AT stroma-vascular fraction, the CD34 + /CD31 cell population was shown to be the only one that possesses adipogenic capability. The present study was undertaken to evaluate the proliferative status of the CD34 + /CD31 progenitor cells within human subcutaneous AT and to determine whether stimuli originating from the microenvironment in which CD34 + /CD31 cells reside such as adipokines and oxygen tension, could modulate their proliferation. We demonstrate, using Ki67 as a proliferation marker, that progenitor cells within the human AT were in proliferative state, the proportion of which being positively modulated by the adiposity of the patients and associated to an increased number of small size adipocytes (diameter<60μm). Moreover, mature adipocyte-and endothelial cell-conditioned media as well as 48 hours of low oxygen tension (1%O 2 ) induced the proliferation of the CD34 + /CD31 cells "in vitro" whereas macrophage-conditioned media were antiproliferative (evaluated by BrdU incorporation assay). Among the adipokines possibly involved, leptin, VEGF, IL-6 and LPA were shown to enhance the proliferation of the CD34 + /CD31 cells whereas adiponectin was without effect. The present study suggests that fat mass extension is associated with the proliferation of AT-derived progenitor cells involving local stimuli arising from mature adipocytes and endothelial cells as well as decreased local oxygen tension. The vagus coordinates central and peripheral nutrient sensing and governs most gastrointestinal functions. Truncal vagotomy causes weight loss or slowed growth via unknown mechanisms. Vagal brain-stem afferentectomy, superselective intraabdominal vagotomies and chemoablation of afferent transmission have contributed to the understanding of vagal physiology, whereas electrostimulation and nerve block are still in early stages of development; anti-cholinergics have limited therapeutic use in obesity because of side-effects. In 1977 In -1980 open truncal vagotomy (TV) without drainage in 21 severely obese patients curbed appetite causing weight loss, with trivial and transient side-effects. These 21 patients with TV and 37 patients with TV plus vertical banded gastroplasty compared to 51 patients randomized to gastroplasty alone during 1980-1995 demonstrate very long-term (mean: 20 yrs) effects of open TV (follow-up:90%). Reoperation rates and all-cause mortality were similar in patients with and without TV. Mean BMI loss in gastroplasty patients with vagotomy is 7.8±1.4 (sem) versus 6.1±1.0 in gastroplasty alone (p<0.05), corresponding to 44% excess weight loss (EWL) versus 33% over the very long term. 52% TV "responders" (BMI loss >8) had a mean 79%EWL compared to 62% among 45% "responders" with gastroplasty alone. Preliminary studies of laparoscopic TV alone and combined with adjustable banding demonstrate similar weight loss and safety outcomes. In conclusion: TV has robust long-term effects on body weight, although weight loss is modest in middle-aged severely obese patients. As with all obesity treatment, patient selection is critical and favors younger patients with less disease to minimize volitional breakdown and cognitive override of autonomic function. It has been suggested that isoprenoids affect cellular processes by multiple mechanisms. Isoprenoids, such as farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), regulate transcriptional and posttranscriptional events that affect various biological processes. In this study, we investigated the effects of FPP or GGPP on adipocyte differentiation because several adipocytokines, which are secreted molecule from adipocyte, have been reported to be involved in systemic insulin responsiveness, and their secretions are closely related to adipocyte differentiation. In 3T3-L1 cells, addition of GGPP during adipocyte differentiation significantly reduced the expression of adipogenic marker genes, such as adipocyte fatty acid binding protein and peroxisome proliferators activated receptor γ, and insulinstimulated glucose uptake. On the other hand, FPP was not effective. The effects of GGPP partially diminished in the presence of liver X receptor (LXR) agonist T0901317, but unchanged in the presence of geranylgeranyl transferase inhibitor GGTI-286. Intracellular GGPP levels were increased in parallel with adipocyte differentiation. Moreover the expression levels of geranylgeranyl pyrophosphate synthase 1 (GGPS1) which catalyzes the formation of GGPP from FPP increased after differentiation. In 3T3-L1 cells, stably overexpressing FLAG-tagged GGPS1, intracellular GGPP levels were significantly elevated. In these cells, after differentiation induction, both the expression of adipogenic marker genes and insulin-stimulated glucose uptake were reduced. In genetic and diet induced obese mouse white adipose tissue, GGPS1 mRNA expression was up-regulated. These results suggest that GGPP may perform as an endogenous regulator of adipocyte differentiation by a mechanism that is partially dependent on the LXR pathway. Larrarte, E 1 , Ares, R 1 , Labayen, I 2 , Simón, E 2 , Margareto, J 1 Introduction (Background & aims): Obesity and central obesity are the most important predictors of non-communicable diseases. In this study two indicators-waist circumference & waist to hip ratio-were compared for identifying overweight/obesity in college student girls in the framework of the effectiveness of iron supplementation with and without vitamin C on oxidative stress markers project. Materials and Methods: In this cross-sectional study, 289 college student girls from Shaheed Beheshti University of Medical sciences dormitories were enrolled voluntarily. Demographic data were obtained by questionnaire. Anthropometric data including height, weight, waist and hip circumferences were measured based on standard protocols and body mass index (BMI) and waist to hip ratio (WHR) were computed. Waist circumference (WC) above 88cm and WHR above 0.85 was considered as central obesity. SPSS software, chi-square test and ROC analysis were used for data analysis. Findings: Mean of BMI, waist circumference and WHR in subjects studied were 22.2±3.1 kg/m 2 , 74.4±8.8 cm and 0.81±0.46, respectively and increased with age (p<0.05). 7.7, 77.4, 13.1 and 1.8% were underweight, normal weight, overweight and obese, respectively. Based on waist circumference, 7.3% and based on WHR, 35.2% of subjects had central obesity. More than 70% of central obese girls based on WHR were categorized in underweight (4.2%) and normal weight groups (67.7%); whereas, only 20% of central obese girls based on WC were categorized in normal weight group. None of the obese ones were included in without central obesity group. Area under ROC curves for identifying overweight/obesity based on WC and WHR were 0.92±0.02 and 0.76±0.04, respectively (p<0.001). WC = 77 cm for identifying overweight in college student girls had better sensitivity (0.85) and specificity (0.75) than WHR =0.79 (sensitivity = 0.70 and specificity = 0.69). Sensitivity of current WC cut off value (88cm) was very low (about 40%). Conclusion: Sensitivity and specificity of waist circumference to identify overweight/obesity in college student girls was higher than WHR and therefore, WC is the better indicator for categorizing this age group based on weight status. Key words: Waist circumference (WC), Waist to hip ratio (WHR), Overweight, Obesity, Central obesity, ROC analysis, College student girls Simultaneous analysis of 3T3-L1 adipocyte methabolism by liquid chromatography mass spectrometry using stable isotope technique. Nagai H 1,2 , Takada M 1 , Deyashik Y 2 , Takahashi N 1 , Kawada T 1 1 Division Of Food Science And Biotechnology; 2 Gifu Prefectural Institude of Health and Environmental Sciences Introduction: Adipocytes secrete a variety of cytokines/chemokines including tumor necrosis factor alpha (TNF-alpha), monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) and many more, and it has been suggested that these adipokines may play a role in the pathogenesis of health complications such as arterisclerosis or type2 diabetes. It is important to control adipocyte methabolism for regulating adipocyte hypertrophy and adipocytekine secretion for therapy of life style related disease. But relations between adipocyte methabolism and hypertrophy or adipocytekine secretion are unknown. In this study, we developed simultaneous analysis system of 3T3-L1 adipocyte methabolism by liquid chromatography mass spectrometry by using stable isotope technique to explain adipocyte methabolism and adipocytekine secretion mechanism. Methods: 3T3-L1 preadipocytes were differentiated for 10day, incubation with thiazolidinediones. After differentiation, medium were replaced by non-glucose DMEM added 13 C 6 -glucose, and incubated for 48h. Glucose, glycerol, fatty acids, and other organic acids of medium and cell lysate were analyzed by liquid chromatography mass spectrometry. Results: We could develop quantitative analysis method to examine of adipocyte major methabolism, lipolysis, glucose-uptake, several fatty acid syntheses with high sensitivity by using stable isotope technique. In 3T3-L1 adipocyte, addition of pioglitazone made 13 C 6 -oleic acid and other mono unsaturated acid synthesis decreased dose-dependently, whereas addition of losiglitazone made them increased. It was suggested that thiazolidinediones not only activate glucose-uptake and fatty acid synthesis but also regulate fatty acid composition in 3T3-L1 adipocyte. Relations between fatty acids composition and adipocytekine secretion or hypertrophy of adipocytes are under examination by the described method. Adrenalectomy and oleoyl-estrone increase the circulating levels of progesterone and the expression of its receptors in liver Serrano M 1 , Grasa MM 1,2 , Janer G 1 , Fernández-López JA 1,2 , Alemany M 1,2 , Remesar X 1,2 1 University of Barcelona, Department of Nutrition & Food Science, Barcelona Spain 2 CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III Oleoyl-estrone (OE) is a natural hormone that reduces body weight in a dosedependent manner through wasting of body fat (sparing protein) coupled to decreased energy intake. OE is counter-regulated by glucocorticoids since corticosterone prevents the OE-induced loss of lipids in adrenalectomized rats, partly by increasing both hepatic 11beta-hydroxysteroid dehydrogenase type 1 and free circulating glucocorticoid, through modulation of serum CBG binding. To study changes in steroid hormones and the receptors implied in glucocorticoid action, female adrenalectomized Wistar rats were implanted with subcutaneous pellets of placebo, 0.48, 1.67, or 4 .76 mg/day of corticosterone; 5 days later, all rats received a daily gavage of sunflower oil, plain or containing OE at a dose of 10nmol/g for additional 8 days. A group of sham-operated rats was used as control of surgery. The expression of the receptors for glucocorticoids, mineralocorticoids and progesterone A and A+B in liver were analyzed by Real-Time PCR and corticosterone, dehydrocorticosterone and progesterone in serum were measured by HPLC-MS/MS. Levels of corticosterone and dehydrocorticosterone increased with the dose of corticosterone in pellets with no effects of OE. Progesterone was higher in all OE-treated rats, corticosterone not affecting its levels. OE increased the expression of glucocorticoid and both progesterone receptors in sham-operated and in adrenalectomized rats treated with corticosterone. Corticosterone alone did not change progesterone receptor expression and affected in a biphasic way receptors of mineralocorticoids and glucocorticoids. In conclusion, OE enhanced both glucocorticoid and progesterone signalling in liver through the increased expression of its receptors and availability of the hormones. ⋅m -2 and 67±5 vs. 54±2 nmol⋅m -2 , P<0.01) and inversely related to insulin sensitivity, with OBS showing tendency towards increased response. Glucose Sensitivity was not related to insulin sensitivity as expected from previous studies and was similar in the two groups (124±11 vs. 112±7 pmol⋅min -1 ⋅m -2 ⋅mM -1 , P>0.2). Conclusion: In fGDM obese subjects insulin secretion compensates for reduced insulin sensitivity (increased ISR b and TIS) though compensation does not involve sensitivity to glucose of the beta-cells. Thus, fGDM obese women have greater insulin resistance compared to lean women, but not beta-cell function impairment. Funding: Supported in part by the Austrian Nationalbank Jubiläumsfonds grant 11198. Organ-specific response to high-fat diet and 3,5-diiodothyronine (T2) treatment; a possible involvement of the AMP-activated protein kinase (AMPK). Dip. Scienze Biologiche Sez. Fisiologia, Università degli Studi di Napoli "Federico II", Napoli, Italy 3,5-diiodo-L-thyronine (T2) prevents body weight-gain and fat accumulation when administered to rats receiving a high -fat diet (HFD). It induces an increase in hepatic fatty acid (FA) oxidation concomitant to their less efficient utilization. The effects of T2 on fatty acid oxidation involve the AMP-activated protein kinase (AMPK), but it is not clear how its modulation is achieved in tissues such as liver and white adipose tissue (WAT). Three groups of rats were used, either receiving a 6 hour, 1 day, 1week or 4-week high fat diet with (group HFD-T2), or without (group HFD), a daily i.p. injection of T2 (25 μg/100 g BW),or a standard diet for the same periods (group N). Within 6 hours, T2 increased liver FA oxidation without induction of AMPK phosphorylation. Only after 4 weeks the HFD -T2-treated rats showed a marked increase in liver AMPK phosphorylation. In WAT, between 1 day and 1 week, T2 induced an decrease in AMPK phosphorylation compared to the HFD rats, concomitant with an increase in lipolysis and serum fatty acid levels, which ceases after 4 weeks, possibly because WAT cell volume reached a minimum. At this timepoint hepatic lipids were barely present and serum lipids were not increased compared to N controls. In conclusion, treatment with T2 increases hepatic FA utilization which does not depend on AMPK phosphorylation in this tissue, but decreases AMPK phosphorylation in WAT, resulting in increased lipolysis. As fatty acid oxidation proceeds, liver AMPK is phosphorylated as a consequence of hepatic fuel-depletion. AMP-activated protein kinase (AMPK) and mammalian Target of Rapamycin (mTOR) are key regulators of cellular energy balance and of the effects of leptin on food intake. Acute exercise is associated with increased sensitivity to the effects of leptin on food intake in an IL-6dependent manner. To determine whether exercise ameliorates the AMPK and mTOR response to leptin in the hypothalamus in an IL-6-dependent manner, rats performed two 3-h exercise bouts, separated by one 45-min rest period. Intracerebroventricular IL-6 infusion reduced food intake and pretreatment with AMPK activators and mTOR inhibitors prevented IL-6induced anorexia. Activators of AMPK increased food intake in control rats to a greater extent than that observed in exercised ones, whereas inhibitors of AMPK had the opposite effect. Exercise was associated with both reduced phosphorylation of the AMPK/ACC signaling pathway and increased phosphorylation of proteins involved in mTOR signal transduction in the hypothalamus. Treatment with leptin reduced food intake in exercised rats that were pretreated with vehicle, although no increase in sensitivity to leptin-induced anorexia after pre-treatment with anti-IL6 antibody, AICAR or Rapamycin was detected. Thus, improved responses of AMPK and mTOR to leptin may contribute to the appetite suppressive actions of exercise. The membrane composition of skeletal muscle has been related to insulin action. Possible mechanisms suggested include changed membrane fluidity, which could affect insulin receptor activation, release of different second messenger molecules influencing cellular processes, and altered cellular energy expenditure influencing lipid stores. However, the factors determining muscle phosphodiester concentrations are yet unclear. Glucose metabolism, ectopic lipid deposition in muscle (IMCL) and mitochondrial function were measured in 10 overweight type-2 diabetic patients (T2DM: age:59±6 a, BMI: 27±3 kg/m 2 ), 10 sex-/age-/body mass-matched elderly (CONo: 57±6 a, 26±3 kg/m 2 ) and 11 younger controls (CONy: 27±2 a, 23±2 kg/m 2 ). Phosphodiester content (PDE), ATP synthetic flux (fATP) and IMCL were assessed with 31 P/ 1 H magnetic resonance spectroscopy, insulin sensitivity was determined via hyperinsulinemic-euglycemic clamp tests (M-value). PDE was ~31% lower in CONy than in overweight CONo and T2DM (T2DM: 2.8+/-0.2, CONo: 2.5+/-0.2, CONy: 1.8+/-0.1 mmol/l, P=0.002) despite comparable muscle lipid contents. M was lower in diabetic patients (-35% vs. CONo, -56% vs. CONy; P<0.05). T2DM had ~37% lower fATP than CONy (8.6±2 vs. 11.8±3μmol.g -1 muscle.min -1 ; P <0.05, CONo (10.4±3). PDE related negatively to M (r=-0.620, P<0.001) and fATP (r=-0.371, P<0.05), and positively to age (r=0.610, P<0.001), BMI (r=0.672, P<0.001), HbA1c (r=0.672, P<0.001) and fasting plasma glucose (r=0.614, P<0.001), but did not relate to IMCL. PDE content of skeletal muscle strongly relates to insulin resistance, is increased in elderly and obese and does not depend on intramyocellular lipid contents. Oxidative status and homocysteine metabolism in occupational obese subjects Subjects with central deposition of adipose tissue show elevated cardiovascular morbidity and mortality. The pathogenic mechanisms leading to endothelial dysfunction could be due to Oxidative Stress, OS, (imbalance between Reactive Oxygen Species, ROS, and Total Antioxidant Capacity, TAC,) and hyperhomocysteinemia (HHcy), probably due to vitamin metabolism imbalance. Possible early vitamin B12 (B12) deficiency can be highlighted by holotranscobalamin, HoloTC, (bioactive cobalamin fraction), assay. To evaluate OS and homocysteine (Hcy) metabolism, an observational study was performed on 50 occupational obese subjects (12M/38F, aged 20-65, median 47 years; BMI 27.3-45, median 34.8 Kg/m 2 ; without traditional cardiovascular risk factors). Serum TAC and ROS levels were measured by spectrophotometric methods (Diacron International, Italy), serum B12 and HoloTC, serum and erythrocyte folate, plasma Hcy concentrations by immunoenzimatic methods (AxSYM, Abbott Diagnostics, USA), lipid panel and inflammatory parameters by routine methods. Data are expressed as median and IQR and analysed using Pearson's correlation coefficient. Forty % of cases showed mild HHcy (12.5 micromol/L, 11.5-16.0). All subjects showed adequate serum and erythrocyte folate levels, but HoloTC values revealed cobalamin deficiency in 22% of cases not congruent with B12 concentrations low only in 8%. Study population showed OS having normal mean TAC values (383 micromolHClO/mL, 359-415; reference value >350) but increased mean ROS concentrations (408 UCarr, 366-458; reference interval 250-300) in 92% of subjects. A significant (p=0.05) positive correlation was found between ROS and C Reactive Protein. Our results showed that obesity possibly increases the prevalence of HHcy, OS, and inflammation heightening the effects of classical risk factors. Blancher F, Membrez M, Jaquet M, Bibiloni R, Corthésy I, Mace K, Chou C Nestlé Research Center Gut microbiota has been shown to influence adiposity. However it is not clear whether gut microbiota is involved in the pathophysiology of type 2 diabetes. To address this issue, we modulated gut microbiota via antibiotic treatments and examined the diabetic phenotypes of diet-induced obese and insulin resistant (DIO) mice immediately after the treatments and after a 4-week washout period. Our data demonstrate that 2-week treatment with polymyxin B/neomycin (0.5 and 1.0 g/L) significantly altered the cecal microbiota profile and reduced the number of cecal Enterobacteria. The blood glucose concentration was also reduced by 6.2% in the treated DIO mice. Norfloxacin/ampicillin treatment (1.0 g/L each) drastically reduced cecal bacterial DNA concentrations below the limit of detection resulting in enhanced glycemic control with a 15.8% reduction in glycemia and improved glucose tolerance in the DIO mice. After the 4-week washout period, the pattern of cecal microbiota was similar to that observed at the end of antibiotic treatments, regardless of the combination of antibiotics. However, the beneficial effect of norfloxacin and ampicillin was restricted to a lowered fasting glycemia, while the mice previously treated with polymyxin B/neomycin showed further improvements in fasting glycemia and oral glucose tolerance. The continuous improvement in glycemic control was associated with the modulated intestinal microbiota rather than the food intake, body weights or body fat of the mice. In summary, our data indicate that treatment with the non-absorptive antibiotics polymyxin B/neomycin ameliorated glycemic control of DIO mice through a mechanism involved in gut microbiota modifications. The aim of this study was to provide a sequential analysis of the expression patterns of key genes involved in lipid metabolism in white adipose tissue (WAT) and liver and their relationship with blood parameters in response to fasting. Adult male Wistar rats were studied under different feeding conditions: feeding state, after 4, 8 or 24 h fasting, and after 3 h refeeding following 8 h fasting. Blood parameters and the expression (by RT-qPCR) of genes involved in lipogenesis and lipolysis in WAT and in liver were analysed. mRNA levels of genes involved in lipogenesis in liver (SREBP1c, FAS and GPAT) had already decreased after 4 h fasting, as well as those of PPARgamma in WAT, while the decrease in SREBP1c, FAS, GPAT and GLUT4 mRNA levels in WAT was observed after 8 h. Concerning lipolytic genes, liver PPARalpha and CPT1 mRNA levels increased after 8 h fasting and those of ACOX1 after 24 h, and in WAT, only ATGL and CPT1 mRNA levels were greater after 24 h. 3 h refeeding increased the expression levels of PPARgamma in WAT, SREBP1c in both liver and WAT, and GPAT in liver, and decreased the expression levels of PPARalpha and CPT1 in liver. These results give new insight into the different adaptive time course response to food deprivation in the expression of genes involved in the lipid metabolism, thus pointing out the very rapid response of lipogenic genes, particularly in liver, and the later response of lipolytic genes, particularly in WAT. Blunted metabolic response to fasting in obese mice. 1 Ueno N, 2 Asakawa A, 2 Inui A The aim of the study was to evaluate metabolic changes in response to fasting in normal and obese mice. C57BL6 and obese (diet-induced obesity (DIO) and ob/ob) mice were used in this study. They were fasted for 24 hours and re-fed for 24 hours. Body weight was monitored before, after fasting and during re-feeding (2 and 24 hours after re-feeding). Food intake was measured 2 and 24 hours after re-feeding began. Blood samples were taken before and after 24 hours fasting. As metabolic parameters, blood glucose, plasma insulin, ghrelin levels and oxygen consumption were measured. Blood glucose and plasma insulin levels in DIO and ob/ob mice were higher than normal mice, and plasma ghrelin levels were lower in DIO and ob/ob mice. There was reduced body weight loss in DIO mice than in normal mice for 24 hours fasting. When they were re-fed, DIO and ob/ob mice consumed less food intake than normal mice. 24 hours food deprivation induced significantly smaller plasma ghrelin elevation in these obese mice. Fasting-induced decrease in oxygen consumption was significantly smaller in DIO and ob/ob mice than normal mice. This data shows that obese mice may have decreased sensitivity to fasting-induced increase in circulating ghrelin and their oxygen consumption exhibited a blunted response to fasting. Ding Q 1 , Kirkby G 1 , Ash C 2 , Mracek T 1 , Merry B 2 , Bing C 1 1 Obesity Biology Unit, School of Clinical Sciences, University of Liverpool, Liverpool, UK 2 School of Biological Sciences, University of Liverpool, Liverpool, UK Ageing is associated with accumulation of body fat and the development of insulin resistance. White adipose tissue (WAT) emerges as an important organ in controlling lifespan. Caloric restriction (CR) delays the rate of ageing, which may be modulated partly by altering the amount and function of WAT. This study examined whether CR alters WAT cellularity, and whether CR affects expression of genes involved in lipid metabolism, including adipose triglyceride lipase (ATGL), adiponectin and its receptors (AdipoR1 and AdipoR2) in WAT and adipocytes. Epididymal WAT was dissected from male Brown Norway rats that had undergone CR (55% of ad libitum intake) for 4 months or been fed ad libitum. Adipocytes were isolated from WAT following collagenase digestion. The morphometric analysis of adipocytes was performed. Gene expression was quantitated by real-time PCR. Circulating FFA, glycerol and adiponectin levels were determined using commercial kits. CR markedly reduced epididymal fat mass (-42%), adipocyte diameter (-17%) and sectional area (-33%). CR led to an increase in ATGL mRNA levels in both WAT and adipocytes (>2-fold), which was paralleled by a 2-fold rise in plasma FFA and glycerol, respectively. Adiponectin mRNA levels were elevated in both WAT and adipocytes (>2-fold) as were circulating adiponectin (2.5-fold) in CR rats. However, CR had no effects on AdipoR1 and AdipoR2 expression at tissue or cell level. It is concluded that CR reduces fat mass and lipid storage in WAT. These changes might result from increased lipolysis in WAT and enhanced adiponectin production to stimulate lipid utilization in other tissues. Funding: Research relating to this abstract was funded by the University of Liverpool R&D Fund, the BBSRC and Unilever R & D, Colworth. 1 Istituto Superiore di Sanità, Rome, Italy 2 Fabia Mater Clinic, Rome, Italy 3 University of Rome "La Sapienza", Rome, Italy Oxidative stress induces insulin-resistance by reducing the response of adipocytes to insulin, consequently affecting their functionality. Obesity is associated with insulinresistance and increased plasma oxidized-LDL. The aim of this study was to evaluate the effects of oxidized-LDL on the sensitivity of human omental adipocytes to insulin stimulation, by evaluating the glucose uptake. Human adipocytes were isolated from omental biopsies obtained from individuals undergoing abdominal surgery for benign conditions. Briefly, adipose biopsies were digested with Krebs-Ringer solution containing collagenase (1mg/g adipose tissue) for 1h at 37°C. The isolated cells were characterized by Oil Red O staining and mRNA expression of leptin and adiponectin. Moreover the expression of Pref-1 was determined to detect possible pre-adipocyte contamination. After 24h, the cells were serum starved for 3h with or without 0.1 mg/ml native-or oxidized-LDL, and incubated with 0.1μM insulin for 30 min. Glucose uptake was measured by 2-deoxy-D- [H 3 ] glucose. The isolated adipocytes showed a mature phenotype and a high sensitivity to insulin stimulation as demonstrated by the 100% increase of glucose uptake with respect to un-stimulated cells. In cells treated with native-LDL the uptake was comparable to that of control cells. On the contrary, the treatment with oxidized-LDL resulted in a marked decrease (-40%) of insulin-induced glucose uptake. This result did not depend on cytotoxicity as demonstrated by the [ 3 H]uridine incorporation which was comparable in treated and control cells. Oxidized-LDL may contribute to insulin-resistance in human omental adipocytes by decreasing the uptake of glucose. These results suggest a close relationship among obesity, increased oxidized-LDL and insulin-resistance. Funding: Research relating to this abstract was partially funded by ISS/NIH 530F/0F18 Effects of trans-10,cis-12 conjugated linoleic acid on body fat accumulation and lipogenic enzyme expression in adipose tissue: a comparative study between young and adult hamsters Miranda J, Churruca I, Fernández-Quintela A, Rodríguez V, Macarulla MT, Simón E, Portillo MP The effectiveness of the trans-10,cis-12 conjugated linoleic acid (CLA) isomer as a body fat-lowering agent can be affected by several factors such as animal species, sex and age, diet composition and treatment period length. The purpose of the present work was to compare the effects of this CLA isomer on body fat accumulation, as well as on lipogenic enzyme expression, between young and adult hamsters, in order to determine the influence of age. Young (9-week-old) and adult (8-month-old) male Syrian Golden hamsters were divided into four groups (n=8) and fed high-fat diets containing 0.5% linoleic acid (control groups) or 0.5% trans-10,cis-12 CLA for 6 weeks. Perirenal (PR), epididymal (EP) and subcutaneous (SC) adipose tissues were dissected and weighed, and acetyl CoA carboxylase (ACC) and fatty acid synthase (FAS) expressions were measured by RT-PCR in SC depot. Young hamsters fed the CLA-enriched diet showed a significant decrease in adipose tissue weight from all the anatomical locations analyzed (PR: -29%; EP: -21%; SC: -29%). In contrast, in adult animals only SC adipose tissue was significantly reduced (-28%) . No CLA effect on lipogenic enzyme expression was observed. Although a tendency towards reduced expression of lipogenic enzymes was found in adult hamsters when compared with young hamsters, the difference did not reach statistical significance. These results show that CLA induced body fat reduction is greater in young than in adult hamsters, suggesting that aging reduces trans-10,cis-12 CLA effectiveness. This difference was not due to a differential effect on lipogenic enzymes. Dipartimento di Scienze della Vita, SUN Aim: High fat diet (HFD) is associated with the development of steatosis and insulin resistance. Recent evidences suggest that 3,5-diiodo-L-thyronine (T2), a naturally occurring iodothyronine, when administered to HFD fed rats, prevents steatosis. However, studies on T2 effects on insulin resistance and oxidative stress, which is known to be involved in insulin resistance and liver steatosis, are still lacking. In the present research, we detected the ability of T2 to improve HFD-induced impaired glucose tolerance, liver steatosis and oxidative stress. Methods: Three groups of rats were used: control rats receiving standard diet (N), rats receiving HFD (D), rats receiving HFD and a daily i.p. injection of T2 (25μg/100 g b.w.) (DT2). The experimental period lasted 4 weeks. Oral glucose tolerance test was performed after 16 hours fasting. In liver mitochondria, aconitase activity, as an index of mitochondrial oxidative stress, and fatty acid oxidation rate were detected. Results: D rats showed decreased glucose tolerance and elevated plasma insulin, while DT2 rats were characterized by improved glucose tolerance. The livers of D rats were lighter in colour than DT2 livers, suggesting that they contained more fat. At the hepatic level, mitochondrial fatty acid oxidation rate progressively increased in N, D and DT2 rats. When compared to N, D rats showed an increase in oxidative stress which was prevented by T2 treatment. Conclusions: T2 improved HFD-induced impaired glucose tolerance as well as prevented liver steatosis by activating mitochondrial fatty acid oxidation rate and decreasing oxidative stress. Research relating to this abstract was funded by MIUR-COFIN 2006 2006051517 S55 T1:PS.78 Caimari, A, Oliver, P, Palou A Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics), University of the Balearic Islands (UIB), Palma de Mallorca; and CIBER Fisiopatología Obesidad y Nutrición (CB06/03), Instituto de Salud Carlos III, Spain Adipose triglyceride lipase -ATGL-(also known as desnutrin) is a citoplasmatic protein which is mainly expressed in adipose tissue and has lipase activity, hydrolyzing triacylglycerols to diacylglycerols, acting together with the hormone-sensitive lipase in the process of lypolysis. ATGL mRNA levels are regulated by the nutritional status, being induced after fasting. We have studied possible differences in ATGL expression in different white adipose tissue depots and in brown adipose tissue of Wistar rats of different ages (1, 3, 5, 7 and 13 months) , distributed in a control and a 14 h-fasted group. The different adipose tissue depots studied express different amounts of ATGL, with the highest levels found for all the ages in the brown adipose tissue in comparison with the white fat. Fasting up-regulates ATGL expression only in white adipose tissue and, moreover, this up-regulation is lost with age, contributing to an increased difficulty for mobilizing lipids in older animals in response to a nutritional stress as is fasting. However, and despite the high levels found in brown fat, ATGL expression is not affected by fasting at any of the ages studied in this tissue. This fact has not been previously reported and would indicate a different regulation for ATGL in brown fat, independent of feeding conditions. In overweight rats oleoyl-estrone and rosiglitazone exert opposite changes in white adipose tissue lipid handling and regulation Ferrer-Lorente, R 1 , Cabot, C 1, 2 , Fernández-López, JA 1, 2 , Alemany, M 1, 2 , Remesar, R Thiazolidinedione treatment often results in redistribution and/or increase in body fat whilst improving insulin resistance. Oleoyl-estrone (OE) treatment also enhances insulin sensitivity, but its main effect is to deplete body lipid stores. We compared the effects of rosiglitazone (RG) or OE, alone or in combination, on different white adipose tissue (WAT) sites in order to gain insight into the mechanism of action of OE and to study ways to limit thiazolidinedione-induced increases in body fat. Four groups of overweight male Wistar rats were used for a 10-day treatment: Controls (C), OE-treated (OET), RG-treated (RGT), and combinated OE plus RG treatment (RG+OET); After sacrifice, ventro-lateral strips of subcutaneous (S), epididymal (E), retroperitoneal strip (R), and mesenteric (M) WAT pads were dissected and used for semiquantitative real time PCR measurement of specific mRNAs concentrations in WAT. In the four sites tested, OE markedly decreased the expression of GLUT4, adiponutrin, fatty acid synthase and acetyl-CoA carboxylase; It also decreased the expression of lipoprotein lipase, SREBP1c, C/EBPalpha, C/EBPbeta and PPARgama1 when considering all WAT. RG elicited an increase in the expression of fatty acid synthase, acetyl-CoA carboxylase and adiponutrin in the four sites and induced global increases in the expression of GLUT4, lipoprotein lipase, PPARgamma1 and PPARgamma2. OE and RG show a widely different pattern of change in WAT energy metabolism and regulatory indicators' gene expression. The results hint that OE induced a marked depression in WAT metabolic activity and decrease adipogenesis while the RG effects on rats were practically the reverse. Insulin resistance and body composition in pre and post-menopause women with or without overweight Mascarenhas M R 1,2 , Camolas J 2,3 , Vieira J 3 , Rodrigues I 3 , Carvalho M R 3 , Colaço D 3 , Baião A 3 , Duarte D 2 , Conceição C 2 , Pinto D S 2 , Bicho M 1 , do Carmo I 3 Oleoyl-estrone (OE) decreases food intake without changes in energy expenditure; the energy gap is fulfilled by stored lipid mobilization. OE decreases circulating cholesterol, the effects being more marked in hyperlipidemic obese rats. Three groups of overweight male Wistar rats were used: controls (C), OEtreated (OEt) and pair fed (PF). All received a daily oral gavage of 0.2 mL of sunflower oil, supplemented in OEt with 10 nmol/g OE. The PF were given only the food consumed by OEt. Plasma cholesterol, liver DNA and mRNA were measured; tissue RNA was used for the analysis of the expression of key enzymes of liver cholesterol metabolism. Plasma cholesterol was halved in OEt and unchanged in PF. Pair-feeding reduced the expression of 3-HMGCoA synthase and the LDL receptor; but cholesterol synthesis was not affected by OE, nor was the expression of LCAT in all groups. Cholesterol disposal for bile acid synthesis was increased in PF and OE rats, as shown by the expression of cholesterol 7 -hydroxylase, suggesting the activation of cholesterol disposal. Reverse cholesterol transport was enhanced in OEt because of increased expression of apoA, apoE and ABC transporter A1. In conclusion, the active disposal of cholesterol by the liver helps explain its marked effects on cholesterol handling, which can not be attributed to decreased energy intake. This study was supported by grants from the "Fondo de Investigaciones Sanitarias" and "Plan Nacional de Investigación en Biomedicina", from the Government of Spain. Adiponectin, an adipokine produced exclusively by adipocytes, exerts antiinflammatory effects on macrophages. It suppresses the production of proinflammatory cytokines in response to bacterial lipo-poly-saccharide (LPS). We have shown that the anti-inflammatory effect of adiponectin is more complicated than previously thought and involves induction of macrophage tolerance. More specifically, in the THP-1 human macrophage cell line, in primary mouse peritoneal macrophages and in primary human peripheral macrophages that have not been pre-exposed to adiponectin, exposure to globular adiponectin (gAd) induces TNF-alpha and IL-6 secretion. However, pre-exposure of macrophages to 10 microg/ml gAd renders them tolerant to further gAd exposure or to other pro-inflammatory stimuli such as TLR3 ligand polyI:C and TLR4 ligand LPS, while pre-exposure to low levels of gAd was ineffective in inducing tolerance. We further investigated the mechanism involved in adiponectin-mediated macrophage tolerance. We have found that adiponectin inhibits the TLR signalling pathway. More specifically, gAd induces IRAK-M expression in macrophages both at the protein and the mRNA level. Homologous deletion of IRAK-M partly abolished the tolerogenic effect of gAd since pre-treatment of IRAK-M -/-macrophages with gAd did not suppress LPS-induced pro-inflammatory cytokine production. In conclusion, our data suggest that the constant presence of high levels of adiponectin in the blood of lean subjects renders their macrophages resistant to pro-inflammatory stimuli, including that of adiponectin itself via regulation of IRAK-M expression. Increased hepatic IRS-2 expression and absence of hepatic steatosis in TNF-KO mice fed high-fat (HF) diet for 4 wk. Asarian, L, Koss, M., Bouter, B, Geary, N, Langhans, W. ETH-Zurich, 8603 Schwerzenbach, Switzerland. Prolonged HF feeding gradually leads to whole-body insulin resistance. TNF-deficiency has been shown to protect against this effect in several models, although the mechanism is unclear. We therefore investigated whether genetic TNF-deficiency affects fat deposition and intracellular insulin signaling in liver and adipose tissue in TNF-KO and wild type (WT) mice fed chow (CH) or HF (60% energy) diet. After 4 wk HF diet access we measured plasma glucose, insulin, leptin and resistin levels after 12-h fasts or 3-h re-feeding, body adiposity and liver fat content, and hepatic PI3K, SOCS3, IRS-2 and PPARg expression. TNF-deficiency had no effect on body adiposity, which increased more in HF than CH mice. KO HF mice had improved insulin sensitivity and lower fed and fasted leptin levels than WT HF mice. Resistin levels were lower in KO vs. WT mice regardless of diet. Liver fat content was increased 3 fold in WT vs. KO HF mice, and the latter was similar to CH mice. Liver fat pad IRS-2 expression was 60 % higher in KO vs. WT HF mice. No other downstream genes were affected in the liver. These results suggest that genetic TNF-α deficiency protects against the development of insulin resistance elicited by 4 wk of HF feeding by (a) up-regulation of IRS-2 in the liver, which prevents downstream insulin signaling failure and hepatic steatosis; (b) preventing the expected increase in leptin levels, probably via a non-insulin dependent mechanism; and (c) diet-independent maintenance of low resistin levels. The 2-keto(1-13 c)isocaproate breath test in obese subjects is associated with the sirtuins gene expression in peripheral blood mononuclear cells (pbmc). Improvement of insulin sensitivity following weight loss does not affect the reduction of total and high molecular weight adiponectin levels induced by hyperinsulinemia. Drapeau, S 1 , Doucet, É 1 , Rabasa-Lhoret, R 2 , Brochu, M 3 , Prud'homme, D 1 and Imbeault, P 1 1 University of Ottawa, Ontario, Canada; 2 University of Montreal, Québec, Canada; 3 University of Sherbrooke, Québec, Canada Weight loss with or without exercise is associated with improvement in insulin sensitivity (IS) and increased levels of total and high molecular weight (HMW) adiponectin in obese individuals. Acute hyperinsulinemia, on the other hand, correlates with reduction of total and HMW adiponectin. To clarify the inhibitory role of insulin on adiponectin, total and HMW adiponectin levels were measured during acute hyperinsulinemia before and after weight loss. Fifty-five postmenopausal women were randomized to either a 6 month caloric restriction alone (CR, n = 28) or CR with resistance training (CR-RT, n = 27). Body composition (DEXA) and IS (hyperinsulinemic euglycemic clamp) were assessed before and after weight loss. Total and HMW adiponectin levels were measured by ELISA at baseline, 60, 160 and 180 minutes of each clamp. Relative mean body weight loss was 7.8% for both groups (CR: -7.7± 0.7%, CR-RT: -7.9 ± 1.0%). IS increased significantly by 11.3% (CR: 9.4 ± 6.3%, CR-RT: 13.2 ± 4.7%). Before each intervention, total and HMW adiponectin levels in both groups significantly decrease in response to hyperinsulinemia (total: 7.8± 2.5% vs HMW: 2.6 ± 1.6 %). Despite the improvement in IS seen after each intervention, a similar pattern of reduction in total and HMW adiponectin levels was observed during hyperinsulinemia. Taken together, these results attest that total and HMW adiponectin levels are reduced during hyperinsulinemia. Also, the insulin-sensitizing effect of weight loss via caloric restriction alone or with resistance training does not alter adiponectin level reduction observed during hyperinsulinemia. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix associated with inflammation in human obesity Henegar, C 1,2 , Tordjman, J 1,2 , Lacasa, D 1,2 , Achard, V 1,2 , Guerre-Millo, M 1,2 , Poitou, C 1,2,3 , Basdevant, A 1, 2, 3 , Stich, V 4 , Viguerie, N 5, 6 , Langin, D 5, 6 , Zucker, JD 1, 7 Investigations performed in mice and humans have acknowledged obesity as a low-grade inflammatory disease. Several molecular mechanisms have been convincingly involved in activating inflammatory processes and altering cell composition in white adipose tissue (WAT). However, the overall importance of these alterations, and their long-term impact on the metabolic functions of the WAT and on its morphology, remain unclear. We analyzed the transcriptomic signature of the subcutaneous WAT in obese human subjects, in stable weight conditions and after weight loss following bariatric surgery. An original integrative functional genomics approach was applied to quantify relations between relevant structural and functional themes annotating differentially expressed genes, to construct a comprehensive map of transcriptional interactions defining the obese WAT. These analyses highlighted a significant up-regulation of genes and biological themes related to extracellular matrix (ECM) constituents, including members of integrins family, and suggested that these elements could play a major mediating role in a chain of interactions which connects local inflammatory phenomena to the alteration of WAT metabolic functions in obese subjects. Tissue and cellular investigations, driven by the analysis of transcriptional interactions, revealed an increased amount of interstitial fibrosis in obese WAT, associated with an infiltration of different types of inflammatory cells, and suggested that phenotypic alterations of human preadipocytes, induced by a proinflammatory environment, may lead to an excessive synthesis of ECM components. Our study opens new perspectives in understanding the biology of human WAT and its pathologic changes indicative of tissue deterioration, associated with the development of obesity. Funding: Research relating to this abstract was funded in part by the HEPADIP project (contract no. 018734). Expression of adipocytokines in adipose tissue of obese type 2 diabetic subjects before and after major weight reduction . Adiponectin (APM1) and visfatin have been linked with obesity in opposite manner. We examined the effect of weight-loss on the APM1, its receptors (AdipoR1 and AdipoR2) and visfatin expression in abdominal subcutaneous adipose tissue (SAT) of morbidly obese subjects with or without diabetes. In 10 obese non-diabetic subjects (NGT) and 10 obese diabetic patients (DM2), SAT tissue was obtained during bariatric surgery and again one year after surgery. mRNA relative quantifications of APM1, AdipoR1, AdipoR2 and visfatin were performed by RT-PCR. After surgery, BMI was reduced in NGT and DM2 subjects (-15.9±3.6 and -15.9±6.1 kg/m 2 , respectively, p<0.0001). Fasting plasma insulin was reduced in both groups (-15.3±11.3 and -13.1±9 .4 μU/ml, p<0.01). Fasting plasma glucose was reduced in DM2 only (-2.9±1.6 mmol/l, p=0.001). Following weight loss, plasma adiponectin increased in both groups (+4.72±3.29 and +6.56±4.92, p=0.0003, respectively), APM1 did not change in NGT, (3.83±1.25 vs 4.08±2.01, p=ns), whereas it increased in DM2 (2.69±1.32 vs 4.77±1.26, p=0.0035). AdipoR1 was not changed by weight loss in either group (3.49±1.18 vs 2.83±0.98 and 2.73±1.29 vs 2.89±2.89 respectively, p=ns); this was also true of AdipoR2 (4.92±2.84 vs 3.88±1.7 and 4.18±3.02 vs 3.76±1.3 respectively, p=ns). Conversely, visfatin expression decreased both in NGT (2.12±1.15 vs 1.02±0.27, p=0.008) and DM2 (3.09±2.56 vs 1.02±0.24, p=0.028) after weight loss. We conclude that, whereas adiponectin receptor expression is not altered following weight loss, visfatin expression in subcutaneous fat falls markedly with weight reduction. In addition, adiponectin expression increases in weight-reduced diabetic subjects, possibly contributing to their improved insulin sensitivity. Wu, JS 12 , Lu, FH 12 , Yang, YC 12 , Lin, TS 3 , Huang, YH 2 , Wu, CH 2 , Chen, JJ 4 , Chang, CJ 12 1 Dietary lipids influence the composition of adipose tissue, the aetiology of obesity, and the development of obesity-related pathologies such as chronic inflammation. The aim of this study was to examine the effects of the major saturated fatty acids found in coconut and palm oil on the expression of key inflammation-related genes (IL-6, adiponectin) in human adipocytes. Coconut and palm oils are rich in capric (10:0), lauric (12:0) and myristic (14:0) fatty acids; palmitic acid (16:0) is found in palm oil, and in meat and dairy products. Methods: SGBS adipocytes were treated after differentiation with 250 μM capric, lauric, myristic or palmitic acids. Further sets of cells were used for time-course and dose-response studies on the effects of lauric acid. Results: IL-6 mRNA level was increased by incubation (24 h) with myristic, lauric and palmitic acids, the largest effect being with lauric acid. IL-6 gene expression in response to lauric acid was increased in a dose-dependent manner (from 125 μM) and was very rapid (within 2 h of treatment). Adiponectin gene expression was increased by treatment with 250 μM myristic acid, but decreased by lauric and palmitic acids. Adiponectin expression in response to lauric acid was decreased in a dose-dependent manner (from as low as 50 μM); it was also rapid, occurring by 4 h. Conclusion: High levels of lauric and palmitic acid, as found in diets rich in coconut and palm oil, may induce an inflammatory state in adipose tissue and impair glucose homeostasis. Funding: This research was partially funded by CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Ministério da Educação, Brazil). Adiponectin is known to be protective against the development of insulin resistance and atherosclerosis. The aim of the study was to evaluate the relationship between the SNP45T>G polymorphism of adiponectin gene (exon2) and adiponectine and insulin levels and lipid parameters in obese versus non obese subjects. Subjects and methods: the study concerned 112 obese subjects and 74 non obese controls. All subjects underwent a clinical examination, biological investigations (basal ad two hours blood glucose and insulinemia, adiponectin, total cholesterol, HDLc and triglycerides) and a genetic study of the adiponectin gene. Results: adiponectin levels were significantly lower in obese vs non obese (4.4 ±0.95 vs 8.7±1.54μg/ml, p<0.001). We noted a higher frequency of the genotype GG in obese vs non obese subjects (8.1 vs 4.0%, NS), a significantly higher basal and two hours insulinemia in GG compared to TG and TT genotypes. There was no significant relationship between the polymorphism of SNP45T>G and HDL cholesterol levels. Conclusion: SNP45T>G polymorphism is associated with obesity and hyperinsulinemia in Tunisian population. Visfatin is a newly discovered adipokine found in abundance in visceral fat... Recent studies indicated that visfatin is one of the inflammatory cytokines as it is known for leptin. Obesity is associated with a low-grade inflammation of white adipose tissue resulting from chronic activation of the innate immune system which can subsequently lead to insulin resistance and diabetes. It is still not clear role of acquired immune response in obesity and related comorbidites such as asthma, cancer or autoimmune diseases. The aim of our study was to assess the association between visfatin and leptin levels in circulation and IL-17, IL-23 and MIF (macrophage migration inhibitory factor). In that order, thirty obese women (BMI =35.59±0.83 kg/m 2 , age=35.53±1.59 yrs) 15 healthy control women (BMI=20.43±0.66 kg/m 2 , age=27.87±0.77 yrs) were included in the study. In each of the investigated subjects, following parameters were measured: Visfatin (EIA Phoenix, ng/ml), Leptin (Linco RIA, ng/ml), circulating Il-17, IL-23 and MIF (macrophage migration inhibitory factor, pg/ml). In separate subgroups (obese and control nonobese women) there was no correlation among investigated parameters except between leptin and BMI (r=0,612, p<0.001). In all investigated women (obese + nonobese) using Spearman's correlation analysis significant positive correlation was found between leptin levels and BMI (r=0.844 p<0.001), leptin and p<0.02 ) and between Il-17 and IL-23 (r=0.506, P<0.05). There was no significant correlation between visfatin and BMI, leptin, IL-17, IL-23 and MIF, , respectively. According our results leptin seems to be a better marker of inflammatory state than visfatin in obese women. Positive correlation between IL-17 and BMI suggests further investigation in order to elucidate relationship between acquired immunity and obesity and obesity-related disorders. Obese adults have raised levels of circulating inflammatory markers, which may contribute to the development of diabetes and cardiovascular disease; however, results from studies in children are conflicting. In this study we measured inflammatory markers in a longitudinal cohort of lean and overweight healthy children, aged 7 and 14 yrs. In 1996, 103 (54 males) children were recruited from western Sydney at baseline (7.9 ± 0.6yrs) and at follow-up 7 years later (14.9 ± 0.2yrs). At both time periods, height and weight were measured and serum interleukin (IL)-6 & IL-8 levels determined. Overweight (owt) and obesity (ob) were defined using the International Obesity TaskForce criteria. Preliminary results show no significant differences in IL-6 (pg/ml) between owt/ob children and lean children at baseline [owt/ob (n=20) median (interquartile range)=2.27 (0.92-3.83); lean (n=60) =1.99 (1.14-3.46)] and follow-up [owt/ob (n=32)= 8.99 (7.85-11.43); lean (n=47)=8.51 (8.18-9.77)]. Similar findings were seen for IL-8 (pg/ml) at baseline [owt/ob (n=20)= 17.3 (8.7-21.7); lean (n=78) =12.6 (8.6-21.7)] and follow-up [owt/ob (n=37)= 23.2 (15.0-29.8); lean (n=65) =20.7 (13.2-27.7)]. There were no correlations between IL-6 and 8 levels and BMI z score at baseline or follow-up. In contrast to findings in adult studies, this study did not show higher levels of pro-inflammatory cyokines in owt/ob children compared to lean children. Obesity-associated inflammation may exhibit different responses from childhood to adulthood. Funding related to this abstract was funded by a Diabetes Australia Research Trust 2007 grant. CST is on a NHMRC/NHF co-funded Biomedical Postgraduate Scholarship The +45 T/G variant in adiponectin is associated with obesity in women. Adiponectin is an adipocytokine which has been implicated in the pathogenesis of obesity and type 2 diabetes. Several association studies have already found SNPs in this gene to be associated with BMI. We set out to perform an association study with SNPs spread throughout the APM1 gene to see whether this gene is also involved in the development of obesity in our population. Six haplotype tagging SNPs were genotyped in 223 premenopausal obese women and 87 female controls. After comparison of the allele frequencies between patients and controls, it was clear that the SNP45 wild-type T allele was more common in patients (89% vs 82 %, p = 0,011). The calculated OR was 1,87 with p = 0,011. None of the other genotyped SNPs showed an allele frequency difference between cases and controls. When looking at haplotypes, we saw that the SNP45/SNP712 haplotype was also significantly associated to obesity in our population (p = 0,004). In order to identify the causative SNP, we performed resequencing on 96 individuals. Resequencing of exon 2, exon 3 and intron 2 did not reveal any SNPs in high LD with SNP45. Therefore, we conclude that SNP45 itself is responsible for the observed association. In conclusion, we found SNP45 T/G in the APM1 gene to be significantly associated to obesity in Belgian women. Further functional studies are necessary to elucidate the effect of this SNP on the adiponectin signaling pathway. Funding: This study was supported by a BOF-grant from the University of Antwerp to LVG and WVH and by a grant from the FWO-Flanders (G.0028.05) to LVG and WVH. SB holds a specialization scholarship from the "Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)". Fasting proinsulin and leptin were measured before and after 3 months of orlistat therapy (120mg tid). No other treatment of POS was performed. Results: Compared with controls (healthy age-matched women without POS; mean normal proinsulin values=0.7-6.0pmol/l), proinsulin levels before treatment were significantly increased irrespective of weight: with normal weight 13.9±1.9pmol/l, in overweight 14.1±2.3, in obese 21.3±5.8. After treatment, proinsulin decreased significantly in all groups: 8.5±1.2; 8.1±1.2 and 6.9±1.3, respectively (p<0.05). Leptin concentrations before treatment were significantly decreased in all groups (normal control values=2.9-5.0μg/l): with normal weight 2.1±0.6μg/l, in overweight 1.8±0.6, in obese 2.1±0.2. After treatment, leptin increased significantly in the normal weight group 3.6±0.2μg/l (p<0.05), and in the 2 other groups there was a non-significant increase: 2.4±0.9 and 2.7±1.3, respectively. In most (16) patients in each of the 3 groups menstrual cyclicity and ovulatory cycle restoration were observed. In addition, pregnancy occurred in one overweight woman. Conclusion: In POS, proinsulin is increased and leptin is decreased independently of BMI. Orlistat 120mg is effective in the improvement of these changes and is a useful adjunct in POS treatment. Funding: Research relating to this abstract was funded by F.Hoffmann-La Roche Ltd. Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver disease. Obesity is an independent risk factor for non-alcoholic fatty liver disease (NAFLD) . The presence of NAFLD may be linked with further increased cardiovascular risk. We hypothesise that altered clot kinetics and platelet function exist in NAFLD and are associated with obesity and its metabolic consequences. This study compared whole blood clotting kinetics in patients with 1) NAFLD (n=28); 2) obese controls without NAFLD (n=27); and 3) lean healthy controls (n=22). Methods: Clotting kinetics were assessed in whole blood using thromboelastography (TEG) . Results: Clot kinetics in patients with NAFLD showed significantly greater clot strength (maximum amplitude (MA); 58.3 ± 6.3mm vs. 52.0 ± 10.1mm, p=0.01) and reduced clot lysis in the presence of t-PA (35 ± 30% vs. 51 ± 26% clot lysis 30 minutes after MA, p=0.03) compared to lean controls. Clot strength was independently associated with body mass index in NAFLD, but not in lean subjects. There was a greater platelet contribution to clot strength in patients with NAFLD compared to lean controls despite similar platelet counts. Conclusion: Patients with NAFLD have disturbances in ex-vivo clot kinetics including increased clot strength and clots that are more resistant to t-PA-stimulated lysis. Changes to clot kinetics in NAFLD are platelet-dependent and not related to the severity of liver injury but rather to the degree of obesity. Oleoyl-estrone (OE) increases glucocorticoids and has no significant estrogenicity. In rodents, limited sample size and high cross-reactivity hampers the multiple measurement of steroid hormones through RIA. Application of HPLC-MS/MS methods, using deuterated internal standards solves the problem. Overweight male Wistar rats were treated with 0.2 mL sunflower oil alone or containing 10μmol/kg/day OE. Plasma samples were supplemented with deuterated standards and then extracted with two sets of organic solvents and analysed by HPLC-MSMS. To measure estrogen levels, samples were previously derivatized with dansyl chloride in acetone. OE increased two-fold the basal levels of corticosterone, while dehydrocorticosterone levels increased in a lower proportion, raising their ratio from 9.8 to 11.4. Progesterone levels were under the limit of detection of the method. OE induced a dramatic decrease of both testosterone and androstenedione. Finally, OE increased basal estradiol and estrone levels by factors of x2.2 and x4.4, respectively. The increase in glucocorticoids agrees with their counter-regulatory effect on OE action. The excess of available estrone due to OE hydrolysis in tissues, is essentially converted to estrone sulphate, but part of the estrone is also converted to estradiol through the 17HSDH activity, which the relatively low estradiol suggests is inhibited by OE. This postulated inhibition results in the dramatic decrease in androgens. We can conclude that OE action on testosterone and estradiol is probably a consequence of its effect on 17HSDH, probably the result of a protective mechanism against massive estrogenization brought upon by the high estrone availability. This study was supported by grants from the "Fondo de Investigaciones Sanitarias" and "Plan Nacional de Investigación en Biomedicina", from the Government of Spain Adiponectin and resistin are two adipose secreted signals with apparently different, opposite functions regarding the control of insulin sensitivity. We aimed to study the sex-dependent response of adiponectin and resistin adipose tissue expression and circulating levels in the onset of dietary obesity. Male and female 4-week old Wistar rats were fed a control or cafeteria diet for 15 days. Body weight and energy intake were monitored. Gonadal (visceral), retroperitoneal (visceral) and inguinal (subcutaneous) white adipose tissue (WAT) depots were collected. Serum adiponectin and resistin and tissue mRNA levels were analyzed by Western blot and RT-PCR respectively. Serum levels of insulin, Tumour Necrosis Factor (TNF) alpha, and glucose were measured by ELISA and a glucose sensor. Insulin resistance was assessed by the homeostasis model assessment (HOMA). Upon cafeteria diet, there was a higher increase in visceral than in subcutaneous fat, especially in females. The effective production of adiponectin and resistin (total levels adjusted per WAT weight) was decreased in the cafeteria groups (more markedly in females for adiponectin) associated with the tendency to lower WAT mRNA levels for resistin but not for adiponectin. Fasting glucose was slightly increased in cafeteria females. HOMA score was not significantly increased by cafeteria feeding, although it tended to be increased in few cafeteria females. Decrease of WAT adiponectin and resistin effective production seems an early response to obesity development under a high fat (cafeteria) diet, with sex-associated differences. This can probably be related with a physiological role of both adipokines modulating the insulin signalling system. Zhou, Yuan Ms 1 , Egeland, Grace PhD 1 , Kubow, Stan PhD 1 , and Nituuchischaayihitaau Aschii Study GROUP 1 School of Dietetics and Human Nutrition, McGill University, Montreal, Canada Emerging evidence shows that Δ5(C20:4 n6/ C20:3 n6), the key regulator in the synthesis of highly unsaturated long chain fatty acids (HUFA), is modulated by a variety of factors including adiposity, diet and diabetic condition. We explored the regulation of these factors and their interaction within a high risk Cree population in Quebec, Canada. Fasting blood was taken from adults (98 female, 68 male, 20-88 yr). Anthropometric and blood biochemical measures, including erythrocyte membrane fatty acids, were analyzed. Obesity is prevalent across age groups in both gender groups (BMI≥30: 20-29 yr 58.33%, 30-39yr 71.11%, 40-49 yr 82.76%, 50 yr+ 62.86%). An interaction was observed between fasting glucose status, adiposity and insulin resistance level HOMA. Body fat% is negatively associated with Δ5 at both normal fasting glucose (r= -.281, p<.01) and impaired fasting glucose (r= -.291, p<.05) . HOMA was negatively correlated with Δ5 activity (r= -.454 p<.001) and HUFA omega6 (r= -.228, p<.05) only at normal fasting glucose status. Surprisingly, age was positively associated with Δ5 at both normal and impaired fasting glucose status (r>.4, P<.001 for both), but it could be driven by exogenous HUFA since such a pattern was only seen in HUFA omega3 (r>.5, P<.001 for both) but not HUFA omega6 (P>.05 at normal fasting glucose). This study indicates that reduced consumption of fish brought about by dietary transition among younger Cree generations may compound the effects of obesity which could reduce bioavailability of HUFA omega3 (through reduced Δ5 activity) and thereby likely aggravate disease risk. Hillebrand, JGG, Koss, MD, Langhans, W, Geary, N ETH Zurich, 8603 Schwerzenbach, Switzerland In order to better understand the control of eating by adiposity, we investigated neuroendocrine changes associated with recovery from weight loss. Male Long Evans rats (~350 g) were fed 60% of baseline food intake for two weeks (RF), which produced a weight loss of 71 g vs. ad libitum fed (AL) rats and, when AL was reinstated, 10-14 d of compensatory hyperphagia as body weight renormalized. Expression levels of leptin receptor (lepR) were measured in the arcuate nucleus (Arc) and nucleus of the solitary tract (NTS) by qPCR, and plasma leptin levels by RIA. RF rats had reduced plasma leptin (2.7 ± 0.6 ng/ml) vs. AL control rats (8.4 ± 1.7 ng/ml). One d AL refeeding (RF-AL+1) increased RF rats' leptin to 5.2 ± 1.5 ng/ml, although they still weighed 48 g less than AL control rats. NTS LepR mRNA levels were reduced in RF-AL+1 rats vs. both RF and AL controls. Arc lepR levels were similar in all groups. These preliminary data suggest that 1) RF down-regulates leptin signaling in the Arc and NTS by reducing circulating leptin levels without changes in lepR expression, 2) weight-loss induced hypoleptinemia begins to normalize during the first day of compensatory hyperphagia, before normalization of body adiposity, 3) expression levels of NTS lepR, but not Arc lepR, are down-regulated by acute hyperphagia, and 4) reduced leptin signaling in the NTS, but not in the Arc, contributes to weight lossinduced compensatory hyperphagia on RF-AL+1. Background: One of the latest continues consciousness state monitoring methods during general anaesthesia is auditory evoked potentials (AEP) registration in the AAI (A-line Arx Index) scale. The MEDLINE database was searched electronically for articles for the period of 1980 through October 2007 and we did not find any rapport of AEP usage during bariatric surgery procedures. Patients and methods: Our group enclosed 15 patients (27-54 years, BMI-49±6 kg/m 2 ) prepared for bariatric surgery. The consciousness level measurement with AEP (AEP monitor/2 version 1, 61, Danmeter A/S, Denmark). Sedation was performed with propofol TCI (Target Controlled Infusion) 3-6 mcg/ml and analgesia with fentanyl. Servin's weight correction formula was adopted for propofol dosage maintenance. We evaluated: consciousness level -AAI scale, influence of muscular tone and surgical electrocoagulation on AAI, time to extubation and TCI value during extubation. Results: Level of AAI correlated with clinical depth of sedation and enabled to maintain proper dosage of propofol. The interdependence between AAI elevation and muscular strength return or surgical electrocoagulation during abdominal wall dissection were stated. In all patients the consciousness return based on AAI was adequate to clinical status and TCI value. The mean value of propofol effect site concentration during extubation was 2,08±0,36 mcg/ml. The mean time to extubation were 12,69±4,39 min. 1. The depth of anaesthesia monitoring during VBG or RYGB enables to adopt TCI propofol dosage. 2. The muscular action and surgical electrocoagulation create changes in AAI reading. The adequate AAI level secures the intraoperative amnesia. Leptin and adiponectin are adipokines implicated in the pathogenesis of insulin resistance. The aim of the study was to evaluate the relationship between insulin, leptin and adiponectin and obesity in our population. Subjects and methods: the study concerned 315 obese (sex-ratio= 0.45, mean age 42.6 ±12.6 years) and 320 non obese control subjects (sex-ratio= 1.01, mean age 49.3± 9.6 years). Each subject underwent a physical examination and biological investigations (basal and two hours blood glucose and insulinemia, total cholesterol, triglycerides, HDLc, leptin and adiponectin). Results: Obese subjects had significantly higher levels of fasting blood glucose (1.19±0 .52 vs 0.94±0.30g/l, p<0.001), basal insulin (12.5±9.8 vs 5.0±5.0 μUI/l, p<0.001) and leptin (20.9±10.9 vs 6.1±4.9 ng/ml, p<0.001) and significantly lower levels of adiponectin (4.4 ±3.5 vs 11.3±17.3μg/ml, p<0.001). The ratio leptin/adiponectin was significantly higher in obese. Conclusion: the study confirms the fact that leptin and adiponectin levels are good indicators of weight excess. Gonzalez-Muniesa, P, Bing, C, Trayhurn, P Obesity Biology Unit, School of Clinical Sciences, University of Liverpool, Liverpool, U.K. The endocannabinoid system (ECS), commonly associated with the stimulation of appetite, has been recently linked with inflammation. There are two major cannabinoid receptors, CB1 and CB2, while both TRPV1 and GPR55 have been considered as putative third receptors. The aim of this project is to examine whether the ECS plays an important regulatory role in the inflammatory process in white adipose tissue. RT-PCR was used to define the expression of the ECS receptors in different cell types within adipose tissue. The regulation of the expression of the receptors was then examined in primary human adipocytes (Zen Bio) by realtime PCR. Firstly, a differentiation time course showed an increase in CB1, TRPV1 and CB2 mRNA levels of 500-fold, 30-fold and 5-fold, respectively, at day 3 post-induction relative to preadipocytes. In contrast, GPR55 was mainly expressed in preadipocytes. Macrophages (U937) expressed all four cannabinoid and putative cannabinoid receptors. TNFα treatment of the adipocytes downregulated CB1 gene expression by more than 8-fold (at 24 h), and rosiglitazone treatment by 2-fold; dexamethasone induced a 4-fold diminution in TRPV1 mRNA level. Under hypoxic conditions, adipocytes exhibited decreases in CB1 (2-fold) and TRPV1 (3-fold) mRNA levels. Western blotting was used to verify expression of the protein in parallel with the receptor mRNA. It is concluded that CB1 expression in adipocytes is influenced by inflammation-related agents, which may indicate that this key cannabinoid receptor could be a target for the pharmacotherapy of inflammatory events within adipose tissue. Research related to this abstract was funded by the BBSRC. , age=37.53±1.59 yrs, BMI after reduction body weight 31.86±1.84 kg/m 2 ) were investigated twice, before and after 10% reduction of body weight achieved with lifestyle changes and hypocaloric diet. Following parameters were measured before and after weight reduction: leptin (Linco RIA, ng/ml), visfatin (EIA Phoenix, ng/ml), adiponectin (Linco RIA, ng/ml), fasting glycemia (mmol/l), fasting insulin (RIA, Inep, mU/l), CRP (mg/L), MIF (macrophage migration inhibitory factor, pg/ml) and HOMA-IR as marker of insulin resistance. There was a significant reduction in leptin levels (36,53±8,11 vs. 19,82±3,17, p<0 .05) and improvement in HOMA index (2,75±0,31 vs. 2,00±0,27, p<0.05). MIF was also significantly reduced 4923,25±2021,92 vs. 1372,12±540,81, p<0.05). There were no significant changes in visfatin (78.06±4.76 vs. 78.36±9.38, p<0.05), adiponectin (5,51±2,26 vs. 8,63±2,49, p>0 .05) and CRP levels (4,44±1,38 vs. 5,06±1,70, p>0.05). In conclusion, reduction of 10% body weight is capable of partial reversing the low-grade inflammation in female patients with obesity. Strande JL 1 , Phillips SA 1,2 1 Medical College of Wisconsin, Milwaukee, USA; 2 University of Illinois, Chicago, USA Previous studies indicate thrombin is elevated in obesity. The inflammatory molecules produced by adipose contribute to the development of insulin resistance and cardiovascular disease. Therefore, the purpose of this study was to test the hypothesis that human adipose express thrombin receptors (PAR1 and PAR4) and that thrombin stimulates a lipolytic and inflammatory cytokine response in human adipose predictive of cardiovascular risk. Methods: Human adipose were dissected and minced for whole tissue (AT) assays or digested for pre-adipocyte (PA) isolation. Pre-adipocytes were maintained in culture or differentiated into adipocytes (AD). PAR1 and PAR4 mRNA and protein were detected by RT-PCR and immunoblot analysis. IL-1 , IL-6, IL-10, FGF-2, VEGF, PDGF and lipolysis (glycerol production) were measured from AT (n=5), AD (n=6), and PA (n=3) supernatants after thrombin (10 U/ml; 24 hrs) treatment. Results: Thrombin stimulated lipolysis in AT (17%, p=0.01) cultures but not AD (10%, p=0.08). Thrombin increased the secretion of all cytokines in AT, AD, and PA cultures (P<0.05) for IL-1 (AT: 195±74% and AD: 616±341%), IL-6 (AD: 3100±1400%), IL-10 (AD: 158±79%) FGF-2 (AD: 195±106%), PDGF (AD: 198±28% and PA 635±131), and VEGF (AD: 401±96% and PA: 634±131%). The direct thrombin inhibitor lepirudin prevented thrombin-mediated cytokine release. Discussion: These data indicate that thrombin PAR1 and PAR4 receptors are present and that thrombin stimulates lipolytic function in human adipose. Thrombin induces the secretion of pro and anti-inflammatory cytokines and growth factors in adipocytes. Therefore, thrombin alters metabolism, inflammatory cytokine release, and may contribute to the chronic inflammation associated with obesity. Funding: Dr. Strande is supported by an NIH training grant (HL07792) Do anthropometric parameters have any effect on the evaluation of prostate cancer? Serin, E 1 , Kandirali, E 2 , Boran, C 3 Background: Concentrations of circulating adiponectin, particularly the high molecular weight (HMW) multimeric form, are negatively associated with obesity and insulin resistance. The molecular mechanisms regulating adiponectin production are unknown and there is controversy regarding the role of adiponectin during weight loss. Methods: Plasma samples were obtained from 13 morbidly obese subjects (BMI > 37 kg/m 2 ) at baseline and 3, 6, 12 and 24 months after weight loss induced by bariatric surgery (i.e., Roux-en-Y gastric bypass or gastric banding). Seven matched obese subjects without surgical intervention and served as controls. Total and multimeric adiponectin concentrations were determined with a commercial kit (EK-MADP Multimeric Adiponectin ELISA Kit, BÜHLMANN Laboratories AG, Schönenbuch, Switzerland). In addition, adiponectin multimers were detected by native SDS-PAGE and western blotting. Results: 3, 6,12 and 24 months after surgery, the respective increase in total adiponectin was 0.63 ± 0.27 μg/mL, 0.99 ± 0.23 μg/mL (P < 0.05), 1.7 ± 0.39 μg/mL (P < 0.05) and 2.2 ± 0.46 μg/mL (P < 0.05), respectively. At the same time points, the increase in HMW adiponectin was 0.25 ± 0.21 μg/mL, 0.43 ± 0.16 μg/mL, 1.1 ± 0.27 μg/mL (P < 0.01), 1.4 ± 0.3 μg/mL (P < 0.01). In contrast, the plasma concentrations of low and middle molecular weight adiponectin remained unchanged. The HMW-specific increase in adiponectin was confirmed by Western blot analysis. Conclusion: Pronounced weight loss increases HMW adiponectin, but not the other multimeric forms. Future studies will clarify the role of HMW adiponectin in weight loss-induced metabolic improvements. Mercader, J, Granados, N, Caimari, A, Oliver, P, Bonet, ML, Palou, A Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics), University of the Balearic Islands (UIB), Palma de Mallorca; and CIBER Fisiopatología Obesidad y Nutrición (CB06/03), Instituto de Salud Carlos III, Spain Retinol binding protein 4 (RBP4) and visfatin are adipocyte-secreted proteins (adipokines) whose relevance to the metabolic syndrome remains controversial. We assessed changes in RBP4 and visfatin serum levels and adipose tissue expression in both a genetic and a diet-induced model of obesity in the rat (obese fa/fa Zucker rats and Wistar rats fed a cafeteria diet, respectively). Compared to lean controls, obese fa/fa rats were hyperleptinemic, hyperinsulinemic and insulin resistant and had reduced RBP4 serum levels and mRNA levels in adipose depots, unchanged visfatin serum levels and reduced visfatin mRNA levels selectively in the inguinal adipose depot. Cafeteria dietinduced obesity resulted in increased fed blood glucose levels, a variable degree of insulin resistance, unchanged serum visfatin and RBP4 levels, and reduced mRNA levels of both adipokines in several adipose depots. Hence, increases of RBP4 or visfatin do not accompany obesity and insulin resistance in the models examined. Adiponectin is a fat derived factor implicated in the protection against a cluster of related metabolic disorders including obesity, dyslipidemia, insulin resistance and cardiovascular disease. Mice lacking adiponectin display impaired hepatic insulin sensitivity and respond only partially to PPARgamma agonists. Adiponectin-mediated metabolic improvements are related the prevention of ectopic lipid deposition and alleviation of dyslipidemia. A modest increase in circulating adiponectin levels leads to an activation of PPARgamma targets and reduction of liver steatosis at the expense of a massive expansion of adipose tissue in ob/ob mice. To study whether the ameliorated lipoprotein profile affects the formation of atherosclerotic lesions, we crossed mice over-expressing adiponectin with LDL-R receptor deficient (LDLR KO) mice. Although these mice have reduced triglyceride-rich lipoprotein and cholesterol levels, the amount of atherosclerosis is unaffected. Surprisingly, increased adiponectin levels are not sufficient to prevent or delay the accumulation of cholesterol in the aortic walls or to reduce plaque volume in the aortic root. A similar phenotype is observed in LDLR KO mice that are adiponectin deficient. A cholesterol rich diet leads to substantial atherosclerosis, albeit the lack of adiponectin does not accelerate the process. In both cases the phenotype may reflect a limitation related to rodent models. Nonetheless, adiponectin Visceral obesity has been suggested to be an independent risk factor for cardiovascular disease (CVD); the role of adipokines in the risk for CVD is less clear. This study was performed to test the predictive value of anthropometric parameters, adipokines and visceral obesity for the risk of CVD. A cross-sectional analysis of apparently healthy males (n=116) and females (n=175) for evaluation of clinical, laboratory, and anthropometric parameters was undertaken. Abdominal subcutaneous and visceral adipose tissues (SAT and VAT) were measured by computed tomography. Adipokines, including retinol binding protein (RBP) 4 and adiponectin, were also determined. The risk for CVD was estimated using the 10-year Framingham Coronary Heart Disease Risk Point scale (10-y FCRP). All features studied contributed to the morbidity associated with an increase in VAT. The 10-y FCRP was significantly correlated with VAT ( =0.123, P=0.049) and RBP4 ( =0.230, P<0.001), after adjustment for age, gender and BMI. The magnitude of the increased the 10-y FCRP correlated with VAT and RBP4 independent of obesity. In a multiple linear regression model, the serum levels of RBP4 at a given BMI and VAT significantly correlated with the 10-y FCRP ( =0.123, P<0.001). does exert major cardioprotective effects leading to a significant reduction of tissue fibrosis in the heart of LDLR KO mice. This suggests that the actions of adiponectin on the cardiovascular system are complex and at multifaceted, with a minimal direct impact on atherosclerotic plaque formation in the murine model. Funding: This work was supported by funding from the American Heart Association The aim of this study was to evaluate the relation between adiponectin and cardiometabolic risk factors and cardiovascular complications, as well as the link between plasma levels of adiponectin and expression of adiponectin gene in visceral adipose tissue, in a group of obese patients. Patients and methods: 40 patients with severe obesity were evaluated. The assessment included clinical parameters (waist, BMI) and paraclinical (lipid profile, HOMA-R index) tests, as well as determination of plasma adiponectin level (ELISA method). Common carotid intima-media thickness (IMT) was bilaterally evaluated by Doppler ultrasound (UF 850XTD Tellus).Visceral adipose tissue was obtained during bariatric surgery and we quantified the variation of expression of adiponectin gene (by RT-PCR, using HPRT as reference gene). Patients were divided in 2 groups: with (26) and without (14 patients) metabolic syndrome (MetS) Results: Plasma adiponectin levels were lower in metabolic syndrome patients (15.57±6.73 vs 18.54±7.04 ng/ml). There was a positive correlation between adiponectin and HDL levels (r=0.603, p<0.01) and a negative correlation with waist circumference, triglycerides (r=-0.3) and HOMA index (r=-0.21, p<0.05). In patients with MetS there was a significant negative correlation between adiponectin levels and common carotid IMT (r=-0.44, p<0.05). Adiponectin expression in visceral adipose tissue correlates with plasmatic levels (r=0.33). Conclusion: Our results prove the existence of a significant relation between low plasma adiponectin levels and metabolic risk factors, as well as vascular complications. Visceral obesity role in the pathogeny of these changes is sustained by the correlation between adiponectin expression in visceral adipose tissue and its serum levels. Interplay between macrophages and adipocytes: stimulation of secretion of adipokines and the role of endocannabinoids The concept of a chronic low-grade inflammatory status of adipose tissue during obesity is now widely accepted. This condition is regarded as a major driver for the development of cardiovascular-and diabetic complications. Macrophage recruitment and -activation is pivotal for the inflammatory process, and the different cell types and forms are involved in a complex interplay. We are investigating the regulation of intercellular communication, with special emphasis on the role of cannabinoid type-1 receptor (CB1) and CB2 mediated pathways. In order to study the effects of macrophage-secreted factors on adipocytes, 3T3-L1 adipocytes were incubated with lipopolysaccharide (LPS) or different RAW264.7 macrophage conditioned media. The release of adipokines by 3T3 cells was measured by multiplex immunoassay. Macrophage-LPS stimulated conditioned medium enhanced the adipokine secretion of especially MCP-1, PAI-1 and adiponectin, whereas release of IL-6 was lower as compared to LPS treatment. No effect on TNF-α secretion was observed. Moreover, an enhanced secretion of MCP-1 and PAI-1, but not IL-6, was measured after treatment with macrophage-stimulated conditioned medium (in absence of LPS). Macrophage conditioned medium but not LPS also increased lipolysis in 3T3-L1 cells. When studying the effects of CB1 and CB2 agonists on macrophages and adipocytes, no effects were seen so far on the TNF-α, IL-6 or IL10 secretion by macrophages stimulated with LPS. We are currently studying other ways of macrophage activation. By contrast, the cannabinoid agonist HU210 induced a 3-fold induction of triglyceride content without affecting adiponectin mRNA levels. The proinflammatory interleukin-18 (IL-18) is elevated in plasma of obese and type-2 diabetic subjects and might participate in the development of these metabolic disorders. In the present study we compared the expression of IL-18 and caspase-1, the key enzyme responsible for active IL-18 production, in adipose tissue and in liver of ob/ob mice and in mice fed a high fat diet (HFD) compared with ob/+ mice and mice fed a chow diet, respectively. Compared with ob/+ mice, the ob/ob mice displayed a 2-fold higher level of circulating IL-18, which was associated with a 4fold increase in IL-18 protein expression in adipose tissue, but only a slight increase (1.3-fold; p<0.05) in hepatic IL-18 protein level. There were no changes in circulating, adipose and hepatic IL-18 protein levels in HFD mice, compared with lean animals. Surprisingly, in ob/ob mice the marked induction of IL-18 protein in adipose tissue was associated with a decrease (1.6-fold; p<0.05) of its mRNA expression. However, caspase-1 mRNA expression and its activity were significantly induced in fat pads of ob/ob mice. In liver of both mouse models of obesity, IL-18 and caspase-1 mRNA expressions were slightly enhanced whereas caspase-1 activity was reduced. In conclusion, IL-18 expression in ob/ob mice is differently regulated between adipose tissue and the liver. In contrast to liver, IL-18 protein induction in adipose tissue of ob/ob mice is directly associated with caspase-1 activation, suggesting that caspase-1 might be involved in the regulation of adipose IL-18 production during obesity. Effect of gastric bypass on serum rbp4 concentrations: relevance of body fat reduction over weight loss and improved insulin sensitivity The Aim of this study was to characterise the effects of conjugated linoleic acid (CLA) on adipose depots and adipokine levels in control and obese mice. Methods: Mice received daily gavages of: 0.15 or 0.5 g CLA / Kg body weight (CLA1 or CLA2 group). Experiment 1: Mice fed a standard (8.7%kcal%fat) or a cafeteria diet for 45 days. Since then, they received CLA1 or sunflower oil (control) for 9 days. Experiment 2: Mice fed a normal-fat diet (10%kcal%fat) and treated with CLA1, CLA2 or sunflower oil for 37 days. Experiment 3: Mice fed with a high-fat diet (45%kcal%fat) and treated with CLA1, CLA2 or sunflower oil for 30 days. Since then, they received a double dose for 35 days. Results: 9-day-CLA treatment did not cause any apparent effect on body and tissue weights or adiponectin and leptin levels in lean or obese animals. In experiments 2 and 3 adiposity, adiponectin and leptin levels were not affected by CLA1 treatment. CLA2 treatment reduced adiposity, although did not attain significantly differences in body weight gain. CLA2 groups showed plasma leptin (22%) and adiponectin (27%) reductions in animals fed on normal-fat diet. Higher reductions were found in animals fed on high-fat diet (34% and 78 %, respectively). Conclusions: CLA treatment reduces adiposity more than body weight gain. The fact that adiponectin and leptin circulating levels reflects the effect of CLA on adiposity when no changes were observed on body weight gain reveals their potential role as early biomarkers of CLA effects. International Journal of Obesity T1:PS.130 Olszanecka -Glinianowicz M, Zahorska -Markiewicz B, Kocełak P, Janowska J, Semik -Grabarczyk E Objective: The aim of the present study was to examine how weight loss treatment modulates serum concentrations of ghrelin and insulin -like growth factor -I (IGF-I) in obese women and to determine whether there is association between possible changes in serum concentrations of these hormones after weight loss. Material and Methods: The study group involved 22 obese women without additional disease (age 40.6 ± 12,9 years; BMI 37.2 ± 4.6 kg/m 2 ). All subjects participated in a 3-month weight reduction program. The measurements were performed at the baseline and after weight loss. Serum concentration of ghrelin and IGF-I were measured by (ELISA) kit. Serum concentrations of insulin was measured by RIA. Results: The mean weight loss was 9.3 ± 4.1 kg (9.7 ± 4.3%). We observed significant positive correlation between increase of ghrelin and decrease of body fat % after weight loss (r=0.44, p=0.03). There are no correlations between change of ghrelin and IGF -I concentrations and between changes of insulin and IGF -I concentrations. In 52 men (60,1± 11,1 years of age), fasting blood samples were collected to measure glycaemia, insulinaemia and of plasma leptin. BMI (kg/m 2 ) and HOMA were calculated. The sample was divided according to BMI in the normoponderal, the overweight and the obese groups. The total body composition was assessed by radiologic densitometry using QDR Discovery W densitometer (Hologic, Inc.). The data were submitted to descriptive analysis, One Way and Multifactorial ANOVA tests, and adjusted for chronological age and, or BMI and, or total fat mass. Results: Mean serum leptin levels were higher in the obese group (P <0.05). The mean HOMA were identical between groups of BMI. A positive relationship was detected between the plasma leptin levels and HOMA (P = 0.001). The plasma leptin concentration was positively related with the total body fat mass and the fat mass percentage (P = 0.0000), but no relationship was detected with the total lean mass. The results of this study, suggest that the concentration of serum leptin is associated with the quantities and the fat mass percentage in men. The relationship between HOMA and leptin plasma levels seems to indicate an association of the leptin with insulin resistance in men. The aim of the study was to compare the body fat distribution of women with polycystic ovary syndrome (PCOS) with age and body mass index matched healthy controls and to investigate if androgens and insulin resistance associated with fat distribution. Thirty-PCOS women were evaluated in terms of body mass index (BMI). Blood samples were obtained for follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, prolactin, thyroid stimulating hormone (TSH), dehydroepiandrosterone-sulfate (DHEA-S), total testosterone, sex hormone binding globulin (SHBG). Insulin and glucose levels. Insulin resistance was estimated by HOMA IR BMI were significantly higher in patients with PCOS (p < 0.05). Total testosterone was found to be positively correlated with fat BMI (r = 0.401, p < 0.05). There was still significant correlation between total testosterone and SHBG after controlling for age and BMI. Low sex hormone-binding globulin was found in obese women with PCOS. Conclusion: Total testosterone and SHBG levels are positively correlated with the BMI in women with PCOS. Influence of partial sleep deprivation on energy balance and insulin sensitivity in healthy women Background: Voluntary sleep restriction is a lifestyle feature of modern societies that may contribute to obesity and diabetes. Objective: The aim of the study was to investigate the impact of partial sleep deprivation on insulin sensitivity and the regulation of energy balance. Methods: In a controlled intervention, 14 healthy women (age 23-38 years, BMI 20.0-36.6kg/m 2 ) were investigated after 2 nights of >8h sleep/night (T0), after 4 nights of consecutively increasing sleep curtailment (7h, 6h, 6h and 4h sleep/night, T1) and after 2 nights of sleep recovery (>8h sleep/night, T2). Resting and total energy expenditure (REE, TEE), glucose induced thermogenesis (GIT), physical activity, energy intake, glucose tolerance and endocrine parameters were assessed. Results: When compared with T0, energy intake (+20%), body weight (+0.4kg), leptin secretion (+29%), free triiodothyronine (+19%), free thyroxine (+10%) and GIT (+34%) significantly increased with sleep deprivation (all P<0.05). Mean REE, physical activity, TEE, oral glucose tolerance and basal ghrelin levels remained unchanged, but the decrease in plasma ghrelin levels following an oral glucose load was reduced at T1. The effect of sleep loss on GIT, fT3, fT4 and cortisol levels was inversely related to fat mass. Sleep lossinduced variances in REE and insulin sensitivity were associated, an increase in REE was related to a decrease in insulin sensitivity (r=-0.73, P<0.01). Conclusions: Short-term sleep deprivation affects both sides of energy balance and leads to net weight gain. Sleep loss induced variances in energy expenditure were associated with fat mass and insulin sensitivity. Plasma interleukin-6 concentration increases in parallel to increased fuel utilization during cold exposure Recent work suggests that interleukin-6 (IL-6) is released during muscle contractions, promoting skeletal muscle lipid oxidation and glucose uptake. In cold-exposed adult humans, involuntary muscle contractions during shivering are mainly sustained through the oxidation of carbohydrates and lipids. The goals of this study were 1) to examine the effects of cold exposure on changes in plasma IL-6 levels; 2) to determine whether these changes are accompanied by these in substrate metabolism during cold exposure. On two different occasions, 6 men (age 24±5y; % body fat 12±3) were exposed to cold (liquid conditioned suit perfused with 4ºC water). During each session, subjects ingested either LOW concentration (0.04g/min) or HIGH concentration (0.8g/min) glucose solution. Using indirect calorimetry and isotope tracer methodology, substrate metabolism was quantified. Plasma IL-6 was assayed from blood drawn at room temperature and every 30 minutes during 2 hours of cold exposure. During cold exposure, plasma IL-6 levels increased significantly over time (1.00 ±0.19 pg/ml to 1.80 ±0.42 pg/ml, p 0.05) regardless of the condition. Lipid oxidation (60 ±12 mg/min to 204 ±26 mg/min, LOW and 55 ±4 mg/min to 155 ±28 mg/min, HIGH; p 0.05) and plasma glucose utilization (50 ±5 mg/min to 192 ±15 mg/min, LOW and 40 ±5 mg/min to 256 ±22 mg/min, HIGH; p 0.05) increased in both conditions but to a greater extent in HIGH. In conclusion: 1-) plasma IL-6 concentrations increase during cold exposure and 2-) these changes are associated with increases in glucose and lipid utilization. Funding: Research relating to this abstract was funded by grants from Natural Sciences and Engineering Research Council of Canada Uncoupling proteins (UCPs) are mitochondrial carrier proteins that increase energy expenditure thus decreasing body weight. Recent evidences suggested that UCP3, the muscle-specific isoform, is involved in lipid metabolism promoting fatty acids βoxidation and reducing their storage. We identified four novel mutations in severely obese (BMI-SDS>2,5) children with early obesity onset (<4y) from Southern Italy: three missense mutations V56M, A111V, V192I, and one non-sense, Q252X, that generates a truncated protein. Here we report preliminary results of in vitro functional analysis of wild-type (wt) and V192I and Q252X mutant proteins. We cloned human UCP3 cDNA wt in the expression vector p3xFLAG-CMV-7.1; mutants were obtained by site-directed mutagenesis. Constructs were transiently transfected in HEK 293 cells, lacking of endogenous UCP3. Mitochondrial localization of wt and mutant proteins was assayed by western blotting. Activity of mutant proteins vs wt was indirectly measured incubating cells with 100 μM palmitic acid mix containing 16,7 μCi/ml of 3 H-labeled palmitic acid for 2 hours with and without β-oxidation inhibitors; 3 H-labeled water, produced by palmitate oxidation, was collected and measured at the end (1). All transfected proteins were correctly localised in mitochondria. V192I generated similar amount (97%) of 3 H-labeled water to respect to wt protein; conversely, Q252X mutant, generated only a low amount (20%) of 3 H-labeled water. Interestingly, children carrying Q252X mutation showed highest QR value (1, 05) Androgen deficiency (AD) alters body composition and contributes to increased adiposity. Determining the androgen status of obese men is limited by suboptimal clinical and biochemical measures of androgen activity. To test the hypothesis that obese men are androgen deficient and weight loss improves androgenicity, we conducted an 18 month lifestyle intervention in 20 healthy obese men. Morning blood samples were analysed for total testosterone, sex hormone binding globulin, albumin and gonadotrophins. A now gold standard HPLC-Tandem Mass Spectrometry method was used for measuring testosterone concentration. An in-house androgen receptor-driven Dual-Luciferase Reporter Bioassay was used to measure androgen bioactivity. At baseline, both total and calculated free testosterone correlated negatively with body fat measured by DEXA (r=-0.592 and -0.537, p<0.05) and positively with fitness using indirect calorimetry during a graded exercise test (r=0.492, p<0.05). There was no correlation with clinical measures including symptoms of AD, hand grip strength and testicular volume. After lifestyle intervention, participants lost 7.4±5.2 % (9.0±6.3kg) of body weight (p<0.001). There was no significant change in testosterone or androgen bioactivity. This may be related to a significant increase in SHBG (3.3±4.4nmol/L) offset by a similar decrease in albumin (6.7±8.4g/L) (p<0.005). We conclude that clinically achievable weight loss in obese men does not alter androgenicity as assessed by comprehensive biochemical and clinical measurements. Despite this, clinical symptoms of AD and hand grip strength improved significantly (P<0.05), possibly due to improved overall well being and fitness. These data suggest that adiposity does not directly alter the gonadal axis or androgen action. In athletes and lean healthy men, intramyocellular lipids (IMCL) are an intracellular source of energy during exercise. IMCL content is increased in trained as well as obese individuals, and is associated with insulin resistance. Androgen deficiency (AD) reduces strength and endurance. Whether the biochemical partial AD of obesity alters the storage or utilisation of IMCL in acute exercise, thereby contributing to reduced endurance, is unknown. To test this hypothesis, we conducted a cross sectional study on 18 healthy community dwelling obese men with a mean weight of 120.9±17.4kg and examined the relationship between blood testosterone levels with IMCL storage and utilisation. IMCL was measured before and after an hour-long session of exercise by Magnetic Resonance Spectroscopy. Early morning blood samples were analysed for total testosterone (by gold standard Isotope Dilution Liquid Chromatography -Tandem Mass Spectrometry), sex hormone binding globulin, albumin and gonadotrophins (by immunoassay). Total testosterone was inversely correlated with percentage of body fat (DEXA) and insulin sensitivity (HOMA) (r=-0.59 and -0.48, respectively) but positively with fitness independent of fat free mass (r=0.49) (each p<0.05). Calculated free testosterone correlated negatively with IMCL stores (r= -0.57) whereas total and free testosterone both predicted a reduced ability to mobilise IMCL during acute exercises (r=-0.53 and -0.61) (each p<0.05). We propose that androgen replete obese men are more insulin sensitive, store less IMCL and therefore have less IMCL stores to be utilised during acute exercise than those who are androgen deficient. Background: Protein-rich diets spare fat free mass (FFM) during energy restriction and weight loss and gain FFM at the cost of fat mass (FM) during weightmaintenance thereafter. Objective: To examine if there is a FFM-sparing effect with a high protein diet without the trigger of intervention, thus in energy balance. Design: The 4-compartment body-composition; FM, bone mass content (BMC), water and protein mass of 25 subjects (BMI 22.07±1.71kg/m 2 ) and blood parameters were assessed before and after a 3-months dietary-intervention of 2MJ supplements of protein, or carbohydrate or fat, as exchange with 2MJ of habitual energy intake, thus creating a range in protein intake of 96-203% of individual's protein needs. Protein intake was calculated based on 24-hour nitrogen. Results: On average, subjects were in energy balance and did not change their physical activity over time. Change in body weight ( BW) ranged between -1.23kg and +1.93kg. FFM increased significantly by 0.73kg (P=0.033), independently of BW. Independently of BW, protein intake explained 24% of variation in %FFM (P=0.047), while habitual leisure-time physical activity explained 45% (P=0.009). Protein intake explained 29% of variation in BMC (P=0.030). FM decreased by 0.34kg. Trunk %FM was negatively related to protein intake (r=-0.598, P=0.014). Fasting FFA concentrations were positively related to FM and negatively to P=0.013) . HDL concentration was a function of protein intake (r=0.647, P=0.009). Conclusion: A 50% elevation in protein intake of individual's protein needs increased FFM independently of BW, with additional positive effects on lipid and bone characteristics. Funding: Research related to this abstract was funded by Top Institute Food and Nutrition (Wageningen, The Netherlands). Whole genome expression profiling of subcutaneous adipose tissue of lean and overweight men reveals a differential functionally relevant response to shortterm dietary intervention van Erk, MJ 1 , Pasman, WJ 1 , Wortelboer, HM 1 , van Ommen, B 1 , Hendriks, HFJ 1 1 TNO Quality of Life, Zeist, the Netherlands Adipose tissue has important metabolic and endocrine functions. Obesity is associated with changes in these functions and with an increased inflammatory state, often leading to a range of complications. The goal of this study was to investigate the effect of a short-term nutritional intervention on gene expression in adipose tissue from lean and overweight subjects. Therefore, gene expression profiles were measured in abdominal, subcutaneous adipose tissue biopsies from 9 lean and 8 overweight men after consumption of a PUFA-enriched spread or a control spread (40 gram of fat daily) for 9 days. Subcutaneous adipose tissue gene expression profiles of lean and overweight subjects were distinctly different, mainly with respect to genes involved in defense response and genes involved in metabolism. Adipose tissue from lean subjects showed a more pronounced and consistent response to the dietary intervention than adipose tissue from overweight subjects. In lean subjects, consumption of PUFAenriched spread resulted in changes in expression of genes related to energy metabolism. In the majority of overweight subjects, down-regulation of expression of inflammatory genes and up-regulation of expression of lipid metabolism genes might reflect a beneficial effect of the intervention. Individual response to the intervention in overweight subjects was highly variable and correlated to obesity phenotype markers waist-hip ratio and waist circumference, suggesting a link between body fat distribution and response to nutritional intervention. This study indicates that whole genome expression profiling in adipose tissue may help to identify relevant targets of nutritional intervention in obesity prevention or treatment. Funding: This study was financially supported by Dutch government through grant "Healthy nutrition" (grant number 04003) Exercise training, but not weight loss, increases muscular work efficiency and enhances fat oxidation. Amati, F, Dubé, J.J, Hames, K, Chomentowski P, Shay C, Goodpaster, B.H University of Pittsburgh, Pittsburgh, Pennsylvania, USA Purpose: Perturbations in body weight have been shown to affect energy expenditure and efficiency during exercise. The separate effects of weight loss and exercise training on muscular efficiency or the proportion of energy derived from fat oxidation during physical activity, however, are not known. The purpose of this study was to determine the effects of exercise training with and without concomitant weight loss on metabolic efficiency and fat oxidation during steady state submaximal exercise in older obese subjects. Methods: 64 sedentary older (67±0.5) obese (30.7±0.4kg/m 2 ) volunteers participated in a 3-arm clinical trial consisting of 4 months of either diet induced weight loss (WL, n=11), exercise training (EX, n=37) or the combination of both interventions (WLEX, n=16). Before and after intervention, energy expenditure (EE), gross efficiency (GE), economy (EC) and proportion of energy expended from fat (EF) were determined during a one hour submaximal (50% of VO 2 max) cycle ergometry exercise. VO 2 max was determined by GXT and fat free mass (FFM) was determined by DXA. Results: The table bellow shows that EX, but not WL alone, increased GE and EC. The addition of concomitant WL to EX (WLEX), however, may have an additive effect on muscular efficiency during moderate physical activity. These effects remained after adjusting for changes in FFM. The proportion of energy derived from fat increased with EX. Conclusion: Exercise training, but not weight loss alone, increases metabolic efficiency and promotes greater utilization of fat during moderate physical activity in previously sedentary, obese adults. Serotonin 2C receptor (5HT2CR) signaling contributes to the feedinginhibitory effects of cholecystokinin (CCK ) and glucagon-like peptide-1 (GLP-1), but not leptin, in mice. Asarian, L, Langhans, W, Geary, N. ETH Zurich, 8603 Schwerzenbach, Switzerland. Central 5HT contributes to the control of food intake, in part by acting at 1BR and 2CR sites the hypothalamic arcuate (Arc) nucleus, a key site for the reception and integration of peripheral endocrine signals. Still unclear, however, is which feeding-control signals 5HT modulates and how this occurs in the brain. To investigate the role of 5HT2CR in the satiating action of gut peptides, we examined (1) the effect of null mutations (KO) of 5HT2CR on the feeding inhibitory potencies of CCK (1, 2, or 4 μg/kg, IP) and 200 and 400 nmol/kg, IP) and (2) the distribution of CCK-induced c-Fos immunoreactivity (cFIR) in the brain. The feedinginhibitory effect of leptin (1 mg/kg, SC) was tested as a positive control (Nonogaki et al., 1998) . Peptides were injected at dark onset. Food intake was measured every 30 min for 4 h. cFIR was measured 90 min after dark onset in separate mice without food access. All CCK and GLP-1 doses decreased food intake in WT, but not KO mice. Leptin decreased food intake similarly in WT and KO mice. CCK (2 μg/kg, IP) induced cFIR similarly in the PVN and Arc of WT and KO mice, but there was significantly more cFIR in the NTS of WT vs. KO mice. These results suggest that 5HT-5HT2CR signaling is necessary for the full satiating effects of CCK and GLP-1 and that for CCK satiation, the NTS is one site where integration with 5HT-5HT2CR signaling occurs. The effects of omitting breakfast on metabolic responses to a standard liquid preload. University of Nottingham, Nottingham, United Kingdom Habitually omitting breakfast adversely affects metabolic parameters [1] . The aim of this study was to investigate the metabolic responses to a standard preload when consumed after a standardized breakfast or extended fast. Twelve normal weight (BMI 23.5 (± SD 1.7) kg.m 2 ), non-smoking males (mean age 24.3 (± SD 7.3) years) took part in a randomised cross over trial. Subjects were assigned to receive breakfast (Rice Krispies and semi skimmed milk equivalent to 10% individual daily energy requirement) at approx 08.00 (NB) or miss breakfast (OB) in a random order after an overnight fast. A standard 250kcal preload (21, 39 and 41 % total energy from protein, carbohydrate and fat respectively and contained 1500mg acetaminophen as a marker of gastric emptying) was consumed at approx 11.00. Arterialized venous blood samples were collected at baseline (fasting), prior to consuming the preload, and at 15 minute intervals for 90 minutes following preload consumption. Plasma glucose and insulin response (iAUC) to the preload were significantly greater in OB trial (P<0.05). FFA were significantly different between trials (P <0.05). There were no significant differences in serum acetaminophen concentrations between trials, but rate of increase of showed a trend to be greater in B trial (P<0.1). Plasma ghrelin responses were not different between trials. The metabolic responses to a standard liquid preload are different when the preload is provided after a breakfast compared with following an extended fast. This aspect of study design should be considered carefully when interpreting results from appetite studies using preloads. Objective: The A-allele of a FTO (rs9939609) associates with obesity in Caucasians, but the function and pathway of FTO is unknown. We hypothesize that the FTO operates through an influence on energy expenditure (EE), and investigated whether the rs9939609 of FTO and physical activity (PA) and/or EE were associated, and whether an association between the FTO variant and obesity was dependent on PA and/or EE. The study population included all obese young men at the draft board examinations in Copenhagen and its surroundings in 1943-77, and a randomly selected group from the same population. Information on fat mass (FM), lean body mass (LBM), PA, maximum oxygen uptake (VO2max) and EE were collected in 1991-93 and 1998-00 (median ages 42y and 48y). Genotyping was carried out in 753 obese and 879 controls. A recessive transmission mode fitted the data best (TT/TA versus AA). Logistic regression was used to assess the odds ratios of the genotype in relation to: PA, EE, and interactions between FM*PA and FM*EE. Results: The A-allele of the FTO variant was strongly linearly associated with FM, but not significantly associated with leisure time PA, VO2max, resting EE or glucose-induced EE. No interactions between FM and the PA measures or EE measures were found. Adjustment for age, FM and LBM had no influence on the results. Conclusions: The examined variant in FTO is not associated with PA or EE, but associated with FM irrespective of the level of PA and EE in our cohort of Caucasian men. Cyclin-dependent kinase inhibitors-related genes are regulated by cafeteria diet and vitamin c supplementation in rats Visceral fat, liver fat and intramyocellular lipids (IMCL) are associated with increased risk of type 2 diabetes. We have investigated the role of weight loss through diet and exercise in modulating these energy stores in 18 obese non-diabetic men. Fat distribution was measured using Dual energy X-ray absorptiometry (DEXA), magnetic resonance imaging (MRI) and spectroscopy (MRS) while insulin sensitivity was assessed using homeostasis model assessment (HOMA). The exercise sessions were recorded with a heart rate monitor and dietary intake was assessed by 3 day diet diaries before and after the intervention. During the intervention, subjects achieved an average 1207±971 kcal exercise per week. VO 2 max increased by 5.1±3.2 mLO 2 *Kg of FFM -1 *min -1 while HOMA decreased by 0.9±2 (p<0.05). Furthermore, the subjects had mean decrease of 20.1±11.5% total body fat, 28.9±18.0% visceral fat, 14.5±11.3% abdominal subcutaneous fat and 54.1±30.0% liver fat (p<0.05). IMCL of soleus muscle was decreased by 9.1±27.3% (p=0.093). Subjects who exercised more had a greater decrease in visceral fat (duration: p=0.037; Kcal: p=0.052). HOMA was correlated to liver fat before and after the intervention (p<0.05), but was not associated with visceral fat or IMCL. Also, the decrease in liver fat was correlated with decreases in plasma lipids (p<0.05). The reduction in IMCL with the intervention was associated with restriction in caloric intake (p=0.003) independent of amount of weight loss. These data suggest that liver fat correlates with metabolic parameters, visceral fat reduction is associated with exercise and IMCL are regulated by energy intake in obese non-diabetic men. Obesity surgery has proved being more success than MED. This can not be explained only by anatomical restriction but also by changes in hunger which could be related to gut hormones responses. Objective: To evaluate changes produced by three treatments for obesity on PYY levels, satiety and hunger with similar excess weight loss (EWL). Method: Prospective study. Three groups of obese patients, RGYB (3), SG (3) and MED(5), BMI 31-47 kg/m 2 , aged 23-52, before and after two months on MED, RGYB and SG. We assessed plasma PYY 3-36 (RIA, Linco, USA), hunger and satiety by visual analogue scales, before and after 30, 60, 90, 120, 180 minutes post-intake of 237ml of a standard meal (Ensure Plus®). Area under curve (AUC) was calculated for each measure by trapezoidal method and the results were analyzed by general linear model for serial measurements followed by post hoc analysis by Bonferroni test. Results: Subjects had similar EWL after treatment (range 45-51%). PYY showed a significant difference between MED and both surgical procedures. Bariatric surgery increases significantly PYY for a similar EWL unlike MED. This might be related to a change in hunger and satiety. Our study showed a tendency for an increasement in satiety and a decreasement in hunger. A bigger sample size might show more conclusive results. Tks1225, a novel oxyntomodulin analogue, reduces food intake and body weight and improves glycemic control in dio rats It is known that obesity is often correlated with a low cardiac variability. Due to the excess load to carry, the obese patients may enter into a vicious circle similar to the athlete "over training". This is characterized by an altered mood state, chronic fatigue and sleep disorders, all of these lowering the quality of life. Moreover, this condition is linked to an increased cardio-vascular risk amongst obese patients. The objective of the study was to assess whether a passive exposition to hypoxia could be related to a modification in the sympathovagal balance of obese patients. In this study, 8 patients followed a protocol were the cardiac variability was measured 1 day before, 1 hour after and 24 hours after a 1 hour passive (maintaining a lying position) exposition to hypoxia (blood O 2 saturation maintained between 70 and 75%). The results show that the sympathovagal balance of the patients was significantly increased from basal (2.0 ± 1.2) to post-exposition (3.0 ± 2.1) (p<0.05) and significantly decreased, compared to basal, 24 hours after exposition (0.8 ± 0.5) (p<0.01). In conclusion, a passive hypoxia exposition is leading to an improvement in the sympathovagal balance at 24 hours. This approach could allow obese patients to walk out from the chronic fatigue and altered state, which seem essential before starting a physical activity training program. Dietary proteins and serine proteases stimulate secretion of satiety hormones by the stc-1 cell line This study showed that inhibition of trypsin or DPP IV by several different dietary proteins stimulated the secretion of CCK and GLP-1. We conclude that these proteins exert strong effects on satiety hormone release, and may therefore be potent dietary supplements for the prevention or treatment of obesity. Men and women show equivalent changes in body weight and body composition in response to exercise: the importance of compliance. It is uncertain whether reports of a gender difference in exercise-induced weight loss is due to variability in physiological regulation or is a consequence of reduced compliance. It was hypothesised that if the exercise was mandatory, men and women would respond similarly with respect to body weight and composition. Fifty eight overweight and obese men (n=19) and women (n=39) with mean BMI=31.8 ±4.5 kg/m 2 , age=39.6 ±9.8yrs and VO 2 max= 29.1 ±5.7ml/kg/min completed 12 weeks of supervised exercise. Body weight (Bwt), fat mass (FM), VO 2 max, blood pressure (BP), resting heart rate (RHR) and waist circumference (WC) were measured at weeks 0 and 12. Total accumulative exercise-induced energy expenditure was not significantly different between men (498 ±103 kcal/kgFFM) and women (447 ±94.0 kcal/kgFFM). Men (-3.12 ±4.0kg) and women (-3.33 ±3.0kg) experienced a significant reduction in Bwt after 12 weeks (t=3.39, p<0.0001 and t=6.93 p<0.0001 respectively). FM and WC decreased significantly in men (2.45 ±4.63kg; 5.58 ±3.76cm) and women (3.14 ±2.55kg; 4.56 ±3.19cm). There was no statistical difference in the decreases in Bwt (t=.23, p=0.82), FM (t=0.70, p=0.49) and WC (t=1.07, p=0.29) between men and women. Men and women also experienced similar health benefits including significant decreases in BP and HR. These data suggest that when the exercise prescription is mandatory and completed, men and women experience the same body weight and composition benefits. These data provide an important and positive health message; women do experience the weight loss benefits associated with exercise when the exercise is completed. This project was funded by the Biotechnology and Biological Sciences Research Council (BBS/B/05079). Background: Fasting is associated with increased growth hormone (GH) pulses and mobilisation of fats, but underlying mechanisms are unclear. Aims: To determine whether ghrelin orchestrates the metabolic changes seen during fasting, and whether administering ghrelin to subjects with low ghrelin affects lipid mobilisation. Subjects and Methods: 10 lean controls (BMI 23.3±3.2), 10 morbidly obese subjects (BMI 50.1±10.6) and 6 post-gastrectomy subjects (BMI 25.2±1.0) were fasted for 36 hours with regular blood sampling. On a separate occasion subjects were infused with either intravenous ghrelin (5 pmol /kg/min) or saline over 270 minutes. Results: Obese and post-gastrectomy subjects had lower ghrelin levels compared to controls (ANOVA p=0.02) during the fast. Controls and gastrectomy subjects showed a similar increase in GH pulsatility, circulating NEFA andhydroxybutyrate. Obese subjects had an impaired GH response (p<0.001), reducedhydroxybutyrate (p=0.01) and a borderline reduction in NEFA (p=0.09) compared to lean controls. Ghrelin infusion increased GH, NEFA and ketone bodies (ANOVA p<0.0001) in all three groups, but GH response was impaired in the obese (p=0.001). Ghrelin also induced a biphasic NEFA response to meals which was not present during the saline infusion. Conclusions: Obese and gastrectomized subjects both have low ghrelin levels, but have different responses to fasting in terms of GH, NEFA release and ketone body formation. Therefore ghrelin is unlikely to explain the metabolic changes seen during fasting. Ghrelin induced a marked biphasic response in NEFA, which may represent increased metabolic flexibility -low ghrelin may contribute to reduced metabolic flexibility in obesity. Epidemiological and clinical data indicate that almonds can be incorporated into the diet without promoting weight gain. This has been attributed to their strong satiety effects, stimulation of resting energy expenditure and limited bioaccessibility of the fat they contain. The mechanisms responsible for these properties have not been elucidated. The present cross-over design study focused on the role of mastication. Following an overnight fast, 13 healthy adults chewed 55g of almonds 10 (C10), 25 (C25) or 40 (C40) times while blood was collected via catheter and appetite was monitored on visual analog scales for 6 hours. Following this, all foods were provided to participants for the next 4 days including daily 55g almond portions that were consumed under the same chewing conditions. Complete fecal samples were collected. This was repeated for each chewing condition in randomized order with a 1 week washout between trials. Hunger was suppressed below baseline longer with C25 compared to C40 (p=0.01) and tended to be lower compared to C10 (p=0.057 Background: More than two thirds of US adults are overweight or obese. Although socioeconomic factors play a role in the differences in obesity between ethnic groups, genetic factors and nutrient intake should also be examined. Methods: Using food frequency questionnaires on 3000 White Americans and 1200 Asian Americans we investigated the role nutrient intake on BMI. We also compared the role of 22 genetic polymorphisms reported in the literature to be involved in nutrient metabolism or obesity. Results: Intake of vitamin B and E supplements, caffeine, saturated fat and refined carbohydrates was much higher in Whites (p<1 x 10 -20 ) than in Asians. Intake of cruciferous vegetables, vitamin A and allium was significantly higher in Asians. Some consistent effects were seen in both ethnic groups: the odds ratio for obesity for each additional SD of saturated fat intake was 1.49 (95%CI 1.26-1.76) in whites and 1.46 (95%CI 1.10-1.95) in Asians. For vitamin A the values were OR=0.82 (95%CI 0.71-0.99) in whites and OR=0.53 (95%CI 0.32-0.88) in Asians. Only a variant in the GSTP1 gene was significantly associated with BMI in whites, and a variant at the CBS gene in Asians. However, a different GSTP1 variant was significantly associated with BMI in whites but only among individuals with low vitamin A intake and not in those with high intake. Conclusions: The role of vitamin A on obesity is consistent with results from animal models. Our data illustrate the complexity of genetic and nutrient determinants of BMI and obesity, and show consistent patterns in two ethnic groups. 1. Conflict of Interest: This work was funded in part by Sciona Inc., Boulder, CO, USA. R. Gill is an employee of Sciona Inc, and K. Grimaldi is a consultant to Sciona Ltd. I. Arkadianos is a distributor of Sciona products in Greece 2. Funding: The contribution of Sciona (KAG, RDG) was partially supported by the European Commission under the FP6-IST4-027333 project "Micro2DNA: Integrated polymer-based micro fluidic micro system for DNA extraction, amplification, and siliconbased detection T1:PS.157 York D, Boghossian S, Park MJ, Lemmon K Utah State University Insulin has been suggested as a longterm regulator of energy balance, acting on the arcuate-paraventricular pathways to inhibit food intake and regulate energy metabolism. Insulin receptors are widely expressed in the brain, including in other areas, such as the amygdala, that are affect feeding behavior. The purpose of this study was to investigate if insulin was effective within the amygdala to inhibit food intake and if this response was influenced by dietary fat composition. Male Sprague-Dawley and S5B/Pl rats adapted to a low fat (10% energy) or high fat (40% energy) diet for 10 days after surgical implantation of guide cannulas to deliver drugs to the central bed nucleus of the amygdala (CBNA) or the third ventricle to deliver drugs to the arcuate -PVN region. In our experiments, insulin (4 or 8mU) given ic3v had no effect on food intake. In contrast, insulin (8mU) delivered onto the CBNA significantly inhibited food intake of SD rats fed the low fat diet over a 24 hour period. This effect was not observed in SD rats fed the high fat diet. Insulin tolerance tests indicated peripheral insulin resistance in these rats. Likewise S5B rats showed a CBNA insulin response that was diet dependent but in this case there was no evidence of peripheral insulin resistance on the high fat diet. These data suggest the CBNA as a site of insulin anorectic action and that central insulin resistance may develop in parallel to (SD rats) or before (S5B/Pl rats) peripheral insulin resistance. Introduction: Ghrelin and leptin are hormones, involved in the regulation of appetite and food intake. Ghrelin is derived from the stomach and has orexigenic effect, whereas leptin is secreted by the fat tissue and decreases appetite. It is still unclear how fructose-rich diet affects the plasma levels of ghrelin and leptin. Aim: The purpose of this study was to investigate the effect of fructose on the plasma and hypothalamic expression of ghrelin and leptin. We used 20 male Wistar rats. Rats were divided into two groups: the first group (experimental, n=10) received a 10 % fructose solution plus chow food; the second group (control, n=10) was fed with standard chow food ad libitum. Both groups were fed for a 13 -week period. Body weight was measured every week. At the end of the nutritional period rats were anesthetized and decapitated. Blood was collected for biochemical measurement of triglycerides, cholesterol and glucose. Hypothalamus and plasma were taken for determination of ghrelin and leptin with ELISA (Biovendor) and Western Blot methods. Results: At the end of the 13 th week body weight of the experimental group was significantly higher than the control group. Moreover, the plasma triglycerides and cholesterol levels were increased in the experimental group. Fructose administration in drinking water induces obesity and changes in lipid metabolism. Our results demonstrate the change of plasma ghrelin and leptin and difference in control and obesity group. Conclusion: Further investigations are needed to clarify the role of fructoserich diet on the plasma and hypothalamic expression of ghrelin and leptin. This study investigated the effect of the whey protein content of a liquid preload on subsequent food intake in men and women. Twelve male and twelve female non-obese healthy subjects completed four trials in a randomised cross-over design. All subjects were unrestrained eaters. Subjects were provided with a standard breakfast on the morning of each trial and then reported to the laboratory at 11am. Subjects completed baseline visual analogue scales (VAS) and then consumed the liquid preload. Further VAS were completed immediately post preload and at 30 min intervals for 90 min. Subjects were then provided with an ad libitum pasta meal. The preloads contained 0% (water), 12.5%, 25% or 50% energy from whey protein. Protein preloads were isocaloric (400 kcal) and isovolumetric. Following the 50% preload, male subjects consumed less energy at lunch than following the 12.5% and 25% preloads (P < 0.005). There were no differences in energy intake at lunch following the protein preloads in female subjects. There were no differences in total energy intake throughout the protocol in the male subjects but total energy intake was higher following the protein preloads than following water for female subjects (P < 0.05). Male subjects reported no differences in VAS ratings of hunger, fullness and desire to eat between trials. Female subjects reported higher hunger and lower fullness and desire to eat scores in the water trial compared to the protein trials (P < 0.05). Whey protein has differential effects on food intake and appetite in male and females. The pre-meal priming of gastrointestinal satiety factors does not affect short-term energy intake in normal weight men. Willbond, S, Doucet, E University of Ottawa, Ottawa, Canada Background: Although experimental studies on meal frequency are few, results tend to show that increasing the number of daily meals leads to decreased energy intake (EI). No studies have yet looked at the type of meal patterning that would maximize this effect. Objective: The purpose of this study was to determine if timed preloads impact on EI, appetite, and PYY and GLP-1 concentrations. Design: Eight normal weight men (79.9 ± 11.1 kg) participated in 3 full-day randomly assigned experimental conditions. In condition 1 (C1), subjects self selected their meals and snacks ad libitum. In condition 2 (C2), subjects consumed a standardized preload (300 Kcal: 40 % protein, 40% carbohydrate and 20 % fat) 15 minutes prior to lunch and dinner. During condition 3 (C3), subjects consumed the preload, at times that maximized their pre-meal fullness levels. During each condition, a standardized breakfast was served, while lunch and dinner were self-selected from a 5 item menu, and eaten ad libitum. Daily EI, fasting and postprandial appetite, PYY, and GLP-1 were sampled every 30 minutes for 9 hours for all 3 conditions. Results: No difference in daily EI, AUC GLP-1, and PYY was noted between conditions. Pre-meal peptide levels tended to be higher during C3. Desire, hunger, and PFC were lowest during C1 (P<0.05 While the current body of medical literature does recognize the surprising prevalence of Vitamin D deficiency, particularly in the overfat population, it does not provide conclusive evidence that replacing Vitamin D stores will result in favorable changes to body composition. The purpose of this study, therefore, is to prospectively examine the effects of Vitamin D repletion on fat-free mass. Overweight and obese patients from our Endocrinology Clinic will be screened for Vitamin D deficiency, electrolyte abnormalities, and renal dysfunction. Those individuals whom are determined to be Vitamin D deficient (as defined by a 25-Hydroxyvitamin D of less than 30 ng/ml) will have a baseline fat mass determination using a Tanita Body Composition Analyzer Goal Setter (Model TBF-310) and will be started on weekly, high-dose Vitamin D 2 (50,000 International Units) for a duration of 3 months (This dose and / or frequency may vary if the patient is known to have malabsorption.). Once Vitamin D replacement is complete, a post-treatment fat mass analysis will be performed (using the same Tanita Body Composition Analyzer) and a repeat 25-Hydroxyvitamin D level (along with serum calcium, phosphorus, and creatinine) will be drawn for comparison. We anticipate an enrollment of approximately 50 overfat, Vitamin D deficient patients, thereby powering this small, pilot study to reliably detect a 3% difference in body fat. We hope to demonstrate that the percentage of fat-free mass in overweight and obese Vitamin D deficient patients will be positively impacted by the repletion of Vitamin D stores. International Journal of Obesity This study aimed to determine whether maternal dietary protein level affects adipose tissue features of the resulting offspring at birth and later in age. Sows were fed control (C, 12% protein), low-protein (LP, 6% protein), or highprotein (HP, 30% protein) diets throughout pregnancy. Birth weight was lower (P < 0.01) in LP (1.14 + 0.03 kg; n = 114) and HP (1.25 + 0.03 kg, n = 87) piglets than in C piglets (1.36 + 0.02 kg, n= 136). At day 1 of age, the percentage of subcutaneous fat tended to be higher (P = 0.10) in LP piglets (11.29 + 0.27) than in C piglets (10.6 + 0.27), whereas it did not differ between HP (10.6 + 0.28) and C animals. Concurrently, the specific activities of fatty acid synthase and malic enzyme, two lipogenic enzymes, were enhanced by 63% (P = 0.01) and 55% (P = 0.06), respectively, in subcutaneous fat of LP piglets compared with C piglets, whereas no differences were observed in these traits between HP and C piglets. Preliminary proteomic investigations using 2dimensional gel electrophoresis (n = 6 per each group) revealed 37 spots significantly different in abundance (fold-change > |1.3|, P < 0.05) in subcutaneous fat from LP piglets vs. C animals; 11 spots differed between HP and C piglets. Differentially-expressed proteins will be further identified, and eventually studied at 185 days of age. In conclusion, preliminary data suggest that maternal protein deficiency could affect body composition and adipose tissue traits in the offspring at birth. Funded by the Deutsche Forschungsgemeinschaft (KA 1844/1-1, ME 1420/8-1), Bonn, Germany Physical activity has a preponderant role in long term body weight maintenance. In the past, programmes had only a feeble impact on patient motivation for physical activity: little mobility during hospitalization and few planned changes in this area at the end of the stay. However, patients have to see physical activity as a priority. Objective: To help patients understand the importance of physical activity, and make them experiment it daily during a 15-days hospitalization weight loss programme. Theory and practice about physical activity were continuously linked together. A specific communication was adopted with the patient: advices and repeated messages were replaced by a knowledge building taking into account the patients' representations. A systematic follow up of patients helped them to express their feelings during and after the experimentations as well as about their past experiences. The practice consisted in adapted physical activities conducted each day of the hospitalization and implemented following a progressive intensity. This was made according to the patient's pleasure and with the aim of providing them a positive experience. At the end of the programme, the patients' response to this intervention was evaluated as well as the implication of helpers, the impact of the group and the safe and non-judgmental framework. In conclusion, patients made links between the experimented physical activity and their body weight loss. They could experiment it with pleasure, this opening perspectives for patients to introduce changes in their life.. Impact of time interval between meal and exercise on substrates oxidation during exercise and recovery in obese children vs 3h: 30.79±12.76mg.kgLBM -1 .min -1 ) were not significantly different between the two conditions. Discussion: During a moderate intensity cycling exercise obese children rely almost totally on CHO whether they are fed 1h or 3h before exercising. Exercising at distance from breakfast does not favour fat oxidation in obese children. Contribution of resting energy expenditure to weight gain in young children -a longitudinal study Hosking J, Metcalf B S, Jeffery A N, Voss L D, Wilkin T J Peninsula Medical School, Plymouth Campus, Plymouth, UK Background: Resting energy expenditure (REE), the largest component of total daily energy expenditure, is potentially important in the regulation of body weight. However, its role remains controversial and little is known of its contribution to weight gain or changes in body composition (fat mass and %fat) in children. Aim: Evaluate the contribution of REE at 7y to weight gain and changes in body composition over 36 months. Methods: REE by indirect calorimetry and body composition by DEXA were measured in 179 children (97 boys) from the EarlyBird cohort, annually from 7y to10y. The effect of REE at 7y on subsequent change in weight, excess weight (SDS), and body composition was analysed using linear mixed effects models with body composition and age at baseline entered as covariates. Results: In girls there were small but statistically significant negative associations between REE at 7y and subsequent change in fat mass (~ -0.1kg/year/100kcal, p= 0.01), %fat (~ -0.4%/year/100kcal, p= 0.0002), and excess weight (~ -0.02sds/year/100kcal, p= 0.01). In boys there were no significant effects of REE at 7y on change in fat mass, %fat or weight SDS (all p> 0.34) but a small positive association was found between REE at 7y and change in weight (~ 0.2kg/year/100kcal, p<0.001). Conclusion: The association between REE and change in weight and body composition was small yet statistically significant, together suggesting with some certainty that REE has little impact on the wide variation in weight gain at this age. Funding: The EarlyBird Study is currently funded by: The Bright Futures Trust, the Child Growth Foundation, the EarlyBird Diabetes Trust, GSK, the Kirby Laing Foundation, Nestle, Novo Nordisk. The effect of nutritional education on knowledge and attitude about fruits,vegetables and dairy products consumption importance in primary school girls in Tehran local (zone 2 ). Kaviani M, Shishehbor F, Aminpour A, Abadi A . National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shaheed Beheshti University, M.C. Background & purpose: Today, incorrect child's food pattern ,specially clear reduction in fruit, vegetable and dairy products consumption , is one of the most important anxiesty of our world. This matter affect child's growth and health .Food selection of this susceptible group is affluent by their knowledge and attitude. In Iran, some studies have been done about the impact of nutrition education on child's knowledge and attitude but the emphasis on fruit, vegetable and dairy product were rare. Also, education sustainability didn't considered . So this survey has been done to determine the impact of nutrition education on knowledge and attitude about fruits, vegetables and dairy products consumption importance in local (zone2) primary school girls in Tehran . This experimental study has been done on 187 4 th grade primary school girls who were selected by polyhedron racemose sampling method from 6 local (zone2 ) primary school in Tehran who were randomly distributed into 2 groups :first group educated by lecture as case and non educated group as control. Data were gathered via a self-administered questionnaire that consisted of 3 section: general, knowledge and attitude questions that it's reliability and validity was confirmed by experienced experts and a pilot study, through pre-test and 2 post-tests that was done before , 1 & 3 weeks after education intervention respectively. Education was performed as lecture trough 3 one-hour sessions by a nutritionist for case group and no education for controls. Data were analyzed by SPSS/WIN soft ware. Results: Knowledge and attitude levels of each 2 groups, case and control, didn't show significant differences before intervention. After intervention, the mean of knowledge score showed significant increase in case group to compared with control and before education in 2 post-tests (p<0.001). The attitude score mean in 2 post-tests to compared with control and before intervention, showed significant statistical differences (p<0.001) but these differences weren't considerable. The results of this study showed that, nutrition education via lecture significantly increased score levels in case group to compared with controls and before education. This increase in knowledge level had good sustainability in long time (after 3 weeks), but this education didn't have considerable effect on students attitude. Key words: school girls, nutrition education, knowledge, attitude, vegetable-fruit-dairy product Not total body fat, but especially fat accumulated in the abdominal site resulting in upper body obesity (UBO) seems to be related with increased metabolic risk. In a previous study we found that a nine day dietary fat intervention affected subcutaneous fat characteristics of lean and overweight subjects. In the present study we examined the differences in subcutaneous fat characteristics and fat metabolism in overweight men with UBO or lower body obesity (LBO). In a cross-over trial 12 male subjects (age 51±7 y; BMI 28.5±0.8 kg.m -2 ) consumed medium chain fatty acids (MCFA) (C8-C10: 65%; C16: 29%; > C18: 6%) or poly-unsaturated fatty acids (PUFA) (< C16: 1%; C16: 28%; > C18: 71%) for three weeks, by replacing in total 60 grams of their normal spread intake by the fat supplement. Handling of the consumed fatty acids is hypothesized to be different in UBO (n=5; WHR 1.04±0.05) or LBO (n=7; WHR 0.97±0.02) men due to their fat disposition and the routing of these fatty acids. MCFA will be transported directly to the liver, while PUFA will be absorbed by the chylomicrons via the lymph and transported through the body to the periphery. The effect of the spread supplements on lipoprotein profile, protein synthesis (lipoprotein and adiponectin), fatty acid metabolism in blood and fat tissue was measured with stable isotopes ( 2 H 3 -Leucine enrichment; and U-13 C18 and 13 C4octanoic acid, resp.), which were supplied intravenously and orally. It is hypothesized that PUFA spread will preferentially dispose fat in the periphery affecting lipoprotein and adiponectin production. Results of the study will be presented at the congress. Obesity is a significant risk factor for metabolic diseases, such as atherosclerosis and heart disease. There is emerging evidence that excess adipose tissue, acting as an endocrine organ, may contribute to systemic "silent" inflammation. Therefore, our objective was to illuminate how further insight into adipose tissue metabolism could help identify nutraceutical ingredients which may reduce obesity related health risks. Excess adipose tissue produces and secretes circulating factors, or 'inflammatory' mediators that may act at distant sites as key modulators of risk for a number of chronic diseases such as insulin resistance, atherosclerosis, and dyslipidaemia. In obese subjects, levels of several pro-inflammatory cytokines, including TNFalpha, IL-6 and leptin were significantly higher compared to nonobese. Recently it was reported that even in normal weight subjects with body fat masses >30%, plasma levels of TNF-a and IL-6 were elevated. Epidemiology shows that weight loss as such does not reduce CVD risk, while fat loss does. Therefore, fat loss represents a safe method for downregulating the inflammatory state and may improve various aspects of health such as risk for diabetes or coronary disease. Evidence is growing that several fat loss enhancing ingredients, like green tea, guarana or CLA may help to sustainable counteract obesity related inflammation. More than 30 clinical studies have demonstrated that CLA, a naturally occurring dietary fatty acid, reduces body fat mass while maintaining lean body mass. While CLA may not reduce obesity induced inflammation per se, it may modulate the immune response associated with the chronic inflammation. Variants in the FTO gene are associated with common obesity in the Belgian population. Oleoylethanolamide (OEA) is the monounsaturated analogue of the endocannabinoid anandamide. Differently from anandamide, which causes overeating and stimulate lipogenesis by activating CB1 receptors, OEA decreases food intake and body weight gain in rats and mice through a cannabinoid receptor-independent mechanism. The effects of OEA on feeding are behaviourally selective and are due to the prolongation of feeding latency and post meal interval. A large body of evidence indicate that they are mediated by the activation of peripheral PPAR-alpha receptors, but the central mechanisms downstream to this activation that are still unclear. Data obtained mapping brain c-fos mRNA levels revealed that the systemic administration of OEA evokes highly localized increase of c-fos transcription in the nucleus of the solitary tract (which is in accordance with the peripheral action of OEA), the paraventricular nucleus (PVN) and the sopraoptic nucleus (SO). The magnocellular components of both nuclei release oxytocin, one of the anorectic hypothalamic neuropeptides. During feeding, magnocellular oxytocin neurons, especially those in the SO, become strongly activated indicating their imminent role in meal termination. We hypothesized that oxytocin neurons, might play a key role in regulating energy intake after OEA administration. In agreement with our hypothesis, we found that OEA enhances the gene expression of oxytocin in both areas and that its anorexiant action can be prevented by pretreatment with a selective oxytocin receptor antagonist. Our data suggest that oxytocin release in the PVN and SO nuclei may be responsible for the mediation of the effects induced by OEA on feeding. Variation in postprandial peptide YY 3-36 status following ingestion of high carbohydrate, high fat and high protein meals in obese females Aim: This study investigates the effect of macronutrient composition of meals on postprandial peptideYY 3-36 (PYY 3-36 ) response, in obese hyperinsulinemic females. Methods: Eight obese females consumed three iso-energetic meals of different macronutrient composition, a high carbohydrate (HC) (60% CHO, 20% protein, 20% fat), a high fat (HF) (30% CHO, 20% protein, 50% fat) and a high protein (HP) (30% CHO, 50% protein, 20% fat), on three separate occasions, 1 month apart. PYY 3-36, insulin and glucose were measured before, and 15, 30, 60, 120 and 180min following each meal. Results: PYY 3-36 levels increased significantly following the three meals with the HC meal resulting in a sustained postprandial increase in PYY level throughout the experimental period. Comparing the three meals, the HF meal induced a significantly higher increase in postprandial PYY 3-36 levels, at 15 and 30min as compared to the HP (p <0.05). whereas the postprandial increase following the HP meal became significantly higher than that of the HF meal at 120min. Postprandial increase in PYY was highest in the first hour following the HF meal, while that of HP meal was delayed by one hour. Conclusion: Increasing both protein and fat content of a meal may induce an immediate and prolonged increase in PYY 3-36 , resulting in increased satiety and its maintenance for a longer period of time. Acknowledgment: This study was supported by the Lebanese National Council for Scientific Research and the University Research Board of the American University of Beirut, Lebanon. Do overweight subjects show consistency on adlibitum food consumption and self-reported food intake in laboratory intervention studies? Effect of a protein-containing liquid preload on voluntary food intake at a subsequent meal Lara J, Astbury NM, Taylor MA, Macdonald IA School of Biomedical Sciences, University of Nottingham, Nottingham, UK Background: Recent studies indicate that certain types of milk protein (eg whey) may be more satiating than others (eg Casein). However, most studies on this topic have been carried out in normal-weight individuals and their replication might not be feasible in overweight/obese subjects. Methods: Six healthy men and two women, BMI 27-32 kg/m 2 , aged 18-45 yrs, not dieting and weight-stable during the previous three months were studied. Women were studied during the first phase of their menstrual cycle. The day of the study participants consumed a standardized breakfast providing 10% of their daily energy requirements. In a randomized cross-over design, 150 minutes after breakfast, participants consumed either a 250 kcal (40% of energy from whey-protein) or a control non-energy flavoured liquid preload (400 ml), with each being repeated on two occasions. Ninety minutes later, adlibitum food intake was assessed at lunch. Visual analogue scales for subjective appetite were scored every 30 minutes. Food intake during the remaining of the day was also reported. Treatments were repeated within a week to assess consistency of results. Results: Eating at lunch and during the remainder of the day was consistent for the repeated exposure of each arm of the study. Energy intake at lunchtime was 115 kcals lower after whey-protein, representing 46% of the preload energy content. No significant differences in appetite ratings were observed between treatments. Conclusions: Our results in overweight/obese subjects participating in a laboratory study showed consistency in ad-libitum and self-reported food intake. Funding: Research relating to this abstract was funded by Mars UK. Baseline leptin levels affect the response of leptin to 6 months of aerobic exercise training. Lowndes, J, Kyriazis, G. Angelopoulos TJ University of Central Florida, Orlando, USA There is inconsistency regarding whether aerobic exercise training (ET) causes a reduction in leptin in weight stable humans. We speculate this may be due to the variability of leptin levels within the studied populations. The purpose of this study was to examine whether baseline leptin levels affect the response of leptin to ET Ninety seven previously sedentary individuals underwent a 6 month progressive and supervised ET program (60-85% VO2max, 45 minutes per day, 4 days per week). Blood was sampled for the measurement of leptin prior to ET, 24 and 48 hours after completion of the final ET session. All participants were instructed to maintain normal eating habits in order to maintain weight. ET resulted in a small reduction in body mass (80.47 ± 18.03 vs 79.42 ± 17.34kg, p<0.01). Leptin was reduced 24 hours post, but returned to baseline values 72 hours post (Pre: 13.51 ± 12.27, 24hr: 12.14 ± 12.34, 72hr: 12.98 ± 11.40 ng/ml). We compared the lowest 10% (n=9) of baseline leptin to the highest 10% (n=9). There was a significant time X baseline leptin interaction whereby the highest 10% did not follow the typical pattern of increasing leptin between 24 to 72 hour post-training. We expanded the subpopulation to the lowest (n=24) and highest quartiles (n=24) of baseline leptin. Despite the larger sample size the time X baseline leptin interaction disappeared These data suggest that ET is successful in reducing leptin levels only in those whose baseline levels are the highest. Insulin sensitivity can be partitioned into basal (hepatic) and peripheral (muscle, adipose tissues) sensitivity. Adipocytokines are important fat mediators for glucose homeostasis in insulin-resistant subjects. However, relationships of abdominal fat with the basal and dynamic components of insulin sensitivity have not been yet elucidated. Aim was the assessment of possible relationships of adiponectin and leptin with these components of insulin sensitivity in overweight type-2 subjects (T2DM) with plurimetabolic syndrome. Methods: T2DM (5F/11M; 59±2 yr; duration=5±1 yr; HbA1c=6.7±0.1%; BMI=29.5±1.1 kg/m 2 ; waist=104±2 cm; basal glucose=134±5 mg/dl; basal insulin=9.4±1.2 μU/ml; uric acid=5.3±0.3 mg/dl) and 16 matched overweight controls (CTN) underwent a 75g-2h OGTT. Lipid profile was (mg/dl): cholesterol=204±8, HDL=53±3, LDL=119±8, triglycerides(TG)=168±27. Abdominal fat was determined as cardiovascular risk factor LAP [lipid overaccumulation=(waist-k)×TG; k=gender constant]. Basal insulin sensitivity was measured with QUICKI index and the peripheral one with OGIS. Results: LAP was 66±8 cm×mM/L. T2DM and CNT adiponectin (7.4±0.5, 7.8± 0.9 μg/ml), leptin (13±3, 13.3 ng/ml) and QUICKI (0.39±0.01, 0.39±0.01) were not different (p>0.2); OGIS (317±11, 406±12.6 ml min -1 m -2 ) was lower in T2DM, p=0.0001. LAP inversely correlated with OGIS (R=-0.57, p=0.026) and QUICKI (R=-0.56, p=0.022) only in T2DM. Cytokines were normalized to BMI (adiponectin=0.25±0.02; leptin=0.42±0.08). Leptin inversely correlated with QUICKI (R=-0.45, p=0.009), adiponectin directly with OGIS (R=0.43, p=0.015), in all subjects. Conclusions: Lipid overaccumulation plays a major role in insulin sensitivity impairment. Adipocytokines mediate insulin resistance, but have different sites of action: adiponectin operates at peripheral tissues level; leptin is active mainly on fasting (liver) sensitivity and is not relevant in diabetic state. Association of angiotensin-converting enzyme dd genotype with diminished thermogenesis in response to acute cold exposure in healthy children Nagai, N 1 , Sakane, N 2 , Kotani, K 2 , Kimura, T 3 , Hamada, T 2 , Moritani, T 3 Introduction: The adipose tissue renin-angiotensin system (ARAS) contributes to regulation of fat mass and may also impact on energy metabolism. We previously reported that an insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme (ACE) gene affected the activity of autonomic nervous system (ANS) in healthy young females. In this study, we therefore examined whether or not the ACE I/D polymorphism was associated with cold-induced thermogenesis in healthy children. Subjects and methods: Twenty-two children (6-11yrs) were genotyped for I/D polymorphism of the ACE gene by applying a PCR-restriction fragment length using buccal samples. Resting energy expenditure was measured by indirect calorimetry for 30 min under thermoneutral (25ºC) or cold conditions (10ºC) in an environmental chamber. The activity of ANS was assessed by power spectral analysis of heart rate variability (HRV). Samples of saliva were collected for cortisol determination at the end of experimental session. Each experiment was performed on 2 consecutive days. Results: During cold exposure, total power of the HRV, an index of overall ANS activity, as well as the salivary cortisol concentration significantly increased in the children with wild-type (II) and heterozygous alleles (ID) (II+ID, n=16); while no response was observed in the carriers of homozygous (DD, n=6). Moreover, the DD group showed a significantly lower thermogenesis compared to the II+ID group. Conclusion: Despite cold-induced sympathetic stimulation, the DD genotype had lower thermogenesis potentially through reduced activity of the sympathetic system, supporting the possibility that ACE DD genotype may be one of the genetic markers for future pathogenesis of obesity. Altered eating patterns and a shift toward night consumption has been reported in obesity. We questioned whether animals susceptible to DIO modify their eating behaviours. Adult Sprague-Dawley rats (n=29) were randomly given, ad libitum, high-fat (canola-oil or butter) diets or chow for 50d, followed by low fat diet for 28d and 40% energy restriction for 32d. By day 28, only rats (n=4) in the butter-fed group were categorized, based on excessive obesity index, as DIO-prone. Their behaviour differed from other rats: when switched from chow to high fat diets, they ate the same volume of food and increased their energy intake (61±4 to 99±4 kcal/d, P=0.001), and weighed more (P =0.027) than other high-fat fed rats by day 50; by contrast, canola-fed animals decreased food volume to maintain energy intake. DIO-prone rats had higher weight at baseline (P=0.044) than other groups, and greater abdominal fat volume and leptin levels (P <0.04) than other restricted animals after weight loss. During high-fat diets, DIO-prone ate comparable amounts of calories during light and dark cycles; during energy restriction, they kept food for later contrary to other food-restricted rats. In conclusion, DIO-prone animals develop obesity by failing to compensate for the increase in energy density, only when given a palatable diet, and eating more at inappropriate times; adjustment to diets reduced in energy density is also altered. These behaviours support the known associations between high fat diets and prevalence of obesity in humans and the therapeutic potential for low fat diets to induce weight loss. There is a tight connection between nutrition and health. Most of increased body mass and obesity problems, one third of all cardiovascular diseases and about 40% of malign diseases could be prevented by changes in nutritional habits and increased physical activity. The aim of this research was to evaluate nutritional status (on the basis of BMI), prevalence of chronic noncommunicable diseases, basic dietary habits, and physical activity of adults according gender (485 male, 2500 female). On line questionnaire was placed on a web pages of Podravka, one of the biggest food industries in Croatia, www.coolinarika.com. According the self reported mass and height and BMI calculated, 55% of participants had normal weight, while 42% of participants showed increased body mass. Among men, overweight and obesity were more common, while among women underweight and normal weight were more dominant. 15% of all participants were suffering of chronic noncommunicable diseases, men a bit more that women. The most common diseases encompass hypertension, heart diseases, diabetes, food allergies and thyroid gland problems. Most of the participants were occupied by sedentary activities 2-5 hours a day, and again with higher prevalence among men than among women. In conclusion, our results showed that women more often respect dietary recommendations, often eat breakfast and light meals, take more care of the foods choice, have lower BMI and lower incidence of the chronic noncommunicable diseases. International Journal of Obesity T1:PS.178 Becerril, S 1,3 , Gómez-Ambrosi, J 1,3 , Rodríguez, A 1,3 , Catalán, V 1,3 , Frühbeck, G 1,2 1 Metabolic Research Laboratory, and 2 Department of Endocrinology, Clínica Universitaria de Navarra, Pamplona, and 3 CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Spain. Background: Leptin mediates several physiological processes through the activation of inducible nitric oxide synthase (iNOS). The aim of the present study was to evaluate the absence of the iNOS gene on energy homeostasis in genetically obese ob/ob mice. Methods: A double knockout (DBKO) mouse model lacking simultaneously the ob and iNOS genes was generated by intercrossing ob/ob mice with iNOS knockout mice (iNOS -/-). Male mice were fed a normal chow diet for 12 weeks. Body weight, food intake and body temperature were periodically registered. Serum free fatty acids (FFA) were measured and mRNA expression of Pgc1-α was analysed by Real-Time PCR. Results: Body weight was significantly lower in iNOS -/mice as compared with wild type counterparts (26.1±0.3 vs 24.9±0.4 g, P<0.05), in spite of not showing differences in food intake. The reduction in body weight was accompanied by decreased epididymal fat pads (0.64±0.03 vs 0.49±0.02 g/100g body weight, P<0.05). Energy expenditure in iNOS -/mice was significantly higher than that of wild type mice as evidenced by rectal temperature ( The results suggest that an increase in dairy consumption over 4 weeks does not affect 24H EE or substrate oxidation. However, since an increase in exercise EE and a decrease in hunger was observed, dairy consumption might play a role in weight maintenance over a longer period. Genetic polymorphisms of the renin-angiotensin system and obesity-related metabolic changes in response to calorie restriction therapy in obese women Several genetic polymorphisms of the renin-angiotensin system (RAS) have been implicated risk factors for hypertension and cardiovascular disease. The polymorphic effects of the RAS (insertion/deletion of ACE gene and A1675G of AT2R gene) on blood pressure (BP) and obesity-related metabolic changes in response to weight loss induced by low-calorie diet (LCD) with meal replacement drinks (diet's®, SUNTORY Ltd.) were investigated in 32 obese women (age 49.9 ± 8.4 yrs). Clinical, metabolic and biochemical profiles were measured before and after a 2month intervention of LCD. RAS gene polymorphisms were determined with a fluorescence-based allele-specific DNA primer assay system. Although weight reduction and nutrient intake did not differ among the genotypes, subjects with the ACE D/D genotype and the AGTR2 G/G genotype remained unchanged systolic and diastolic BP, insulin, LDL-and HDL-cholesterol levels, triglyceride, and whole body fat oxidation. Importantly, the AGTR2 G/G genotype showed significantly less improvement of systolic BP (2.5 ± 5.0 vs. -7.2 ± 8.5mmHg, P<0.01), LDLcholesterol levels (-3.5 ± 9.8 vs. -13.6 ± 11.6mg/dl, P<0.05), and whole body fat oxidation (0.1 ± 9.9 vs. 8.3 ± 11.9mg/min, P<0.05) than other AGTR2 genotypes. Furthermore, reduction in body fat after weight loss was significantly less in ACE D/D genotype than in other ACE genotype (-0.8 ± 1.6 vs. -2.3 ± 1.4%, P<0.001). These findings suggest that the homozygous form of the ACE and AGTR2 gene could be a polymorphic marker predicting difficulty in improving BP and obesityrelated metabolic profiles following a LCD to induce weight loss in obese women The energetic and cardiovascular response to walking and cycling in obese women Physical activity has a main role in obesity management, but exercise capacity is compromised in obese individuals due to excess of mass altering energetics of movements and to dysfunctions of regulatory mechanisms affecting cardiovascular responses. To compare the energetics of walking and cycling, and the related cardiovascular responses in obese individuals, in order to define the exercise modality most sustainable and effective for obesity rehabilitation and weight loss programs, 15 obese (OB) and 6 normal weight (NW) women exercised on treadmill (TM) and cycle ergometer (CE) while gas exchange, heart rate (HR) and metabolic rate (E) were determined. Net cost of transport (NCOT) was calculated for walking and mechanical efficiency (ME) for cycling. During walking, net E was 2.2-2.3 fold higher in OB than in NW (p<0.001), as well as net E/(body mass, BM) and NCOT (p<0.05), which correlated with BM (p<0.001-0.01). During cycling, net E was significantly (p<0.01-0.001) higher in OB than in NW (about +23%) and correlated with BMI (p<0.001). Net leg movement E depended from BMI and, when accounted for, no difference in cycling E between groups remained. While net ME was significantly lower in OB (p<0.001), work ME was similar for OB and NW (p=0.193). In both groups, HR was higher during CE than TM at the same oxygen uptake (VO2), but in OB the HR increment over VO2 was greater for CE than for TM (p<0.001). Due to body mass mechanics, TM locomotion in given conditions is much more costly for OB than NW. When accounting for extra mass, differences in E among groups are abolished for CE, indicating no obesity derangement of muscle efficiency, but not for TM, suggesting that differences in biomechanics may explain the higher E/BM and NCOT of OB. Nonetheless, due to different cardiovascular responses to TM and CE in OB, walking is more convenient, enabling OB to attain target energy expenditure at lower HR, or in shorter time. Olszanecka -Glinianowicz M, Zahorska -Markiewicz B, Janowska J, Kocełak P, Semik -Grabarczyk E Objective: The aim of the study was to determine the prospective changes of proinflammatory cytokines concentrations in obese women in relation to weight changes during 5-year observation. Material and methods: 30 obese women without concomitant diseases (n = 68, age 53.4.0 ± 8.4 y, BMI: 38.9 ± 5.6 kg/m 2 ) were subjected to the complex weight reduction therapy. Serum concentrations of TNF-α, sTNFRs, NO and IL-6 were measured by ELISA method at the beginning of observation, after three months of complex weight therapy and after 5 years. Results: Three-month weight reduction therapy led to mean weight loss 7.9 ± 4.4 kg. After 5 years 7.6 ± 6.6 weight gain was observed. No changes of TNF and IL-6 levels were detected after weight gain. It is interesting observation that serum concentrations of sTNFRs increased after both weigh loss and gain. IL-6 (pg/ml) 10.9 ± 4.6 8.8 ± 2.3** 7.9 ± 3.5** ++ + p < 0.05; +++ p < 0.0001; ** p < 0.0001;***p < 0.0001 Conclusion: The results of our prospective observation suggest that weight loss causes long-term inhibition of systemic inflammatory activation and subsequent yo-yo effect does not reverse this beneficial effect. The Aim: estimate efficacy of correction nutrition by using individual select elimination diet based on results Antigen Leukocyte Cellular Antibody Test (ALCAT) Material: 1150 patients have been included in research (women -676, men -474). Middle age -39±2,1. Methods: we calculated body-mass index (BMI), quantity of total fat, visceral fat, muscular mass -device OMRON BF 306, BF 500 to all patients, parameters were estimated each months. We corrected nutrition to patients with overweight and obesity based on results of ALCAT -device ROBOCAT II; individual elimination diet was determined for 3 and 6 months. Results: we distributed patients on 3 groups. 374 persons were in the first, BMI did not exceed 25; 517 -in the second, BMI within the limits of 26-30; 259 -in the third, BMI exceeded 30. After 6 months observance elimination diet according ALCAT at 448 patients in the second group BMI did not exceed 25, at 35 was within the limits of 26-28. In 178 patients at the third group BMI was lower 26, and at 44 was within the limits of 26-28. Conclusion: we have been discovered high prevalence of visceral fat among man and high percent of total fat in woman with overweight and obesity; OMRON BF 500 more effective for estimation efficacy of individual select elimination diet in patients. ALCAT is effective method of individual select elimination diet for patients with overweight and obesity in Ukraine which gives proof effect of normalization and stabilization of weight during long time. Weight and eating patterns' evolution, 5 years after gastric by-pass. Gastric by-pass is the recommended treatment for morbidly obese patients. Published data show 80% success rates at one year, and 50% at 5 years. Data on weight evolution after 5 years are sparse. Our aims were to measure weight and eating behaviour changes, and to identify factors associated with 50% excess weight loss (EWL) > 5 years after gastric by-pass. Patients who underwent gastric bypass and were followed at the Obesity consultation of University hospitals of Geneva, Switzerland, were included. Of 141 eligible patients, 74 (52%) accepted an appointment during which two dieticians weighed them, investigated eating patterns, anxiety and depression, by means of interviews and questionnaires. Baseline body mass index was 46 (+7) kg/m 2 . Mean duration since operation was 7 (+1.2) years. One year after surgery, all patients had lost weight (mean 36 +12 kg) and 88% experienced >50% EWL. Between the second and the 7 th year, 15% lost >5kg, 28% stabilized weight and 57% regained weight: 17% 5 to 9 kg, 29% 10 to 19 kg and 11% > 20 kg. Among the 41 patients who regained weight, 19 presented nevertheless 50% EWL. After seven years, 64% presented >50% EWL, but 51% suffered from binge eating disorder or night eating syndrome. Among women, factors independently associated with 50% EWL were depression (p=0.01), lower energy (p=0.01) and protein intake (p=0.02). Gastric by-pass has very good results in terms of weight loss more than five years after the operation. Many patients, however, suffer from eating disorders. Effect of genotype at TCF7L2 rs7903146 on weight loss: interaction with fat and carbohydrate content of hypo-energetic diet Grau K 1 , Cauchi, S, Taylor, MA 2 , Holst C 1 , Toubro, S 2 , Polak, J 2 , Clément, K 2 , Martinez, JA 2 , Langin, D 2 , Oppert, J-M 2 , Stich, V 2 , Macdonald, I 2 , Arner, P 2 , Saris, WHM 2 , Pedersen, O 2 , Astrup, A 2 , Froguel, P 2 , Sørensen, TIA 1,2 1 Institute of Preventive Medicine, Copenhagen University Hospital, Centre for Health and Society, Copenhagen, Denmark; 2 Nugenob Consortium. Objectives: To investigate if TCF7L2 rs7903146 genotypes (CC, CT, TT), of which TT is known to be associated with type 2 diabetes, affects changes in obesity related phenotypes during hypo-energetic diets with different fat-and carbohydrate content. Subjects and Methods: In a 10-week, European, multi-centre dietary intervention study 771 weight stable, obese (BMI >=30 kg/m 2 ) men and women were randomised to a high-carbohydrate (20-25 % of energy from fat; 60-65 % of energy from CHO) or high-fat (40-45 %E fat; 40-45 %E carbohydrate), hypo-energetic diet (-600 kcal/day). Of 739 genotyped, 622 completed the intervention with an average weight loss of 6.8 kg. Results: Adjusting for gender, age, centre and baseline value of outcome, we found significant interaction between rs7903146 (recessive effect) and diet in weight loss (Δweight) (P=0.023), loss of fat free mass (ΔFFM) (P=0.032), waist circumference (ΔWC) (0.023) and decrease in homeostasis model assessed insulin resistance (ΔHOMA-IR) (P=0.001), but not in insulin secretion. Changes in obesity related phenotypes were similar for TT on high-CHO diet; and for CC and CT on either diet. In patients randomised to high-fat diet, the TT group Δweight was 2.08 kg (95%-CI: 0.50-3.65), ΔFFM 1.3 kg (95%-CI: 0.19-2.42), ΔWC 2.4 cm (95%-CI: 0.32-4.47) and ΔHOMA-IR 1.26 (95 %-CI: 0.52-2.00) smaller than the CT and CC groups. The genotypes had a similar effect on loss of fat mass, but in an additive model. Background: Effects of reduced or more sustained postprandial glucose rises on appetite are inconsistent, perhaps due to lower energy availability of the carbohydrates tested. A true "slow carb" is completely digested in the small intestine but at a slower rate. We compared effects of a true "slow carb" versus rapidly digestible carbohydrates on glucose, insulin and appetite responses. Methods: In a 4-way fully randomised double-blind crossover design 35 normal weight volunteers received Slim.Fast meal replacement drinks with 15 g maltodextrin (control), or with maltodextrin replaced by 15g long-, medium-or short-chain Pullulan (LCP, MCP, SCP: 200, 23 and 10 kDalton, respectively). Appetite scores (6 line scales), digestibility (breath hydrogen) and (in an n=12 subset) blood glucose and insulin levels were measured for 5 hours. All parameters were analyzed using ANOVA and baseline values as covariates. Results: 77, 89, and 23% of SCP, MCP and LCP, respectively was digested in the small intestine, and at a slower rate than control. Breath hydrogen data confirmed the same pattern. Consistent with this, LCP produced the lowest, and control the highest blood glucose and insulin excursions, with MCP and SCP showing intermediate and more sustained patterns. All appetite scores were significantly improved after LCP versus control, while after MCP it was significantly improved for "satiety" only. All differences were apparent during the first 150 min. Discussion: MCP provided more available energy than the largely indigestible LCP, and can be regarded as a true "slow carb". However, LCP had the most consistent effects on appetite. We conclude that more modest rises in glucose have minimal effects on appetite, when tested in products only differing in carbohydrate digestibility rate and extent. Conflict of Interest/Funding: all authors are Unilever employees. All research relating to this abstract was funded by the Unilever Food & Health Research Institute Background: Tesofensine (TE) is an inhibitor of the presynaptic uptake of noradrenaline, dopamine and serotonin, important for appetite and energy balance. Objective: To evaluate the effect of TE on body composition. Design: This randomized, double-blind, placebo-controlled, Danish multi-centre, phase IIb trial assessed the efficacy and safety of TE in healthy obese subjects. After a 2 week diet and exercise lead-in period 203 obese men and women (ITT population), 18-65 yrs of age and with a BMI of 30-40 kg/m 2 , were randomized to 0.25, 0.5 or 1.0 mg of TE or corresponding placebo once daily for 24 weeks. Body composition was assessed by DEXA, waist circumference and sagittal diameter. Results: Body weight loss was 2.3±5.2% in the placebo group compared to 6.8±5.9, 11.4±6.3, and 12.7±5.3% with increasing TE dose. Sagittal diameter decreased with 0.6±1.9, 2.1±1.9, 3.3±2.0 and 3.5±1.8 cm, while waist circumference decreased by 3.0±5.7, 6.4±6.2, 9.8±6.0 and 9.8±5.5 cm after placebo, 0.25, 0.5 and 1.0 mg of TE respectively. According to the DEXA scans the corresponding changes in fat mass were -2.8±4.4, -5.7±4.6, -9.2±4.6 and -10.1±4.8 kg, accounting for 108, 85, 81 and 79% of total weight loss. Discussion and conclusion: Compared to placebo 0.5 and 1.0 mg TE resulted in weight reduction twice that produced by currently approved obesity drugs, of which ~80% could be accounted for by a reduction in fat mass. The concomitant decrease seen in sagittal diameter and waist circumference therefore indicates that TE is highly effective in reducing central obesity. Background: Increasing food volume with air or water can increase satiety and decrease subsequent food intake. We examined the effects of gas-filled version of a liquid food, prepared using advanced interfacial design technologies, on measures of hunger and satiety over 4 hours, with foods eaten as a single large serving or 2 half-servings. Method: In a randomised crossover trial, 24 subjects (age 42±9 y; BMI 26.2±2.4 kg/m 2 ) received isocaloric amounts of a standard or gas-filled version of a liquid meal, varying in volume and/or frequency of ingestion: (A) full volume liquid meal (325 ml, 190 kcal) at 0 min, (B) gas-filled full volume liquid meal (1000 ml, 190 kcal) at 0 min, (C) half volume of treatment (A) (162.5 ml, 95 kcal) at 0 and 120 min, (D) half volume of treatment (B) (500 ml, 95 kcal) at 0 and 120 min. Appetite ratings were measured for 240 min. Results: Both the full-and half-size gas-filled versions of the liquid meal significantly reduced measures of appetite vs. the respective standard liquid meals. Despite 50% less energy, the gas-filled half-volume meal also reduced appetite vs. the full volume standard liquid meal. Increased reports of gastrointestinal complaints were only noted for the full volume gas-filled meal (1000 ml). Conclusion: A gas-filled version of a liquid food, prepared using advanced interfacial design technologies produces a dramatically increased satiety response. This was observed when the food was given as a single large volume at 0 min or 2 half-volumes at 0 and 120 min. Adjustable gastric banding (AGB) is performed to produce a stable body weight reduction in severely obese subjects. The success of the procedure is highly dependent upon patient adherence to permanent dietary restriction and long term follow-up visits. In this study presurgical psychological and psychopathological characteristics were analyzed to predict the outcome of AGB in obese women. 125 females (mean age 41.2±11.7 yr, preoperative BMI 42.6±5.4 and postoperative BMI 31.9±4.5) were administered the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) before surgery. Patients with alcohol abuse or taking psychoactive drugs were excluded. A statistical analysis was applied via a multiple regression analysis, with Excess Weight Loss at 24 months follow up (EWL24) as a dependent variable associated with scores of clinical and content scales of MMPI-2. Using a stepwise algorithm by backward elimination, only the independent variables Hypochondriasis, Fears, Type A, Low Self-Esteem and Work Interference were within the confidence interval of 95% with a R=0.47. To improve the goodness of fit, a nonlinear multivariate analysis, based on MNP, was then considered: R increased up to the value of 0.62. A clustering analysis was then performed to divide patients into quartiles according to the score obtained by the MNP analysis of the selected variables of MMPI-2. The mean ± SEM EWL24 was 35.3±2.5 in the first quartile and it was 65.3±2.8 in the fourth one. In conclusion, MMPI-2 scores processed by a non linear multivariate analysis based on MNP can be helpfully employed to predict the surgical outcome of AGB in obese women. Obesity is increasingly common in developed countries. Obese pregnant women have increased rates of maternal and neonatal complications, but few studies focus on morbid obesity (BMI>40) in pregnancy. Our aim was to investigate the incidence of pregnancy related conditions, method of delivery and pregnancy outcomes in morbidly obese pregnant women. We did a retrospective analysis of case notes of patients who booked with BMI > 40 from April 2006 to end March 2007 and compared outcomes with women whose booking BMI was within the range 19 to 25 (2282 women 59% total). Within this period 59 (1.53%) of all our deliveries [3845] were to women with booking BMI > 40. Of these 59 women, 5 developed hypertensive disease of pregnancy (9.2%, usual incidence 5%), 3 developed obstetric cholestasis (5.8%, published incidence 0.6%) and 4 gestational diabetes (6.7% compared with 3% in rest of obstetric population Morbidly obese pregnant women have high rates of pregnancy related complications including hypertension, obstetric cholestasis and caesarean section. Therefore they need increased surveillance during pregnancy and delivery. Introduction: The first "anorectic drugs" come from the sixties and are still used in many countries. These drugs act mainly reducing food ingestion. Most frequent side effects are related to sympathetic stimulation and psychiatric disorders, but clinical benefits related to weight loss may counterbalance these alterations. Anorectic drugs misuse has been reported due to malpractice and manipulation. There are very few well designed studies in literature to support the clinical use of anorectic agents nowadays. Objectives: The aim of the present study is to evaluate efficiency, safety and tolerability of diethylpropion (DP) in the treatment of obesity. Materials and Methods: Seventy obese patients participated in this two-phase prospective clinical trial. The first phase (0 -24 th week) was double-blind with patients randomized to DP 50 mg twice a day (n = 38) or placebo (n = 32). Fifty three patients concluded the 24-week protocol (31 in DP group and 22 in placebo). The second phase (24 -48 th week) was open with all patients receiving DP. Thirty three patients concluded the whole study. Results: Significant weight loss was found in diethylpropion group (-10,7%) versus placebo group (-3,1%). There was improvement in the metabolic parameters glucose, insulin, total cholesterol and triglycerides in the treated group (p<0.05). Blood pressure and cardiac rate did not change significantly. The psychiatric status (anxiety and depressive symptoms/disorders) was not altered after DP or placebo. Conclusion: According to our data, diethylpropion promoted a significant weight loss, improved some metabolic parameters and showed a favorable safety profile. Monteagudo Patrícia T 1 , Falcão Adriana 1 , Verreschi Ieda TN 1 , Zanella M Teresa 1 . In male obese occurs aromatase hyperactivity associated with hypogonadothrofic hypogonadism. In female obese, depression is frequent. Non-obese depressive men have decreased testosterone compared to non-depressive. And higher estrogen levels and variability are related to less dopamine sensibility and depression in women. To evaluate relationship between hormones, male obesity and depressive symptoms (DS), we analyzed 43 men with 19-60y of age and body mass index 30-55kg/m². Excluded if severe or psiquiatry diseases, low comprehension, hypothyroidism, drugs or ethanol abuse, diabetics. Three repeated LH (UI/mL) and total testosterone (TT, ng/mL), and basal estradiol (E2, pmol/L), SHBG (nmol/mL), TSH, prolactin, glycemia (mg/dL), insulin (μU/mL), hemogram, creatinine and hepatic enzymes were measured. Estrogen/progesterone (E2/T) ratio and HOMA-IR were calculated. DS were evaluated by "Beck Depression Inventory" index (BI). Seventy-two % with low BI (0 to 15; G1), or low depression, versus the 28% with moderate to severe depression (BI >16; G2) didn't differed in abdominal circumference, glycemia, insulin, HOMA-IR. Results in mean±SD, except BI median (variation Clinical evaluation of body fat and lean tissue is recommended when monitoring overweight patients under treatment. The methodology used should be precise, accurate, accessible, and rapid. In this study the clinical utility of body composition assessment with dual-energy x-ray absorptiometry (DXA) in a group of patients treated for obesity is reported. Fifteen subjects (ten women/five men; age 51±10 years; BMI range 25-42) were followed during obesity treatment for 6 months. Lean body mass (LBM), fat body mass (FBM), and %fat were measured with a Lunar Prodigy DXA (GE Healthcare) at baseline and 6-month follow-up. Average subject weight decreased from 88,9kg to 79,7kg after six months. Gynoid and android regional %fat values decreased during treatment. Lean mass was also monitored and training schedules were adapted when a significant decrease in lean mass was detected. We conclude that DXA is a highly useful clinical tool for following patients under treatment for obesity. The Lunar Prodigy provides information on total body and regional fat distribution, lean mass and bone density. Evaluation of regional fat and lean values (e.g. android and gynoid), in addition to total body results, can help the clinician adapt individual diet and treatment programs. DXA body composition offers an accessible technology with very low radiation dose and rapid assessment. Purpose: Controversy exists over the effect of resistance training (RT) vs. aerobic training (AT) on fat-free mass (FFM) and RMR, particularly in overweight/obese individuals. This study was designed to analyze the relative impact of three training types (RT, AT, and AT+RT) on FFM and RMR in overweight women. Methods: Subjects were 38 healthy, sedentary, pre-menopausal, overweight women (38.9±7.0 years; BMI, 29.3±3.5 kg.m -2 ; %FM, 42.0±5.5%; VO2max, 31.1±4.6 ml.kg -1 min -1 ), who were randomized into three training groups: AT, RT and AT+RT. All groups trained for 60 minutes,3 days.week -1 , for 5 months. RMR was measured by indirect calorimetry. FFM was estimated with dual-energy x-ray absorptiometry (DXA). Within-group differences after 5 months were calculated and ANCOVA was performed to detect differences between groups after training, adjusting for baseline values. Results: Significant reductions in absolute (RT: -205±215; AT: -181±229; AT+RT: -110±164 kcal.day -1 , p<0.05) and FFM-adjusted (RT: -6.75±4.7; AT: -6.27±5.4; RT+AT: -5.47±4.13 kcal.kgFFM -1 .day -1 , p<0.001) RMR were observed. Results for FFM showed increases for AT: 3.99±2.0 kg; RT: 4.02±2.4 kg; AT+RT: 4.62±2.4 kg (p<0.001). No between-group differences were observed (p>0.05). ANCOVA showed an effect of baseline RMR on changes after the training (absolute p<0.01, FFM-adjusted p<0.001). The principal finding of this study was that RMR was suppressed after controlled physical training, despite marked FFM increases. This adaptation should be considered in overweight women undergoing weight reduction. Additionally, resistance training did not induce a differential effect over any measured variable over aerobic training, as predicted from previous research. This abstract was funded by Institute of Sport from Portugal Fibrinogen is an important factor contributing to blood coagulation, it's serum concentration has not been extensively evaluated in the early phase of weight loss in severely obese patients undergoing bariatric surgery. We have studied 28 patients (14 M, !4 F, age 42.0±7.2 years, BMI 50.3±6.1 Kg/m 2 ) undergoing laparoscopic Gastric Bypass. Anthropometry (BMI, waist circumference, visceral and subcutaneous fat) and haematobiochemical parameters (glycaemia, cholesterolaemia, trygliceridaemia, HOMA, CPR, haematocrit, albuminemia, etc.) were assessed at baseline (before surgery) and following 10% and 25% weight loss (WL), obtained on average six and thirty weeks after surgery respectively. All parameters improved at 10% and 25% WL in all patients and we did not find any significant differences between males and females. Only fibrinogen values showed a significant difference between sexes at 10% WL (370.3±73.4 vs 436.3±73.7 mg/dL; p= 0.03) and at 25% WL (333.2±97.1 vs 448.4±82.9 mg/dL; p=0.004). Following WL there is a different gender response of serum fibrinogen in patients undergoing bariatric surgery. Further investigations are needed to evaluate long term effects of WL on coagulation factors and to clarify the underlying pathogenetic mechanisms in high thrombotic risk patients. Foltz, M 1 , Maljaars, JPW 2 , Peters, HPF 1 , Wiseman, SA 1 , and Masclee, AAM 2 1 Unilever Food and Health Research Institute, Vlaardingen, The Netherlands 2 Department of Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands Evidence that ingested fat acts in the intestine to produce satiety originates from studies showing that intraintestinal infusions of fat decreases food intake more than intravenous infusion. Although some studies suggest that even small amounts of dietary fat can induce short term satiety, the satiating properties of orally ingested fat remain poorly understood. In this pilot study we determined the effect of phase separation of fat in the stomach to delay fat absorption in order to influence satiety parameters differently to that of emulsified fat. Six healthy young males were intubated nasogastrically on 4 different occasions (duplicate measures). In the ON TOP treatment (OT) subjects received orally a fat-free meal replacement drink (325ml, 145kcal) followed by intragastric infusion of 5g canola oil labelled with 13 Ctriolein, to mimic phase separation in the stomach. In the EMULSION treatment (EM) the drink contained labelled canola oil (5g) as a fine emulsion; saline was infused as a control. 13 C-oleic acid plasma appearance was significantly (p<0.05) delayed up to 1 h in OT compared to EM. C max and T max values of CCK were not significantly different between treatments; CCK AUC 240-480min. values were higher (p<0.05) in OT. Between-meal ratings of appetite revealed that hunger and appetite for a snack was diminished to a greater extent by EM than by OT up to 120 min postprandially. However, between 150-240 min appetite for a snack was reduced by the OT. These results indicate that 1) fat emulsions ingested with a meal replacement drink are absorbed more rapidly, whereas absorption of phase separated fat in the stomach is strongly delayed leading (2) to prolonged elevation in CCK plasma levels. The observations from this artificial application of fat suggest that the physicochemical characteristics of small amounts of dietary fat largely affect fat digestion and absorption; its effect on downstream physiological parameters however are much smaller, but could be of benefit in increasing satiety when successfully implemented in food products. Funding: Research relating to this abstract was funded by Unilever High intensity exercise is associated with fat oxidation during post-exercise recovery and after food intake in overweight men. Low-intensity (LI) exercise is known to favour fat oxidation. The efficacy of high-intensity (HI) exercise is unclear in overweight subjects. We studied the effect of either HI or LI on fat oxidation (FO) during exercise and the 7-hours recovery period including food intake after exercise among overweight men. Ten healthy and sedentary overweight men (27.9±5.6 years, BMI:27.8±1.3 kg/m 2 ) cycled to ensure an energy expenditure assessed to be equal to 300 kcal at a LI (35% VO 2 max) or HI (70% VO 2 max). Subjects were fed (in energy balance) 30 min after the exercise bout with an amount of energy intake that did not differ from the amount of energy expended. From indirect calorimetry, Respiratory Exchange Ratio (RER) and oxidization of fatty acids oxidized (FO, g) were calculated over exercise, 30-min recovery before the meal and over 6 hours after the meal. During exercise, a preferential lipid oxidation was observed during the LI exercise session: RER was higher for HI than for LI trial (p=0.02) and FO was higher for LI trial (17.4±2.2 vs 7.7±1.1 g; p<0.0003). Over the 6 hours of recovery after the meal, FO was higher for HI than for LI trial (39.6±7.9 vs 35.5±5.9 g for HI and LI trials respectively; p=0.03). When considering the cumulative period fitted over the exercise period plus all the recovery period, no difference was observed between HI and LI trial. HI exercise could be considered for weight management of people, as HI does not impair FO compared to the recommended moderate intensity activity. Influence of a walking program on the metabolic risk profile of obese postmenopausal women. Mauriège P 1,2 , Roussel M 2 , Garnier S 2 , Lemoine S 2 , Gaubert I 3 , Bessodès L 2 , Lemieux I 4 , and G. Auneau 2,3 . 1 Division of Kinesiology, Department of Social and Preventive Medicine, Laval University, Québec, Canada; 2 UFR STAPS, Université P. Sabatier, Toulouse, France 3 FFEPGV, Paris, France and 4 Laval Hospital Research Center, Québec, Canada. Menopause transition is well recognized to be associated with an increased prevalence of metabolic syndrome which may partially explain the higher coronary heart disease (CHD) risk. The impact of a 16-week walking program on the metabolic risk profile of sedentary and weakly active postmenopausal women 50-65 years-old, whose body mass index ranged from 29-35 kg/m 2 was examined. Another aim was to verify whether ameliorations in their metabolic risk profile may occur independently from cardiorespiratory fitness (CRF) changes or rather depend on body fatness changes. Methods: 153 women among whom 90 were sedentary and 63 weakly active (1h exercise/week) were subjected to 3 sessions/week of 45 min-walking at 60 of heart rate reserve. Body composition, resting blood pressure (BP), fasting lipid-lipoprotein profile and CRF estimated by O 2 max were measured before and after endurance exercise. Results: Sedentary women were heavier, fatter and had lower O 2 max at baseline (0.01
4 mm Hg (P 50 ) in diet V subjects, diet C subjects, and all subjects as a whole. The higher increment of Ca/protein ratio and the index of nutritional quality (INQ) were also protection factors in diet C. When only those women who were hypertensive at the start of the study were taken into account, an increase in the calcium density and the INQ for calcium were associated with a reduction in the sysolic blood pressure of > 4 mm Hg (P 50 ) (OR= 0.9496, 95%CI 0.9102-0.9908; p<0.01, and OR= 0.0049, 95%CI 0.00053-0.4676; p<0.05, respectively). Conclusions: Calcium intake could have beneficial effects on blood pressure and therefore cardiovascular risk in women following hypocaloric diets. Background and Aims: An increase in lipid storage as a consequence of feeding animals with high glycemic index GI diets has been observed by many authors. Fasting plasma ghrelin is lower in Pima Indians, a population with a very high prevalence of obesity, Tschöp et al observed that fasting plasma ghrelin levels are negatively correlated with per cent body fat. The aim of the study was to evaluate the effect of diets with different GI on food intake, growth performances, fat deposition; fasting plasma levels of glucose, ghrelin and insulin. Methods: 20 rats were used, divided in two groups and fed ad-libitum for 21 days with different diets matched for macro and micro-nutrients, but with a different amylaceous fraction and therefore a different GI. Results: In rats fed high GI diet vs low GI diet was observed: increased food intake (18,9±0,6 vs 16, 4±2 grams/day; P<0,01); increased weight gain (28.8±6,6 vs16,4±6 % of initial weight; P<0,01); the % weight (related to total weight) of fat pads were higher ( 1,7±0,4 vs 1,4±0,3 %; P=0,05 ); total ghrelin levels were lower (41,1±10,7 vs 59,5±9,8 pg/ml); fasting glucose and insulin levels were similar. Conclusions: Ghrelin is one of the most important orexigen hormones; despite higher ghrelin levels, rats fed the low-GI diet did not increase their food intake, suggesting a decreased ghrelin sensitivity. These findings confirms an enhanced lipodeposition in rats fed the high GI diet; in the same group decreased ghrelin levels may explain the higher fat pad mass. Effects of a high-protein diet versus a normal-protein diet on body weight and body composition in women with polycystic ovary syndrome. International Journal of Obesity Clinical Nutrition, Dept. Internal Medicine, University of Rome "Tor Vergata" Context: The impact of sex hormones on body fluids during the menstrual cycle has been studied with divergent results. Some renal and systemic alterations, (primary vasodilation) have been shown in the post-ovulatory phase, and seric osmolality exhibits a diminishing trend from the follicular to the luteal phase. Phisiological studies on extracellular osmolality variations suggest that cell volume changes may influence substrate metabolism, but this has not been proved in specifical menstrual cycle studies on obese people. Aim:To verify if variations in Extra Cellular Water and Total Body Water are associated to changes in substrate metabolism and BMI. Subjects: 15 normally cycling overweight and obese patients, aged 25-45 yr, ( 25>BMI>40 ) Methods: Along their menstrual cycle, subjects reported food intake, weight, appetite and thirst daily, and underwent physical examination, body composition assessment (by anthropometric measurements and bioelectrical impedance analysis for the evaluation of TBW, ICW, ECW, FFM and FM) and Resting Metabolic Rate with substrate oxidation (by indirect calorimetry), in the midfollicular, ovulatory, midluteal phase of their cycle. Food intakes macronutrients and micronutrients were processed with the aid of a dietetic software. : Not yet available as the patients have not completed all the steps of the study. Till now the RMR seem to follow a common trend, the lowest values being situated in the ovulatory phase and the highest in the follicular one. For as regards substrates, lipid oxidation is higher during the luteal phase, in contrast to carbohydrate oxidation. Visfatin expression in subcutaneous adipose tissue of premenopausal women: relation to hormones and weight reduction. Aim: The objective of this study was to investigate the relationship of visfatin expression in adipose tissue with potential hormonal regulatory factors such as insulin, testosterone and tumor-necrosis factor-alpha (TNFalpha• and the effect of the diet-induced weight-reduction on adipose tissue mRNA expression and plasma levels of visfatin. Materials and methods: Biopsy of subcutaneous abdominal adipose tissue (SCAAT) and plasma samples were obtained from 28 premenopausal women (age 38.7 ± 1.7 years, BMI 27.9 ± 1.4 kg/m 2 ), consisting of 10 lean and 18 overweight/obese subjects. The subgroup of 18 overweight/obese women (age 39.4 ± 2.1 years, BMI 32.2 ± 1.4 kg/m 2 ) underwent a 12 week hypocaloric weight-reducing diet. Biopsy samples were analyzed for visfatin and TNFalpha mRNA levels and plasma was analyzed for relevant metabolites and hormones. Result: Visfatin mRNA expression in SCAAT was negatively correlated with plasma free testosterone in all subjects (r = -0. 532, p < 0.01), plasma insulin (r = -0.469, p < 0.01) and BMI (r = -0.488, p < 0.01) and positively correlated with adipose tissue TNFalpha mRNA expression (r = 0.648, p < 0.001). The diet resulted in the reduction of body weight (by 8%): plasma insulin levels, free testosterone and TNFalpha were also reduced. Visfatin and TNFalpha mRNA expression in adipose tissue and plasma levels of visfatin remained unchanged. Conclusion: In obese females, visfatin mRNA expression in SCAAT is related to TNFalpha expression and to plasma free testosterone and insulin. This suggests the regulatory role of these hormones. Adipose tissue visfatin expression is not altered by a moderate, diet-induced, weight loss. Background: There is concern regarding both compliance to and adverse events (AEs) of weight loss compounds. Drop out from any cause can be interpreted as a composite measure for safety and compliance, and AEs as a general indicator of safety. Objective: To investigate the safety and compliance of orlistat, sibutramine and rimonabant. Methods: A systematic search of PubMed was performed (2007-11-07) . Data were collected from RCTs>1y (n=27; n patients =13685) using doses within the EMEA indication. Pooled risk ratios (RRs) for drop out were calculated by a random effects model. Results: Treatment with orlistat was associated with a significantly reduced risk of drop outs from any cause compared to placebo (Table) . Similar trends were observed for rimonabant and sibutramine. Rimonabant and orlistat resulted in significantly more drop outs due to AEs than placebo, while there was a trend of no difference in risk for sibutramine. The placebo groups showed similar drop out rates for any cause, but not for AEs, for the different compounds. Orlistat was associated with the best compliance, while the greatest risk (absolute&relative) for drop out due to AEs was seen for rimonabant. The heterogeneity in drop out rate due to AEs in the placebo groups calls for common comparator adjusted analyses and/or head-to-head trials. Regional fat distribution in adolescent anorexic patients before and after medium and longterm weight gain Objective: To examine the independent and additive effect of exercise in addition to weight loss on body fat distribution and at the metabolic syndrome. Method: A total of 79 obese but otherwise healthy men and women (age 36.6±7; BMI 34.5±4 kg/m 2 ) were randomized into three treatments groups: DIO (8 weeks very low energy diet (VLED) 600 kcal/d + 4 weeks weight maintenance diet); DEX (8 weeks VLED 800 kcal/d + 4 weeks weight maintenance diet together with 12 weeks supervised exercise); EXO (12 weeks supervised exercise without diet restriction). MRI technology was used to quantify the visceral adipose tissue (VAT) and subcutaneous abdominal tissue (SAT) and the NCEP ATP3 definitions were used to define the metabolic syndrome. Results: Subjects in the DEX and the EXO group improved their VO2max with 15% whereas no change in VO2max in the DIO group was observed. A relative weight loss of 11% in the DEX and DIO group was achieved, with a trend to a higher relative reduction of VAT in the DEX group (P=0.08). A total weight loss of 3% in the exercise-alone group (EXO) was accompanied by a 15% reduction of VAT. At baseline the metabolic syndrome was present in 51% of all subjects (DEX 67%; DIO 42%, EXO 41%) whereas after intervention for 12 weeks the prevalence was decreased to 12% (DEX 14%, DIO 5%, EXO 18%) Conclusion: Regular exercise without diet restriction reduced VAT with 15% and decreased the prevalence of the metabolic syndrome with 25%. In combination with diet restriction, exercise has pronounced effect at body composition and the obesity-related metabolic disturbances. Paul-Ebhohimhen, V 1 , Avenell, A 1 1 Health Services Research Unit, University of Aberdeen, Aberdeen, United Kingdom. Objective: To systematically review evidence for the use of group versus individual modes of delivery of treatments for adult obesity. Method: Based on agreed a priori criteria, we searched electronic databases and secondary references for randomised controlled trials of treatments for adult obesity among participants with BMI>28kg/m 2 , and age>18 years, comparing at least one group-based to one individual-based treatment group, and follow up of at least one year. Data extraction and quality assessment were performed by one reviewer and checked by the second. Meta-analyses comparing weight change in group-based to individual-based treatment groups were conducted. Results: Six studies fulfilled all criteria (two from the UK and four from the US), and were conducted by dieticians and psychologists. Included studies failed to report some important aspects of randomised controlled trials (concealment of random allocation, blinding, and intention to treat analysis). All studies stated numbers of dropouts, and reasons for withdrawals were described in three studies. Participants' ages ranged from 20 to 76 years, and BMI from 30 to 49kg/m2. Socio-economic data were reported in only two studies, and provision of training in group-based treatment delivery was explicit in one study only. We found a significant difference in favour of group-based rather than individual treatment at 12 months. Post hoc subgroup-analysis also showed that trial attributes associated with greater effectiveness were the use of financial incentives, the health professional being a psychologist, and participants being women. Background: In a previous 12-week study of obese patients, taranabant, a cannabinoid-1 receptor inverse agonist, induced significant weight reduction and was generally well tolerated. Here we present 24-week results from an 80-week randomized placebo controlled trial. Methods: 532 obese patients (81% female; BMI 27 to 43 kg/m 2 ; age 18 years) were randomized to taranabant 2, 4, 6 mg qd or placebo for 80 weeks. The primary endpoint was change from baseline in body weight at week 24. A subset of 200 patients underwent total body MRI for adiposity assessments. Tolerability was evaluated with clinical/laboratory examinations and reported adverse events. Adverse events were analyzed with a multi-tiered approach. Results: Baseline characteristics were similar among groups. Discontinuation rates were 32, 25, 24, and 21% for taranabant 2, 4, 6 mg, and placebo. Least-squares mean body weight changes from baseline at week 24 for taranabant 2, 4, 6 mg and placebo were -5.9, -6.5, -7.2, and -2.8 kg, (p<0.001 taranabant vs placebo). Percentages of patients who lost ≥10% body weight were 23, 24, 29, and 9% for taranabant 2, 4, 6 mg and placebo (p 0.005 taranabant vs placebo). Significant reductions in visceral adiposity were seen with taranabant. Taranabant (2, 4, and 6 mg) was associated with increased psychiatric, gastrointestinal, and nervous system adverse events at the system organ class level. Conclusions: Taranabant at all doses led to clinically and statistically significant weight loss at 24 weeks. Taranabant was associated with increased incidence of psychiatric, gastrointestinal, and nervous system adverse events. Research relating to this abstract was funded by Merck & Co., Inc. Predictive equations for resting energy expenditure (REE) are mainly based on a wide BMI range and often limited by over-/underestimation. We tested nine established and two new equations in severely obese women. Study group consisted of 160 women (age=41.3±13.2y, BMI=42.8±7.5kg/m 2 ) with a REE of 1919±129kcal/d measured by indirect calorimetry (REE-IC). Nine established equations were used to predict REE. REE and REE-IC were compared by Bland-Altman-Plots. New REE prediction equations were calculated by linear regression analysis, based on anthropometric (REE1) or body composition parameters FM and FFM by BIA (REE2) and were tested in a validation group of 33 obese women (age=40.4±7.9y, BMI=37.2±4.6kg/m 2 , REE-IC=1947±128kcal/d). In the study group REE-IC correlates with all established equations (r>0.782, p<0.001), although six equations underestimated REE-IC (p<0.05) in general. For all equations REE was predicted accurately (i.e. REE-IC±5.0%) in only 32.2±10.8%. All equations overestimated REE within low and underestimated REE within high REE-IC range (p<0.05). For REE1 weight and age explained 64.9% of REE-IC. Employing body composition parameters, FM combined with FFM and age explained 65.2%. In the validation group REE1 and REE2 correlated with REE-IC (r>0.687, p<0.001), but underestimated REE-IC (p<0.05) as did seven established equations. New as well as established equations over-and underestimated REE in low and high REE-IC range, respectively (p<0.05). All equations showed a poor prediction of REE in obese women. Embedding body composition parameters to equations did not improve the quality of prediction. To minimize over-and underestimation, area of application for all equations should be stated precisely. International Journal of Obesity Two snps in the cd36 gene promoter are associated with lipid profile during a weight loss and maintenance period in obese subjects Goyenechea, E 1 , O´Dell, SD 2 , Collins, LJ 2 , Parra, D 1 , Abete, I 1 , Crujeiras, AB 1 , Martínez, JA 1 . 1 Dpt. Nutrition, Food Science, Physiology and Toxicology, University of Navarra, Pamplona, Spain. 2 Nutritional Sciences Division, King's College London, London, United Kingdom. Introduction: Different common polymorphisms of the CD36 gene have been associated with lipid metabolism and cardiovascular disease. The aim of the current study was to investigate the association of two CD36 gene promoter SNP genotypes with anthropometrics, dietary intake and lipid profile in subjects with excessive body weight during a weight loss and maintenance period. Methods: A group of 183 (95 male/ 88 female) individuals [Body mass index: 30.6 ± 3.0 kg/m 2 ; age: 35 ± 5 y] were genotyped for CD36 gene -33137 A/G (rs1984112) and -22674 T/C (rs2151916) promoter polymorphisms by pyrosequencing. Anthropometrical measurements and circulating lipid profile were measured at baseline, following an 8-week low calorie diet (LCD) and 6 months later. Dietary intake was determined before and after the LCD with a validated 24 hours weighted food records. Results: Both SNP genotypes were in Hardy-Weinberg equilibrium (p>0.05) and in complete linkage disequilibrium (D´=1.0). At baseline, the saturated fatty acid (SFA) intake tended to be lower in carriers of the minor alleles (G+/C+) (p=0.085), reaching significance at the end of the weight loss period (p=0.034). Six months after the end of the LCD, the minor allele was significantly associated with lower total-(p=0.032) and LDL-(p=0.014) cholesterol and higher HDL-cholesterol (p=0.013). Conclusion: These results suggest that in obese individuals both SNPs of the CD36 gene promoter are associated with lower SFA intake during a weight loss period, and with improved lipid profile in the subsequent weight maintenance stage. Funding: E. Goyenechea is supported by the Dpt. of Education, Universities and Research of the Basque Government, Spain. The project was supported by the Linea Especial from University of Navarra (LE/97), Spain and by the Wellcome Trust, Project grant No. 073142, UK. Gripeteg, L 1,2 , Karlsson, J 1 , Torgerson, J 1 , Lindroos, AK 1,3 1 Department of Molecular and Clinical Medicine, Institute of Medicine, the Sahlgrenska Academy, Göteborg University, Göteborg, Sweden; 2 The Vårdal Institute, Lund, Sweden; 3 MRC Human Nutrition Research, Cambridge, United Kingdom Aim: To find predictors for successful and nonsuccessful outcome of a 12-week VLCD treatment. Subjects: 267 patients (177 women, 90 men, mean±SD age 40.2±9.7, BMI 41.9±6.4 kg/m 2 ) remitted to an obesity intervention study initiated with a 12-w VLCD. Methods: 10 % or greater weight loss was regarded as successful outcome. Stepwise multivariate and logistic regression were used to predict 12-w weight loss, successful outcome and attrition. Women and men were analyzed separately. Potential predictors were anthropometry, eating behaviour, health-related quality of life and socio-economic variables at baseline. Results: 64 % of patients lost more than 10 % of their weight. Weight loss in successful women was 16.1±3.5 % and in men 17.1±4.7 %. Nonsuccessful women and men lost 5.8±2.7 % and 5.9±2.4 %. 12-w weight loss in women was predicted by higher number of children, lower educational level and better physical health (sum. score SF-36), R 2 = 12.7 %. In men, weight loss was predicted by better ambulation capacity, cohabiting and higher frequency of ice-cream intake, R 2 =39.4 %. Successful outcome was predicted by less psychosocial problems in women (OR, 95 % CI) 0.98 (0.97-0.999), and in men, better functioning in social interaction 1.02 (1.004-1.04) and ambulation 1.02 (1.003-1.04). Attrition was predicted by lower age 0.92 (0.88-0.97) and higher hip circumference 1.03 (1.001-1.07) in women, and in men, lower perceived general health 0.97 (0.94-0.99). The range of outcome predictors is different for women and men. Functional health seems important for success in men, whereas age predicts VLCD attrition in women. The increasing prevalence of childhood obesity in the Western world has resulted in intervention projects aiming to positively influence the diet and exercise habits of young people. Whilst there has been research into their effectiveness, there has been little consideration of participation from the child's perspective. This small-scale interpretive study employed semistructured interviews to explore experiences and perceptions of 10 pupils on a school-based intervention project. Consideration was given to the structure and content of sessions, and the nature, form and impact of participation. Analysis of the data revealed key themes related to: perceptions of the project; feelings about being identified as 'over-weight' or 'obese'; motivations to attend and adhere to the scheme; the impact of attendance; long-term expectations and impact on family members. The findings revealed a positive view of all aspects of the scheme, with the 'fun' activities, the inclusion of friends and the activity and diet task cards being identified as key motivators. Pupils accepted responsibility for the 'over-weight' label and welcomed the opportunity to positively influence their health and fitness. Attending the project had assisted when seeking support from family members; participants placed value on behaviour endorsed by the project and in making changes to exercise patterns and diet, gained pleasure from resultant feelings of control. Pupils assigned a high priority to long-term aims relating to more positive social interaction, loss of weight, and increased fitness levels enabling them to take a more active part in identified sports and activities. The intervention was funded by Tanita UK but this had no bearing on the outcomes of the research Efficacy and consistency of a franchising weight loss programme in the swedish commercial sector 11.4] , 86 % women) were included. The programme consisted of 20 one hour group sessions on diet and exercise behaviour change, physical activity (circle training 2-3 times/wk á 30-45 min + pedometers), individual coaching at 0, 10, 26 and 52 weeks, meal replacements, home assignments, and food and exercise diaries. Participants paid their own fee (approx €1000/yr.). Results: Mean weight loss at 12 months was 10.5 kg (95 % CI: 10.0 to 11.1). In unadjusted analysis, there was a significant weight loss difference between centers (p=0.03) but not between years (p=0.16). After adjustment for covariates, the difference in weight loss between centers was attenuated (p=0.10). Predictors of weight loss were instead baseline body weight (Beta=-0.3 per baseline kg, p<0.001), group session attendance (Beta=-0.49 per session, p<0.001), gender (Beta=2.4 men>women, p<0.002), and age (Beta=0.06 younger>older, p<0.008). Conclusions: Commercial companies, operating according to a defined manual including regular quality controls, can provide consistent weight loss results across time and locations. Conflic of interest: EH works part time as Itrim's Programme Director. JS and CM are members of Itrims Scientific Advisory Board. Beta-glucan and/or fructo-oligosaccharide in bars does not suppress hunger or energy intake when taken for two days Peters, HPF 1 , Boers, HM 1 , Haddeman, E 1 , Melnikov, SM 1 , Qvyjt, F 2 1 Unilever Food and Health Research Institute, Vlaardingen, The Netherlands 2 Unilever R&D, Covington TN, USA Background: Increasing gastro-intestinal viscosity or colonic fermentation are suggested to reduce hunger and food intake. Beta-glucan (BG) and fructooligosaccharide (FOS) are food ingredients proposed to act this way, but results so far remain inconclusive. We have tested FOS, BG, or their combination on hunger and energy intake during 2 consecutive days. Methods: In a 4-way cross-over double-blind randomized design 21 volunteers (BMI 25.9) received during 2 consecutive days, a Slim·Fast high protein meal replacement bar at 09.00h and an ad libitum lunch at 13.00h. On day 1 only, subjects consumed a second (identical) bar at 17.00h and a fixed snack at 19.00h. Bars (isocaloric) contained either 1) oats (control, 0.3g BG), 2) 1g added BG (using barley), 3) 8g added FOS, or 4) 1g added BG and 8g added FOS. To accommodate added fibres, all or part of the oats was removed. Hunger/satiety parameters (6 line scales) were regularly scored, and ad libitum meal intake measured. Bar viscosities were also determined under simulated gastric conditions. All parameters were analyzed using ANOVA and (where appropriate) baseline values as covariates. Results: Addition of BG, FOS or their combination did not diminish hunger or food intake, although addition of BG to the bar doubled apparent gastric viscosity (841 vs 351 mPa.s). Discussion: BG, FOS or their combination in bars at these levels did not affect hunger when given for 2 consecutive days. Efficacy might be increased by testing them for a longer period, increasing the BG content, or by using BG with even higher gastric viscosity. High-protein foods are more satiating and have a higher thermogenic effect than normal protein foods, over the short as well as over the long-term. We hypothesized that an acute effect of higher protein intake on satiety may be related to acute metabolic and hormonal responses. The study had a single blind, randomized, crossover design. Subjects underwent two indirect calorimetry tests for measurement of energy expenditure (EE) and substrate oxidation. After a standard subject-specific breakfast, subjects received one of two randomly assigned treatments: appropriate protein (AP) lunch (10%E protein, 60%E carbohydrate, 30%E fat), or high-protein (HP) lunch (25%E protein, 45%E carbohydrate, 30%E fat). Post-lunch EE increased 0.85±0.32 kJ/min after HP lunch and 0.73±0.22 kJ/min after AP lunch (p=0.07). RQ was 0.84±0.04 in HP condition and 0.86±0.04 in AP condition (NS). Satiety Visual Analog Scales (VAS) scores were significantly higher 30min, and 120min after HP lunch than after AP lunch. AUC satiety VAS score was significantly higher after HP lunch than after AP lunch (HP 263±61 VAS mm.h, AP 236±76 VAS mm.h; p<0.02). Observed effects on satiety and diet induced thermogenesis did not coincide with effects on plasma ghrelin, GLP-1 and PYY concentrations. A single HP lunch, therefore, seems to exert its acute effect on satiety not through increased concentrations of satiety related hormones. Short-term effects of the single high protein meal on satiety in the present study may reflect satiation rather than satiety. Other factors, which may explain the HP effect on satiety, may be metabolites or amino acids. The study was funded by DiOGenes (Contract no. FP6-513946) which raises no potential duality of interest. Background: Zantrex-3 is a popular dietary supplement for weight control that consists of a combination of yerba mate, guarana, caffeine and damiana. The combination has previously been shown to decrease gastric emptying and it is likely that the weight controlling effects are related to an increased satiety and thermogenesis. Objective: To investigate the effect of Zantrex-3 on energy expenditure, hemodynamic factors, subjective appetite sensations, and on ad libitum energy intake (EI). Design: Twenty-three men (BMI: 23.9±3.2 kg/m 2 , mean±SD) participated in a randomized, double-blind, placebo-controlled crossover study. The Zantrex-3 compound contained 300 mg xantines (caffeine and caffeine-like stimulants), yerba mate, guarana and damiana. The thermogenic effect was measured for 3 hours postintake. Blood pressure (BP), heart rate (HR) and appetite ratings were assessed every half hour. Results: Zantrex-3 induced a thermogenic response of 7% above baseline value (62.1±8.1 kJ/3-h (mean±SE), P<0.0001) compared to placebo and increased the respiratory quotient by 2% (0.02±0.01, P=0.03). Systolic and diastolic BP were increased by 4% (5.1±1.1 mmHg, P<0.0001) and 3% (2.1±1.0 mmHg, P=0.03) compared to placebo, whereas no effect was observed on HR. The sensation of satiety and fullness increased by 8% (P=0.01) and 11% (P=0.001), compared to placebo, whereas the sensation of hunger and prospective intake decreased by 7% (P<0.0001) and 5% (P<0.0001), respectively. Conclusion: Zantrex-3 induced a thermogenic response of 7% and seems to have potential appetite suppressants properties. The increase in BP was acceptable and consistent with the caffeine content, and has been shown to decrease with chronic use due to tachyphylaxia. Funding: Research relating to this abstract was funded by Basic Research, Salt Lake City, UT, US. Background: Usually, treatment of patients with juvenile obesity is equal between genders, although caloric needs, nutrition, trainability, interests, and life styles differ. Such uniformity has to result in a different gender related success rate. The present study evaluates the gender related 2-year follow-up of an inpatient intervention on body fat. Methods: 5 obese girls and 13 boys were tested before (IN) and after an 8-week inpatient program (8W), after 6 months (6MFU), 13 months (13MFU), and 24 months (24MFU) post-hospitalization program. Girls were 13.8±2.1 years old with a body weight of 74.8±11.8kg and a body mass index of 33.9±2.8kg/m 2 (P>98); boys 13.8±2.1 years, 79.9±17.2kg and 34.3±2.9kg/m 2 (P>98). The inpatient program was based on a multicomponent treatment and education focusing on nutritional changes, behavioral modifications and physical activity. A major effort was done in planning for, and monitoring each patient's post-hospitalization program. Body fat was measured by DEXA. Conclusion: Equal multi-disciplinary treatment of both genders was not as effective in girls as in boys concerning body fat. Specific therapeutic intervention may be indicated to reach success also in females. International Journal of Obesity Introduction: Increased physical activity is beneficial in the treatment of childhood obesity. The aim of the study was to reduce the degree of obesity by using a sports camp followed by six months support from local sports clubs. Patients and Methods: Seventy-seven children (50% males) aged 8-12 years (mean age 10.5 years, mean BMI 29.0, SD±3.0; mean BMI SDS 3.43, SD±0.5) were sent from school health care to a tertiary referral centre for treatment and invited to participate in a sports camp of one week. The subjects were randomized in 2 groups (control and intervention). The intervention group tested various sports every day during the camp. In the end of the camp the children chose their favourite sport. A sports trainer from a local sports club was assigned to support the child to participate in the chosen sport in this sports club during six months. Body weight and height were measured at baseline and after 12 months. Results: Twelve months after the sports camp the intervention group had a significant decrease in BMI SDS (baseline BMI SDS 3.21; follow up BMI SDS 3.10, p=0.02). The control group also decreased their BMI SDS (baseline BMI SDS 3.27; follow up BMI SDS 3.19, p=0.02). There were no differences within and between groups, as well as with gender. The intervention focus on physical activity had not effect on the degree of obesity as compared to an untreated control group. This could imply that family needs to be part of the program. Funding: Research related to this abstract was funded in part by Swedish Savings Bank Foundations, the Swedish Sports Association and Östra Göinge municipality. Thermogenic effects of α-lipoic acid: differential impacts on body composition during growth and catch-up growth Yepuri G, Brown CM, Montani JP, Dulloo AG Department of Medicine / Physiology, University of Fribourg, Switzerland α-lipoic acid, a widely marketed dietary supplement with potent anti-oxidant properties, has been reported to possess anti-diabetogenic and anti-obesity (leptin-like) properties in rodents. We investigated whether the reported thermogenic properties of α-lipoic acid could be of value in preventing excess body fat accretion in response to high-fat consumption during normal (spontaneous) growth or during catch-up growth after caloric restriction. Studies of energy balance and body composition were conducted for 2 wks in groups of Sprague-Dawley rats which were either fed or semistarved-refed on a high-fat lard diet -with subgroups consuming isocaloric diets that were supplemented or not with α-lipoic acid (0.25%). The results indicate that α-lipoic acid supplementation resulted in significant attenuation of weight gain (-20%, p<0.01) both during spontaneous growth and during catch-up growth. Analysis of data on energy balance and body composition however reveal that the increases in energy expenditure with αlipoic acid resulted in a lower gain both in fat mass and in lean body mass in the spontaneously growing (fed) group. In the refed groups showing catch-up growth, by contrast, the increases in energy expenditure with α-lipoic acid resulted entirely in a lower gain in lean body mass, without alterations in the high rate of fat deposition. These studies indicate that the stimulatory effects of α-lipoic acid on energy expenditure lead to differential effects on body composition during growth and catch-up growth, and underscore the need for human studies that would address the potential effects of this widely marketed dietary supplement as a protein catabolizer. Observations of epidemiological studies indicate that dietary fibre intake is involved in body weight control. A dietary fibre component that may be of specific importance is resistant starch (RS). Acute effects of RS on energy expenditure and substrate oxidation have hardly been studied. In addition, the effects of RS on ghrelin, PYY and GLP-1, in relation to changes in hunger and satiety are unknown. Thirty subjects (age: 31±14y, BMI: 23.8±2.8kg/m 2 ) were studied 2 times in a randomized controlled crossover design. After 30 minutes resting on a bed, resting metabolic rate was measured by a ventilated hood system. Subsequently lunch (35% of daily energy intake) was served. The two lunch conditions were: i) normal pasta and ii) resistant starch pasta. The macronutrient composition (energy %) of the lunches was: 60% carbohydrates/ 10% protein/ 30% fat. During 3 hours after the lunch diet induced energy expenditure (DEE) was measured. Furthermore anchored 100mm visual analogue scales on the appetite profile were collected before the lunch and after the lunch, and blood samples were taken for analysis of GLP-1, PYY, and ghrelin concentrations, before and at different time points after the lunch. Satiety and energy expenditure were not different after RS lunch compared with the control lunch. Ghrelin, GLP-1 and PYY responses were not different between the RS lunch and the control lunch. In conclusion, RS supplementation has no acute effect on substrate utilisation appetite feelings and gut derived hormones. The study was funded by DiOGenes (Contract no. FP6-513946) which raises no potential duality of interest. The acute effects of a lunch containing capsaicin on energy and substrate utilization, hormones, and satiety Smeets, A.J.P.G. 1,2 and Westerterp-Plantenga M Background: Addition of capsaicin to the diet has been shown to increase satiety and thermogenesis. The effects of capsaicin on ghrelin, PYY and GLP-1, in relation to changes in hunger and satiety are unknown. Methods: Thirty subjects (age: 31±14y, BMI: 23.8±2.8kg/m 2 ) were studied 2 times in a randomized controlled crossover design. After 30 minutes resting on a bed, resting metabolic rate was measured by a ventilated hood system. Subsequently lunch (35% of daily energy intake) was served. The two lunch conditions were: i) lunch without capsaicin and ii) lunch with capsaicin (CAPS). The macronutrient composition (energy %) of the lunches was: 60% carbohydrates/ 10% protein/ 30% fat. During 3 hours after the lunch diet induced energy expenditure was measured. Furthermore anchored 100mm visual analogue scales on the appetite profile were collected and blood samples were taken for analysis of GLP-1, PYY, and ghrelin concentrations, before and at different time-points after lunch. Results: Satiety and energy expenditure were not different after CAPS lunch compared with the control lunch. Fifteen minutes after lunch CAPS lunch increased GLP-1 (p<0.05) and tended to decrease ghrelin (p=0.07) compared with the control lunch. PYY responses were not different between the CAPS lunch and the control lunch. Conclusion: Acute lunch containing capsaicin had no effect on satiety, EE, and PYY, but increased GLP-1 and tended to decrease ghrelin. The study was funded by DiOGenes (Contract no. FP6-513946) which raises no potential duality of interest. Introduction: Iron deficiency is a major global public health problem and common in the UK especially in young women. Habitual dieting can deplete iron stores. Women often specifically exclude red meat while slimming, which has potential implications for iron status. Aim: To determine the effect on iron status (serum ferritin) of a weight management programme (12 weeks weight loss & 12 weeks weight maintenance), which included the regular consumption of lean red meat compared to one that excluded it. Methods: A randomised controlled trial of 36 overweight, pre-menopausal women, mean serum ferritin 15.8 (SD 3.1) ug/l. Dietary advice was delivered using a one-to-one approach with review every two weeks. Results: Thirty women completed the study. Weight loss at week 12 was -2.8 (SD1.9) kg, p<0.0001 (meat), -2.6 (SD 2.4) kg, p<0.0001 (no meat). Serum ferritin improved in both diet groups at wk 24 and was significant for the groups combined +3.24 (SD 9.02) ug/l p=0.03. There was some suggestion (p =0.07), that in women consuming meat, better adherence to dietary advice, with greater weight loss, led to greater improvements in serum ferritin Conclusion: The data, although inconclusive, suggest better iron status with regular consumption of red meat. A larger study with greater weight loss is required for definitive health promotion advice. Including red meat provides variety and a rich source of dietary iron and should be an option in any weight management programme. Funding: This study was funded by the Meat and Livestock Commission. Non-Surgical Weight Loss-Use of water-filled Intra-gastric Balloons. Since 2001 we have endoscopically inserted 92 water-filled intra-gastric balloons (BioEnteric Intragastric Balloon BIB™) into 73 obese patients (63 F, 10 M) unable to lose weight using reduced fat diets, exercise, VLCD, sibutramine or orlistat. In many patients, relatively rapid weight loss was indicated prior to hip replacement or back surgery. In the initial 3 years we experienced spontaneous deflation in 13 balloons. There were no further deflations in the subsequent 3 years. Most deflated balloons remained in the stomach and were removed endoscopically. Seventy-nine (79) balloons were fully inflated at removal from 73 patients. In the total patient group including deflated/faulty balloons, n = 92, mean weight loss was 10.5 kg (p<0.0001). There were no bowel obstructions despite 4 deflated BIBs transiting the bowel. In the intact BIB™ patients (full inflation at removal, n = 79, age 42.0±1.4 years, mean insertion BMI 41.9±1.0 kg/m 2 , mean duration 196.2±9.2 days), mean weight loss was 11.0 kg (p<0.0001). In this group, 12 BIBs (15.1%) were removed prematurely due to either intractable vomiting (7), nausea (1), belching (2), prior to emergency surgery (1), or at the patient's request (1) . The BIB™ procedure is a safe, low-risk intervention producing a moderate weight loss in weight -loss resistant obese patients. Introduction: Obesity is an accepted risk factor for increased cardiovascular (CV) risk. The "obesity paradox," decreasing mortality with increasing body mass index (BMI) has been suggested in patients with congestive heart failure (CHF). Its validity is questioned in relation to intentional weight loss and degree of obesity. Patients with CHF (NYHA Class I/II only) were eligible for the SCOUT trial, which is assessing the impact of weight management on CV outcomes in high-CV-risk patients. All received sibutramine (SIB) 10mg with weight management during a 6-week lead-in period before randomization into the long-term, double-blind phase. This analysis compares the response of obese patients with or without CHF to short-term weight management. Patients and Methods: Eligible patients were overweight or obese with CV risk factors. Of 10,742 patients treated in the lead-in period, approximately 900(8.5%) reported a history of CHF treated with medication. Median Changes at End of 6 Weeks (LOCF analysis) Long term efficacy of low carbohydrate and very low calorie diets and their effects on liver and kidney function are still uncertain. A randomized control trial is in progress to assess weight and cardiovascular risk factors with 3 diets: 1. a healthy eating/low calorie diet (HE). 2. a very low calorie diet (LighterLife-LL) and 3. a protein sparing modified fast (PSMF). 120 patients underwent a screening process for 3 months in which they consumed HE. Patients who achieved a 5% weight loss at 3 months remained on HE. Patients who did not achieve 5% weight loss were randomized to LL or PSMF. Data presented here are for 3 months post-randomization. 72 patients were randomized (LL, n= 35 and PSMF, n =37). From baseline to 3 months post-randomization, urea decreased (-0.53 mmol/L SD 1.4) on LL but increased on PSMF (+0.63 mmol/L SD 1.8), whereas albumin increased (+0.41 g/L SD 1.7) on LL but decreased on PSMF (-0.05 g/L SD 2.1). The changes over 3 months differed significantly between the diets.No differences were found for all other analytes: sodium, potassium, chlorine, creatinine, alanine aminotransferase, alkaline phosphatase and gamma glutyl transferase. Although there were differences for urea and albumin 3 months post randomization between the diets, there were no differences found for all other analytes, this may indicate that neither diet causes adverse effects on liver and kidney function. More long term results need to be obtained before this can be concluded. Svendsen, M 1 , Tonstad, S 1 . 1 Department of Preventive Cardiology, Ullevål University Hospital, Oslo, Norway. We studied the effect of orlistat on the maintenance of dietary changes and predictors of weight loss in patients with sleep related breathing disorders (SRBD). Methods: Men and women with SRBD aged 32-62 years (n=63) participated in a 3-month dietary intervention program. After an initial weight loss of 3.0% mean (SD) BMI was 34.6 (4.7) kg/m 2 . Thereafter, they were treated with orlistat for one year and dietary and behavioural interventions were provided in the course of 14 group sessions. Dietary intake was assessed with a food frequency questionnaire before and after orlistat treatment. Results: After one year, body weight decreased by 3.5 kg (P=0.0012). E% saturated fat, intake of fatty diary products and energy density increased ( Conclusion: Treatment with orlistat for one year induced further weight reduction after an initial diet alone induced weight loss, but dietary composition deteriorated despite a behavioural treatment program. Increased protein and lower saturated fat intakes were associated with better weight loss. Funding: This study was sponsered by Roche Norway AS. The not so different body dissatisfaction in boys and girls Aims: Body dissatisfaction (BD) has long-been thought to affect mainly females but evidence is accumulating that boys are experiencing dissatisfaction even before adolescence. The study aims were to determine the prevalence and character of pre-adolescent BD, and its associations with sex and BMI categories. Methods: A primary school-based, state-wide, cross sectional survey of children's eating habits, physical activity and psychosocial status in New South Wales, Australia, that included figure rating scale choices of current and preferred body shape. Participant N=2813 and mean age=11.2 yrs. Results: Boys and girls on average chose a similar figure for current body shape, but girls desired a thinner body shape (TBS) than boys. There was only a marginal difference between the sexes for mean degree BD (disregarding direction of desire). 42.9% and 54.6% of boys and girls respectively desired a TBS and 14% and 7.1% of boys and girls respectively desired a fatter body shape. As weight increased so did BD, with 88.9% and 97.1% of obese boys and girls respectively desiring a TBS and over 60% of the obese children reported extreme BD. Obese boys were 17.6 (95%CI 6.8-46.0) and obese girls were 35.7 (95%CI 9.0-140.6) times more likely to report desiring a TBS. Conclusions: BD is very common in preadolescents. Boys once thought to be immune to BD and in particular a desire for thinness, are now reporting levels similar to girls. Obese children are particularly vulnerable to BD which maybe damaging at a time when their sense of self is developing. This research was funded by the National Health and Medical Research Council of Australia. Fierabracci P., Santini F., Martinelli S., Anselmino M.*, Ricco I., Galli G., Scartabelli G., Salvetti G., Giannetti M., Pucci A., Bellini R *, Di Salvo C.*, Pinchera A. Department of Endocrinology and Metabolism, * Department of General Surgery, University Hospital of Pisa, Pisa, Italy BS allows a stable body weight reduction in morbidly OP. Aim of this study was to evaluate the prevalence of endocrine disorders in a series of OP before BS. We studied 495 OP (393 F, 102 M; age 18-70 years, mean±SD 44±12; BMI 35-91 Kg/m 2 : mean±SD 45.7±8.4). Thyroid, parathyroid and pituitary function was evaluated; hypercortisolism was diagnosed by an overnight 1 mg dexametasone suppression test. Thyroid ultrasound and fine-needle aspiration biopsy were performed when indicated. 5 OP had an undiagnosed Cushing syndrome: 3 had a Cushing disease due to a pituitary adenoma, and 2 had an hypercortisolism due to an adrenal adenoma. 119 OP had a multinodular goiter (43 newly diagnosed). 1 medullary and 1 papillary thyroid cancer were discovered. The prevalence of autoimmune thyroiditis was 88/495 OP (67 with hypothyroidism under L-T4 therapy, 5 with untreated hypothyroidism). 1 patient was hypothyroid after treatment with amiodarone. 16 OP were under L-T4 therapy after thyroidectomy for papillary thyroid cancer, Graves' disease or toxic multinodular goiter. 4 OP had an unknown primary hyperparathyroidism. The pituitary hormonal screening revealed 1 hyperprolactinemic man with a non-functioning pituitary adenoma causing hypothalamic disconnession, and 1 central hypogonadism due to an empty sella. The overall prevalence of endocrine dysfunctions requiring specific treatment before BS was 104/495 (21%). In conclusion, a careful endocrinological evaluation of OP before BS should be adviced. This may reveal undiagnosed dysfunctions that require specific treatment and/or contraindicate bariatric surgery, and allows proper adjustment of hormonal therapy in patients with previously diagnosed endocrine diseases. Getting the balance right -a pragmatic community intervention programme for overweight/obese children in gateshead. Aims: In Gateshead, a quarter of 10-11year olds are overweight or obese. Getting the Balance Right is a holistic intervention aimed at tackling this problem in school aged children, specifically, aiming to improve Body Mass Index (BMI) in children completing the pathway of care for a twelve month period. Methods: After inter-disciplinary consultation, between health, social services and leisure services locally, a pathway of care was developed to identify and assess children who were overweight or obese. Personalised programmes of nutritional and behavioural advice and physical activity were offered to children and families. School health advisors or dieticians did initial assessments; paediatricians reviewed children thought to have underlying medical conditions and all children received coaching by a trained leisure worker. All data are quoted as means. BMI adult equivalent (Adeq)and BMI standard deviation scores (SDS) are given. Results: Over 30 months, 231 children with a BMI_Adeq of 28.9±5.8 and BMI_SDS of 3.0±0.7 entered the programme. One hundred and seventy-five (11.4±3.3years, 59% female and 78% obese) attended four dietetic appointment over 6.6±3.1 months and BMI_Adeq decreased by 0.9±1.7 and BMI_SDS by 0.14±0.25 (both p<0.0001). A significant decrease in BMI was maintained and 20 children, who still had not been discharged from dietetic review, attended their ninth appointment at 14.9±3.6 months, when BMI_Adeq had decreased by 1.8±3.1 and BMI_SDS by 0.27±0.44 (p<0.01). Foundation Trust and the council. It has uniquely produced a sustained and significant improvement in BMI in a large cohort. The results compare favourably with other shorter, smaller-scale interventions and other community projects 1,2 . Our approach could be used in other areas as a strategy to combat the rise in childhood obesity. Funding: We are grateful to Gateshead Council and the Dept of Health for funding this project through a local public service agreement. There are no conflicts of interest to disclose. Which pre-operative factors predict adequate weight loss following laparoscopic gastric band insertion? Mulla MG 1 , Singh R 1 , Clarke D 1 , Rickers L 1 , Cresswell K 1 , Parry L 1 , Leeder PC 1 , Larvin M 1,2 , Tan GD 1,2 1 Trent Regional Bariatric Surgical Service § , Derby Hospitals, Derby, UK 2 Nottingham University School of Graduate Entry Medicine & Health, Derby, UK Introduction: Laparoscopic gastric band insertion (LGBI) is being performed more frequently, but not all patients achieve adequate weight loss. This study aimed to analyse whether weight at initial assessment, age, gender, pre-operative weight loss or device type predicted total post-operative weight loss. Methods: A retrospective analysis was performed on data on LGBI patients attending a regional bariatric centre over 3 years. Patients were operated on if BMI>35kg/m 2 with an associated co-morbidity, or BMI>40kg/m 2 without. All received professional dietary advice pre-operatively, and pre-operative calorie restriction of 900kcal for 2 weeks prior to surgery. Devices used included the Lap-Band TM , Swedish adjustable band, or Heliogast TM device. Results: There were 246 consecutive patients analysed: 197 female (80%), median age 42y (IQR 36-49); 49 male, median age 49y (IQR 45-55). Mean waiting time between initial assessment and LGBI insertion was 7.8 months. Median postoperative follow-up was 16 months. Initial assessment weight significantly correlated with pre-LGBI weight loss (p<0.0001, Spearman). Patients with BMI 50kg/m 2 (n=75) lost 6.4±1.0kg before the LGBI, compared to a weight loss of 2.1±0.5kg pre-LGBI in patients with a lower BMI (n=109). Pre-LGBI weight loss correlated with post-LGBI weight loss (p=0.016, Spearman). Post-operative weight loss was not correlated with age, gender or device used. Conclusions: Patients with high assessment BMI, and those with greatest weight losses pre-LGBI appear to achieve greater post-LGBI weight loss. It appears that pre-operative diet predicts post-LGBI compliance and thus weight loss. Obesity and chronic kidney disease incidence in adult women: Tehran Lipid and Glucose Study Background: Epidemiological data comparing different aspects of obesity in predicting CKD in a cohort are limited. Objective: We examined the association between BMI and CKD incidence and compared it with other anthropometrical measurements to define best predictor of CKD in women. Methods: In this population-based cohort study, a representative sample of 2498 women, older than 18 years of age, free of CKD at baseline, were followed for 3.5 years. We estimated GFR by using the abbreviated equation from the Modification of Diet in Renal Disease Study and defined CKD as GFR less than 60 mL/min/1.73m2.Multivariate logistic regression was used to examine the relation between the baseline anthropometrical measures and CKD incidence. Results:Mean BMI of our participants at baseline was 27±5kg/m 2 .After 3.5years CKD developed in 148 (5.3%) of participants. Higher baseline BMI was associated consistently with increased incidence of CKD. The incidence of CKD in, normal BMI ( 25),overweight (25.1to 30) and obese ( 31.1 kg/m 2 ),were 3.2,8.1, and 10.8%respectively. The crude ORs for having CKD across normal, overweight and obese women categories were 1.00 (reference),2.67 (1.71-4.17 ) and 3.66 (2.34-5.78), respectively, (p for trend<0.01). After adjustment for age, smoking, baseline blood pressure, baseline diabetes, change in BMI, waist and WHR, the odds ratios for CKD incidence were 1.00 (reference), 1.68 (0.95-2.96) and 1.75 (0.86-3.57), respectively; (P for trend<0.05). Waist and WHR were excluded from the model. Similar results were noted after exclusion of participants with baseline diabetes mellitus. Conclusion:BMI,but not waist and WHR, is an independent, strong, and potentially modifiable risk factor for CKD in women.Weight loss might represent a novel intervention to reduce risk of CKD development and progression. A randomized controlled trial on the effect of dietary advice on gestational weight gain in obese pregnant women: preliminary results Departments of 1 Nutrition and 2 Obstetrics and Gynaecology, Catholic University Leuven, Belgium. Maternal obesity is a major risk factor for obstetric complications including gestational diabetes, hypertensive complications and operative delivery. Excessive gestational weight gain (GWG) further increases these risks. The optimal follow-up to reduce GWG in these patients is not known. We therefore randomised obese pregnant women (age: 29 ± 4 years; BMI: 33.5 ± 4.0l g/m 2 ) in 2 intervention groups: one group receiving nutritional advice through a purpose-designed brochure (A) and one group additionally receiving active lifestyle education (B). The hypothesis is that nutritional advice through a brochure or active education results in reduced GWG. Nutritional habits were evaluated every trimester by means of three 7-day food records and compared with a control group (C). Preliminary results in obtained in 99 obese pregnant women demonstrate that dietary habits at the start of the study did not reach recommended values, but were comparable between the groups. After the intervention, total energy intake was lower in groups A and B than in the controls (p=0.033). This effect was mainly due to a decreased fat intake in the 2 intervention groups versus control group (p=0.008). There were no significant differences in mean (SD) GWG between the three groups (11±7 vs 10±6 vs 10±7 kg). Birth weight of the babies was comparable. These preliminary results show that nutritional advice improves dietary habits of obese women (reduced energy and fat intake), but had no significant effect on GWG or birth weight. International Journal of Obesity The objectives of the present study were to identify 1) the exercise intensity that elicits the maximum fat oxidation rate during walking and cycling and 2) the intensity at which the lactate concentration starts to accumulate in plasma. Fifteen obese boys (mean BMI: 37.6 kg/m 2 ; fat-mass: 38.6%), aged 13 to 17 years, participated in this study. Body composition was assessed by bioelectrical analysis. Subjects performed a graded exercise test on a cycle-ergometer and on a motorised treadmill. Peak oxygen uptake and maximal fat oxidation rate were determined by indirect calorimetry and stoichiometric equations were used to calculate fat oxidation rate. Blood samples for lactate analyses were collected at the end of each stage of the graded exercise test. The exercise intensity, which elicits maximal fat oxidation, corresponded to (mean±SD) 39±4% V'O 2 max, or 55±6% HR max , without significant differences between walking and cycling. At this exercise intensity, fat oxidation rate was higher during walking than cycling (0.48±0.04 vs 0.30±0.05 g/min, p<0.001). The intensity at which lactate concentration increased above baseline corresponded to 40 ±3% V'O 2 max for walking and cycling. However, at this exercise intensity, lactate concentration was lower during walking than cycling (1.2±0.3 vs 1.8±0.4 mmol/L, p<0.001). In conclusion: i. maximal fat oxidation rate was reached at the same exercise intensity for both walking and cycling; ii. fat oxidation rate was 37% higher during walking than cycling at 55% V'O 2 max; iii. accumulation of plasma lactate was strongly correlated with the reduction in fatty acid oxidation with increasing exercise intensities; iv. lactate accumulation was lower during running than cycling. Funding: Research relating to this abstract was funded by Progetti di Ricerca Corrente, Italian Institute for Auxology, Milan, Italy. Gasteyger, C 1 , Larsen TM 1 , Toubro S 2 , Astrup, A 1 . 1 Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark 2 Reduce, Research Clinic of Human Nutrition, Hvidovre University Hospital, Copenhagen, Denmark Background: Data on the regional fat composition of a body weight change are limited. Methods: We assessed changes in visceral (VAF) and subcutaneous (SAF) abdominal fat at L4-L5 level by MR and changes in body composition (including trunk fat mass) by DXA scans in 112 obese subjects (26 men and 86 women) before and after an 8 week low-calorie diet with 800-1000 kcal/day. Results: The mean body weight loss was 11.3% (SD 2.7) in men and 10.3% (1.9) in women (p=0.04). A weight loss of 10% produced a body fat loss of 15% (95% CI 14-16), a reduction in SAF of 14% (12-16) and a reduction in VAF of 20% (16-25). Relative changes in VAF and SAF were significantly correlated with changes in trunk fat mass (r=0.45; p<0.001 and r=0.44; p<0.001, respectively). After correction for relative changes in trunk fat mass, the relative reduction in VAF was 34% (28-39) in men and 21% (18-24) in women (p<0.001). Relative changes in SAF did not differ significantly between men and women (p=0.85) after correcting for relative changes in trunk fat mass. Conclusion: For a given percentual reduction in body weight, the accompanying reduction in visceral fat is about twice that size (10 versus 20 %), which is consistent with the visceral fat deposition being easier mobilizable. However, for any weight loss compound claiming a selective effect on visceral fat it is not enough to demonstrate that greater percentage of visceral fat than body weight is lost. Methods: Twenty-eight individuals were randomly allocated to an immediate treatment or to a wait-list condition. Binge eating was studied according to EMA (seven days) at the beginning of wait-list condition, before and after treatment. Results: Before treatment, interpersonal conflicts, negative mood, or situational triggers such as evening time or specific weekday most often triggered binge eating. After binge eating, cognitions regarding low selfefficacy were most prominent. After treatment analyses the same antecendents and consequences were associated with the few binges still exhibited. Conclusion: EMA based assessments show before and after CBT that most often, binge eating is triggered by interpersonal conflicts and negative mood. Further situational aspects, play a major role in triggering binges. After binge eating cognitions regarding low self-efficacy in dealing with the problem dominate. These findings might help tailoring treatment protocols to specific BED patients populations. Objectives: To explore feasibility of Ecological Momentary Assessment (EMA) in evaluating a short-term CBT. Methods: Twenty-eight individuals were randomized to an immediate short-term CBT (8 weeks) or to a wait-list condition (8 weeks). EMA was accomplished during seven days at the beginning of wait-list condition, before and after treatment. Results: Ratings of acceptance and compliance with EMA were high. EMA-based estimates of bingeing were lower than rates assessed by retrospective questionnaires or interviews. Binges assessed by EMA were significantly reduced from 2.75 to 0.5 per week. Craving, feelings of hunger and control remained stable. Conclusion: EMA was well accepted and patients adhered to the EMAprotocol. We find indices of retrospective memory distortion regarding questionnaire and interview based assessment of binge eating. Short-term CBT is efficacious in reducing binge eating, whereas EMA shows, that feelings of loss of control, hunger, craving remain stable. Binge eating may be the tip of the iceberg, which can be remitted in CBT, but craving and reduced feelings of control might represent more stable aberrations of impulse control. Helmy A 1 , Ruparelia R 1 , Young L 1 , Finer N 1,2 1 Centre For Obesity Research, Luton, UK; 2 Institute for Metabolic Science-Metabolic Science Laboratories, Cambridge, UK Low Energy Liquid Diets (LELD 800-1200 Kcal/day = 3.35-5.02 MJ) have proved an effective strategy for weight loss induction, and weight loss maintenance over 1-3 years. The addition of pharmacotherapy improves weight loss maintenance. The optimal duration of LELD for subsequent weight loss maintenance is not known. We randomised 38 obese patients to an out-patient programme of either an initial 4% weight loss target over a maximum of 4 weeks (Group 1) or 8% in 8 weeks (Group 2) with an LELD, followed by reintroduction of solid food over an 8 week period towards maintenance on a 30% restriction from estimated energy needs for a total treatment time of 6 months together with sibutramine 10-15 mg daily. Mean baseline weight was 132 ±35 kg (86-203kg); BMI 45.6±8 kg/m² (35 -67 kg/m²); waist circumference 124 ± 20cm (89.5cm -164 cm). Total weight loss in completers in Group 1 (n=13, 14.5, 6.1, 8.4kg ; completers, total, LELD, maintenance phases) did not differ from Group 2 (n=10, 16.2, 10.4, 5.8 kg). Changes in body composition (BodPod) did not differ between groups. Group 1 had a lower drop out rate with none during the LELD; 30% of group 2 patients failed to complete the LELD. Significant improvements in lipid profile and quality of life were seen. A shorter period of LELD may give similar results to longer duration treatment and result in better patient retention. High prevalence of micronutrient deficiencies in severely obese patients Excessive food intake is the pathophysiological basis of obesity in most cases, but the quality of ingested foods might be poor. We report results on a comprehensive micronutrient assessment in 205 severely obese patients (BMI ε35 kg/m 2 ; mean ± SD: 44.6 ± 6.0 kg/m 2 ), who were evaluated for bariatric surgery. Deficiencies were found in 8.3% of the subjects for phosphate, 4.9% for magnesium, 6.3% for ferritin, 26.8% for zinc, 2.9% for folate, 18% for vitamin B 12 , and 89.3% for 25-OH vitamin D. In addition, 63.4% of the patients did not only show a mild (<75 nmol/l) but a moderate (<50 nmol/l) and 26.3% even a severe (<25 nmol/l) 25-OH vitamin D3 deficiency. According to the high prevalence of 25-OH vitamin D3 deficiency, 39% of the patients displayed a secondary hyperparathyroidism with PTH levels above 65 ng/l. In a subgroup of 76 patients selenium deficiency was found in 32.4% of the subjects, vitamin E deficiency in 2.4%, vitamin B 3 deficiency in 6.6%, and a vitamin B 6 deficiency in 2.6%, while none of patients had below cut-off levels for copper, vitamin A, and vitamin B 1 . Data indicate a high prevalence (>10%) of zinc, selenium, vitamin B 12 , and 25-OH vitamin D3 deficiency in severely obese patients and a high rate of secondary hyperparathyroidism approaching almost 40%. Although the clinical significance of the found micronutrient deficiencies remains to be established, present results suggest that poor micronutrient state could contribute to the health impairing effects of obesity. Longitudinal measurement of abdominal obesity in primary care. Increasing epidemiological evidence links excessive central adipose tissue with cancer, cardiovascular and metabolic diseases. One of the challenges of providing health care for overweight and obese people is the limitations of the available methods to distinguish between weight change and adipose tissue distribution. Body mass index (BMI) is the gold standard for classification of overweight and obesity while waist circumference (WC) and sagittal abdominal diameter (SAD) have been proposed as methods of measuring central adiposity. The stability of these methods in a primary care setting was explored in a pragmatic longitudinal study, in which 28 people consented to repeated measurement at eight-week intervals for up to four years in a general practice surgery. Recording of BMI (weight/height 2 ), WC using a simple tape measure, and SAD using the Holtain Kahn abdominal calipers enabled exploration of the reliability of these measures in the context of central adiposity. SPSS was used for the longitudinal and cross-sectional analysis of data by Pearson's correlation coefficient and linear regression. In the cross-sectional data both SAD and WC performed well, although SAD correlated more strongly with BMI than did WC, with the exception of the overweight women. In the longitudinal data SAD showed a significant (p<0.01) stability for individual participants. In linear regression, only SAD performed consistently. SAD is theoretically a better measure of intra-abdominal obesity than WC, and from a practical perspective within these findings SAD can be recommended for assessing central obesity in primary care. Funding: Research relating to this abstract was funded by Anglia Ruskin University Purpose: To further understanding on the clinical significance of binge eating in children. Emerging evidence suggests that childhood binge eating is likely associated with overweight and obesity as well as with increased eating disorder and general psychopathology. Methods: 60 children with binge eating, defined as ≥ 1 episode of loss of control over eating (LOC+) within the past 3 months, and 60 matched children without LOC history were recruited from the community. Clinical interviews and self-report questionnaires were used for psychopathological assessment. Results: LOC+ children reported 5 LOC episodes during the past month, mostly objective bulimic episodes, assessed though the Child-Eating Disorder Examination. Recurrent LOC was reported by 31 children (51.7%). LOC episodes were associated with overweight and obesity (36, 60.0%), greater eating disorder psychopathology, depressiveness, but not with psychiatric diagnoses or general behavioral disturbances. A hierarchical cluster analysis based on the DSM-IV and other proposed research criteria of binge eating disorder in children showed a recurrent binge eating cluster including children with ≥ 1 LOC per month, high level of distress, and increased eating disorder psychopathology; an emotional eating cluster including highly depressed children who binge ate at lower frequency; and a nondisturbed cluster with no or occasional binge eating. Both binge eating clusters revealed increased body mass index. Conclusions: These results show that the presentation of binge eating in children is heterogenous. Recurrent binge eating varies along dimensions of eating or mood disturbances. These findings suggest a differential indication for treatment of children from both binge eating clusters. Funding: Research relating to this abstract was funded through grant HI 1111/1-1 by the German Research Foundation (Deutsche Forschungsgemeinschaft and through educational grant 01GP0491 from the German Federal Ministry of Education and Research. External funding bodies had no impact on design, conduct of this study, data analysis, results, or terpretation. International Journal of Obesity T2:PS:71 Thaler Th, Suter PM University Hospital of Zurich, Zurich, Switzerland Background: Obesity is characterized by an increase in fat mass. Usually in the setting of overweight and obesity fat is deposited in all body locations. Abdominal obesity -reflected in an increased waist circumference -is associated with an increased health risk. A positive relation exists between the body mass index (BMI), the total fat mass (TFM) as well as the waist circumference (WC). For cultural reasons patients often do not want to undress or refuse even anthropometric measurements. In this study the relationship between buccal skin fold thickness (BSF) with TFM, BMI and WC was studied in young adults. Methods: 409 students (m/f = 179/230) at the age of 15 -22 years (BMI 21.09 ± 1.81 kg/m 2 ) were examined. Body weight, WC and BMI were measured according to the usual guidelines. The BSF was measured vertically in the middle of cheek between tragus and angulus oris using a calliper (Holtain LDT Crymych, UK). The average of three measurements was used. TFM was determined by bioimpedance (Tanita BF-410, Japan). Results: There correlation coefficient (r) for the relationship between the different variables was for males/females: 0.44/0.35 0.43/0.36 0.48/0.4 0.47 / 0.35 p for all < 0.01 Discussion/Conclusions: A significant relationship was found between BSF and body weight, BMI, WC and TFM. The relationship was strongest between BSF and WC in male (r = 0.48). Our data suggest that the measurement of the BSF might be a useful easy accessible proxy marker for the assessment of fat distribution in patients who do not want anthropometric measurements for cultural reasons. Herberholz N 1 , Brown K 1 , Dickson E 1 , Hall T 2 , Walker L 1 , Hay S 2 , Dale A 1 1 Gateshead Health Foundation Trust, Tyne and Wear, UK 2 South of Tyne Primary Care Trust, Tyne and Wear, UK Background: We offer a multidisciplinary intervention for obese children aged 5-16, 258 children have been recruited since April 2005. Aims: To assess family history, physical exercise and self-image on recruitment. Method: On entering the project questionnaires were filled in. Questionnaires were evaluated for 52 randomly selected children, which are representative of all participants with respect to age, gender and BMI. Results: 67% of children have other family members who worry about their weight, 61% of these are 1 st degree relatives. Weight related illnesses (cardiovascular or diabetes type II) occur in 12% of 1 st degree and 40% of 2 nd degree relatives. Almost all children (98%) report to exercise, but 35% solely attend school PE lessons. Only a minority (13%) exercise at least 60 minutes/day. 89% of children own a bike, only 29% ride it regularly. 54% walk to school, but often infrequently. Much time is spent watching TV or playing computer games with 30% of the children spending more than 2 hours per day. 71% of children have expressed concerns about their weight and 50% experienced bullying. Conclusions: Obesity and its complications are common in the children's families. Most children report being active, but actual levels of exercise are mostly inadequate. The emotional cost on children was highlighted with high rates of bullying and concern about body weight. Recognition of these characteristics have contributed to the development of our local project with family participation, dietician and school nursing involvement and promotion of physical exercise through local authority facilities. Funding: We are grateful to Gateshead Council and the Department of Health for funding this project through a local public service agreement. There are no conflicts of interest to disclose. Comprehensive nutritional education can result in improving not only the quality of diet but also in reducing metabolic disorders. The aim of this study was to assess serum leptin and insulin levels in overweight or obese patients with essential hypertension attending nutritional education program provided by dietitian. A total of 125 pharmacologically-treated patients were recruited from the Outpatients Clinic of Hypertension at the National Institute of Cardiology in Warsaw. The study group consisted of 81 subjects (mean age 62.3±8.8 years and BMI 32.7±4.2 kg/m 2 ) attending nutritional program. Forty four individuals from the control group (mean age 56.8±10 years and BMI 32.4±4.5 kg/m 2 ) received standard medical counseling. Baseline serum leptin and insulin levels, measured before nutritional education, were 22.8±15.5 μg/L, 15.9±7.9 μU/ml and 19.8±14.0 μg/L, 14.7±6.9μU/ml, in both groups respectively. After 6 month of education statistically significant decrease of leptin ( from baseline -4.04μg/L, p 0.05) and insulin levels ( from baseline -1.84μU/ml, p 0.05) was observed in the study group. Increase of both markers was found in the control group ( from baseline 0.09μg/L, NS, and 2.36μU/ml, p 0.05, respectively). A decrease in body mass was found in 72% of individuals from the study group and in 41% subjects from the control group. Statistically significant decrease in both, systolic and diastolic blood pressure was found only in the study group (130±6 versus 127±6 mmHg, p 0.05; and 84±3 versus 83±4 mmHg, p 0.05, respectively). It was concluded that nutritional education could be effective strategy for hypertension and obesity management. Background: Ramadan fasting is a religious daytime fasting, which might result in loss of body weight and percentage body fat. We sought to find changes in body weight and percentage body fat in women adhering to Ramadan fasting. Methods: Women from a nearby community center were asked to participate into the study. Body weight and composition were measured by densitometry (BOD POD). Measurement were taken a few days before the start of Ramadan, about 25 days later (3.5 weeks into Ramadan) and about 25 days later (3 weeks after Ramadan). One sample t-test was used. Results: Included were 21 women, loss to follow-up 9. For 12 women mean age was 33 (sd 11) y, BMI 24.6 (5.1), body weight 63.9 (14.2) kg, percentage body fat 31.4 (10.9) %. By the end of Ramadan body weight had decreased by 0.17 kg (95% CI -0.64-0.29) and body fat percentage by 0.68% (95% CI -2.03-0.66). However, between end of Ramadan and 3 weeks after Ramadan body weight increased by 0.88 kg (p= 0.005; 95% CI 0.32-1.44) and percentage body fat increased by 2.09% (p=0.061; 95% CI -0.1-4.3). Total increase in body weight over 7 weeks was 0.65 kg (p=0.063; 95% CI -0.04-1.35). The benefit of Ramadan fasting for body weight and percentage body fat seems to be of short duration. For overweight women, short term weight loss might be a risk factor for weight cycling. Bortolotti, M 1 , Rudelle, S 1 , Schneiter,P 1 , Vidal, H 2 , Loizon, E 2 ,Tappy, L 1 , Acheson, KJ 3 . Dairy calcium supplementation has been proposed to increase fat oxidation and inhibit lipogenesis. This study investigated the effects of calcium supplementation on markers of fat metabolism. Ten overweight/obese individuals with habitually low calcium intakes received 800 mg/d dairy calcium for 5 weeks. After 4 weeks, an adipose tissue biopsy was taken for analysis of gene expression. Respiratory exchange, glycerol turnover and subcutaneous adipose tissue microdialysis was performed for 7 hours after consuming 400 mg calcium or placebo, with randomized slow release caffeine (SRC; 300 mg) or lactose intake (500 mg). One week later the test was repeated with the SRC/lactose cross-over. Calcium supplementation increased urinary calcium excretion 28% (p<0.05), but did not alter plasma PTH and osteocalcin concentrations. Resting energy expenditure (REE; 59.9 ± 3.0 kcal/h vs 59.6 ± 3.3 kcal/h), fat oxidation (FO; 58.4 ± 2.5 mg/min vs 53.8 ± 2.2 mg/min), plasma free fatty acid concentrations (FFA; 0.63 ± 0.02 mmol/L vs 0.62 ± 0.03 mmol/L) and glycerol turnover (3.63 ± 0.41 μmol/kg/min vs 3.67 ± 0.38 μmol/kg/min) were similar with or without calcium supplementation. SRC increased FFA concentrations, resting FO and REE. During microdialysis, epinephrine infusion increased dialysate glycerol concentrations 255% without and 254% with calcium supplementation. Expressions of 7 key metabolic genes in subcutaneous adipose tissue were not affected by calcium supplementation. Calcium supplementation, in overweight subjects with a low habitual calcium intake, failed to alter whole body lipolysis, lipid oxidation, and energy expenditure under resting conditions and during stimulation by caffeine or epinephrine. Personality and eating behaviour in obesity: poor self-control in emotional and external eating but personality assets in restrained eating In linear regression models personality could explain 10 to 42 percent of the variance in the eating behaviours. Conclusion: These results imply that poor self-control seen in impulsiveness and lower self-discipline was most important for eating due to negative emotions as well as in response to external food stimuli, suggesting that the inhibition of eating and difficulties to govern ones behaviour are major aspects of these eating behaviours. Attempts to control food intake and body weight seen in restrained eating were associated with more character strengths and ambitions, and also a more outgoing personality style with more stable emotions. What is the Energy Deficit Required Per Unit Weight Loss? Hall, KD National Institutes of Health, Bethesda, U.S.A. One of the most pervasive weight loss rules is that a cumulative energy deficit of 3500 kcal is required per pound of body weight loss, or equivalently 32.2 MJ per kg. Under what conditions is it appropriate to use this rule of thumb and what are the factors that determine the cumulative energy deficit required per unit weight loss? Here, I examine this question using a modification of the classic Forbes equation that predicts the composition of weight loss as a function of the initial body fat and magnitude of weight loss. The resulting model predicts that a larger cumulative energy deficit is required per unit weight loss for people with greater initial body fat -a prediction supported by published weight loss data from obese and lean subjects. This may also explain why men can lose more weight than women for a given energy deficit since women typically have more body fat than men of similar body weight. Furthermore, additional weight loss is predicted to be associated with a lower average cumulative energy deficit since a greater proportion of the weight loss is predicted to result from loss of lean body mass which has a relatively low energy density in comparison with body fat. The rule of thumb approximately matches the predicted energy density of lost weight in obese subjects with an initial body fat above 30 kg but overestimates the cumulative energy deficit required per unit weight loss for people with lower initial body fat. This work was supported by the Intramural Research Program of the NIH, NIDDK. Cognitive-behavioral treatment (CBT) approaches of different length and delivery format (e.g. group and individual setting, therapist-guided selfhelp) have demonstrated efficacy in the treatment of binge eating disorder (BED). This study evaluated the efficacy of a short-term CBT including 8 weekly sessions, followed by five booster sessions during the 12-month follow-up period. Thirty-six female participants with BED were randomly assigned to eight weeks of CBT or a waitlist condition. Core symptoms of BED (abstinence rates from binge eating, number of objective binge episodes, self-reported weekly binges, body mass index) and associated eating disorder psychopathology (shape and weight concern, eating concern, dietary restraint) were assessed repeatedly up to 12 months following treatment using structured diagnostic interviews and self-report measures. Participants' compliance and therapist's adherence to the treatment protocol were assessed. Statistical analyses were conducted using Linear Mixed Models for continuous variables, and Generalized Linear Models (GLMMs) for dichotomous variables. Short-term CBT produced significant reductions in the number of objective binge eating episodes and significant improvements in the percentage of patients abstaining from binge eating at 12-month follow-up. Findings suggest that the short-term CBT is efficacious in reducing core symptoms of BED, thus providing a cost-effective treatment option for patients with BED. International Journal of Obesity Growth hormone (GH) is an important regulator of growth and body composition. It has been shown that GH-release can be promoted by intravenous or oral administration of various single amino acids (AA), either alone or in combination. The effects of dietary protein on GH-secretion, however, are less well described. The effects of dietary protein on GH-secretion are investigated in two different studies: firstly, we compared oral ingestion of hydrolysed soy protein and complete soy protein with an AA-mixture (reflecting the AA composition of soy protein) and, secondly, we compared ingestion of a complete meal containing soy protein as the sole protein source with soy protein alone. Both studies were performed in eight healthy women (age:19-36y, BMI:19-26 kg/m 2 ) in a randomized single blind, placebo-controlled crossover design. Serum GH was determined every 20 min during 5 h. Ingestion of the complete soy protein, hydrolysed soy protein and the AAmixture all increased plasma GH-responses (either by area under the curve or peak values) to a similar extent, when compared with placebo (p<0.05). The GH-responses to ingestion of soy protein (p<0.05 versus placebo) were completely abolished when soy protein was ingested as part of a complete meal. In conclusion, ingestion of soy protein, either hydrolysed or intact, as well as amino acids reflecting soy protein stimulates GH-release to a similar extent. This effect, however, is not present when soy protein is ingested as part of a complete meal, suggesting that other macronutrients counteract the somatotropic actions of soy protein. Caterson, I 1 , Sharma, AM 2 , Coutinho, W 3 , Finer, N 4 , Van Gaal, L 5 , Maggioni, A 6 , Torp-Pedersen, C 7 , and James, WPT 8 , on behalf of the SCOUT Investigators Introduction: SCOUT is an ongoing, placebo-controlled trial to assess cardiovascular (CV) outcomes in overweight/obese patients at high CV risk. It is a post-approval commitment to the European Regulatory Authorities prompted by concern that sibutramine's (SIB) mode of action could exacerbate hypertension (HT). SIB would be contraindicated in most patients eligible for SCOUT; however, approximately 10% of those enrolled were at lower risk and met criteria in current EU Summary of Product Characteristics (SPC-"label"). Data from the 6-week lead-in period when all patients received SIB 10 mg plus weight management allow an assessment of initial response in these 2 groups. Patients and Methods: Patients eligible for SCOUT were aged ≥55 years with BMI ≥27 to ≤45 kg/m 2 , or ≥25 to <27 kg/m 2 , waist circumference ≥102 cm (men)/≥88 cm (women), blood pressure ≤160/≤100 and had a history of CV disease (coronary artery disease, myocardial infarction, stroke) or had type 2 diabetes mellitus (DM) and another risk factor. The subset of SCOUT patients who met "label" criteria were ≤65 years, with BMI >27 kg/m 2 , BP≤145/90 mmHg, with DM and another risk factor, but without a contraindicated CV history. Median Changes at End of 6 Weeks (LOCF analysis) Initial body weight ( 3.0 1.5 Conclusion: SCOUT patients who are normally contraindicated for SIB treatment (current SPC criteria) showed greater median falls in BP and smaller increases in heart rate compared to the "current labelled" population; this was despite similar weight loss. The per-"label" group showed similar changes in BP and heart rate to those seen previously in randomized controlled trials. Committee of the SCOUT study. Funding: Research relating to this abstract was funded by Abbott Laboratories. The efficacy of intragastric balloon on reducing weight, alleviating psychological discomfort and improving quality of life in obese patients: a prospective study Karaivazoglou K 1 , Katsakoulis E 2 , Triantos C 2 , Assimakopoulos K 1 , Theocharis G 2 , Louvros M 2 , Kolovou D 2 , Nikolopoulou V Background and aims: Obesity has become a modern epidemic associated with poor quality of life (QOL) and increased levels of psychological discomfort. The intragastric balloon is a non-surgical, reversible obesity treatment with promising yet inconclusive results. The aim of the current study was to assess its effect on controlling body weight and improving patients' psychological function and QOL. Patients and methods: Thirty seven (37) adult obese patients with no contraindications to balloon placement were enrolled to this prospective study. Participants were interviewed before the intragastric balloon placement (time 1) and at 6 months (time 2), when the balloon was removed. Psychological function and QOL were assessed by the Hospital Anxiety Depression Scale (HADS) and the Short Form Health Survey (SF-36), respectively. Results: Two patients (5.4%) had the balloon removed before study completion, because of nausea and vomiting. Patients' mean initial body weight was 117.9 (22.1) kg with a mean BMI of 41.7 (5.0). At time 2, patients' mean body weight was significantly decreased (p=0.000) with a mean loss of 17.5 (11.3) kg. In addition, patients reported a significant reduction in anxiety (p=0.035) and depression (p=0.046) scores and a major improvement in all subscales of the SF-36 including physical functioning (p=0.000), role functioning due to physical (p=0.001) or emotional (p=0.002) problems, bodily pain (p=0.021), vitality (p=0.012), social functioning (p=0.003), general (p=0.005) and mental (p=0.013) health. The intragastric balloon is a well-tolerated obesity treatment, associated with significant weight reduction and major improvement in patients' psychological function and QOL. Heart rate variability and baroreflex sensitivity responses to weight loss following bariatric surgery Conclusion: Weight loss after bariatric surgery leads to significant improvement in autonomic nervous system function, as assessed by both baroreflex sensitivity as well as heart rate variability. Objective: Weight loss surgery may lead to nutritional complications. Wernicke's Encephalopathy (WE) is a medical emergency caused by severe deficiency in thiamine (vitamin B-1); the classical clinical features are mental confusion, eye movement disturbances, and gait instability. This review summarises the presentation and outcomes of WE reported after bariatric surgery. Methods: Literature searches were done in PubMed, and bibliographies of relevant articles were hand searched. WE was diagnosed using Caine's operational criteria. Only one instance was counted when the same case was reported several places. Patient outcomes at latest reported follow-up were defined as complete recovery or incomplete recovery (any residual deficit observed clinically). Results: A total of 76 cases of WE after bariatric surgery published during 1977 to 2007 met the operational criteria. These patients were admitted median 90 days after weight loss surgery, and 70 (92%) were admitted within 6 months. Frequent vomiting was a precipitating factor in 67 patients (88%). Patient outcomes ranged from full recovery to death, with incomplete recovery in 42 patients (55%). The 43 cases reported year 2000 or later had significantly better outcomes compared with 33 cases reported earlier, odds ratio for complete recovery 3.7 (95% confidence interval, 1.4 to 9.8). WE occurred after all types of weight loss procedures. The number of Wernicke's encephalopathy cases following bariatric surgery is substantially higher than previously suggested. Nearly all cases presented within 6 months of surgery in association with frequent vomiting. Improved patient outcomes recent years might indicate an increased awareness of this complication. Funding: Research relating to this abstract was funded by a research fellowship grant from Eastern Norway Regional Health Authority. Pretlow, R 1 1 eHealth International, Seattle, Washington, USA Healthcare resources are grossly inadequate to treat the estimated 25 million obese/overweight children and adolescents in the United States. Technology offers potential solutions. An Internet-based weight loss system was created, by which overweight children and adolescents may: 1) be educated on healthy eating and exercise; 2) receive support from overweight peers; and 3) selfmonitor weight with online support and guidance from their healthcare provider. Results of a two-year outcomes study on 124 overweight school and clinic children, with 36 providers, are encouraging. Obstacles encountered include: 1) minimal computer knowledge by providers; 2) lack of provider time to monitor data and post supportive messages; 3) lack of reimbursement for Internet-delivered care; 4) lack of home Internet access by children; 5) lack of time for children to access the system at school; 6) licensure issues when delivering care across state borders, 7) provider privacy concerns that personal information may be stolen from the database, 8) provider liability concerns that a hacker/predator may obtain a provider's password and spoof/prey upon a child. Solutions developed include: 1) automatic email notification to providers of excessive weight gain and when a child has weighed-in or not weighed-in within the provider specified time frame; 2) automatic weigh-in reminders to children, if not weighed-in within their provider-specified period; 3) prewritten weight control messages (templates) sent automatically to children at the provider-specified interval, including provider's photo and signature; 4) Internet-connected scales, constituting "electronic accountability". Internet technology has the potential to impact on childhood obesity, if remaining obstacles can be overcome. Conflict of Interest: The web system described in this abstract is owned by eHealth International. Hesseling MG 1 , Dekker M 1 , van Bavel-Verreijen AM 1 , Weijs PJM The quality of life (QoL) has been measured with generic questionnaires such as the SF-36. The present pilot study assessed whether these QoL scores correlated with BMI, socioeconomic status, and biochemical markers of nutritional status. We included 71 subjects (52 women), aged 40.4±11.8 years with BMI 32.4±9.6 (min 18.5, max 56.8). The subjects completed the SF-36 questionnaire and were interviewed for evaluation of socioeconomic status. Blood samples were taken for measurements of 17 biochemical markers related to nutrition. Body composition was determined using bioelectrical impedance analysis. A factor analysis was used to calculate four subjacent factors for the biochemical markers and its scores were used in the analysis. Pearson correlation analysis and the MANOVA test were performed. SF-36 scales correlated with BMI: Physical function (r=-0.43), physical activity (r=-0.30), pain (r=-0.29), general health (r=-0.23), vitality (r=-0.46), social function (r=-0.25), emotions (r=-0.32) and mental health (r=-0.46), p<0.05, for all. Other measurements such as body fat percentage and waist circumference showed the same trend of correlations with the SF-36 measures. Only the mental health portion of the QoL was correlated with the nutrition factor 2 (r=0.3), suggesting a relation between mental health deterioration and low serum concentration of iron, hemoglobin, homocysteine, and transferrin. Vitality was inversely associated with socioeconomic status, after adjustment for sex and age. We conclude that QoL is greatly affected by BMI, the nutrition factor that implies variables related to iron status was inversely correlated with mental health. Data exist that support this association. Other studies have shown that vitality is associated with fatigue, our findings suggest this vitality score is independent explained by BMI and socioeconomic status. Objective: To determine subjacent factors that can explain biochemical markers associated with body composition. Methods: We included 71 subjects (52 women) with age 40.4±11.8 years and BMI 32.4±9.6 (min 18.5, max 56.8). Blood samples were taken for quantification of 17 biochemical markers related to nutritional status. Basic anthropometric measures were taken and body composition was measured using bioelectrical impedance. A factor analysis was used to assess at least four subjacent factors of nutritional status and their association with the anthropometric and body composition variables. Results: We found two nutritional factors that were directly related to BMI. However, factor 1 was associated with lean mass, while factor 2 was associated with body fat. Factor 1 correlated with BMI (r=0.46) and lean mass (r= 0.62); indicating that triglycerides, insulin, retinol-binding protein, ferritin and homocysteine had a direct correlation but HDL-C, serum folate and cobalamin was inverse. Factor 2 showed inverse correlation with BMI (r=-0.45) and body fat percentage (r=-0.54). As body fat increased there was a decrease in serum iron level, hemoglobin, and an increase in homocysteine and transferrin. Prealbumin was inversely related to body fat (r=-0.38) and BMI (r=-0.32), while pepsinogen was directly associated with BMI (r=0.33) and gastrin (r=0.33). Serum creatinine was related to waist circumference (r=0.42), and lean body mass (r=0.70). Interestingly, creatinine/height index and gastrin did not show an important effect in this group of patients. Conclusion: Biochemical nutritional status markers had differential associations with body composition. The least useful index was the creatinine/heght index that did not show any correlation with the studied variables. We found that nutritional markers are not useful for the assessment of malnourishment in obese subjects. These nutritional markers have been used for undernourished subjects. Recently some researchers have suggested that obese patients have a degree of malnourishment; this study does not support this concept. The findings in obese individuals may reflect an epiphenomenon related to circulating marker dilution due to the higher blood volume found in obese individuals. "Dr. Ionova's clinic" has the 5 years experience of obesity management. There are same directions of obesity management in the clinic: individual nutritional counseling, individual psychological counseling, group nutritional and psychological counseling, massage and cosmetic procedures. On the 1 st session dietitian clarifies the request of client, evaluates its reality and suggests the program which meets his needs. On the 1 st session dietitian obtains the history, appoints the examination, and forms the primary diagnosis. Psychologist defines the primary psychological profile of client. The nutritional program consists of weekly sessions for meeting the result. Dietitian forms the diagnosis and designs the individual nutrition program which meets all requirements of client. The weight reduction is controlled by weekly bioimpedance analysis, so one of the dietitian targets is to keep body cell mass of client and to reduce mostly body fat. Depending on the obtained weekly results the diet can be changed. All dietitians of clinic have skills of nutritional behavior changing and they weekly analyze it and help to improve client's nutritional behavior. So For psychological consulting, a combination of CBT, Art Therapy and Gestalt Therapy methods was employed. After achieving his object client is offered the program of keeping the result for 6 months. The program includes monthly nutritional and behavioral sessions when the client is taught to extend the diet and keep the result. The using of specialized protein shake "formlik" in nutritional practice This high-quality specialized product "FormLik" was developed in "Dr. Ionova's clinic" in 2001 and has been used since that. Reliable data of the effectiveness of using the product for nutritional patients have been received by now. The effect is reached by means of active components of the shake. The shake includes soy protein (with all essential amino acids), a complex of vitamins, minerals and lactulose. As a fiber, lactulose gives the filling of fullness, stabilizes the function of intestinal tract, provides probiotical effect of intestinal tract improvement, which lasts for a long time after finishing the nutrition program. Indications: obesity, low nutrition, as additional nutrition at exercises. Contraindication: individual intolerance, renal-hepatic insufficiency. The comparative analysis of two groups of patients (1 st -taking the shake during weight reduction, 2 nd -omitting the shake during weight reduction) showed: 1. 1 st group patients (1GP) lost the weight faster, than 2nd group patients (2GP). 2. 1GP doesn't have hunger attacks, they feel fullness faster, than 2GP and for a longer period. 3. 1GP has fewer nutrition breaks. 4. 1GP normalizes the blood cholesterol and other lipids levels faster, than 2GP. 5. 1GP improves the intestinal function. The patients get easy cooking. Preparation: the necessary amount of shake is stirred with dairy products ore sour-milk products. It is used for breakfast and/or for dinner. The portion and the period of shake intaking are determined by the supervising doctor. In women, menopause transition is associated with numerous metabolic disturbances named as metabolic syndrome. To the best of our knowledge, no study has yet examined the metabolic risk profile of middle-aged pre-and early postmenopausal obese women. Methods: 14 pre-(49 ± 2 years) and 11 postmenopausal women (52 ± 3 years) whose body mass index was 32 ± 3 and 30 ± 2 kg/m², respectively (p=0.12) were compared for their metabolic and inflammatory profiles after 3 sessions/week of 45 min-walking each, at 60% of heart rate reserve, during 16 weeks. Body composition was assessed by bioelectric impedance and O 2 max estimated by the 2 km-walking test. Fasting plasma triglyceride, cholesterol (CHOL), lipoprotein fractions as well as PAI-1, C-reactive protein (hs-CRP), fibrinogen and cytokine (adiponectin, TNFα and IL-6) levels were determined. Plasma glucose, free fatty acid (FFA) and insulin responses to an oral glucose tolerance test (OGTT) were measured. Results: At baseline, postmenopausal women were characterized by lower lean mass and higher HDL-CHOL concentrations (0.01
30kg/m 2 ), with hypercholesterolemia (total cholesterol >200mg/dl, HDL-cholesterol<40mg/dl), type 2 diabetes mellitus, and hypertension -were included into an educational program consisting of diet and exercises. The lifestyle changes of these patients aimed to a decreasing cardiovascular risk. The educational program included a description of the risk factors and their primary prevention, a distinct diet (with decreased calory, lipid and sodium intake) and moderate intensity exercises (at least 3 days/week, for a minimum of 30 minutes). Every patient included in this program was clinically reevaluated each 2 months. Measurements of blood pressure, glycemia and lipid levels were taken after 6 months. Results Background: Obesity and associated comorbidities have developed in epidemic dimensions worlwide. Lifestyle-improving interventions are indicated for conventional, presurgical, and postsurgical treatments. In this prospective uncontrolled study, the long-term effect of a 20 week multifactorial group intervention on weight reduction was investigated with a total follow-up of 3 years. Methods: 48 women (median, range, 52, 22-69 years, BMI 31.3, 22.1-54.5 kg/m 2 ) and 33 men (55, 24-69 years, 31.5, 26.0-44.6 kg/m 2 ) completed the intervention. The intervention consisted of a 1.5 hour group meeting once a week for 20 weeks, including recommendations on diet, daily physical activity, eating habits, and stress management. 68.8% of the women and 81.8% of the men were enrolled in the 1, 2, and 3 year follow-up. Results: The weight difference in women after 20 weeks was (median, range) -6.2% (-22.4/-1.6), 1 year -5.8% (-25.0/+2.9), 2 years -7.0% (-32.9/+10.0), and 3 years -7.5% (-27.1/+11.4). In men, the difference after 20 weeks was -6.3% (-22.6/0.0), 1 year -5.3% (-20.4/+8.5), 2 years -4.6% (-15.9/+3.2), and 3 years -5.0% (-15.0/+7.1) with p>0.05. After 1 year, 87.9% of the women and 92.6% of the men showed reduced body weight, after 2 years 87.9% and 74.1%, and after 3 years 81.8% and 77.8%, respectively. Conclusions: 80% of the patients maintained a weight reduction of 5-8% of their initial weight throughout 3 years following a 20 week multifactorial lifestyle-improving group intervention. The multifactorial approach presents a more optimistic outlook than monofactorial strategies. Interventions of longer duration are likely to yield improved long-term success rates. The aim of the present study was to verify body composition, psychosocial issues, eating behavior and physical activity of NWO women. 23 healthy non-obese (BMI < 25 kg/m 2 and Fat % < 30%), 42 NWO (BMI <25kg/m 2 and Fat % > 30%) and 123 preobese (BMI = 25-30 kg/m 2 and Fat % > 30%) women without metabolic syndrome were studied. Anthropometrical variables, body composition and fat distribution evaluated by DXA, cardiovascular (CVD) risk factors, basal metabolic rate by indirect calorimetry, assessment of physical activity, presence of depression, binge eating and yo-yo phenomenon were evaluated and compared between groups. Mean age was the same in all groups. Total and abdominal fat but not body weight or CVD risk factors were significantly different between healthy non-obese and NWO women. Compared with healthy non-obese women, NWO women presented significantly more frequently depression, binge-eating, yo-yo phenomenon and had lower physical activity levels. NWO women, a group of women at risk, can be misclassified if body fat and fat distribution are not evaluated. NWO women are vulnerable because, except of the signs of early inflammation related to the excess body fat, they seem to be less active, frequently depressed and present more frequently binge eating and greater oscillations of their body weight. Regulatory guidance on the design of studies evaluating weight loss medications differs with respect to requiring a dietary lead-in. Weight loss during the first 12 weeks of treatment with orlistat 120 mg has previously been shown to be a good indicator of long-term weight loss, whereas loss of >2.5 kg during a 4 week lead-in adds little predictive benefit [1] . A similar analysis was conducted for orlistat 60 mg by pooling data from two randomised, double-blind, placebo-controlled trials. After a 4 week lead-in with a hypocaloric, low-fat diet, subjects (BMI 28-43 kg/m 2 ) were randomised to treatment. Data presented are for subjects who completed 1 year of treatment. For subjects who lost >3% baseline weight after 12 weeks of treatment, mean relative weight loss at 6 months was 8.1% (n=200) compared with 1.3% (n=114) in subjects who lost <3% (p<0.0001). Findings were similar at 1 year. Loss of >5% weight at 12 weeks was also closely associated with long-term weight loss. Conversely, lead-in weight loss (>2.5 kg or <2.5 kg) provided lower predictive value for relative weight loss at 6 months in those who lost >3% (8.8%; 6.8%) or <3% (1.1%; 1.3%) at 12 weeks (p=0.0083). No relationship was observed between weight loss during the lead-in and at 1 year (p=0.4120), nor did it have a significant effect on weight loss at 6 months or 1 year in subjects who lost >5% weight at 12 weeks. Weight loss achieved after 12 weeks treatment with orlistat 60 mg is an accurate predictor of successful weight loss at 6 and 12 months. Lead-in weight loss provides little additional value. Hospital AZ Jan Portaels, Vilvoorde, Belgium Rationale: Last years obesity is treated more frequently with bariatric malabsorptive surgery. However the long term safety and complications of these procedures are not well known. I describe here seven female patients who underwent about seven years ago a bariatric surgery procedure for treatment of obesity, now presenting with severe osteomalacia and bone loss. Methods: Out of the ambulatory endocrinology clinic, I describe seven patients suffering from severe bone pain and -fractures. All these patients have characteristics of osteomalacia and in the past a bariatric procedure. All patients underwent clinical examination, fasting blood sample for calcium, alkalic fosfatase, vitamin D and PTH. Results: Mean age of the patients is 39 ± 6 years Duration of operation is 9.2 ± 3 years Mean loss of weight is 27 ± 3 kg Mean BMI is 27.3 ± 4.2 kg/m² All patients had hypocalcaemia with a mean value of 7.9 ± 0.4 mg/dl normal 8.6-10.2 mg/dl Mean vitamin D-status is 9.7 ± 1.8 mg/dl normal 7.1-45 mg/dl All patients had an elevation of PTH 173 ± 22 mg/dl normal 9-78 mg/dl Alkalic fosfatase : 277 U/l ± 37 normal 240 U/l Conclusion: In this case report I present seven post-bariatric surgery patients with severe osteomalcia with hypocalcaemia, vitamin D-deficiency and secondary hyperparathyreoidia. All patients had sever bone pain and vertebral fractures. The osteomalacia in this patients is caused by malabsorptive bariatric surgery and can be considered as a long term complication of this procedure. The treatment of this patients is difficult and consists of oral and intravenous administration of calcium and vitamin D. Further larger studies are needed to examine the frequency of this severe long term complication and when planning this surgical procedure, the surgeon must evaluate and communicate to his patient this possible severe complication. On the 1 st session of clients with eating disorders (ED) there must be a mutual consultation of both dietitian and psychologist. It helps to design effective individual program of nutritional and psychological treatment. Every specialist has his own specific number of tasks. Dietitian clarifies the client request, obtains the history, appoints the examination, forms the primary diagnosis, clears up individual food strategies which let the doctor determined the level of ED. The obtained information determines the further approach of the treatment, gives a possibility to offer an individual nutrition program, to prescribe the individual diet, which meet the client's requirement, taking into consideration his somatic state. The psychologist focuses on defining the primary psychological profile, motivation level, actual psychological problems and inner personal resources. The level of cooperation, optimal number of sessions and planned level of psychological assistance are evaluated. Clients' detailed informing by the psychologist and dietitian helps to choose an optimal and the most comfortable and convenient program. This results in contracting the treatment program. The contracting helps to motivate doubting and unconscious clients and select out unmotivated people. The creation of comfortable and confidential climate by psychologist and dietitian gives the positive direction of treatment and brings to successful results. Cooperation of the specialists, the opportunities of mutual assistance are of prior importance. Mutual initial session provides faster and more objective helps to define approximate period and initial plan of treatment. This allows the therapy to obtain the results more effectively.
Dicembrini I, Pala L, Cresci B, Rotella CM Department of Pathophysiology, Unit of Endocrinology, University of Florence Body Impedentiometric Analysis (BIA) is easy, non-invasive, relatively inexpensive and can be performed in almost any subject. Recently some data suggest that anthropometric indices used as indirect measures of total or visceral fat mass could be correlated with some of the parameters of the BIA. More recently a new anthropometric index, the ratio between height (m) at cube and waist (cm) at cube (H 3 /W 3 ) has been proposed. Aim of this study was to evaluate whether parameters obtained with BIA can be used as predictors of qualitative weight loss in obese patients undergoing non-pharmacological treatment. Free Fat Mass (FFM) is correlated with H 3 and therefore we evaluated possible relations among H 3 /W 3 and BIA parameters. An observational cohort study was performed on a consecutive series of 142 obese. The follow up was of 3,6,12 months. The parameters measured were: weight loss, waist, BMI, blood pressure, FFM, Fat Mass (FM), Total Body Water (TBW), Muscle Mass (MM). The analysis was performed by intention to treat, with a weight loss >5% of initial body weight defined as a therapeutic success. A multivariate analysis, after adjustment for age and sex, showed that H 3 /W 3 correlates in a different way on the basis of the follow up: in the short term it is negatively correlated with the weight loss; in the long term this parameter is significantly correlated with FFM and inversely with FM. H 3 /W 3 could be an easy to use anthropometric index useful in monitoring obese patients following a weight loss program based on lifestyle intervention.
International Journal of Obesity Health Center of Karlovassi, Samos, Greece Background and Aim: Childhood obesity is evolving into an epidemic in many regions of the world but the exact roles of its contributory factors remain elusive. Our aim was to record dietary habits and physical activity in adolescents in a rural region. Methods: The study included 668 students [14.26±0.33 years old, Body Mass Index (BMI): 22.04±0.20 Kg/m 2 ] attending randomly selected schools. The students were subjected to anthropometric measurements and were asked to fill in a questionnaire regarding dietary behavior and physical activity. A diet score was developed taking into account the weekly consumption of meat, legumes, fruits, vegetables, full fat dairy products and snacks. In particular, we assigned ratings from 1 to 3 for each food group with higher scores indicating consumption closer to the Mediterranean pattern. Results: Overall prevalence of overweight and obesity was 24.6% and 10.5% respectively. Mean diet score did not differ between normal BMI and overweight/obese students (9.43±0.11 vs. 9.67±0.14 respectively, p=0.07). However normal BMI students reported higher level of physical activity compared to overweight/obese (1.27±0.03 vs. 1.06±0.04 hours/day respectively, p<0.001). Boys also, spent more time in physical activity in comparison with girls (1.40±0.04 vs. 1.01±0.03 hours/day respectively, p<0.001). Conclusion: A high prevalence of obesity was recorded in our population. Physical activity was higher in boys and in students with normal BMI. In contrast, dietary habits did not correlate with BMI, fact which could reflect dieting or knowledge of favorable choices or even underreporting in obese individuals. Although obesity is closely associated with diabetes and cardiovascular diseases, there is still no definitive method for healthy weight-loss in a short term. We have developed a novel anti-obesity method according to the Traditional Chinese Medicine which named Sai-Style Chinese Qigong Meridian Therapy (SQT). SQT can enhance the life energy qi through whole body acupressure (Dianxue), and make the qi circulate the entire body smoothly and consequently results in healthy weight-loss. Here, we try to report 68 Japanese female cases of effective weight-loss by SQT from June 2004 to September 2005. SQT was performed 25 min at a time, 3~5 times a week. The average age and height were 36.55 years and 158.35 cm, respectively. The average body weight, body fat percentage, and body mass index (BMI) were reduced from 62.18 kg, 32.43%, and 24.80 kg/m 2 to 56.77 kg, 27.78 % and 22.64 kg/m 2 respectively after 20 sessions of SQT within 1 month, and were further decreased to51.62 kg, 24.52% and 20.59 kg/m 2 after 40 sessions of SQT within 2 months. SQT also succeeded in controlling food intake at minimum levels without feeling hungry. Symptoms such as constipation, irregular menstrual cycling, menstrual pain, humpback, swelling, and cold hands or feet also reduced markedly or disappeared after SQT. In conclusion, SQT is a novel and very effective method to treat overweight and obesity. We are planning to explore the molecular mechanisms of SQT and popularize this healthy therapy in Asia, America and Europe in the near future.
Double-blind, randomized clinical trial of high protein and nutritionally balanced conventional partial meal replacement low-calorie diets for reduction in visceral obesity with Korean people with metabolic syndrome.
Lee, K 1 , Lee, J 3 , Bae, W 2 , Cho, B 2 1 Seoul National University Bundang Hospital, Seongnam, South Korea 2 Seoul National University Hospital, Seoul, South Korea 3 Wonkwang university Sanbon Hospital, Gunpo, South Korea Background: Metabolic syndrome has reached epidemic proportions in Korea. Various partial meal replacement low-calorie diets(PMR-LCDs) plans are a popular option for Korean people with metabolic syndrome in the weight loss and maintenance program. The effectiveness of high protein PMR-LCDs(P-PMR-LCDs) and nutritionally balanced conventional PMR-LCDs(C-PMR-LCDs) on visceral obesity is, however, still unknown in Korean people with metabolic syndrome. We aimed to evaluate and compare the effectiveness of P-PMR-LCDs and C-PMR-LCDs on reduction in visceral obesity. Method: Eighty obese adults with metabolic syndrome were double-blinded, randomized to either P-PMR-LCDs group and C-PMR-LCDs group. Visceral fat area was measured with computed tomography(CT) and total body fat mass was measured with dual energy X-ray absorptiometry(DEXA), each before and after the 12-week trial. Participants got diet meal plan at 1200 calorie a day for women and 1500 calorie a day for men from clinical dietitian and received a six session of dietary counseling every other week. Result: Visceral fat area by CT was decreased in the amount of -23.1 ± 30.0cm 2 in P-PMR-LCDs group and -30.5 ± 30.2cm 2 in C-PMR-LCDs group(P value 0.248). Total fat mass by DEXA was also decreased in the amount of -2.5 ± 2.2kg in P-PMR-LCDs group and -2.3 ± 2.2kg in C-PMR-LCDs group(P value 0.770). Conclusion: 12-week diet plan for obese patients with metabolic syndrome using both P-PMR-LCDs and C-PMR-LCDs were associated with significant and comparable weight loss and improvements on visceral obesity. But, no significant differences were observed between two groups in this study. Glycomacropeptide (GMP) is a peptide that has been shown to stimulate release of cholecystokinin which may promote satiety. Aim: The aim of this 1-year study was to examine whether greater weight loss could be achieved and sustained with a GMP-enriched whey powder supplement compared to a skim milk powder supplement. Methods: In a randomised, double blind, parallel design study using meal replacements, participants had weight, body composition (dual energy X-ray absorptiometry), blood pressure, fasting lipids, glucose and insulin measured at baseline, 6, and 12 months. Supplements contained 15g protein from GMP-enrichedwhey-protein-isolate (T1), or skim-milk-powder (T2) and 900 kJ/sachet. Volunteers were advised to consume 2 sachets/day instead of 2 meals for 6 months and 1 sachet/day for a further 6 months. One hundred and twenty seven participants (34 men, 99 women, 95.5±15.4 kg, BMI 33.4±3.4 kg/m 2 , 50.0±12.4 yr) commenced, 82 completed 6 months and 72 completed 12 months of the study. Results: At 6 months weight loss was -9.5±5.8 vs -11.0±6.0 kg, T1 and T2 respectively and -9.9±8.8 vs -10.8±7.4 kg T1 and T2 respectively at 12 months (P<0.001 compared with baseline, at both time-points) with no differences between treatments. Total and LDL-cholesterol, triacylglycerols, glucose and insulin, systolic and diastolic blood pressure decreased at 6 and 12 months (All P<0.01 compared with baseline with no difference between treatments). HDL-cholesterol was significantly increased at 12 months (P<0.001 compared with baseline). Conclusion: Weight loss of 10kg was sustained after 12 months with improvements in cardiovascular disease risk markers. GMP had no additional effect. Funding: Research relating to this abstract was funded by Murray Goulburn Nutritionals, Victoria, Australia ; and ISLL 2.06±0.60vs1.58±0.57 N.kgSMM -1 (p<0.001). No significant differences were found in maturation and PA.
The main finding of this study was that OB presented a higher levels of IS, although their SMM index and CMJ were lower. These results suggest that an overload due to an excess of %FM should be a stimulus to increase IS, since habitual PA is performed with overload. More research is needed to fully understand this relationship.
International Journal of Obesity Background: Body composition of obese adolescents can be measured accurately by dual energy x-ray absorptiometry (DXA). Bio-impedance spectrometry (BIS) is a quick and easy tool for clinical practice, less expensive and without radiation. The aim was to validate published equations for the prediction of fat free mass (FFM) based on bio-electrical impedance, with DXA as reference in obese adolescents. Methods: Predictive equations were included when based on weight, height, gender, age, impedance, resistance and/or reactance data. FFM was measured with bio-impedance spectroscopy and DXA. Accuracy of equations was evaluated by the root mean squared prediction error (RMSPE), the mean percentage difference between methods (bias), and the percentage of patients predicted within 5% of FFM measured by DXA. Results: Included were 33 predictive equations and 85 (F 49, M 36) obese adolescents. Mean age 14.6 y, mean BMI 33.3 (range 24.0-44.5) kg/m 2 . The RMSPE ranged from 2.9-27.5 kg and the percentage of patients with acceptable prediction ranged from 75-0 % depending on the equation used. The DeLorenzo equation (FFM = 2.330 + 0.588 Height (cm) 2 /Resistance (Ohm) + 0.211 Weight (kg)) had almost lowest RMSPE (3.0 kg), smallest bias (-1 %) and the highest percentage (75 %) of subjects predicted well. This was consistent over gender, BMI and age groups. Conclusion: When bio-impedance spectroscopy is used in obese adolescents 12-18 years of age, the most accurate predictive equation for fat free mass appears the DeLorenzo equation. Funding: Vumc, Zonmw
Ranetti, A-E; Spiroiu C; Mazilu, A Central Military Hospital, Bucharest, Romania
As it knows the erectile dysfunction is a frequent complaint of the patients. Thru the multiple causes of erectile dysfunction, diabetes is very common, this one being more than twice frequent. The onset at relatively younger ages affects more deeply live quality and the couple relationships in these patients. We evaluated 530 diabetic patients and other 520 patients with another pathology excepting diabetes mellitus in a period of 12 months. From the lot of diabetic patients 424 (80% ) described various degrees of erectile dysfunction. From the other lot -no diabetes only 195 (37.5% ) were diagnosed with erectile dysfunction. The treatment was chosen dependent of present of micro-or macro-vascular complications with: PDES inhibitors, substitution with testosterone, intracavernous injections, yohimbine, psychotherapy and vacuum devices. In the patients presenting with obesity we divide in two groups depending of the therapy sibutramine (10-15 mg/day) and life style changing versus only life style changing. Comparing the results we evidences the best results in the group treated with PDES inhibitors, substitution with testosterone and sibutramine -90%( 20 treated in these group) in non diabetic group and 60% (30 treated) in the group of diabetic patients. The results in the groups without sibutramine the results was 80% and 50%. The weight change in the sibutramine treated group was 8.5% in non diabetic patients group and 6.3% in the diabetic patients group.We consider that sibutramine represent a helpful tool in the management not only of weight, even for erectile dysfunction in diabetic patients.
Nasseri, E¹, Dorosty, A.R¹, Hosseini, M², Chanari M² ¹National Nutrition and Food Technology Research Institut, Tehran, Iran ² Tehran University of Medical Sciences, Tehran, Iran Aim: Obesity is independent risk factor for cardiovascular disease, which may be mediated by increased secretion of inflammatory proteins by adipose tissue. Widespread popularity of high protein diets, questioned the superiority of these diets in how best can achieve both weight loss and clinical benefit by these diets. We aimed to evaluate the effects of high protein diets on weight loss and cardiovascular disease risk including inflammatory proteins in obese women. Methods: Twenty-eight (20-48 y) obese women (BMI: 30-41 kg/m²) were assigned to a high protein (HP: 30% of energy) or a standard protein (SP: 15% of energy) diet, for 10 weeks of weight loss dietary intervention. Results: Weight loss (6.0 ± 2.3 kg with HP and 4.9 ± 2.4 kg with SP; P = 0.43) and fat loss (4.6 ± 2.1kg with HP and 3.9 ± 2.0 kg with SP; P = 0.63) did not significantly differ between groups. Insulin sensitivity index improved more by HP diet (P = 0.01). The reduction in serum triacylglycerol concentration was significant in both groups (HP; P = 0.005, SP; P = 0.03) without any diet effect. Total cholesterol, HDL-C and LDL-C did not change significantly. Plasma leptin decreased more) (Diet effect; P<0.05) with HP (8.7 ± 8.8 pg/ml) rather than the SP diet (0.6 ± 6.4 pg/ml. No significant changes either in adiponectin, TNF-a, IL-6 or logCRP were observed after weight loss, although there was a trend of improvement in all inflammatory proteins. Conclusions: High protein diet was more effective in lowering plasma leptin concentration and improving insulin sensitivity index than the standard protein diet. However, the magnitude of weight loss, improvement in serum lipids or plasma inflammatory proteins did not differ significantly between an energyrestricted high in protein or with standard protein content.
Effect of a 2 years multifactor approach on weight regain Background and Aims: We have considered a multifactor approach to control weight regain after weight loss: diet, physical activity, cognitive-behavioral therapy, orlistat "on-off" treatment. Materials and Methods: 50 patients (mean BMI 36.4 kg/m2) were enrolled after a mean weight loss of 17%. Patients came to the clinic every 2 months (first year) and every 3 months (year 2). Patients received diet and physical activity counseling and in case of a ≥ 2.5% weight regain: food questionnaire, cognitive-behavioral therapy, orlistat 120 mg tid. as long as weight regain was ≥ 2.5% ("on-off" treatment). In case of special occasions, orlistat was also prescribed at patient request. Results: Baseline mean age was 43 ± 11 years, BMI 30.1 ± 5.7 kg/m2 . 5 patients dropped out. After 2 years, no weight regain was observed: 80.7 kg ± 17.1 compared to 82.1 kg ± 15.6 at baseline. 58% of the patients had at least an additional weight loss or stable weight and 38% at least one episode of weight regain. Orlistat was prescribed in 48% for special occasions, in 34% for special occasions and continuous intake, in 8% for continuous intake and in 10% no intake. For the "weight loss" group, occasional orlistat intake was present in 83% of the patients and for the "weight regain" group in 68%.
In conclusion, this new multifactor approach with an "on-off" orlistat program appears to be promising. These results should be confirmed with the weight loss maintenance program at 4 years which is actually ongoing. Funding: This study was funded by Roche Pharma (Schweiz) AG. Obesity is a rapidly expanding epidemic in Western Societies, with rates of over 30% across Europe. A contributing factor is the modern lifestyle with reduced physical activity and removal from Mediterranean diet (MD). The aim of our study was to examine the adherence to MD of the Greek obese and overweight population and further investigation of their nutritional habits. 91 adult subjects (14 males, 77 females) with Body Mass Index (BMI)>25 Kg/m 2 completed the Food Frequency Questionnaire. The anthropometric measurements were taken and biochemical parameters were estimated. The mean BMI of the sample was 34,9 ± 6,2 kg/m 2 and the mean daily energy intake was 1570,2±555,2 Kcals. According to the nutrient intake we created 4 groups: high fat intake group (43,9%), high fat and protein intake (25,3%), high carbohydrate intake (14,3%) and the group that followed the MD (16,5%). MD group presented lower incidence of type 2 diabetes mellitus (DM2), arterial hypertension, dyslipidemia and low daily energy intake. High fat intake group has the greatest daily energy intake (1796,7±674,6 Kcal/d) and tend to loss more weight (5,7±4,4% loss of initial body weight) after low-caloric diet. High carbohydrate intake group presented greater incidence of DM2 (15,4%) and the lowest weight loss (2,9±2,7%) after energy intake reduction.
In conclusion, only 16,5% of the Greek obese subjects follow the MD while the nutritional habits of the rest 83, 9% present a modulation of MD ingredients with increased amounts of fat, proteins and carbohydrates in different combinations. The aim of the study was to investigate whether 1) the antilipolytic action of insulin in adipose tissue is present during exercise 2) obese subjects aresimilarly to resting conditions -resistant to this action of insulin. 6 lean (BMI 23.6±0.4 kg/m2, age 25.5±0.4 yr) and 6 obese (BMI 31.4±1.3 kg/m2, age 28.3±1.8 yr) subjects performed a 45 min aerobic exercise (intensity at 50% of VO2 max) on two occasions: 1) during a constant insulin/glucose infusion keeping the insulin and blood glucose levels stable during the exercise 2) in control conditions (saline infusion). Exercise-induced lipolysis in subcutaneous adipose tissue was assessed using microdialysis and glycerol concentrations were measured in two microdialysis probes: one being perfused with Ringer solution and the other with phentolamine (alpha adrenergic antagonist). In control conditions the exercise-induced lipolysis in subcutaneous adipose tissue was lower in obese than in lean subjects and it was potentiated by phentolamine only in obese. During insulin infusion, the exercise-induced lipolysis was reduced in lean subjects by 67% and 71% in control and phentolamine probe, respectively, and only by 39% and 26% in obese. The exercise-induced responses of catecholamines were similar in both conditions in lean as well as in obese subjects. Results suggest that the antilipolytic effect of insulin in adipose tissue is present during the exercise and that the obese subjects are, when compared to lean, resistant to this action of insulin. This resistance may be one of the elements of the reduced flexibility of metabolic responses in obese individuals. Background: Maintenance of weight loss is a core problem in the treatment of obesity. Structured Weight control programs can improve maintenance and body composition in obesity. Objective: To assess long-term effects of body weight and body composition during a standardized obesity program emphasising on fat loss Design and Methods: Obese patients (n=508) were recruited in a primary care setting and followed a standardized obesity program using meal replacements (AENGUS ® , Austria). Body composition was evaluated by both conventional and vector bioelectrical impedance analysis (RXc Graph). Patients having completed up to 6, 12, 18, 24, 30, or more than 30 months of the treatment program (groups I-VI) were analysed, the results were compared to their baseline data. Introduction: The aim of the study was to assess the influence of eight-week weight reduction therapy with use of orlsitat on lipolytic activity and orocecal transit time of solid meal. Patients and methods: 40 obese women without concomitant diseases were enrolled into the study and randomly assigned to the eight-week weight-reducing treatment with use of orlistat (age 28.2 ± 6.3 y, BMI 37.7 ± 7.4 kg/m 2 ) or placebo (age 28.8 ± 7.2 y, BMI 36.6 ± 5.6 kg/m 2 ). All the subjects received weight-reducing program. 13 C-MTG breath test was used to assess intrajejunal lipolytic activity. Orocecal transit time was assessed with hydrogen test meal Results: Weight reduction was 9.1 ± 4.1 kg (9.0 ± 3.2 %) and 5.8 ± 3.2 kg (5.9 ± 3.2 %) in placebo group.
Orlistat group n = 20
Placebo group n = 20 Before treatment Guarana and maté are commercially-available as herbal-derived substances that are advocated for weight-loss. The amounts of caffeine in these products are below those known to increase metabolic rate, and the amounts of catechin-polyphenols are well below those found to interact with caffeine for thermogenic stimulation. However, maté also contains caffeoylquinic-polyphenols that might interact synergistically with caffeine and catechins (contained primarily in guarana) to promote thermogenesis. In this study we investigated whether a mixed extract of guarana and maté (Guaramaté) stimulates thermogenesis without having a significant effect on cardiovascular regulation.
In a double-blinded cross-over study, 10 healthy volunteers ingested capsules containing placebo or Guaramaté. Each dose of Guaramaté contained caffeine (47-75 mg), catechins (12-27 mg) and caffeoylquinic derivatives (63-111 mg). Energy expenditure and respiratory quotient were assessed continuously by ventilated hood indirect calorimetry, while heart rate and blood pressure were measured continuously using a Task Force Monitor.
Ingesting the Guaramaté capsules, but not the placebo, after an overnight fast led to significant increases in resting energy expenditure over a 2h period (+ 4%, P<0.05). Furthermore, Guaramaté significantly enhanced the thermogenic response to a mixed meal by about 30% over a 3-h period (P<0.01). No significant differences in respiratory quotient, heart rate and blood pressure were found between Guaramaté or placebo treatment -whether under conditions of basal metabolism or postprandial metabolism.
These studies indicate that this Guaramaté product, which has no significant impact on acute cardiovascular responses, may contribute to weight control through its stimulatory effects on thermogenesis and energy expenditure. Acknowledgements: Research relating to this abstract was funded by Arkopharma Laboratories (Nice, France). Background: Diabetes and obesity are intimately linked diseases. Whether the linking factor is insulin resistance or hypersecretion, obese subject are thrice more likely to develop T2DM than lean subjects, irrespective of other factors. The risk also increases with increasing BMI. Therefore reducing the demands on islet cells by reducing the contact between food and foregut and weight reduction should be beneficial in treating and, indeed, curing T2DM. All types of bariatric procedures showed beneficial effect on glycaemic control, with gastric banding (GB) leading to a normalisation in oGTT in more than 50% of subjects. Since 1991, our unit welcomes every year about one thousand obese and/or type 2 diabetics patients for a nutritional rehabilitation based on theoretical and practical workshops animated by various professionals (doctors, nurses, dieticians, physiotherapists, psychologist). In order to guarantee an optimal care of obese patients, we tried to identify relevant medical criteria to determine the necessity of an hospitalisation in patient care.
We also listed all the characteristics of the patients during the first half of 2006 and compared them with the weight loss and with the evolution of the educational knowledge of the patients. This audit allowed to establish a list of criteria of no admittance for which the education does not seem to bring any supplementary profit. These criteria existed in 2 % of the patients welcomed during the considered period. Among these criteria, we found a body mass index lower than 27 kg/m2 without associated comorbidity (as mellitus diabetes), the existence of psychotic confusion or untreated psychiatric pathology, the absence of personal motivation, and more than 3 stays in the unit. We suggest to take in account these criteria to know nether obese patients could improve with a therapeutic education in diet rehabilitation unit.
How much weight loss is needed to improve each component of metabolic syndrome? were evaluated for body composition and metabolic profiles before and after 1.5 years of weight reduction program entailing diet and physical activity. Moving average of each 25 subjects across the entire range of % weight change (-0.2% to -31.2%) and respective % change in metabolic parameters were used to assess the association between weight loss and improvement in metabolic variables.
The mean % weight change ranged from -3.2% to -21.5%, and all the metabolic parameters improved as the moving average of % weight loss became greater. However, the degree of improvement differed among variables; visceral fat area, blood pressure and glucose area during glucose tolerance test showed statistically significant improvement (-12.1%, -3.2% and -5.4%, respectively) even for the 25 subjects who lost the least weight (i.e. -3.2%). HOMA-R and insulin area showed significant reduction only for those who lost >7% of the initial weight, and log TG and HDL-C showed significant improvement only for those who lost >12%. Conclusion: These data suggest that the level of weight loss needed to improve each metabolic parameter differs, and the target level of weight loss for each MS subject must be individualized, considering their metabolic abnormalities.
Examination of fatty acid intake in overweight, obese and morbidly obese persons in the morbidly obese group. The ratio of n-6/n-3 intake by BMI groups was: overweight0:27.4(SD:12.0), obese 0:25.8(SD:11.1) morbidly obese0:28.1 (SD:11.5) (n.s.), and the highest values were found in the age group above 60: 31.8/1 (norm: 4/1). Conclusion: Similar fatty acid intake was found in overweight and obese persons, and extremely high intake in the morbidly obese. Attention should be paid to the fatty acid intake of overweight and morbidly obese patients. The risk of sudden cardiac death of the latter is 40 times higher.
International Journal of Obesity The aim was to evaluate the effects of peanuts on appetite and appetitive hormone concentrations when served as part of a meal or as a snack. Sixty participants were divided randomly into 3 treatment groups (PG: peanut, MG: mix and PMG: peanut + mix). Each participant completed 4 sessions (1 control meal, 1 control snack, 1 treatment meal and 1 treatment snack). Appetite, anthropometric indices, body composition, physical activity and dietary intake were monitored during the sessions. Plasma leptin, ghrelin and insulin analyses were conducted on a 30 volunteer subsample. Individuals felt hungrier when peanuts were added to a meal of sandwich + banana + chocolate (control) compared to an isocaloric amount of the same meal without peanuts. The same held for the addition of the MG which was matched to the peanuts on volume, energy and macronutrient distribution. This result may be due to smaller gastric volume associated with the PG and MG loads compared to control. Participants also reported a stronger desire to consume something sweet on days the PG and MG were consumed. The control meal also led to a more rapid meal termination. No significant differences were observed in hormone concentrations. In this study, the addition of peanuts or a mix with similar volume, energy content and macronutrients distribution did not augment satiety or appetitive hormone responses relative to isoenergetic meals without these loads. The prevalence and incidence of obesity increase during the last 10 year in whole world. In Czech Republic more than 25% inhabitants are obese. Obesity is a risk factor leading to many serious civilization diseases. Complex access using pharmacotherapy is real good way to lose weight. Methods: In 212 obese men and 28 obese women with BMI over 30 kg/m 2 and with failure of lipid metabolism the reduction of body mass was carried out. The whole pharmacotherapy was 4 months. The changes of selected anthropometric (weight, BMI, % of fat, WHR) and biochemical (TAG, GLY, TCHOL, HDL, LDL) parameters were monitored. Goal: Monitor of effect of taking a dose of 10mg of sibutramin a day. By patients meet inclusion criteria. Results and conclusion: After a 4-month pharmacotherapy reduction we noticed that average decrease of weight was 6,8 kg, of BMI 2,0 kg/m 2 . In both group (men also women) was found statistically significant decrease of body fat. The decrease of whist was 5,2 cm in group of men and 6,6 cm in group of women. The positive effect therapy of decrease of level TCHOL, GLY, TAG was noted too. The level of HDL was not changed. We evaluated, in man, the relative role of various factors involved in the lipid mobilization during exercise like insulin, adrenergic system, Atrial Natriuretic Peptide (ANP) and growth hormone (GH). Eight lean young men matched for age and physical fitness performed a 60 min exercise bouts at 50% of their maximal oxygen consumption one day under placebo infusion and another day under octreotide infusion. Lipolysis in subcutaneous adipose tissue (SCAT) was evaluated using local microdialysis with selected antagonists: phentolamine (alpha-AR antagonist), propranolol (beta-AR antagonist) and aminoplylline (PDE inhibitor). Octreotide infusion at rest decreased plasma insulin which remained low during exercise. Octreotide suppressed the exercise-induced increase of plasma epinephrine and GH. In both conditions, norepinephrine and ANP increased similarly during exercise. The increase of plasma glycerol concentrations during exercise was largely majored under Octreotide. In the microdialysis Ringer probe, the exercise-increased dialysate glycerol concentrations (DGC) were higher under octreotide than placebo. In the phentolamine and propranolol probe, the higher DGC under octreotide than placebo revealed the contribution of insulin during exercise. The lack of difference in DGC between phentolamine probe and phentolamine plus propranolol probe under octreotide suggest the absence of norepinephrine involvement. But under placebo, DGC were lower in phentolamine plus propranolol probe than in phentolamine probe, showing the beta-adrenergic action of epinephrine. In aminoplylline probe, the DGC were strongly enhanced in both conditions at rest, and the lack of difference in exercise-increased DGC between placebo and octreotide conditions argues for a possible ANP contribution.
The effect of the arg16 alelle of the beta (2)-adrenergic receptor polymorphism in the reponse to EGCG intake on obese women after weight loss.
Ares, R 1,2 , Margareto, J 2 , Simón, E 1 , Larrarte, E 2 , Barrenetxea, L 1 , Alcorta P 3 , Labayen, I 1 . The most abundant catechin of green tea, epigallocatechin gallate (EGCG), could have some health benefits on obesity treatment. The presence of Arg16Gly polymorphism in ADRB2 gene has been related to insulin resistance. The aim of the present study was to explore the effect of EGCG in the insulin resistance of obese women with Arg16 allele in ADRB2 gene after a hypocaloric diet treatment. 38 healthy obese women (BMI>30 kg/m 2 ) followed a balanced hypocaloric diet (REE, Vmax, x 1.3 -600kcal/day) during 12 weeks. They were divided into 4 groups according to genotype (RT-PCR real time), Arg carriers (Arg-Gly + Arg-Arg) and Gly-Gly group, and treatment (EGCG, 99% TEAVIGO, or placebo, 300 mg/day). BMI, body composition (DEXA) and blood insulin and glucose (ELISA) were assessed before and after treatment and HOMA-IR was calculated. There were not statistically significant differences in weight (P=0.960) and fat mass loss (P=0.890) between the groups. There was a significant interaction effect (P=0.013) of genotype in the response to the EGCG treatment on the HOMA-IR change adjusted with weight loss. Arg16 women were more insulin resistant than Gly-Gly group after weight loss without EGCG (P<0.05). The improvement of insulin sensitivity in Arg16 carriers was higher after EGCG treatment (P<0.05).
In conclusion, EGCG, as energy restriction program helper, improves insulin sensitivity in women carriers of Arg allele in the ADRB2 gene. Backgrounds: Mesotherapy is widely used for aesthetic management of localized fat or cellulite in developed countries without sufficient evidence. This study was performed to verify the efficacy and safety of ephedra and green tea mesotherapy on fat mobilization. Methods: Twenty-five otherwise healthy 20-35 year-aged overweight women (body mass index 23kg/m 2 ) were recruited and randomly assigned to two groups: experimental (ephedra and green tea mesotherapy) group (n=13), placebo (saline) group (n=12). Total 8 times of herbal mesotherapies were performed once a week, the previous 4 times were performed on right thigh (1st period), after wash-out of 1 week, the latter 4 times were performed on left thigh (2nd period) without any modification of diet or exercise. Body composition, thigh circumference were measured at each period before and after. Subcutaneous fat was measured by CT scan at the 1st period before and after and free fatty acid (FFA) was measured immediately before 1st treatment, 1 hour later, 24 hours later, and 7 days later. Subjective satisfaction score and adverse events were also evaluated. Results: In the subcutaneous fat, there were no significance between groups, but in the circumference, experimental group had significant change when compared with placebo group (p<0.05). In serum FFA, experimental group has significant elevation in 1 hour after the 1st treatment (p<0.05). There were no serious adverse events in both groups. Conclusions: Herbal mesotherapy with ephedra and green tea may have possibility of size-reduction effect on localized fat through regional lipolytic action. Key words: mesotherapy, localized fat, ephedra, green tea Acknowledgement: This research was funded by The Society of Korean Medicine for Obesity Research. Objective: Childhood obesity shows an increasing tendency in the developed countries meaning a predisposing factor to the later cardiovascular morbidity and mortality in adulthood. We investigated the effects of lifestyle changes on three adipokines -leptin, adiponectin, TNF-level -and on the activity of PON1 because of their main role in the process of atherosclerosis. Patients and methods: 23 obese, non-diabetic children (age: 11.45±1.82 years) took part in a two-week long program consisting hypocaloric diet and regular physical activity. Levels of adipokines -leptin, adiponectin, TNF--and paraoxonase and arylesterase activity of PON1 were measured before and after the intervention. Results: Two-week long diet and physical activity resulted in the significant decrease of the anthropometric data (BMI: 29.13±5.05 vs. 27.79±4.9 kg/m² p<0.0001; body fat percentage (BFP): 41.3±6.37 vs 40.0±6.86% p<0.001), in leptin (55.02±33.42 vs. 25.76±19.94 ng/ml p<0.0001) and significant increase in adiponectin levels (7.53±3.26 vs. 8.79±3.44 μg/ml p<0.05) and PON1 paraoxonase activity (107.19±72.87 vs. 121.75±93.48 U/l p<0.05). We found significant correlation between leptin and adiponectin (r=-0.402 p<0,05); TNF-(r=0.321 p<0.05). Conclusion: Our data suggest that short-term lifestyle changes resulting in weightloss influence the metabolic state to an antiatherogenic direction in obese children regarding the changes in leptin, adiponectin levels and PON1 paraoxonase activity. This draws attention to the importance of physical activity and appropriate nutrition in childhood. The aim of the study was to asses the anaerobic threshold before and after weight-reducing therapy in obese and normal subjects.
Patients and methods: 42 obese women (age 30,5±6,9 y, BMI=33,6±3,7 kg/m 2 ) and 26 lean women (27,6±7,0 y, BMI=21,2±1,9 kg/m 2 ) performed incremantal ramp exercise test up to exhaustion on cycle ergometer. The test was performed again in 19 obese women after weight loss (mean 12,31±4,2%). The lactate threshold (LT and 4 mmol) and the ventilatory thteshold (VT) was determined.
Obese ( Obese in comparison to the lean women have higher lactate threshold. After obesity treatment both the lactate and the ventilatory threshold did not change, however 4 mmol lactate threshold was transferred to the right side. RQ in obese subjects was lower than in normal one during the test.
The higher lactate threshold in obese women could be connected with increased usage of fat in supporting the energetic requirement.
In the obese women lactate threshold appears at higher oxygen consumption in comparison to the ventilatory threshold, whereas in the control group both thresholds occur at the same time. Introduction: The aim of the study was to assess the influence of eight-week weight reduction therapy with use of orlsitat on solid phase gastric emptying in obese subjects. Patients and methods: 40 obese women were enrolled into the study and randomly assigned to the weight-reducing treatment with use of orlistat (age 28.2 ± 6.3 y, BMI 37.7 ± 7.4 kg/m 2 ) or placebo (age 28.8 ± 7.2 y, BMI 36.6 ± 5.6 kg/m 2 ). All the subjects received weight reducing program consisting of fat-and simple carbohydrate-restricted 1200 kcal diet and regular physical activity (30 minutes three times a week). Gastric emptying was assessed with breath test method with use of the test meal (a pencake consisiting of 355 kcal with addition of 13 C-octanoic acid) and evaluation of 13 CO 2 content in air samples taken after eating test meal. Results: Weight reduction was 9.1 ± 4.1 kg (9.0 ± 3.2 %) and 5.8 ± 3.2 kg (5.9 ± 3.2 %) in placebo group. Background: Sibutramine administration has been proved efficacious in terms of weight loss but requires parallel monitoring of blood pressure and heart rate. Verapamil sustained release/Trandolapril 180/2 mg (Ve/Tra) is a fixed combination indicated for the treatment of hypertension in patients who require more than one agent to achieve blood pressure (BP) targets. Objective: The primary end-point of this study was to evaluate the 6-month effect of sibutramine and Ve/Tra combination on blood pressure and heart rate in obese patients who had grade 1 hypertension (140-159 and/or 90-99 mmHg). Secondary end-points were the effects on anthropometric and metabolic variables. Methods: Patients (n=32) received a low-fat low-calorie diet and prescribed a combination of sibutramine 10 mg and Ve/Tra 180/2 mg daily for 6 months. Results: Combined treatment resulted in significant body mass index reduction. Significant reductions in systolic (SBP) and diastolic blood pressure (DBP) were observed (14.1% for SBP and 15.1% for DBP, p < 0.01) at the end of the 6-month treatment. After the 6-month treatment 78% of patients had BP readings below 140/90 mmHg. None of our patients experienced blood pressure increase during treatment. Heart rate did not significantly change during this period. Significant reductions were also observed in HOMA index, total cholesterol, triglycerides and low density lipoprotein cholesterol (LDL-C) (all p<0.05). Moreover, a significant decrease of small dense LDL-C, as well as of plasma visfatin levels, was observed.
The combination of Ve/Tra and sibutramine in obese hypertensive patients significantly reduced BP levels and improved anthropometric and metabolic parameters. Introduction: Energy restriction in diet (D) and increasing physical activity (Ex) must be the primary lifestyle-intervention for improving the risk for developing metabolic syndrome (MS), which is a common cause of cardiovascular diseases. However, the inherent effect of each intervention on improving the anthropometric measures as well as the risks have not yet been clearly elucidated. This study investigated the effect of each Ex and D intervention on the anthropometric measures and metabolic parameters in patients with MS. Methods: Twenty-one obese Japanese subjects (10 males, 11 females; age 40-75 years) who demonstrated risk factors regarding the diagnostic standards of the Japanese committee on MS, participated in a weight loss program during a 12-week period. The subjects were randomly assigned to either the D group or Ex group. The maximal oxygen uptake during a graded cycling test was assessed as an index of cardiorespiratory fitness. The percentage of whole body fat was measured by the underwater method. Results/Discussion: Both groups achieved a substantial BW loss. The waist circumference and lean body mass significantly decreased in the D group, whereas they did not change substantially in the E group. In addition, the arteriosclerosis index and small dense LDL both significantly improved in only the E group. Our results suggested that exercise intervention has beneficial effects to improve the lipid profiles in MS without dramatically changing any anthropometric measures, including the waist circumference in comparison to diet intervention. Acknowledgements: This work was supported in part by the Grant-in-Aid for Scientific Research(A)19200049 from the Japanese MEXT. This study was conducted to investigate the effects of 12 weeks of low calorie diet (LCD) included in the nutrition counseling on metabolic syndrome risk factors in the overweight and obese men and women in Korea. A total of 44 subjects (17 men, 27 women) who were healthy and overweight or obese (BMI >25 kg/m 2 ) took parts in the study during May-October, 2007. During the study period, the subjects attended nutrition counseling 4 times and consumed 1,100-1,300 kcal/day. Body weight, fat mass (FM), fat free mass (FFM), waist circumference, blood pressure, blood lipid profiles (triacylglycerol, total-cholesterol, HDL-cholesterol, LDL-cholesterol, free fatty acid), glucose, insulin, and HOMA-IR were measured at the beginning and end of the study. After 12 weeks of LCD, there were significant changes in body weight, FM, FFM, and waist circumference in both men and women. The means body weight loss for men and women were 4.0 ± 0.5, 4.8 ± 0.7 kg, respectively and the losses of fat mass were 2.31 ± 0.49, 2.03 ± 0.15 kg, respectively. The levels of plasma total-cholesterol and LDL-cholesterol decreased significantly and free fatty acid increased. HOMA-IR increased however, glucose and insulin levels were not changed significantly. The results confirmed that the low calorie diet had positive effects on the metabolic syndrome in both men and women through their weight reduction.
Cardiovascular load in response to isometric leg exercise in obese women before and after an integrated weight-reduction program Isometric muscle contractions elevate heart rate and blood pressure, stressing the cardiovascular system. Because of the increased weight to support, obese individuals may be subject to particularly large isometric stresses in their everyday lives. We tested whether participation in a weight-loss program that comprises a substantial physical training component might have the beneficial effect of attenuating the cardiovascular responses to isometric exercise, either through improved muscle strength, autonomic function or both.
In ten obese female patients (age 31±3 years, height 1.62±0.01 m, initial weight 103.9±2.7 kg, body mass index 39.6±1.0 kg/m 2 ) we measured heart rate and blood pressure responses to isometric leg contractions at 10, 20, 30 and 40% of the maximal isometric force. Autonomic function tests were also performed. After completion of the 3-week weight loss and training program, the patients had lost 4.1±0.4 kg (P<0.01). Maximal isometric force improved by 39±10%. Resting heart rate and blood pressure were significantly lower, as were the values of heart rate recorded during isometric contractions. However blood pressure values during isometric work were not significantly different after weight loss. There were no significant changes in autonomic function. The reduction in heart rate at rest and during isometric exercise suggests a lower cardiovascular load during isometric stress in obese women after completing an integrated weight-loss program. A weight-loss program with a physical training component might therefore lessen the potential cardiovascular load experienced by obese individuals during everyday tasks. Acknowledgements: Research relating to this abstract was funded by the Swiss National Science Foundation, the Italian National Research Council and by the Progetti di Ricerca Corrente, Italian Institute for Auxology, Milan, Italy. Background: While gastric bypass (GBP) is more efficient than adjustable gastric banding (AGB) on weight loss and comorbidities, we and others have previously shown that GBP is associated with a high frequency of nutritional deficiencies. Our goal was to assess the incidence of nutritional deficiencies in patients properly monitored. Methods: We performed a one year-prospective study of nutritional parameters in 70 consecutive obese patients, who have undergone bariatric surgery, including 21 AGB and 49 GBP. After GBP, multivitamin supplements were systematically prescribed and vitamin B12 supplementation was introduced only if a deficiency was observed. Results: Patients lost more weight after GBP than after AGB (40 ± 13 vs 16 ± 8 kg, p < 0.001). Only GBP induced significant decreases of vitamin -B12, -E, serum prealbumin and creatinin concentrations, with only minor clinical consequences. Vitamin B1, vitamin C and iron deficiencies were frequent but were not worsened by bariatric surgery. Anemia was observed in 10% of the patients after both procedures. Hemoglobin concentration was not correlated to vitamin B12 or folate concentrations but was related to iron status, which was better assessed by transferrin saturation than by ferritin in this obese population. Conclusion: Severe nutritional deficits can be avoided after bariatric surgery if patients are systematically supplemented with multivitamin and carefully monitored. However, specific care is required to avoid iron and vitamin B12 deficiencies, anemia and protein malnutrition. Introduction: Severe obesity has serious psychosocial consequences.
measuring quality of life and handicap, incidence of depression and anxiety and comparing patients with a binge eating disorder (BED) or a depression with other patients. Methods: 234 patients candidates for bariatric surgery were evaluated. By way of average of the structured interviews and self appraisal tests, handicap (WHODAS II), quality of life (WHOQOL and IWQOL-Lite), depression (Beck Depression Inventory), anxiety (Beck Anxiety Inventory), presence of BED (DSM-IV diagnostic criteria) and characteristics of the habits and alimentary behaviour (Eating Disorder Inventory) were measured. Results: 50% of the patients suffer a moderate or severe depression and 32% suffer severe or moderate anxiety. Patients suffering a moderate or severe depression had a superior handicap and a quality of life significantly inferior to the one of the other patients without depression or with mild depression and patients with a BED were more depressed and felt more handicapped than patients with BED. Conclusion: Amongst the patients suffering from severe obesity, patients suffering from depression or BED are the most affected by psychosocial disorders.
International Journal of Obesity Background: In secondary care obesity management there is a real risk of overlooking day-to-day aspects of obesity and obese individuals' self perceptions, both of which have the potential to influence outcomes. Methodology: Previously validated self assessment questionnaires were used to acquire data from a person-centered perspective of obesity. These assessments were obtained at first referral visits to a secondary care obesity clinic Results: 94 individuals (79 females) provided assessments, ages 18-73 years with BMI 30.2-81.1kg/m². 76.6% identified previous attempts at weight loss. Of those, 56.9% quantified up to 50 attempts and 43.1% were unable to enumerate attempts. Nobody wanted to lose <10% of their body weight and almost half (47.8%) wanted to lose >30%. Problems with activities of daily living in this sedentary group were high: 60.6% reported moderate/high scores for difficulty (correlation with BMI = 0.3, p <0.01). They reported high levels of food cravings, poor sleep, body pain, sweating and breathlessness. Statistically significant correlations were found between food cravings and guilt, boredom and poor sleep. Beliefs indicated that 72.9% felt responsible for their own weight. While responding to questions about external locus of control only 22.8% agreed. Conclusion: Health professionals should take account of the perceptions of those who seek treatment for their obesity. Weight loss expectations and beliefs should be addressed before implementing weight loss interventions. We show the feasibility and utility of incorporating physical, emotional and social needs self-assessments into a secondary care obesity setting.
Body composition and body image perception in portuguese and spanish college students: Comparative study between overweight /obese and normal weight women Background and Aims: The prevalence of overweight and obesity has increased dramatically in Brazil mainly as a consequence of disturbances in energy balance. In this way, it was verified the effects of short-term multidisciplinary therapy on resting metabolic rate, the rate substrate oxidation in resting, food intake and body composition in obese Brazilian adolescents. Methods: Twenty post-puberty obese adolescents were enrolled, including 11 boys (BMI 36.00 ± 4.23 wt/ht 2 ) and 9 girls (BMI 34.75 ± 3.70 wt/ht 2 ). Resting metabolic rate and nutrient oxidation was measured by indirect calorimetry. Food intake was assessed by 3 days recordatory inquiry. Body composition was measured by Plethismography and visceral fat was analyzed by ultrasound. Results: We could observe a significant decrease of body mass and BMI in both groups after six months of multidisciplinary intervention. Analyzing macronutrients intake, we verified a significant decrease of the FAT and carbohydrate (CHO) intake in both gender. The FAT oxidation presented a significant increase in both gender after therapy. Conclusion: Our investigation demonstrated that short-term multidisciplinary therapy was effective to improve energy balance to promote obesity control. Results: 98% of patients considered, that bariatric procedure improved their health, 92% admitted that complies with the dietary suggestions and has healthy lifestyle with adequate exercise. 85% of patients was satisfied with the outcome of the operation. The most bothersome problems 6 months postoperatively were: feeling cold in 80% of, increased hair loss in 70%, nail brittleness in 56% of patients. There were also changes in the nutritional habits such as repugnance to meat in 73%, more willingness consume diary and fish products. In the assessed group there was no statistically significant differences between the sexes and between the groups with VBG and RYGB procedures.
1. As a result of a continuing education most patients improved their lifestyle and changed their nutritional habits. 2. Their self-assessment regarding their appearance and coping with the everyday life improved substantially. 3. Some of their problems that arose during the early postoperative period did not influence substantially their overall assessment of the results of the procedure.
Heart sympathetic activity and pulmonary function in obese pregnant women. A longitudinal study Background: During pregnancy it has been reported an increase in sympathetic activity and changes in pulmonary function. However, no longitudinal studies have evaluated these changes in women according to their body mass index or weight gain during pregnancy. Objective: To evaluate heart sympathetic activity and pulmonary function in obese women during pregnancy.
We evaluated 178 pregnant women (88 obese and 90 non obese) at first visit of pregnancy and at third trimester. In both visits we measured blood pressure, glucose, insulin, leptin levels and performed a 60 minutes electrocardiograph monitoring and forced spirometry.
Results: Blood pressure levels, glucose, insulin and leptin levels were significantly higher but forced expiratory volume at 1 s/ forced vital capacity (FEV1/FVC) ratio was lower in the obese group than in the non obese group at two evaluations during pregnancy. Total power and SD of all the R-R intervals (SDNN) were lower in obese than in non obese women at the beginning and at third trimester respectively. In the multiple regression analysis only SDNN change and obesity at the beginning of pregnancy independently of weight gain were associated to increase in LF/HF index (R 2 =0.21; p<0.0001 for the model). More pregnancy complications were found in the obese group independently of weight gain. Conclusions: Heart sympathetic overactivity and lower FEV1/FVC ratio was found in obese women during pregnancy. The increase in LF/HF index at third trimester of pregnancy is associated with obesity at the beginning of pregnancy and SDNN change independently of weight gain.
The present study is set to assess the impact obesity has over the members of one family. Material and Method: We included in the study a number of 180 patients who were overweighed or obese. To all patients we assessed the age, gender, height, body weight, abdominal circumference, BMI. All patients responded to an application which contained questions related to feeding habits, to possible factors involved in the appearance of obesity, and to the presence of obesity per se to the other family members. Results: 67% of our patients related about some others of their family members as being obese or overweight, while 72% of them were female patients. 39% of the family members who presented obesity were children or teens. The causes that induced the weight increase: Giving up smoking at 38%; ceasing of the physical activity at 22%; sedentariness at 80%, stress at 55%; alcohol intake at 22% of patients, bad feeding habits; fast food intake at 25%, ingestion of hyper caloric food at 85%. Out of these patients, it is important to mention that only 30% of them appreciate in an objectivable manner that the excessive aliment intake as the cause which induces obesity. Conclusions: Obesity within the family constitutes a major problem, due to its social and medical impact. It is important that the educational process regarding the nutritional elements to be extended over all the family members, in order to get aware and to correct the alimentary bad habits. Objective: In obesity the medication is useful adjunct to diet and exercise. We proposed to determine the long-term weight loss maintenance under sibutramine (Reductil ® ) treatment and the efficacy of this drug on lipid profile. Material and Methods: Thirty-four obese patients (25 women and 9 men) treated with 10 mg/day sibutramine for 12 months. The inclusion criteria: age 16 to 65 years, body mass index (BMI) ≥ 30 kg/m 2 , blood pressure ≤150/95 mmHg, pulse rate ≤ 90 beats/min. Clinical parameters was: waist circumference, hip circumference, waist/hip ratio. At initial assessment and at 6 months were measured : serum fasting glucose, total -cholesterol (total-C), high-density lipoprotein cholesterol (HDL-C), lowdensity lipoprotein cholesterol (LDL-C) and triglyceride. Results: Weight loss dropped from 95.3±10.2 kg to 85.7±10.2 kg (-10.1%) at 6 months and to 81.4±10.2kg (-14.6%) at 12 months. BMI feel from 34.8kg/m 2 to 31.7 kg/m 2 (6 months) and 29.9 kg/m 2 (12 months). The mean waist circumference decreased from 99.2 cm to 94.8 cm (6 months) and to 93.9 cm (12 months). Significant reduction from baseline to the 6 months for the lipid parameters: total-C from 215±38 mg/dl to 197.5±38 mg/dl; LDL-C from 126.9±24 mg/dl to 110.6±24 mg/dl; triglyceride from 129.1±46 mg/dl to 110.1±46 mg/dl; HDL-C risk from 43.7±8.6 mg/dl to 46.26±8.6 mg/dl. Conclusion: Sibutramine therapy and lifestyle for 12 months in obesity management resulted in weight loss. The weight loss was paralleled by a favorable metabolic lipide profile for six months. Drop-out to 12 months was at 22 patients (35.2%).
International Journal of Obesity T2:PS:193
Moldovan C, Vâtc L, Farca D, Demian L University of Oradea, Faculty of Medicine and Pharmacy
The Aim: of the study is to compare the efficacy and the tolerability of therapy with insulin glargine versus NPH insulin in patients with diabetes mellitus type2 with obesity. Method: 60 obese patients poorly whom type 2 diabetes was not well controlled, who were treated initialy with NPH insulin once daily + metformin, were switched on therapy with insulin glargine once daily + metformin. Insulin dosage was titrated to target FBG 100 mg/dl using a weekly forced titration algorithm. In time (initial, at 3 and 6 months) we evaluated BMI, fasting blood glucose (FBG), HbA 1 c's value and the number of hypoglycemic symptomatic episodes. Results: After 6 months of therapy with insulin glargine we obtained an important lowering in FBG (190,3±22,7 mg/dl vs. 115,6±13 mg/dl -p<0,001), HbA 1 c's value (8,9± 1,8% vs. 6,8± 0,8% -p<0,001) without an important increasing in BMI value (36,2±3,1 kg/m 2 vs. 34,4±3,7 kg/m 2 -p>0,05). Timing of administration of the insulin glargine (8 a.m. or 10 p.m.) didn't have an important influence on FBG value (98,5±10,3 mg/dl vs. 110,3±13,2 mg/dl) or on HbA 1 c's value (6,7±0,8% vs. 6,9±0,8%) when these were evaluated at 6 months. At patients treated with insulin glargine, the risk for symptomatic hypoglycemia is 1.8 times lower then in the group treated with NPH insulin. Conclusions: Insulin glargine therapy with metformin in patients with diabetes mellitus type 2, who were also obese, is associated with a better metabolic control, even on a short period (expressed by FBG) of time but also on a long period of time (expressed by HbA 1 c) without an increasing in body weight. Timing of insulin administration hasn't any influence on the metabolic control. Key words: glcemic control, hypoglycemia, insulin glargine, diabetes mellitus type2.
Betahydroxybutyrate level changes durig excercise test as a predictor weight reduction?
Matoulek M 1 , Stránská Z 1 , Šupová R 1 , Fábin P 1 , Vilikus Z 2 , Svacina Š 1 1 3.interna clinic 1 st Medical Fakulty, Charles University in Prague, 2 Department of Sport Medicine, 1st Medical Fakulty, Charle University in Prague Introduction: Prediction of effect weight reduction is important for compliance of patients dutiny weight redukction process. The changes of betahydroxybutyrate (BOH) level as a marker ketogenesis duting one-day starvation test and as a predictor of weight reduction have been demonstrated.
The changes of BOH level during CHR (clamped heart rate) exercise test and thein relation to weight reduction during three month programme with physical activity (TPPA). Characterization of Group: 44 obese (34 female + 10 male) with 47,1 ± 9,07 yo average, BMI 34,9 ± 5,8 kg/m2 a 37,9 ± 7,1 % fat mass. Methods: Patients with overweight and obesity attended TPPA on training heart rate (THR) prescribed after spiroergometry and CHR test. BOH level was measured before 40 minutes exercise test (BOH1), after test (BOH2) and 60 minutes after test (BOH3). The changes of BOH level durin test and after 60 minutes resting were compared with weight changes during TPPA. Results: There we no significant changes in BOH1 a BOH2 levels (0,12 mmol/l vs. 0,11 mmol/l). Increase of BOH level was observed between BOH1 a BOH3 (0,12 mmol/l vs.0,31 mmol/l; p < 0,001). The significant change weight reduction was observed during TPPA (100,8 kg vs 97,2 kg ; p < 0,001). Weight reduction positive correlates with difference of BOH level on the start of exercise test nad after 60 minutes resting after test DIFBOH1-3 (r= -0,428; p < 0,05). Conclusion: It seems that CHR test with assessment of BOH level during test and after resting could predicate weight change during weight reduction programme with physical activity. We should compare results of exercise test and BOH level group dividing according weight changes during TPPA (minimal weight changes or patients with not finished TPPA). It could help with identification of "unsuccessful patient" or method. Another methods or combine with other methods than only physical activity program should be prescribed in patients if weight reduction can not be predicated after TPPA. There is no conflict of interest. Funded partly in project Health plus The study into the problem of treatment of patients with BN has been carried out. The number of patients -23 females, aged 18-23; duration of counseling -weekly sessions for an hour during 3 months. Based on preliminary psychological diagnostics (MMPI, Lusher test, Spielberger's State Anxiety, Beck Depression Inventory, TAS-20), the tasks of counseling were set. With the numerous tasks and a complex character of the disease, it is advantageous to use a combination of different methods of psychotherapy. At the beginning of counseling, the use of relaxing methods, Art Therapy caused lowering of internal stress and anxiety, and gave rise to internal resources activation. Then therapeutic efforts were focused on resolution of personal and interpersonal conflicts. To replace distractive nutritional habits and irrational thoughts we used the CBT techniques. For realization of own feelings and needs, for responding to negative emotions, for integration of internal contradictions, Art Therapy and Gestalt Therapy were used. Repeated diagnostics showed: reduction in situational anxiety (P<0.0065) and depression (P<0.014); widening of range of emotional response; increase in assertiveness; rise in social activity. Against the background of improvement of emotional state, bulimia symptoms reduced. Also, we could notice a change in quality of doing drawing tasks. Previously formal and fragmentary drawings gradually came to be detailed and filled with emotions. Consequently, complex psychotherapy of patients with BN makes it possible to attack the problems thoroughly thus affording the positive changes to be made. For the effective treatment, the long-term systematic psychological counseling is required. The aim of the study was to evaluate dietary habits and leisure time activities in school children 6 to 10 years (1st to 4th class of elementary school) in the middle European region. Two methods were used: interview of the child and questionnaire given to the parent. Two hypotheses were set: 1. There are differences in children diet and leisure time activities in a small village (Horná Streda-Slovakia and in a big city Prague-Capital of Czech Republic). 2. Obesity and education of parents has some impact on children. By questionnaire or by interview 113 children in Prague and 95 children were evaluated. Results: The prevalence of higher then normal BMI was from 1st to 4th class in the small village: 25%, 50%. 43%, 33%, in the big town 25%, 14%, 22%. 14%. Children in the big town are eating more fried food and fast food but children in the small town are eating more fatty home made food. Children in the town have more leisure time activities. Obesity in children is more prevalent in families with obese parents in both samples. In both samples no relation was found of parents educational status (basic, middle school, university) to obesity in children.
There are more obese children in the small village and in both samples there is an influence of parents BMI on children BMI. Education of parents had no effect on obesity in children. Special programs for diet education are needed especially in rural population.
There is no conflict of interest. Partly funded by the 6th framework EU project Health Plus.
Comparison of low energy breakfast based on special egg white spread product with a standard breakfast The aim of the study was to evaluate the influence of low calorie breakfast in comparison to standard low fat cheese breakfast. A special spread based on egg white was used. Egg white derived products are widely used for weight reduction in our country. Glucose level, insulinaemia and C peptide were evaluated in 0, 60, 120 minute after breakfast. Psychological questionnaire was used to evaluate the taste and satiety. 12 persons were tested on different days with both types ofbreakfast: mean age 38.5+-10.7 years, mean BMI 24.6 kg/m 2 . Results: Standard breakfast: insulinaemia 6.3…34.6…11.0 IU, C peptide 0.6…1.6…1.0 pmol/l, glucose 5.0…5.4…4.8mmol/l Low energy breakfast: insulinaemia 6.6…24.6…10.7 IU, C peptide 0.6…1.4…1.0 pmol/l, glucose 4.8…5.1…5.0 mmol/l .Paired t-test was used for evaluation. Now difference in blood glucose level was found, borderline significances of insulinemia in 60 minute (p= 0.056) and in C peptide (p= 0.089). Significant difference in decrease of insulinemia between 60 and 120 minute (p= 0.03) and borderline significant decrease in C peptide (p=0.055) shows shorter insulin secretion after low calorie breakfast and good insulin sensitivity in this group of lean subjects. Higher satiety and worthier taste were found using low energy breakfast. Conclusion: Low calorie breakfast induces lower and shorter insulin secretion and has a good metabolic effect in lean subjects. Testing in obese subjects will follow. Egg white derived low calorie products have a beneficial effect on insulin response without any difference in ingested carbohydrate quantity. Funded by the project MŠMT2B 06172.
The estimation of effectiveness of low caloric diet with special product for treatment of patients with obesity Pogozheva A.V., Baturin A.K.,
The Institute of Nutrition, Moscow, Russia.
Objectives: The effectiveness of dietary treatment for patients with obesity based with to study the body composition dynamics. Material & Methods: There have been examined 230 patients with obesity. All the patients were given diet with 1400 kcal energy (20% protein, 30% fat) with supplement of fibres or extracts of cafe and tea, or special protein product with complex of vitamins, during three weeks. We estimated of anthropometric data and body composition by bioimpedansmetria, physical activity fixed by an accelerometer "Caltrac". Results: The fat free mass and total body water were higher, and the fat mass was lesser in the old people. The fat free mass and total body water were lesser, and the fat mass was higher in the obese people. The level of physical activity was lesser in the old men. Before treatment an average diet energy value was 3120±180 kcal for men and fat content more 38% by energy. In 21 days body weight has reduction under the influence of diet therapy comprised from 4,8% to 6,4%. Waist measurement of obesity patients reduced 3,6-4,8% correspondingly. Hips reduced 2,1-4,2%. The waist/hips ratio reduced not significantly. Fat mass reduction: 5,6-8,5%; fat free mass reduction -1,3-3,8%. Fat free mass quote relative increase: 0,8-1,4%. Water component reduction: correspondingly 1,4-6,1%.
The most effectiveness demonstrated of diet with a supplement of fibres. Diet is the primary therapeutic approach for persons with increased risk of premature heart disease as a result of elevated cholesterol levels. The aim of this study is to observe changes in fatty acid (FA) composition between males and females in their response to a dietary regime. The study involved 20 overweight/obese women and 15 overweight/obese men (aged 55±6, BMI>25kg/m 2 ) with middle hypercholesterolemia (total cholesterol>5.2 mmol/l and <7.8mmol/l). Patients followed an AHA-Step 1 diet for 12 weeks. Main goal of the dietary treatment was to reduce energy intake from saturated plus trans unsaturated fats to no more than 10% and replace them partly with monounsaturated and polyunsaturated (fish recommended as main meal once of twice a week) fats, and to increase intake of fruit, vegetables, and dietary fiber. Patients' dietary regime was analysed using NUTPLAN, a software with wide applications among which are recipe calculation and diet planning, harmonised with EuroFIR recommendations. Serum phospholipid (PL) fraction was isolated by one-dimensional thin layer chromatography. PL FA composition was determined using gas chromatography. In overweight/obese hypercholesterolemic patients statistically significant difference in total cholesterol, saturated FA, n-6 and n-3 FA was not found between genders. After AHA-Step 1 diet, total cholesterol and saturated FA decreased and n-6 and n-3 FA increased in serum PL.
Our results indicate that PL FA composition could be a valuable biochemical parameter that would enable planning and follow-up of nutrition treatment in overweight/obese patients with middle hypercholesterolemia. This work was completed on behalf of the EuroFIR Consortium (FOOD-CT-2005-513944) Objectives: By means of a metaanalysis were compared results from different clinical studies with the objective of evaluate the reduction of the glucose levels and HbA1c in obese patients treated with orlistat, rimonabant or sibutramina compared to placebo. Methodology: The selection criteria were: patients with at least 18 years old, with a BMI between 27 and 30 kg/m 2 both bounds included, with one or two comorbilites related with the obesity. Double-blind, controlled randomized with any of the three medications of the study and with a minimal duration of 1 year. A number of 27 studies published during the last 5 years were selected. The selection was conducted through MEDLINE, EMBASE and the Cochrane Controlled Trials Registers databases. By means of the Delphi index the quality of the studies were evaluated. All the studies were considered with a good quality with an index greater or equal to 5. Results: Orlistat showed a net glucose reduction significantly supperior to zero and a slightly advantatge to sibutramina. The patients treated with rimonabant did not present variations in the glucose levels. Orlistat, besides to present minor variability, showed a bigger reduction of HbA1c (0.39%) in comparison with rimonabant (0.35%) and sibutramina (0.26%). Conclusion: Orlistat and Sibutramina presented a significant reduction of the glucose levels. Regarding the HbA1c, the three medications presented significant reductions where orlistat was the drug with the bigger reduction in addition of the minor variability.
International Journal of Obesity Introduction: We have previously reported that overweight and obese subjects reduce their daily fat intake during and after treatment with Orlistat. Aim: The aim of the study was to evaluate the changes in lifestyle, resp. in fat intake of overweight and obese subjects after treatment with Orlistat.
The study group consisted of 96 patients -65 women and 31 men (mean age 45.2 years, mean BMI 44.6 kg/m 2 , mean fat mass 41.6 %, mean waist circumference 110 cm). They were examined for a 7 -month period: in the first 4 months patients undergone a diet and received Orlistat 120 mg twice/daily; the last 3 months -only diet. Antropometric evaluations were performed at the begining and at the end of the study. The fat intake was measured using patient's food diaries. Results and discussion: At the end of the fourth month 3 women and 1 man dropped out. Our results demontrated that the average fat intake decreased from 108 g/daily to 56 g/daily at the fourth month and to 50.2 g/daily at the end of the study. Moreover, we observed changes in the antropometric parameters as follows: BMI decreased with 6.8 %, mean waist circumference became 94 cm and fat mass -30.8 %.
Our results suggest that Orlistat 120 mg, given twice/daily, leads to beneficial change in lifestyle of overweight and obese subjects after the treatment.
The influence of the family in the treatment of the childhood and adolescence obesity The childhood and adolescence obesity is in constant increase in Italy, with a prevalence in the province Reggio Emilia above the regional and national average. The Division of Pediatrics has a multidisciplinary outpatient department for the treatment of obesity, with different professional figures: paediatric endocrinologist, nutritionist, dietician and psychologist. The workup starts with a clinical and dietetic evaluation, which can be followed by psychological talks. 34 obese children (16 males ]. During first visit child and family alimentary consumptions were collected and presented to the family to spots most common errors and instruct for a more correct feeding. A second visit was carried out at 30-45 days distance to verify correct application of previous counselling and eventual nutritional modification; if lab results show metabolic alterations an individual diet is designed. !3 over 34 children had a pathological obese first degree relative within the family When present a member of the family in weight excess the child would change effectively his/her alimentary habits (p 0,0009) and/or will present with increasing body weight during follow-up (p 0,0015), furthermore compliance to diet counselling is extremely low (p<0,0001). The family and the presence of obesity in other members or the family has a fundamental infuence on the treatment of children affected by pathological obesity. The patient undergone treatment with diet (proteins 20 en.%) and Orlistat 120 mg 3 times/daily for 6 -month period. In this case it was impossible to advise increase in the physical activity. Results: At the end of the study we found body weight reduction with 40 kg, waist circumference decreased with 22 cm and fat mass -with 12 %. We observed an improvement in the cardio -vascular paramaters and psychological state. Discussion: Our data show that the combination of high -protein diet with Orlistat 120 mg have a beneficial effects on the antropometric parameters in severe obesity.
The traditional method for determining whether a person is overweight or obese is to determine his/her body mass index (BMI), but it doesn't work very well in the elderly. Numerous studies report a U or J shape relationship between BMI and mortality in adults, but in elderly people this is not so clear. Material and methods: In January 2000, anthropometric data of 63 institutionalized men from Madrid (aged 65 and over) were collected (weight, height, skinfolds and body circumferences), following the norms set out by the WHO. Subjects were classified as low-weight, normal-weight, overweight (OW) or obese (OB). Mortality data were taken from the sanitary records three years later. Results: BMI ranged from 16.5 to 43.7 kg/m 2 . 25.6% of the group had died in the 3 years after the onset of study. In the whole group, BMI is a protection factor for mortality (OR: 0.7; CI: 0.8-0.9; p<0.01). Taken into account the established BMI groups, the BMI is a protection factor in OW group (BMI between 25 and 30 kg/m 2 ) (OR: 0.3; CI: 0.1-1.0; p<0.05), while BMI is neither a protection nor risk factor for mortality in the other groups. Conclusions: In our elderly male group, a slight overweight seems to be a protection factor for mortality. The 25 kg/m 2 normal limit for BMI may therefore be too restrictive in elderly men, and the appropriate BMI for this age group could be higher. Introduction: Obesity is very often combined with metabolic disorders: hyperinsulinaemia, hyperleptinaemia and hypertension. These disorders can have their origin in adolescence. The aim of the study: was the assessment of leptin and insulin concentration in young hypertensives with obesity. Material and Methods: The examined group included 27 patients at the age of 17 to 19 with primary hypertension and overweight and/or obesity. Average BMI in examined group was 31,4 +/-4,5 kg/m 2 , average value of diastolic blood pressure was 148 +/-5,9 mmHg, and systolic blood pressure 92 +/-4,6 mmHg. The control group included 22 patients in similar age with proper blood pressure values, BMI 27,1 +/-3,9 kg/m 2 . Insulin and leptin were described by radioimmunological methods. Results: Average insulin concentration in patients with obesity and hypertension was 14,88 +/-7,7 μIU/ml, whereas in control group 9,2 +/-3,2 μIU/ml. Average leptin concentration in group with obesity and hypertension was 20,7 +/-7,9 μg/ml, in control group 14,8 +/-4,1 μg/ml. These results were statistically significant (p<0,05) Conclusions: Insulin as well as leptin showed higher values in group of patients with obesity and hypertension and this change was statistically significant.
Hıp cırcumferences to body weıgth rates and cardıometabolıc rısk markers ın obese women Bayraktaroglu T 1 , Kutluturk F 2 , Azezli AD 3 , Orhan Y 3 1 Zonguldak Karaelmas Univesity, Faculty of Medicine, Endocrinology and Metabolism 2 Gaziosmanpasa University, Faculty of Medicine, Endocrinology and Metabolism 3 Istanbul University, stanbul Faculty of Medicine, Endocrinology and Metabolism Introduction: We analysed the relationship between hip ciscumferences to body weight rates and cardiometabolic risk markers in obese women. Materials and Methods: Selected subjects recruited retrospectively from outpatient clinic for this study were 5835 overweight or obese women. Their hip circumferences to body weight (HC/BW)rates were calculated. Median HC/BW ratio was 1.378, then subjects divided to low HC (HC/BW is <1.378) and high HC (HC/BW is > 1.378). Thereafter, we determined and compared body compositions (body mass index, abdominal fat mass), resting blood pressures, plasma lipoprotein levels, glucose homeostasis and other related biochemical parameters. Results: There were 2913 (49.9 %) subjects in low HC group and 2922 (50.1%) subjects in high HC group. Mean BMI, body fat mass, waist circumferences, abdomal fat mass, systolic and diastolic blood pressures, fasting glucose, fasting insulin, HOMA values, total cholesterol, triglycerides, uric acid and high sensitive Creactive protein levels, counts of leukocytes, liver transaminase activities, were significantly higher in low HC/BW group than high HC/BW group (p<0.05). But mean age was not different between groups (p>0.05). Mean HDL-cholesterol and LDL-cholesterol levels were lower in low HC/BW group than high HC/BW group (p<0.05) Conclusion: It was shown that increased hip circumferences decrease cardiovascular risk factors and incidence of type 2 diabetes. In conclusion, obese or owerweight women with high hip circumferences corrected and calculated to body weight, have lower cardiometabolic risk markers than women who have low hip circumferences to body weight. It is estimated that up to 40-70% of obesity is attributable to genetic factors. The prevalence of overweight and obesity among Iranian children (Kelishadi et al, 2003) is 8.82% and 4.5% respectively. The prevalence of monogenic forms of obesity has not previously been studied in the Iranian population.
We present the first patient with a monogenic obesity syndrome identified in Iran. The patient presented with a history of extreme hyperphagia, rapid progressive weight gain and recurrent infections. He was born through a normal pregnancy in a highly consanguineous marriage. His birth weight had been normal. At age of 18 months he weighed 28 kg. Apart from obesity and incidental syndactyly of second/third digits in both feet, there were no other abnormalities on physical examination. His fasting serum leptin was 45 ng/ml, consistent with the degree of obesity. Genotyping revealed the patient to be homozygous for a 66-bp deletion in codon 514 of leptin receptor gene. At the age of 22 months he was admitted to the local intensive care unit with a severe respiratory tract infection. Unfortunately he did not respond to intensive treatment and died following a cardiorespiratory arrest. Leptin receptor mutations can be associated with altered immunity and recurrent infections in association with severe obesity. Genetic assessment is recommended in severely obese patients especially those with a childhood onset.
Low caloric diet therapy with enhanced satiation by ear acupuncture, herbal medicine and supplementary food on outpatient basis
Ikezono E New Obesity Research, Tokyo, Japan Introduction: Obese patients were classified in two groups by physical constitution. That is; Boiougito group with perspiration and no constipation, and Bofutsushosan group with no perspiration and persistent constipation. To provide a feeling of satiation in both groups, a therapy combining ear acupuncture (stomach, god gate, brain point), the ingestion of herbal medicine and supplementary drink (cocoa, soy bean powder, wheat germs, honey, fructose) mixed with soybean milk has found to be successful in treating overweight patients (more than one thousand patients) on an outpatient basis. Methods & Results: Two weeks after sustained auricular acupuncture in stomach point, depressant to the feeding center, 3,4-dihydroxybutilic acid (3,4-DB) increased from 174.3±89.8 to 305.7±104.8 μmol (p<0.05, n=7). After ingestion of supplementary drink with soybean milk, stimulant to the feeding center 2,4,5-trihydroxypentanoic acid (2,4,5-TP) decreased from 332.8±208.8 to 124.1±87.8 μmol (p<0.05, n=5). Obese patients were well tolerated the low caloric diet therapy. Among them, 8 obese patients of BMI of 31.6±1.3 rapidly reduced 18±5 Kg in 5.7±1.8 months. Prior to the treatment systolic radial pressure increased following the detection of the stomach point in the ear lobe but not at the immediately after weight loss. Conclusion: Both ear acupuncture in the stomach point and the ingestion of the supplementary drink developed adequate satiety to reduce food intake and excess weight. Classification of obese patients in Boiogitou group and Bofutsushosan group helped the reduction in weight loss.
International Journal of Obesity
High molecular weight adiponectin is raised in cord blood of newborns, but is unaffected by pre-eclamptic pregnancies. Objective: The adipocyte-derived adipokine adiponectin exhibits antiinflammatory, antiatherogenetic and antidiabetic roles, as well as insulinsensitizing properties. It is abundant in human plasma where it circulates as several characteristic multimeric forms: the high molecular weight HMW-form is supposed to be the most active form. This study is the first to report HMWadiponectin in newborns of normal and pre-eclamptic pregnancies (PE). Newborns of PE-mothers have a greater susceptibility to metabolic syndrome linked diseases in adult life. Study design: Cross sectional, hospital-based study dealing with adiponectin levels in newborns to mothers with pre-eclampsia. Venus cord blood samples were collected immediately after birth; 30 cases and 62 controls were enrolled into the study. The study was approved by the local ethics committee and all participants gave written consent. Methods: Total-and HMW adiponectin were measured by commercially available Enzyme-Linked ImmunoSorbent Assay.
The main outcome was that total adiponectin level was high in newborns. No differences in adiponectin levels were found between case and control groups when corrected for gestational age (GA). In combined groups: log (total adipo) = 0.40 + 0.027*GA; r = 0.38. Furthermore, the HMW form was the dominant form of adiponectin (HMW adipo = -5.06 + 0.81*total adipo; r = 0.90). Conclusion: Newborns exhibit higher adiponectin levels than adults and the elevated total adiponectin level is mainly explained by the presence of HMWadiponectin. Its role in early post-natal life and is yet unknown. There is no apparent association between newborns' adiponectin levels and pre-eclampsia in our study. Introduction: The endocannabinoid system (ECS) plays an important and not yet fully understood role in peripheral regulation of food intake, obesity, and metabolism. Two single nucleotide polymorphisms (SNP) have been identified in CB1 receptor gene: the 3813 A /G variant in exon 4 (rs12720071) and 5489 A/G (rs2023239) in exon3. We studied a group of obese-hypertensive patients with high cardiovascular risk. The aim for our findings was to evaluate the frequency of a genetic polymorphism of CB1 and to study its correlation with clinical parameters. Methods: We analyzed 280 obese hypertensive patients (age <65 years) excluding diabetics in therapy and 280 unselected subjects coming from the same geographic region, as reference population. Genotyping for CB1 SNPs were performed using PCR-restriction length polymorphism. The metabolic syndrome (MetS) was identified by ATPIII criteria. Results: There was not difference in genotype distribution between obese hypertensive and control populations. No association was found for the 5489A/G variant, whereas the 3813 A /G variant had a significant association with the MetS. Patients with MetS had a higher frequency of ancestral allele (A/A) than obese hypertensive without MetS (P=0.033). We calculated that 3813G conferred risk for MetS of 0.4 (95%IC 0.1-0.8). Moreover, the 3813G allele was associated with higher levels of HDL in patients without statin therapy (n=201 P=0.03). Conclusion: These results suggest a role for the 3813G allele as an endocannabinoid protective factor in obese-hypertensive patients, and may provide indirect evidence to support cannabinoid antagonist treatment strategies in obesity.
The activity of nuclear factor-κB (NF-κB) in circulating mononuclear cells and muscle but not in subcutaneous adipose tissue is associated with central obesity but not physical activity in non-diabetic adults Metformin is a potent antihyperglycemic agent as well as an insulin sensitizing agent. Two mechanisms of action have been proposed in mediating its effect, inhibition of complex I of mitochondrial electron transport chain (ETC) and activation of AMP-activated protein kinase (AMPK). In this study, we investigated the relationship between the two mechanisms taking the unique approach of measuring simultaneously oxygen consumption rate (OCR) and glycolysis rate in C2C12 myocytes treated with metformin. Inhibition of complex I by either metformin or phenformin lowered basal OCR and elicited a compensatory increase in glycolysis rate as measured by an increase in extracellular acidification rate (ECAR). In metformin-treated cells, palmitate addition induced an increase in OCR while glucose did not suggesting that metformin-treated cells selectively oxidize fatty acids over glucose. Palmitate-CoA can transfer electrons directly to ubiquinone in the ETC via ETF dehydrogenase while glucose cannot. Unlike metformin, treatment with the AMPK activator AICAR stimulated FAO but did not prevent glucose oxidation. Taken together, these data suggest that metformin exert their effect primarily via inhibition of complex I which leads to subsequent AMPK activation in C2C12 myocytes. This provides a mechanistic explanation of metformin's beneficial effect in lowering intramyocellular lipids leading to reduced insulin resistance. Finally, our preliminary results indicate that this mechanism did not operate in primary rat hepatocytes. This suggests that it is likely the insulin sensitization effect of metformin in energy utilization tissue (muscle) is independent of its antihyperglycemic effect in energy homeostasis tissue (liver). Funding/Research relating to this abstract was funded by Seahorse Bioscience S133 T3:PS.05 Obesity is associated with the development of low grade inflammation. Adipose tissue produces many pro-inflammatory factors (cytokines, interleukines) potentially involved in the progression of insulin resistance associated with obesity. Each step of a weight loss program is associated with molecular adaptations in adipose tissue, potentially modulating insulin sensitivity (InS) and the inflammatory status by mechanisms which remain poorly understood. Eight obese women followed 4 weeks of energy restriction (ER) and 6 months of weight stabilization (WS). Gene expression profiling of subcutaneous adipose tissue was performed using pangenomic DNA microarray during ER, WS and the whole dietary intervention (DI). We identified 596, 814 and 568 significantly regulated genes during ER, WS and DI, respectively. Although ER affected transitorily genes related to energy metabolism, WS induced a maintained down regulation of genes involved in immunity-related processes and/or encoding secreted proteins. Partial Least Square analysis (PLS) was used to model the relationship between InS improvement and differentially expressed genes within each phase. Approximately 90 genes appeared to contribute to InS variation in each optimal PLS model. It showed the involvement of inflammation-related genes during DI and identified ALOX5AP, S100A8 and MLXIPL among the most relevant genes. We validated the correlation between InS improvement and mRNA level change of these genes by RT-qPCR. This study shows that the changes in adipose tissue gene expression contributing to InS are clearly different between ER and WS/DI. Further investigations are required to identify the targets and the effects on cellular response to insulin of the new candidate genes. The hepatic left lobe volume (HLLV) has been proposed as an indicator of visceral adiposity, strongly associated with various risk factors of the metabolic syndrome. This longitudinal study was aimed to evaluate the relationship between weight loss, metabolic improvement and the reduction of liver volume in obese women. Swedish Adjustable Gastric Banding (SAGB) was chosen as a model since it produces a sustained weight loss without major alterations of the anatomy and physiology of the gastrointestinal tract. Fifty severely obese women (mean age 44.5 ± 11 yr; mean BMI 43 ± 5 Kg/m 2 ) were enrolled. The postoperative follow-up was 22 ± 7 months. Abdominal ultrasound was performed for determination of HLLV, subcutaneous and visceral adipose tissue thickness. Reduction of various anthropometric parameters was, on average, -22.5 % for BMI, -13.3 % for subcutaneous adipose tissue, -41.6 % for visceral adipose tissue and -43.6 % for HLLV. Reduction of HLLV was independently related to reduction of both BMI and visceral adipose tissue. Reduction of liver enzymes, serum glucose, insulin and triglycerides was independently related only to reduction of HLLV. Reduction of serum uric acid was independently related only to reduction of visceral adipose tissue. In conclusion, weight loss obtained by SAGB is associated with a marked reduction of liver volume. Ultrasound measurement of HLLV is confirmed as a reliable, simple and low-cost tool for the estimation of visceral adiposity in obese women. Introduction: Both genetic and environmental factors are involved in the pathogenesis of insulin resistance. Amongst environmental factors, there is raising concern regarding fructose consumption as a contributor to metabolic disorders. We therefore assessed the effects of a high fructose diet (HFrD) on hepatic fat and insulin sensitivity (IS) in offspring of patients with type 2 diabetes mellitus (OffT2D), a subgroup of individuals at higher risk for insulin resistance. Methods: Male OffT2D (n=9) and controls (Ctrl, n=5) were studied in a crossover design after either a 6-day control diet or a-6 day HFrD (3.5g/kg fat free mass/day). IS was assessed by a 2-step hyperinsulinemic clamp (0.3 and 1.0 mU/kg/min) to measure liver and muscle IS. Hepatic IS index was calculated as [100÷(hepatic glucose production×fasting insulin)]; whole-body IS was estimated from the glucose disposal rate. Intrahepatocellular-(IHCL) and intramyocellular lipids (IMCL) were measured by 1 H magnetic resonance spectroscopy. Results: HFrD increased (P<0.05) fasting plasma VLDL-triglycerides (Ctrl: +55%; OffT2D: +148%) and IHCL (Ctrl: +62%; OffT2D: +105%) and decreased ketone bodies (Ctrl: -72%; OffT2D: -61%) in both groups. Magnitude of change in VLDL-TG was greater in the OffT2D (P<0.05). Hepatic IS decreased (Ctrl: -15%, P=0.3; OffT2D: -10%, P=0.01), in association with higher alanine aminotransferase (Ctrl: +73%, P=0.1; OffT2D: +89%, P=0.01). Whole-body IS was lower and IMCL higher in OffT2D at the control condition (P<0.05). Conclusions: HFrD induced substantial hepatic alterations after 6 days. These deleterious effects of fructose were more marked in the OffT2D, meaning that they may be more susceptible to HFrD. A single bout of prolonged, moderate-intensity exercise lowers fasting and postprandial triacylglycerol (TAG) concentrations the next day. However, the TAG-lowering effect of exercise is dose-dependent and does not manifest after light exercise of low energy cost (<2 MJ). We aimed to investigate whether superimposing mild calorie intake restriction to such exercise potentiates the hypotriacylglycerolemic effect. Eight healthy, sedentary, premenopausal women (age: 27.1 ± 1.3 years, body mass index: 21.8 ± 0.9 kg . m -2 ) performed two oral fat tolerance tests in the morning on two different occasions: once after a single bout of light exercise (100 min at 30% of peak oxygen consumption, net energy expenditure: 1.04 ± 0.01 MJ) coupled with mild calorie restriction (1.39 ± 0.22 MJ) on the preceding day, and once after resting coupled with isocaloric feeding on the preceding day (control). Fasting plasma TAG, TRL-TAG and serum insulin concentrations were 18%, 34% and 30% lower, respectively, after exercise plus diet compared with the control trial (P<0.05). Postprandial concentrations of plasma TAG and TRL-TAG were 19% and 27% lower after exercise plus diet compared with the control condition (P<0.01), whereas postprandial insulin concentrations were not different. It is concluded that a combination of light exercise along with mild hypocaloric diet comprises a practical and feasible intervention to attenuate fasting and postprandial triacylglycerolemia, especially for people who cannot exercise for prolonged periods of time at moderate-to-high intensities, such as many sedentary or obese individuals. Research relating to this abstract was funded by the Greek Governmental Institute of Scholarships.
Metabolic syndrome is not associated to arterial dysfunction in obese children. Aim: To determine whether metabolic syndrome was associated with arterial alterations in obese children. Methods: 161 obese children aged 11.7 ± 0.2 years were studied. Metabolic syndrome was defined in three different ways, two commonly used and one personal. Non-invasive ultrasonic measurements were performed to evaluate intima-media thickness (IMT), cross-sectional compliance (CSC) and distensibility, and incremental elastic modulus at the common carotid artery level. Endothelial function was assessed at the brachial artery level by flow-mediated and glyceryltrinitratemediated dilation measurements. Results: The prevalence of metabolic syndrome was 11.2%, 11.8% and 16.8% according to the three different definitions used. IMT was positively correlated to LDL-cholesterol (r=0.21, p<0.01) and negatively correlated to HDL-cholesterol (r=-0.17, p<0.05). In adolescents (11-18 years), CSC was negatively correlated with abdominal fat (r=-0.22, p=0.02). We found no significant difference in vascular variables between patients with and without metabolic syndrome, with any of the three definitions used. The only synergistic effects between individual metabolicsyndrome components was an effect of insulinaemia and systolic blood pressure on CSC (4.05; p<0.05). Conclusion: Metabolic syndrome in obese children was not statistically related to arterial dysfunction, whereas several of its individual components were associated with vascular alterations. These data suggest that the metabolic syndrome concept may not be helpful in managing cardiovascular risk in obese children. Instead, risk factors should be evaluated and controlled individually.
Pasarica M, Xie H, Smith SR Pennington Biomedical Research Center 6400 Perkins Rd, Baton Rouge, La 70808, USA Introduction: Women have more body fat than men. However, this is not associated with increased metabolic disease risk. We hypothesized that adipocyte size subdistribution and number will help us understand this apparent paradox. The aim of the present study was to compare the postprandial metabolic response to the ingestion of glucose (GLUC) vs. trehalose (TRE) and sucrose (SUC) vs. isomaltulose (IMU). We hypothesized that the reduced rate of digestion and absorption of TRE and IMU will induce lower glycemic and insulinemic responses, leading to higher postprandial fat use when compared to GLUC and SUC, respectively. In a randomized, cross-over study, 10 overweight subjects (age=31± 4 y, BMI=27.7± 0.8 kg/m 2 ) were given 4 different carbohydrate drinks following an overnight fast (AM) and in combination with a subsequent standardized meal (PM). Blood and expired breath samples were taken before ingestion and then every 30 min, substrate use was measured by indirect calorimetry. Ingestion of carbohydrates in combination with a mixed meal resulted in both a lower peak glycemic response as well as ΔAUC of TRE vs. GLUC and of IMU vs. SUC. Significant differences in peak insulinemic response and ΔAUC were observed with TRE vs. GLUC and IMU vs. SUC during PM. Additionally, postprandial fat oxidation was higher with IMU as compared to SUC when ingested with a mixed meal (ΔAUC/min -0.003 ±0.006 g vs. ΔAUC/min -0.02 ± 0.007 g). Ghrelin response was significantly reduced after ingestion of IMU compared to SUC during AM. In conclusion, the lower glycemic and insulinemic responses with IMU (combined with a mixed meal) stimulate postprandial fat use, and may represent an effective strategy to support weight loss by promoting a negative fat and energy balance. Fat accumulation in the visceral adipose tissue (VAT) is believed to be particularly dangerous because it is highly correlated with cardiovascular and metabolic risk factors. We investigated whether or not some weight loss interventions are better than others at targeting the reduction of VAT. We hypothesized that changes of VAT are allometrically related to changes of total fat mass (FM), regardless of the type of intervention, as defined by the differential equation dVAT/dFM = k VAT/FM where k is a dimensionless constant. We performed a systematic search of the published literature for weight loss studies that measured FM changes along with VAT changes via MRI or CT imaging. 37 studies satisfied our search criteria, representing 1407 men and women using a variety of weight loss interventions. The allometric equation accurately modeled the data with k=1.3 ± 0.1 and the model had an R^2=0.73. The same equation applied for both genders as well as a wide variety of weight loss interventions including bariatric surgery, caloric restriction with or without exercise, and exercise alone. We conclude that changes of VAT are primarily determined by FM changes as well as the initial VAT to FM ratio. This work was supported by the Intramural Research Program of the NIH, NIDDK.
Jeffery AN 1 , Metcalf BS 1 , Hosking J 1 , Voss LD 1 , Wilkin TJ 1 1 Peninsula College of Medicine and Dentistry, Plymouth, UK
The hyperbolic relationship between insulin sensitivity (%S) and insulin secretion (%B) defines the behaviour of the glucose-insulin feed-back loop, and underpins the HOMA model. Disposition models (dynamic plots of %B against %S) offer new insights into the impact of BMI on glucose control over time. Aim: To map the shifting relationship between insulin sensitivity and insulin secretion in healthy young children as they grow. Methods: Changes in BMI(SD), fasting glucose, %S (1/HOMA-IRx100), %B (HOMA-%B) and their product, the disposition index (DI), were monitored annually from 5-10y in 218 children (126 boys) from the EarlyBird cohort. The changing relationship between %B and %S was plotted yearby-year. Results: BMI(SD) did not change significantly from 5-7y (+0.02SD, p=0.4) but rose from 7-10y (+0.17SD, p<0.001). Glucose rose (4.3-4.8mmol/l, p<0.001) throughout the 5y period, and the DI fell (186.3-115.6, p<0.001), suggesting progressive weakening of loop control. From 5-7y, the fall in DI was attributable to loss of %B, with some compensatory rise in %S (see graph). Around 7y, %S ceased to rise further, the trajectory reversed, and the continuing fall in DI became attributable to falling %S (rising insulin resistance). Conclusion: A disposition map for healthy children, with its switch in direction around 7y, has not been shown before. The trajectory is clear and may reflect the gain in BMI that precedes puberty. Its inflexion may signify a crucial event on the path towards obesity-related morbidities. Besides weight loss, quality of life (QL) is another measurement of treatment impact. If QL depends only on weight loss could be considered as surrogate and in this case could loss significance. This study investigated the relation between QL score and weight loss. The time of permanence in follow up was considered another variable of interest for QL assessment. We used the IWQOL (Impact of Weight on Quality of Life) developed in the University of Duke. It has 8 areas, validated by our team. We included 69 patients, 55 with complete data (44 women and 11men) (1.9-4.9) (<0.001) -0.04 (0.78) Fifty percent of conditioned success weight lost of 5 or 7% using Kaplan-Meier analysis was obtained at 6.3 months. We concluded obese subjects with BMI >30 improved the QL score independently of BMI decrease and the time of follow up at the clinic. To obtain at least 50% of conditional success in weight loss patients should be maintained in treatment for more than 6 months.
Background: In adults, central obesity predicts cardiovascular risk better as compared to BMI, but in children, cross-sectional studies are controversial and longitudinal data are lacking. We investigated two questions: Is BMI is inferior to other anthropometric measures regarding its association to CVRF and body fat? Do changes in anthropometric measures correlate to changes in CVRF and does the inclusion of baseline anthropometric measures in the prediction model improve this relationship? Methods: We examined a randomly selected population-based sample of 502 1 st and 5 th grade Swiss schoolchildren in a cross-sectional design and then followed 205 children (randomly selected control group) for 10 months. Outcome measures included hs-CRP, sex hormone binding globulin (SHBG) and fasting insulin concentrations, HOMA-IR and blood pressure, a metabolic risk score and percent body fat (%bf; done by DXA). Exposure variables included BMI, waist circumference and the sum of 4 skinfolds (sfs).
In cross-sectional analyses, BMI, waist circumference and sfs were significantly correlated to hs-CRP, Insulin, HOMA, SHBG, blood pressure, the metabolic risk score (r 2 10-85%, all p<0.001), after adjusting for age group, sex and pubertal status. No clinically relevant differences between those measures were observed except that the pbf was best predicted by the sfs. Stratifying by sex, pubertal status or weight status (normal weight vs overweight or obese) did not significantly alter these results. Changes in anthropometric measures were associated with most changes in CVRF and % body fat, albeit less strongly. Adding baseline anthropometric measures to these models improved their association with changes in CVRF (r 2 3-37%, mostly p<0.05). In this total models, changes in CVRF were predominantly associated with the model that included baseline and changes of waist circumference. Conclusion: BMI in children is not inferior to other anthropometric measures in its association with CVRF in cross-sectional analyses, but might be inferior to waist circumference in longitudinal analyses. In addition to changes in anthropometric measures, baseline anthropometric measures add to the prediction of change sin CVRF. This raises the question, if there exists an entity of "cardiovascular memory". The inflammatory component of non-alcoholic steatohepatitis (NASH) in obese humans is generally evaluated by conventional histology. A better characterization of the inflammation is needed since the nature of the inflammation may have important implications for NASH progression. We have characterized the distribution of neutrophils, macrophages/Kupffer cells and activated hepatic stellate cells by immunohistochemical staining of liver sections of 41 severely obese patients, applying antibodies to human neutrophil peptide 1-3 (HNP1-3), myeloperoxidase (MPO), CD68 and alpha-smooth muscle actin. Furthermore, expression of chemokines IL-8 and CXCL1, and macrophage phenotype markers IL-6, IL-1beta, IL-10, CLEC7A and EMR-1 was determined. According to the Brunt scoring system, 16 patients showed simple steatosis whereas 25 patients had NASH. The number of HNP1-3 expressing neutrophils, CD68-positive macrophages/Kupffer cells and activated stellate cells did not differ between these two groups. In contrast, the number of MPO-expressing cells was much higher in the NASH group (13.0 vs 38.8 cells/area). A significant proportion of the inflammatory cells surrounded lipid laden hepatocytes, resembling the 'crown-like structures' frequently found in obese adipose tissue. Both IL-8 (r s =0.350) and CXCL1 (r s =0.401) expression correlated with HNP1-3 positive cell number, but not with the number of MPO expressing cells. Analysis of macrophage M1 and M2 phenotype markers indicated that both pro-and antiinflammatory macrophages are present in NASH. Taken together, our data show that the presence of MPO expressing macrophages/ Kupffer cells is characteristic of the inflammatory lesion in NASH and indicate that there are important similarities between inflammatory processes in the obese liver and obese adipose tissue. Research relating to this abstract was funded by Senter Novem IOP Genomics grant IGE05012 Abstracts S136 International Journal of Obesity T3:PS.18
Objective: To investigate the effect of long term (three years) weight loss on serum levels of the non-traditional cardiovascular risk factors such as hs-CRP, adiponectin, interleukin-18 (IL-18), and matrix metalloproteinase-9 (MMP-9). Moreover, to assess the significance of the magnitude of the weight loss and evaluate potential effects of the lipase inhibitor, orlistat, on these parameters. Design: 68 abdominally obese subjects completed eight-weeks of very low-energy diet (VLED~800 kcal/day) followed by three years of randomized treatment with either orlistat or placebo together with life style intervention. Serum levels of these risk factos were measured by flowmetric xMAP technology. Results: Changes in the levels of IL-18, MMP-9, hs-CRP, and adiponectin were similar in the orlistat and the placebo group during this study. Thus, the two groups were combined for further analysis. A weight loss of 8.4 ± 8.8 kg from baseline to three years was associated with significant decreases in IL-18, MMP-9, hs-CRP (p<0.001) and an increase in adiponectin (P< 0.001). MMP-9 was, however, significantly increased after 8 weeks of VLED-induced weight loss (p<0.05).The long term changes in IL-18 were significantly associated with changes in BMI independent of changes in blood pressure and lipids. Levels and changes of these risk factors were significantly associated with each other. Conclusion: Diet induced long term weight loss decreased IL-18, MMP-9, hs-CRP and increased adiponectin. The decrease in IL-18 was associated with changes in BMI independent of changes in blood pressure and lipids, indicating that even a minor weight reduction ( >7%) maintained for up to 3 years has beneficial effects on non-traditional cardiovascular risk markers. Orlistat treatment had no independent effects on these inflammatory markers in the present study.
The relationship of liver tests with the components of the metabolic syndrome in overweighed and obese women.
Antwerp University Hospital, University of Antwerp, Antwerp, Belgium Aims: To investigate wether liver tests [AST, ALT, alkaline phosphatase (ALP), GGT] are increased in subjects with the metabolic syndrome (MS) as defined by the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII). Methods and Results: Waist circumference, blood pressure, fasting glucose, triglycerides, HDL cholesterol, and liver tests (AST, ALT, ALP and GGT) were assessed in overweighed and obese women (n=447). According to the NCEP-ATP III criteria 25.3% of the subjects was diagnosed as having the ms. In 51.3% of the subjects with the MS, one or more of the liver tests were above the upper limit of normal. Comparing subjects with and without the ms, we found significant differences for ALT (37±22 U/l vs 33±32 U/l, p=0.007), ALP (78±19 U/l vs 75±26 U/l, p=0.026) and GGT (34±22 U/l vs 29±32 U/l, p<0.001). For AST we observed a trend (25±11 U/l vs 24±14 U/l, p=0.070). Differences in ALT and GGT remained significant even after adjusting for BMI, ferritin and CRP. When subjects were classified according to the number of components of the MS, levels of ALT, GGT, ferritin and CRP significantly increased with the number of components present (p<0.05). Stepwise multiple regression analysis, with the components of the MS as independent variables and liver tests as dependent variables, showed mainly fasting glucose and triglycerides as the most important determinants of liver markers. Conclusions: Increasing features of the MS are associated with increased prevalence of disturbed liver tests and inflammation suggesting a causal link between the MS and NAFLD. This work is part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme (Contract LSHM-CT-2005-018734).
Cell biology aspects of alström syndrome, a monogenic model of metabolic syndrome.
Zulato, E 1 , Milan, G 1 , Romano, S 1 , Veronese, C 1 , Centobene, C 1 , Urbanet, R 1 , Granzotto, M 1 , Favaretto, F 1 , Maffei, P 1 , Vettor, R 1 1 Endocrine -metabolic Laboratory, Department of Medical and Surgical Sciences, University of Padua, Italy Introduction: Alström Syndrome (ALMS) is a rare, autosomal monogenetic disease, caused by mutation in ALMS1 (Chr 2p13), a new gene ubiquitously expressed of unknown function. ALMS is characterized by severe impairments of multiple organ systems, resulting in blindness, hearing impairment, interstitial fibrosis, childhood-onset obesity, hyperinsulinemia, insulin resistance and type 2 diabetes. Aim: we aimed to study some pathophysiological aspects of ALMS which recapitulates most of the features of the metabolic syndrome. Research design and methods: we investigated in primary fibroblast cultures from ALMS patients: 1) the insulin sensitivity assayed by insulin-dependent 2-3 H-Deoxy-D-Glucose uptake; 2) the gene expression profile by cDNA microarray analysis and real-time PCR; 3) their ability to differentiate into adipocytes under adipogenic conditions. Lipid accumulation was assessed by oil red O staining and morphological changes by microscopy. Moreover we studied the changes in Alms1 gene expression during adipogenic differentiation of 3T3-L1 fibroblasts. Results and conclusions: we did not observe any variation in insulin sensitivity between ALMS and control fibroblasts. Comparative analysis between the differential gene expression profiles of ALMS and control showed a significant increase in INSR without any difference in GLUT4. 11 genes coding for different types of collagen resulted up-regulated suggesting an involvement of ALMS1 in the multi-organ fibrosis. The adipogenic potential of ALMS fibroblasts was clearly increased compared with controls. A downregulation of Alms1 was observed during the 3T3-L1 differentiation, suggesting that Alms1 could have an influence in the early phase of adipogenesis thus partially explaining the propensity of ALMS patients to obesity.
Astrup, A 2 , Brøns, C 1,2 , Lilleøre, SK 1,2 , Jensen, CB 1 , Storgaard, H 1 , Toubro, S 2 and Vaag, A 1 Identification of the most appropriate dietary approach for the treatment of the atherogenic dyslipidemia remains still under investigation. Recently small, dense low-density lipoprotein (sd-LDL B ) has been highlighted as a risk factor for CHD. Visceral fat exhibits more enhanced lipolytic activity and inflammatory phenotypes than other fat depots. However, it is unclear whether the vicious phenotypes are associated with immune dysfunction in obesity. Because adipose tissue is anatomically associated with lymph nodes, the secondary lymphoid organ, we hypothesized that visceral fat accumulation influences the cellularity of lymphoid tissue embedded in visceral fat. Mesenteric and inguinal lymph nodes were isolated from obese mice fed a high-fat diet and control mice fed a regular diet. T cell population, activation state, and the extent of apoptosis were determined by flow cytometric anlaysis or TUNEL assay. The weight of mesenteric lymph nodes of and the number of lymphoid total cells in the obese mice significantly decreased compared with those in the control mice, however, no change was observed in the weight of inguinal lymph nodes. The numbers of CD4+ and CD8+ T cells in the mesenteric lymph nodes of obese mice significantly decreased compared with those of the control. Enhanced T cell activation and apoptosis were observed in the mesenteric lymph node cells of the obese mice. The treatment of lymph node cells with free fatty acids and oxidative stress, which are obesity-related factors, resulted in lymph node T cell activation and apoptosis. These results suggest that visceral fat accumulation can cause the atrophy of mesenteric lymph nodes by enhancing activation-induced T cell apoptosis. Visceral fat accumulation may be crucial for obesity-related immune dysfunction. 2 ) underwent a whole-body DXA-scan (manual segmentation: arms, legs, abdomen). In 149 subjects visceral fat (vcFM MRI ) was analyzed by MRI at L4-L5 and abdominal fat by DXA-segmentation. CR (mean arterial blood pressure (MAP), cholesterol, triglycerides (TG), HDL-C, LDL-C, glucose-and insulin-levels (calculation of insulin-resistance by HOMA-Index)) were assessed. Results: Women had significantly higher proportions of leg-FM DXA /total-FM DXA (f:41%, m:32%), whereas men showed significantly higher proportions of abdomen-FM DXA /total-FM DXA (m:46%, f:40). Partial correlations adjusted for age, sex and %FM DXA revealed significant, positive relationships (negative association for HDL-C) between abdomen-FM DXA /total-FM DXA and CR (r=-0.26(HDL-C), r=0.20(LDL-C), r=0.21(MAP), r=0.24(insulin), r=0.24(HOMA), p<0.01), but inverse associations between leg-FM DXA /total-FM DXA and CR (r=0.26(HDL-C), r=-0.22(LDL-C), r=-0.22(insulin), r=-0.23(HOMA), r=-0.18(MAP), p<0.01). In a partial correlation adjusted for abdomen-FM DXA /total-FM DXA the inverse associations between leg-FM DXA /total-FM DXA and CR remained significant. There were significant and positive associations between different methods to assess abdominal or visceral fat (abdomen-FM DXA vs. WC (f:r=0.79, m:r=0.81), WC vs. vcFM MRI (f:r=0.73, m:r=0.77) and abdomen-FM DXA vs. vcFM MRI (f:r=0.61, m:r=0.76)). Conclusions: CR increased with higher ratios of abdomen-FM DXA /total-FM DXA , whereas greater proportions of leg-FM DXA /total-FM DXA seem to be protective. These effects remained significant after adjusting for abdomen-FM DXA /total-FM DXA.
The contribution of organ and tissue masses to interindividual. Resting energy expenditure (ree)-variances: Influence of sex and obesity . Magnetic-Resonance-Imaging (MRI) was used to assess organ-masses (brain, heart, liver, kidneys, spleen =OM) and visceral fat-mass (vcFMMRI) at L4-L5. Fat-mass (FM), lean body mass (LBM) and muscle-mass (MM) were measured by Dual-Energy-X-Ray-Absorptiometry (DXA). REEm was measured by indirect calorimetry, adjusted for LBM (REEadj) and compared to REEc calculated from organ-and tissue-masses times specific metabolic rates according to Elia, 1992 . To explain REE-variance thyroid hormones (T3, T4, TSH) and fasting glucose-and insulin-levels (insulin-resistance by HOMA-Index) were assessed. Results: REEm and REEadj were significantly higher in men when compared with women (REEm:7.47±0.90 vs. 5.95±0.75MJ/d, REEadj:7.98±0.98 vs. 5.45±0.79MJ/d; p<0.01). In both gender normal-weight(nw) subjects had significantly lower REEm than overweight(ow) subjects (m:-0.70MJ/d, f:-0.46MJ/d) and obese(ob) subjects (m:-1.46MJ/d, f:-1.26MJ/d) (p<0.01). Adjusting REE for LBM significant differences between nw and ob subjects remained (m:-0.45MJ/d, f:-0.71MJ/d) (p<0.01). No differences were found for REEm-REEc between gender (m:-51KJ/d vs. f:25KJ/d) or BMI-classes (m: 31KJ/d(nw) vs. -169KJ/d(ow) vs. 29KJ/d(ob); f: 47KJ/d(nw) vs. -62KJ/d(ow) vs. 44KJ/d(ob)). In a multiple regression analysis LBM explained 78% of REEm-variance. OMMRI, MMDXA, FMDXA and vcFMMRI explained 86% of REEm-variance. HOMA-Index and plasma thyroid hormone-levels did not further explain the REEm-variance. Conclusion: The contribution of high metabolic rate organ-masses explains sex-differences as well as obesity induced differences in REE adjusted for LBM. Fenugreek (Trigonella foenum-graecum L. Leguminosae) is one of the oldest medicinal plants, much cultivated in India and Mediterranean countries. It is one of the spices which are contained in curry powder. Fenugreek has various medical effects such as nourishing, lactation stimulant, treatment of indigestion and anti-inflammatory. Recently, hypoglycemic effect of fenugreek on type1 and type2 diabetes was reported. However, its mechanism is still uncertain. And it is difficult to apply fenugreek to foodstuff, because fenugreek has a strong bitter taste. Furostanol saponins contained in fenugreek are major cause for bitterness. Enzymatic cleavage at the O-linked sugar chain of fenugreek saponins yielded fenugreek with reduced bitterness (FRB). To evaluate the effect of FRB on diabetes and investigate its mechanism, we examined the effects of FRB on the metabolism of glucose and lipid in obese diabetic KK-Ay mice.
Hyperglycemia accompanied with obesity was ameliorated in KK-A y mice fed with FRB. Glucose tolerance was also improved in mice fed with FRB. This treatment increased the expression of peroxisome proliferator-activated receptor (PPAR ) and PPAR target genes, while decreased slightly the expression of macrophage-specific genes in white adipose tissue. Moreover, hyperlipidemia and hepatosteatosis were ameliorated in mice fed with FRB. Interestingly, this treatment decreased the expression of sterol regulatory element-binding proteins1c (SREBP1c) and SREBP1c target genes in liver. These results indicate that FRB improves the disorder of glucose and lipid metabolism. Consequently, FRB may be useful for ameliorating diabetes accompanied with obesity.
Ferritin was associated with metabolic syndrome Hsiao TJ 1,3 , Chen JC 2 , Wang JD Adipokines are involved in the obesity-induced chronic inflammatory response that plays a crucial role in the development of obesity-related pathologies such as type II diabetes and atherosclerosis. We here demonstrate that capsaicin, a naturally occurring phytochemical, can suppress obesity-induced inflammation by modulating adipokine release from and macrophage behavior in obese mice adipose tissues. Capsaicin inhibited the expressions of IL-6 and MCP-1 mRNAs and protein release from the adipose tissues and adipocytes of obese mice, whereas it enhanced the expression of the adiponectin gene and protein. The action of capsaicin is associated with NF-κB inactivation and/or PPARγ activation. Moreover, capsaicin suppressed not only macrophage migration induced by the adipose tissue-conditioned medium, but also macrophage activation to release proinflammatory mediators. In vivo experiment, dietary supplement of capsaicin significantly decreased the expression levels of MCP-1 and IL-6, and macrophage accumulation and increased the expression of adiponectin in adipose tissue of the obese mice compared with those of the control. Moreover, capsaicin improved the impairment of glucose tolerance in the obese mice. Capsaicin may be a useful phytochemical for attenuating obesity-induced inflammation and obesity-related complications such as insulin resistance. Visceral adipose tissue is recognized as an independent risk factor for metabolic syndrome in adults. Estimation of abdominal obesity by anthropometry is frequently imprecise, particularly in children. The study aim was to estimate whether epicardial fat (EF) measured by transthoracic echography correlates with waist circumference and metabolic syndrome components in overweight children. In 52 overweight children (23M, 29F) in the mean age 11.6 ±2.87 years and in 61 normal weight healthy children (24M, 37F) in the mean age 13.4±2.13 years, measurements of EF thickness on the right ventricle was obtained by two-dimensional M-mode echocardiogram . In all children weight status was assessed according to IOTF criteria and their waist circumference was measured. Fasting total cholesterol (TCh), HDLcholesterol (HDL), triglycerides (TG) and insulin (Ins) were measured, LDLcholesterol (LDL) was calculated and systolic (SBP) and diastolic blood pressure (DPS) were measured in overweight children. In overweight children EF thickness was 5.52 mm (4.97-6.07 95%CI) vs 2.53 mm (2.32-2.74 (95% CI) in non-overweight, the difference being statistically significant (p<0.0001). EF significantly correlated with weight, BMI, BMI z-score and waist circumference (p<0.0001). There was no correlation between EF and TCh, HDL, LDL, TG, Ins, SBP and DPS, in model adjusting for of weight, age and sex. It is concluded that although epicardial fat in overweight children shows a strong correlation with BMI and waist circumference it does not seem to be independent predictor of metabolic syndrome in this age group.
Mertens, I, Verrijken, A, Van Gaal, LF Antwerp University Hospital, University of Antwerp, Antwerp, Belgium Aims: To investigate whether the relationships between visceral adipose tissue (VAT) and markers of hemostasis and fibrinolysis are independent of low-grade inflammation. Methods and Results: Fibrinogen, von Willebrand factor antigen (vWF:Ag) plasminogen activator inhibitor-1 (PAI-1) and high-sensitive creactive protein (hs-CRP) were determined in a group of 292 non-diabetic overweight and obese women. A CT-scan (L4-L5) was performed to estimate the amount of visceral adipose tissue (VAT). Fibrinogen levels were significantly higher in subjects with high levels of hs-CRP (median value; p<0.001), while differences in vWF:Ag (p=0.058) and PAI-1 activity levels (p=0.088) were borderline significant. After correction for hs-CRP, VAT was not related to fibrinogen levels (r=0.10; p>0.05), while there was a significant relationship with vWF:Ag (r=0.18; p<0.01) and PAI-1 activity levels (r=0.34; p<0.001). In multiple regression analysis, hs-CRP was the only independent determinant of fibrinogen (r²=0.19; p<0.001), but did not determine levels of vWF:Ag or PAI-1. Conclusion: In this group of pre-and postmenopausal women, the relationship between VAT and fibrinogen probably is just a marker of the relationship of both factors with inflammation, while the relationship between PAI-1 and VAT is independent of inflammation. Levels of vWF:Ag are only modestly related to inflammation and VAT. This study aimed to determine the requirements for improving metabolic syndrome through an explorative approach. A total of 323 Japanese women, 24-67 years of age, were recruited as subjects, and they met the following criteria: (i) a body mass index (BMI) of 25-40 kg/m 2 , and (ii) at least 1 metabolic syndrome component (abdominal obesity, dyslipidaemia, hypertension, or hyperglycaemia, conforming to the Japanese criteria). The subjects participated in a 3-month low-calorie-diet-induced weight-loss program. We examined the requirements for improving the metabolic syndrome by using classification and regression tree (CART) analysis. Of the 323 subjects, 309 who completed the weight-loss program were included in the analyses. The average percentage weight loss was 11.9% ± 4.2%. The CART analyses showed that the percentage change in weight (cutoff: -8%) was the best requirement for improvement in at least 1 metabolic syndrome component (79.6% in the high-weight loss group vs. 44.1% in the low-weight loss group). In the former group, the baseline BMI (cutoff: 25.9 kg/m 2 ) was the best requirement for further partition. Similarly, classification trees were generated to determine the requirements for improving abdominal obesity (best requirement: -13% change in weight), hypertension (best requirement: baseline age of 42 years), and hyperglycaemia (best requirement: -13% change in weight); however, no classification trees were generated to determine the requirements for improving metabolic syndrome prevalence and dyslipidaemia. These results suggest that moderate weight loss of 8-13% contributes to improvements in metabolic syndrome components in overweight Japanese women.
Sjöholm K 1 , Gabrielsson BG 1 , Jernås M 1 , Gummesson A 1 , Svensson P-A 1 1 Sahlgrenska Center for Cardiovascular and Metabolic Research (CMR), Department of Molecular and Clinical Medicine, the Sahlgrenska Academy, Göteborg University, Göteborg, Sweden Aldoketoreductase 1C3 (AKR1C3) is a functional prostaglandin F synthase and is a negative modulator for the availability of ligands for the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARγ) in macrophages. Furthermore, expression of AKR1C3 is known to be associated with adiposity, one of the components of the metabolic syndrome. Hence, the aim of this study was to investigate AKR1C3 expression in relation to the metabolic syndrome. We studied the expression of AKR1C3 in adipose tissue samples from obese subjects with or without metabolic complications, during very low calorie diet-induced weight loss as well as in isolated human adipocytes of different sizes using microarray analysis and real-time PCR. Adipose tissue AKR1C3 expression levels were lower in obese subjects with the metabolic syndrome compared with healthy obese subjects (p<0.05). Adipose tissue mRNA levels of AKR1C3 were reduced during and after diet-induced weight-loss (p<0.001 at all time-points) compared to baseline levels. In addition, gene expression of AKR1C3 correlated to adipose tissue mRNA and serum leptin levels at baseline (p<0.01 and p<0.05, respectively). AKR1C3 was shown to have its main site of expression in subcutaneous adipose tissue compared to 64 other human tissues. Furthermore, large adipocytes display higher expression of AKR1C3 than small adipocytes (1.5-fold, p<0.01). In conclusion, adipose tissue and adipocyte AKR1C3 expression is altered in metabolic disease. Research relating to this abstract was funded by grants from The Swedish Research Council, the National Board of Health and Welfare, the Swedish Diabetes Foundation, the Sahlgrenska University Hospital Foundation, the IngaBritt and Arne Lundberg Research Foundation, the Fredrik and Ingrid Thuring, the Swedish Foundation for Strategic Research and the Swedish federal government under the LUA/ALF agreement.
Benfield, LL 1 , Peters, DM 2 , Fox, KR 1 , Blake, H 3 , Rogers, I 3 , Grant, C 4 , Ness, A 5
The aims were to investigate the association between DXA measures (trunk fat and total body fat) and MRI measured intra-abdominal adipose tissue (IAAT) and subcutaneous abdominal adipose tissue (SAAT) volumes, and cross-validate prediction equations using DXA and anthropometric measures for estimating IAAT and SAAT. Seventy four boys (age 13.4±0.4yrs) and 96 girls (age 13.5±0.5yrs) were selected from volunteers enrolled in the Avon Longitudinal Study of Parents and Children. MRI was used to assess SAAT and IAAT and DXA measures utilised paediatric software. Height, weight, and waist circumference were measured and stage of sexual maturation was available via self report. DXA-derived trunk fat was the best predictor for IAAT and explained 78.1% and 67.3% of the variance of IAAT in boys and girls, respectively. DXA tended to underestimate IAAT in children with more MRI determined IAAT and overestimate IAAT in children with less MRI determined IAAT. DXA trunk fat was the best predictor for SAAT in boys (92.2% variance explained) and DXA total body fat was the best predictor for SAAT in girls (79.9% variance explained). In the absence of DXA, BMI could be a good surrogate measure for estimation of SAAT (89.4% variance explained in boys; 74.5% in girls). DXA regional trunk fat mass is a relatively good proxy measure of IAAT at the group level but not at the individual level. The DXA prediction equations for SAAT should perform reasonably well at both individual and group levels using regional trunk fat in boys and total body fat in girls.
Bourlier, V 1,2 , Zakaroff-Girard, A 1,2 , De Barros, S 1,2 , Maumus, M 1,2 , Sengenes, C 1,2 , Decaunes, P 1,2 , Galitzky, J 1,2 , Bouloumié, A 1,2 1 Institut National de la Santé et de la Recherche Médicale (INSERM), U858, Toulouse, France 2 Université Toulouse III Paul-Sabatier, Institut de Médecine Moléculaire de Rangueil, Equipe n°1 AVENIR, IFR31, Toulouse, France
The stroma-vascular fraction (SVF) of adipose tissue (AT) contains inflammatory cells. Among them, macrophages were shown to be increased with the growth of the fat mass. The present study was undertaken to further characterize the role(s) and phenotype(s) of these macrophages (i) in human subcutaneous AT of lean to overweight patients and (ii) in subcutaneous and visceral ATs of obese patients. FACS analysis was performed on the SVF using antibodies directed against macrophage cluster of differentiation (CD) markers. AT macrophages (ATMs) were isolated using an immunoselection/depletion approach and real-time RT-PCR analysis was performed. In subcutaneous AT of lean to overweight individuals, ATMs were mainly composed by CD45+/CD14+/CD206+/CD16-cells and showed a mixed expression of pro-(TNF-α, IL-6, IL-23, MCP-1, IL-8, COX-2) and anti-inflammatory (IL-10, TGF-β, AMAC-1, COX-1) factors. Fat mass enlargement was associated with a decreased expression of IL-8 and COX-2 and an increased expression of LYVE-1, a remodeling marker. Interestingly, ATMs exerted a significant pro-angiogenic effect on the AT-derived endothelial and progenitor cells. Comparison of ATMs from obese patient subcutaneous and visceral ATs showed no marked differences in the amount of macrophage accumulated in both locations. However, visceral ATMs exhibited higher transcript levels for COX-1, IL-6 and LYVE-1. These data showed that ATMs exhibit a specific phenotype, characterized by a mixed expression of pro-inflammatory and remodeling factors, together with a proangiogenic activity. Extension of the fat mass is associated with modulation of the ATMs number and phenotype. Finally, AT location modulates the phenotype of ATMs and not their number. Funding: Research relating to this abstract was funded by a grant from the Agence Nationale pour la Recherche (ANR "RIOMA").
Glucocorticoids (GC) are important regulators in a variety of processes such as body composition, metabolism, and immune function. Response to glucocorticoids has in part been attributed to variation in the glucocorticoid receptors (GR) gene. The aim of study was to assess the genotype-phenotype interaction of BclI and N363S polymorphism of GR gene in women with abdominal obesity (AO) in comparison with normalweight, healthy women (NW). The study was performed on 153 AO aged 19-46 yrs and 84 age-matched NW. We evaluated: body mass index (BMI), parameters of body composition, lipid profiles, HOMA and QICKI, cortisol, GH, IGF-1, acylated ghrelin, leptin and adiponectin serum concentration. BclI and N363S CR polymorphism was assessed by PCR-RSLP. Genotype distributions, and G and A allele frequency did not differ between study groups. Amongst AO with CC, GC and GG genotypes of BclI we found significant differences in adiponectin serum concentration and adiponectin/BF ratio. Amongst AO women with AA, AG and GG genotypes (N363S) we found differences in QICKI, serum insulin and leptin concentrations. AO women with wild type (for BclI and N363S) showed lower serum leptin levels In conclusion, our results suggest that G allele donors of BclI and N363S GR polymorphism gene are less prone to control the metabolic disturbances. Obesity and other risk factors included in the definition for the metabolic syndrome are associated with chronic low-grade inflammation, including slightly raised serum levels of the acute phase protein Serum Amyloid A (SAA). Serum levels of SAA are strongly linked to coronary artery disease (CAD) and we therefore hypothesized that genetic variants of SAA1 and the SAA receptor SelenoproteinS (SELS) are of importance in development of CAD. Two amino acid-substituting SNPs in the SAA1 gene were genotyped using RFLP analysis in a study comprising of 484 well-characterized patients with CAD and 621 healthy controls. In addition, three SNPs in SELS were genotyped in 650 CAD patients and 648 controls using TaqMan genotyping assays. Preliminary data showed that subjects with SAA1 3010TT are more likely to develop CAD (OR = 2.17, 95% CI 1.36-3.47) and this link was even stronger in men (OR = 2.28, 95% CI 1.36-3.83). A weaker link was found to genotype 2995CC (OR = 1.52, 95% CI 1.04-2.22). The SAA1 C2995T SNP was associated with BMI and WHR in women (nominal p-value < 0.05 and < 0.05, respectively). Two of the SELS genotype variants were associated with triglyceride and HDL levels (rs4965814 SNP: nominal pvalue 0.016 and 0.006, respectively; G-105A SNP: nominal p-value 0.010 and 0.005, respectively). In conclusion, our results indicate that SAA1 genotypes are associated with CAD and that SAA1 and SELS are involved in the regulation of CAD risk factors. Research relating to this abstract was funded by grants from The Swedish Research Council, the National Board of Health and Welfare, the Fredrik and Ingrid Thuring foundation, the Royal physiographic society in Lund, the Jeansson foundation, the Swedish Foundation for Strategic Research and the Swedish federal government under the LUA/ALF agreement T3:PS.42
S. Shakeri-Manesch, G. Prager, A. Bohdjalian, F. Langer
Background: It is estimated that up to 80% of persons with diabetes mellitus type 2 are overweight. Effective weight control can lead to improvement or even resolution of their diabetes in these subjects. Laparoscopic methods currently used in bariatric surgery represent a suitable option for sustained weight loss in severely obese-diabetic subjects. Methods: In this prospective review, we analysed the change in the diabetic status in 74 obese-diabetic subjects undergoing three different bariatric procedures in a single institution over 12 months. Included subjects had diabetes for at least 6 months. Evidence of stable treatment was required with oral hypoglycaemic agents or insulin for at least 12 months. They were matched with 74 obese non diabetic subjects on the same conditions. Results: Six months after bariatric procedure the 74 diabetes subjects had a mean excess weight loss (EWL) of 37.8%. EWL dropped by 50.3% in 57 (77.0%) subjects after 12 months. In 47 (63.5%) subjects diabetes resolved completely and 25 subjects (33.8%) had significantly improved their diabetes mellitus (compared with HbA1c) after 12 months. The control group exhibited an average EWL of 41.6% at 6 months. EWL reached 53.4% in 57 control subjects after 12 months. Long-term total mortality after gastric bypass surgery was significantly reduced, particularly deaths from diabetes mellitus. Conclusion: Laparoscopic bariatric surgery resulted in significant and sustained weight loss leading to significant improvement of diabetes. This technique may facilitate treatment of diabetes in subjects refractory to oral medication or on insulin. Key words: bariatric surgery, excess weight loss, diabetes mellitus S142 International Journal of Obesity Inflammation plays a causal role in several morbidities related to obesity, such as nonalcoholic steatohepatitis (NASH). The complement system is an important component of the innate immune system and could play a role in the pathophysiology of NASH in obesity. Therefore we studied the activation of the complement system in the livers of severely obese patients. Liver tissue sections of 38 severely obese patients were immunohistochemically stained for the presence and distribution of activated C3 (the central component of the complement system) and for mannose binding lectin (MBL), the initiating factor of the lectin pathway. Deposition of activated C3 was detected in 66% of the patients. Staining patterns varied between patients and between liver regions. Intense staining was frequently observed around lipid laden hepatocytes. A similar staining pattern was observed for MBL. Presence of MBL was detected in 79% of the patients. Colocalization of MBL with C3a was seen in most C3a-positive livers. Staining of complement factors of the classical pathway and the alternative pathway is in progress.
Our results support a role for the complement system in NASH in severe obesity. The observed staining patterns suggest the triggering of the complement system by fat accumulation in the liver. Conclusion At all measurement sites WC showed a close association with VAT. No difference between sites was observed in men whereas in women WC measured just below the lowest rib was the best index for VAT. The use of unique cut-offs for WC at different anatomic sites leads to substantial discrepancies in the classification of metabolic risk.
Brown CM, Dulloo AG, Yepuri G, Montani JP
Overconsumption of soft drinks has been linked with the obesity epidemic and is recognized as a major public health concern. The present study was aimed at determining the contribution of caffeine to the cardiovascular load imposed by soft drinks. In a randomized crossover study, 12 (8 male) healthy volunteers (aged 20-30 years) ingested drinks containing sucrose with either a caffeine or a placebo tablet. The volume (500ml), sucrose concentration (11%) and caffeine content (50mg) were chosen to simulate a standard soft drink. For 30 min before and 2 hours after each drink, we recorded arterial blood pressure (finger plethysmography), heart rate (ECG) and cardiac output (impedance cardiography). Total peripheral resistance (TPR) was calculated as mean blood pressure divided by cardiac output. Ingesting sucrose+placebo significantly increased heart rate and cardiac output but had no overall effect on blood pressure due to a decrease in TPR. In contrast, ingesting sucrose+caffeine resulted in a gradual increase in mean blood pressure that, after 2 hours, was 7.3±1.4 mmHg above the basal value. The increases in heart rate and cardiac output after ingesting sucrose+caffeine were not significantly different from those in response to the sucrose+placebo drink. However, the average drop in TPR was considerably less (-0.40±0.46 mmHg/l min -1 ) after sucrose+caffeine compared with sucrose+placebo (-1.25±0.44 mmHg/l min -1 ). These data suggest that addition of caffeine to a soft drink, even in small amounts, causes a substantial increase in blood pressure. This effect seems to be due to a caffeine-mediated attenuation of the vasodilatory response to sugar ingestion. Acknowledgements: Research relating to this abstract was funded by the Swiss National Science Foundation, the Swiss Heart Foundation and the Swiss Foundation for Nutrition Research.
Obesity Research Center, Research Institute for Endocrine Sciences, Shaheed Beheshti MC Introduction: We examined the influence of apolipoprotein E (apoE) polymorphism on lipid profile, especially HDL subfractions, in Iranian population and studied the effect of the lifestyle changes in this relation. Materials and methods: We performed a cross-sectional study of 1030 subjects (452 men and 578 women) from the Tehran Lipid and Glucose Study. Triglyceride, cholesterol, FBS, HDL-C levels and its subfractions, apolipoprotein B and apolipoprotein A1 were determined and body mass index and blood pressure were measured. A segment of the mentioned gene was amplified by PCR and the polymorphism reveled by RFLP using HhaI restriction enzyme. Results: Allele frequencies obtained for APOE*2, APOE*3, and APOE*4 were 5.77%, 85.92%, and 8.3%, respectively. The presence of the 2 allele was significantly associated with increased HDL-C levels (E2= 50 ± 14 mg/dl vs. E4 = 44±10 mg/dl for P<0.001), HDL-2 levels (E2= 19 ± 9 mg/dl vs. E4 = 15±7 mg/dl for P<0.001) and HDL-3 levels (E2= 32 ± 8 mg/dl vs. E4 = 28±6 mg/dl for P=0.005). The relations were significant even after adjustment for age; sex but smoking and diabetes status decreased the effect of APO E2 in HDL-C and HDL subfractions. Conclusion: The observed genotype and allele frequencies were similar to those reported for other Caucasians samples. The finding showed that APOE2 increased the level of HDL-C and HDL subfractions. These findings highlight the important effect of variation in this gene on lipid levels. Key words: Apo B, Polymorphism, Frequency, Lipid
Melnichenko G., Butrova S., Eliseeva A.
Non-alcoholic fatty liver disease (NAFLD) is a new, emerging problem among obese patients. Aim: The aim of our study was to determine the prevalence of NAFLD in obese subjects and to characterize the relationship between NAFLD and insulin resistance and cardiovascular risk factors. Methods: The study was performed in 223 alcohol-and virus-negative obese men and women. Anthropometric parameters, blood pressure, lipid profile, ALT, AST, blood glucose and insulin, HOMA-IR, oral glucose tolerance test and liver ultrasonography were measured in each subject. The metabolic criteria were defined according to the IDF. Plasma adiponectin, leptin, TNF-, C-reactive protein (CRP) and PAI-1 were measured in subjects with NAFLD and metabolic syndrome (n = 60). Results: The prevalence of NAFLD was 78,5%, 71,4% of them had metabolic syndrome, 84%-insulin resistance, 56,7%-hyperinsulinemia, 47%-hypertriglyceridemia, 46%-decreased HDL-C, 61%-hypertension. The prevalence of increased ALT levels was 41,7%, AST -22,9%, AST, ALT-22, 9%. Triglycerides, insulin and HOMA were significantly higher in subjects with NAFLD (p<0,001). Increased ALT activity was significantly associated with fasting insulin, HOMA-IR and TNF-. (p< 0,05). Low adiponectin levels was observed in 44,4% patients, hyperleptinemia-96, 3%, increased CRP-22,2%, increased TNF--24%. All patients had high-level PAI-1. Waist circumference, BMI positively correlated with liver steatosis & negatively with adiponectin. Conclusion: The prevalence of NAFLD is high in obese subjects and strongly associated with cardiovascular risk factors. Results: ADQ (μg/mL) decreased significantly between 0' and 120' of OGTT in obese patients only: controls 10.78±6.00 vs. 7.49±10.29; overweight 7.41±5.91 vs. 4.84±4.03, in moderately obese 7.25±4.07 vs. 3.29±2.12 (p<0.0001) and severely obese 7.48±4.12 vs. 3.11±1.92 (p<0.0001). RES (μg/mL) had the same downward trend but appeared not significant 0' vs. 120' changes: controls 9.83±7.40 vs. 4.63±0.93; overweight 11.14±9.56 vs. 5.32±0.61; moderately 11.96±12.16 vs. 5.53±2.03 and severely obese 14.33±22.76 vs. 6.04±4.19. RES values at 0' correlated to 120' in controls (r+0.884; p<0.004) and in obese children (r+0.699; p<0.036). ADQ:RES ratio was lowered in both obese subgroups at 0': 0.59±0.44 (p<0.007) or 0.52±0.43 (p<0.048) and at 120' 0.59±0.43 (p<0.027) or 0.49±0.34 (p<0.042) if compare to controls: 1.08±0.69(0') and 1.68±1.52(120'). There were found ADQ (from p<0.004 to p<0.03) and ADQ:RES (p<0.01) negative correlations at 0' and 120' to body mass, BMI and BMI-SDS. Conclusions: Hyperinsulinemia and/or hyperglycemia in course of OGTT are suspected to be responsible for abrupt fall down of adiponectin and its ratio to resistin in obese children. Investigations are supported from government sources (MNiSW N407 057 32/2522). The aim of this work was to characterize changes in vascular function of resistance vessels related to diet-induced obesity (DIO). Four-week old CB57BL/6J male mice were assigned either to a low-fat (LF) (10 kcal % from fat) or to a high-fat (HF) diet (45 kcal % from fat). After 40 weeks on dietary treatment, HF animals weighed 20% more than LF animals (p<0.05). Both leptin (13.6±2.0 ng/ml vs 28.4±6.1 ng/ml, p<0.05) and insulin plasma levels (2.1±0.3 μg/l vs 5.8±0.6 μg/l; p<0.001) were significantly increased in HF animals. In contrast, plasma adiponectin was reduced in this group (9918±359 ng/ml vs 7758±415 ng/ml; p<0.001). Reactivity of resistance vessels was characterized by perfusion of the isolated mesenteric bed (flow of 1.5 ml/min). Contractions to KCl (6 to 75 mM) as well as responses to noradrenaline (10 -7 to 10 -5 M) were significantly higher in HF animals. Relaxant response to acetylcholine (10 -9 -10 -4 M) was significantly impaired in HF animals (90.7±4.1% vs 60.1±1.7%, p<0.001). Endothelium-independent relaxations, elicited by sodium nitroprusside, as well as basal release of nitric oxide, determined by the contractile response to L-NAME (10 -4 M), were not modified by dietary treatment. However, superoxide anion production, determined by confocal microscopy, was significantly higher in the HF group. These data show that DIO induces alterations in metabolic parameters which might be related to endothelial dysfunction in resistance vessels. We tested the hypothesis that adipose tissue significantly contributes to increased levels of proatherogenic endothelial cell adhesion molecules (CAM) in obesity and explored the influence of very low calorie diet (VLCD) on this production. 25 obese females (OB) and 14 lean healthy females (C) underwent blood drawing and subcutaneous (s.c.) and visceral (visc.) adipose tissue sampling during gastric banding and elective cholecystectomy surgery, respectively. In VLCD substudy, 20 obese females underwent blood drawing and s.c. fat biopsy before and after 3 weeks of VLCD (550 kcal/day). Serum concentrations of insulin, ICAM-1, VCAM-1 and E-selectin were measured using Lincoplex kits, CAM mRNA expression in fat was measured using RT PCR and protein CAM levels in fat were measured using Lincoplex kits and normalized to protein content. BMI, serum insulin levels, HOMA index, ICAM-1 and E-selectin concentrations of OB were significantly higher relative to C. Serum concentrations of VCAM-1 did not differ. Messenger RNA expression and protein levels of CAM in s.c. fat were not affected by obesity while in visc. fat ICAM and VCAM mRNA expression and its protein levels were significantly increased in OB relative to C. Three weeks of VLCD decreased circulating Eselectin levels while it did not change circulating ICAM and VCAM or its mRNA expression in s.c. fat. We conclude that obesity increases visceral but not subcutaneous adipose tissue production of CAM. This finding may partially explain the closer relationship of visceral fat accumulation in obesity to cardiovascular complications. Supported by MZO 000064165 and IGA 8302-5
Hedayati M, Daneshpour MS, Halalkhor S, Eshraghi P, Azizi F Obesity Research Center, Research Institute for Endocrine Sciences, Shaheed Beheshti MC Introduction: The Apo A1 is one of the genes, which play a role in the regulation of lipid metabolism, especially in obesity. In other studies two MspI polymorphisms in the ApoA-I gene (G-75A [M1] and C83T [M2]) has been shown to be associated with obesity, and in the present study our aim is to determine this association in an Iranian population. Materials & Methods: Subjects were randomly selected from the Tehran Lipid and Glucose Study and classified into 3 in three groups according to their body mass index: BMI<25, 25≤BMI<30, BMI≥30 and finally 227(100 in men and 127 in women). We measured FBS, HDL-C, triglyceride and cholesterol levels and evaluated body mass index and blood pressure for all individuals. A segment of the mentioned gene with PCR was amplified and the polymorphism with RFLP (MspI) revealed. The MS is very common in obese children and adolescents, but is also represented in overweight subjects. These data suggest the importance of an early intervention to prevent overweight, obesity and their metabolic complications. Introduction. The RAS is linked to visceral adiposity and cardiometabolic complications. Differences in expression pattern between subcutaneous and visceral adipose tissue (SAT; VAT) might have functional relevance. The aim of the study was to compare RAS expression in SAT and VAT using kidney as control tissue. The relation between clinical parameters and RAS expression was also studied. Methods. Samples of kidney cortex, medulla, and VAT were obtained from 38 patients undergoing nephrectomy (from 14 of these patients SAT was also sampled). Renin, (pro)renin receptor (PRR), angiotensinogen, ACE1, ACE2, AT1 receptor, AT2 receptor, and aldosterone synthase gene expression was evaluated by Real Time-PCR and normalized with GAPDH gene expression. Anthropometric and metabolic characteristics were evaluated before surgery.
Results. Kidney cortex is the main expression site for renin and ACE2. Angiotensinogen was largely expressed in VAT (about 7 folds higher than SAT; P=0.002), whereas ACE1 and AT1 were many folds more expressed in adipose tissue (both SAT and VAT) than in kidney. AT2 and PRR had low expression levels both in adipose and renal tissues, whereas, aldosterone synthase didn't result expressed in neither kidney or adipose tissue. VAT mRNA levels of AT1 was higher in normal-weight than in overweight patients (P=0.017). Discussion. The results suggest that VAT is an important source of angiotensinogen and angiotensin-II. Moreover, adipose tissue is a main target organ of angiotensin-II. It's possible also to hypothesize an AT1 "downregulation" due to increased of AngII production in VAT of obese patients. Results: 478 patients were analysed, of whom 70% were male. The mean BMI was 31.9 kg/m 2 and ranged from 15 to 64.7 kg/m 2 . 69.3% of patients had an AHI of 10 or above, of whom 78.8% were male. Mean BMI of those with an AHI of 10 or above was 32.9 kg/m 2 (95% CI 32.0 to 33.8), compared to 30.0 kg/m 2 (95% CI 28.6 to 31.4) for those with an AHI of below 10. Amongst the whole cohort, mean AHI was 26.6 (95% CI 24.4 -28.9), and mean ODI was 22.7 (95% CI 20.3 -25.3). Median ESS was 11 (n = 287; IQR 7 -15). BMI positively correlated with AHI, ODI and ESS; Kendal's tau-b = 0.277, 0.361 and 0.086 respectively, all P < 0.05. Discussion: The majority of patients referred for sleep study had obstructive sleep apnoea. ODI correlated better with BMI than AHI, suggesting that body weight may have a more significant pathological contribution to propensity to desaturate, than to the AHI. Many appetite hormones have been suggested to be involved in the pathogenesis of the metabolic syndrome. The purpose of this study was to investigate the postprandial response of peptide YY 3-36 (PYY 3-36 ) and acylated ghrelin to varied macronutrient composition in adult males with and without the metabolic syndrome. The International Diabetes Federation criteria of metabolic syndrome were used. Subjects received, on separate occasions, a high carbohydrate (HC), a high protein (HP) and a high fat (HF) meal. PYY 3-36 levels increased, while acylated ghrelin values decreased, following the three meals, in subjects with and without the metabolic syndrome. Even though the HC meal induced a higher acute PYY 3-36 peak, both HC and HF meals tended to maintain a continuously higher than baseline PYY 3-36 response throughout the postprandial period, in metabolic syndrome subjects. In control subjects, HF meal tended to induce an acutely, while HP meal a longer term, higher increase of PYY 3-36 above baseline. Postprandial acylated ghrelin decrease tended to be more pronounced following HC meal as compared to HP and HF meals, both in metabolic syndrome and control subjects. However, at 180min for MS subjects and at 180 and 240min for control ones, HP meal tended to maintain acylated ghrelin levels' change from baseline lower than that following HC and HF meals. In conclusion, findings suggest that modulating the release of endogenous appetite hormones, such as PYY 3-36 and acylated ghrelin, through alteration of dietary composition could provide a rational treatment for obesity and metabolic syndrome. Please note that EASO encourages full disclosure of all relevant sources of funding in relation to abstracts submitted to this congress. If you wish to disclose a conflict of interest or any funding, please do so briefly at the foot of this abstract as follows: Funding: Research relating to this abstract was funded by CEDRE "Coopération pour l'Évaluation et le Développement de la Recherche" program, implemented by the National Council for Scientific Research, Lebanon. Bariatric surgery is nowadays the recommended treatment for subjects suffering from morbid obesity (or severe obesity with important comorbidities). There is no clear consensus regarding the link between psychological factors, eating behaviour and post-surgery body weight evolution. Objective: To observe the predictive value of psychological state and eating behaviour on body weight loss for obese patients 2 years after a gastric bypass. Method: 43 female patients (BMI: 44.7 ± 0.4 kg/m 2 ) who underwent gastric surgery have been psychologically evaluated with the help of questionnaires on depression (BDI-II), anxiety (HAD) and eating behaviour (EDI-II) before the intervention, and at 1 and 2 years. Results: Excess weight loss at 2 years was 32.1 ± 1.1 and body weight remained stable between the first year (81.3 kg ± 1.7) and the second year (79.8 kg ± 1.7). Depression (p<.01), anxiety (p<.05) and eating behaviour disorder (p<.01) improved between 0 and 2 years. There is no correlation between basic psychological factors in basal state and body weight loss at 1 and 2 years after surgery. However, excess body weight loss at 2 years correlate with psychological factors (depression r=-.30, p<.01 ; anxiety r=-.46, p<.01).
In conclusion, psychological factors and eating behaviour disorder do not predict the effective weight loss at 2 years post-surgery. However, these factors improve after weight loss, and maintained body weight is directly linked with the psychological state at 2 years after weight loss. Background: Dietary protein seems to play an important role in body weight regulation. Objective: To compare the effects of high or normal casein-, soy-, or whey with or without glycomacropeptide(GMP)-protein breakfasts on amino acid, satiety, and 'satiety' hormone respones. Design: Twenty-five healthy subjects (mean+SEM BMI:23.9+0.3 kg/m 2 ;age:22+1 years) received a subject-specific standardized breakfast (20% of daily energy requirements): a custard with either casein, soy, or whey+/-GMP as protein type with either 10/55/35(normal) or 25/55/20(high)En% protein/carbohydrate/fat in a randomized, singleblind design. Appetite profile (Visual Analogue Scale,VAS), plasma glucose, insulin, GLP-1, ghrelin, and amino acid(AA) concentrations were determined for four hours. Results: At 10En%, whey+/-GMP were more satiating than casein or soy (p<0.05), coinciding with higher leucine and lysine responses (p<0.05). This was not underscored by concentrations of glucose, insulin, GLP-1, or ghrelin since differences were not significant. At 25En% however, there were no differences in satiety. Whey+/-GMP triggered the strongest responses with respect to changes in concentrations of GLP-1 (p<0.05) and ghrelin (p<0.05) compared with soy or casein; and insulin (p<0.001) compared with casein. Conclusion: A difference in satiety between different proteins appeared at the normal concentration of protein, namely at 10En% the whey-protein breakfasts were more satiating than the casein-or soy-protein breakfasts, coincided with higher leucine and lysine concentrations but unrelated to changes in hormone concentrations. A difference in changes in hormone concentrations between different proteins appeared at the concentration of protein of 25En%; the whey-protein breakfasts triggered stronger responses than the casein-or soy-protein breakfasts. Aims: Obesity and increases in body weight in adults are considered to be among the most important risk factors for type 2 diabetes (T2D). Low birthweight is also associated with increased rate of T2D. We aimed to examine the association between body shape history from childhood to adulthood and the risk of developing T2D during middle adulthood.
The E3N study is a prospective study of risk factors of breast cancer that included, in 1990, 98 995 women (40-65 y) living in France and followed by questionnaire every 2 years. At baseline, subjects reported their current weight, height and body silhouette, and their body silhouette at 8 years, puberty, 20-25 years and 35-40 years. Birthweight was recorded in the most recent questionnaire. Cases of T2D were ascertained though both self-report and a drug reimbursement database. We evaluated the prevalence of metabolic syndrome (MS) in obese adolescents (age > 10 year) consulting for overweight at our hospital and looked for associated clinical and biochemical risk factors for atherosclerosis. 106 obese (BMI SD > 2) adolescents, aged between 10 and 16.8 years, were retrieved. Beside standard blood analysis for MS screening, also insulin, LDL cholesterol, fibrinogen, homocysteine and uric acid concentrations were measured in fasting condition. Standardized anthropometry and blood pressure measurements were performed. MS, as defined by the recent IDF criteria for children, was found in 52 (49%) subjects. In all subjects waist circumference was above the 90 th percentile. Hypertension was present in 35, low HDL cholesterol in 23, hypertriglyceridemia in 19 and abnormal fasting glucose in 3 patients. No significant differences in gender, age, birth weight, gestational diabetes, paternal obesity and acanthosis nigricans were found between subjects with and without MS. Maternal BMI (30.0 ± 5.5 vs 27.6 ± 4.8; p=0.035), fasting insulin (15.2 ± 9.3 vs 11.3 ± 9.8; p=0.035) and uric acid (5.4 ± 1.3 vs 4.8 ± 1.2; p=0.021), was higher in the MS subjects compared to the non MS group. Fibrinogen concentration, LDL cholesterol and homocysteine were comparable between both groups. In conclusion, half of obese Belgian adolescents have MS by the recent IDF criteria. MS was associated with insulin resistance, but not with a prothrombotic state in this age group. Maternal, but not paternal obesity appears to be a risk factor for MS in obese adolescents.
Is obesity driving the high prevalence of hypertension in black south african women? Hypertension is highly prevalent in South Africa, resulting in high stroke mortality rates. Since obesity if very common amongst South African women, it is likely that obesity drives the hypertension prevalence. The aims were to determine whether black African women have higher blood pressures (BP) than Caucasian women, and if obesity is related to their cardiovascular risk. Apparently healthy African (N=102) and Caucasian (N=115) women, matched for age and body mass index, were included. Age-adjusted correlations between obesity (representing total body fat, abdominal obesity and peripheral fat) and cardiovascular risk markers (hemodynamic variables, lipids, inflammatory markers, clotting factors, adipokines) were compared between the ethnic groups. Comparisons between low and high BP groups were also made for each ethnic group. The results confirmed that African women had higher BP (p<0.01), with significantly increased vascular resistance. African women also showed unexpected and significantly weaker correlations between obesity measures and cardiovascular risk markers when compared to Caucasian women (specifically systolic BP, vascular resistance, cardiac output, HDLcholesterol, fibrinogen, plasminogen activator inhibitor-1, leptin, resistin). Interestingly the latter five risk markers were also not significantly different between low and high BP African groups. But African women showed significant correlations of obesity with triglycerides, C-reactive protein and insulin resistance that were comparable to the Caucasian women. Obesity is associated with impaired postprandial triacylglycerolemia, an independent risk factor for atherosclerosis. Very low-carbohydrate diets decrease postprandial triacylglycerol levels, presumably by suppressing triacylglycerol hepatic secretion. However, they are criticised for their high saturated fat content. In this study we examined the effects of 10% weight loss induced by a low-carbohydrate lowsaturated fat diet on postprandial triacylglycerolemia. Twelve obese but otherwise healthy, sedentary, men and women (age: 38.2 ± 3.3 years, body mass index: 34.8 ± 1.3 kg . m -2 ) performed two oral fat tolerance tests, before and after 10% weight loss. Dietary intervention consisted of low carbohydrate intake (60g/day for the first two weeks followed by a stepwise 10g increase the following weeks if weight loss was greater than 0.3 kg/week), restriction in saturated fat intake, and increased in protein, mono-and polyunsaturated fatty acids intake. Subjects lost 10.4 ± 0.6% of their initial body mass after 15 ± 2 weeks. Homeostasis model assessment of insulin resistance (HOMA-IR) was 47% lower after intervention (P<0.01). Postprandial concentrations of plasma triacylglycerols and serum insulin were 41% and 50% lower, respectively, after dietary intervention (P<0.01), whereas postprandial glucose concentrations were not different. Delta HOMA-IR was correlated with changes in postprandial concentrations of plasma triacylglycerols (r=0.678, P=0.015). It is concluded that moderate restriction in carbohydrate and saturated fat intake comprises an alternative intervention to reduce body mass and attenuate postprandial triacylglycerolemia and insulinaemia possibly through increases in insulin sensitivity.
Research relating to this abstract was funded by the Greek Governmental Institute of Scholarships and the Hellenic Heart Foundation.
Intraabdominal fat mass has been described as an independent risk factor for coronary heart disease. Sagittal abdominal diameter has been found to be closely related to the amount of visceral adipose tissue. The aim of our study was to evaluate the relationship between supine sagittal abdominal diameter (SAD) and other indicators of fat distribution and body size with cardiovascular risk factors in patients with metabolic syndrome.
The study was conducted in a group of 200 patients (age: 36,68 +/-10,65 years, BMI: 37,55 +/-5,87 kg/m 2 ) with metabolic syndrome (defined using the ATP-III guidelines) in whom, apart from standard measures (weight, height, BMI, waist), SAD was measured by means of specially constructed caliper (Holtain Kahn Abdominal Caliper). Overall, SAD showed a slightly higher correlation with most cardiovascular risk factors, especially with insulin resistance (HOMA-IR 0,260, p<0,001), insulinemia ( 0,250, p<0,001), HDL-Cholesterol (0,158, p< 0.05), systolic and diastolic blood pressure (p< 0, 01) than other anthropometric measures. A significant correlation was observed between SAD and calculated 10-year Framingham CHD risk. SAD showed a stronger correlation to 10-year Framingham CHD risk (+0,224) than waist circumference (+0,199) . When adjustments were made for age and BMI, the correlation became slightly stronger between SAD and HOMA-IR. The results suggest that SAD, as a simple, cheap and noninvasive anthropometric measurement, could be a clinically useful marker of risk factors and insulin resistance in patients with metabolic syndrome. When further comparing the measures of central obesity and the correlation with PWV by stratifying for gender, the correlation between PWV and SAD was significant in both genders (men; r=0.18; p=0.01, women; r=0.26; p=0.01). However, in a corresponding analysis between PWV and Waist, the correlation was significant only in men (men; r=0.23; p<0.01, women; r=0.16; p=0.10). Conclusions: BMI, Waist and Sagittal Abdominal Diameter were associated with arterial stiffness and LVM in patients with type 2 diabetes. When exploring the associations by gender, SAD appears to be superior to Waist in predicting arterial stiffness in female patients with type 2 diabetes.
Velásquez-Meléndez, G 1 , Parra, F 3 , Gazzinelli A 1 , Rodrigo Correa-Oliveira 2 ,Williams-Blangero S. The main purpose of this study was to investigate whether phenotypes of glucose homeostasis are genetically dependent and whether this control is shared with other adiposity traits. This relationship is still unknown particularly in Brazilian populations. Methods: The Jequitinhonha Community Family Study was based in above 18 years old probands. Extended pedigrees were constructed using the pedigree based data management software PEDSYS. Eighty eight percent (n=252) of the individuals belonged to a single pedigree which was highly informative for genetic analysis. A total of 285 individuals (m:136, f:149), aged 18-88 years were sampled. The degree of insulin resistance was assessed by homeostasis model assessment (HOMA-IR) method. Levels of fasting serum high-density lipoprotein cholesterol (HDL-C), triglycerides and anthropometric parameters (BMI, waist circumference and mid upper arm circumference) were also measured in each subject. Overall heritability and bivariate variance-components analyses were performed using the SOLAR software. All estimates were adjusted by sex and age. Heritability estimates for glucose metabolism traits ranged from 19% to 47% (p<0.005). The highest heritability estimated was for glucose (h 2 =47%, p<0.000). Significant genetic correlations (P < 0.05) were observed between HOMA-IR and BMI ( g =0.64), waist circumference ( g =0.60), HDL-C ( g =-0.60). Serum insulin levels were also correlated with the same traits. Additionally there were significant environmental correlations between those traits, except with HDL-C.
These results indicate that in rural Brazilian population glucose metabolism traits is highly heritable and share common genetic effect with body adiposity traits supporting the role of these traits as a potential determinants of diabetes and cardiovascular diseases.
Relationship between white blood cells number and total body fat as well as visceral fat, in smoking and non-smoking subjects.
Diabetes, Obesity and Metabolism Department, Metropolitan Hospital, Neo Faliro, Athens, Greece.
Introduction: Obesity is currently considered as a low-grade inflammatory state. Aim: To investigate any relationship between White Blood Cells (WBC), a clinical marker of inflammation, and obesity. Subjects-Methods: We studied retrospectively 247 males and 355 females from our outpatient clinic. A) Exclusion criteria: medications affecting WBC, infections, liver dysfunction, sedimentation rate>40, WBC>11,000/mm 3 , thyroid dysfunction, type-1 diabetics and uncontrolled type-2 diabetics. B) Fasting blood measurements: hematology, sedimentation rate, biochemistry, HbA1c, insulin and HOMA-IR. C) Anthropometry: BMI, Waist Circumference (WC), WHR, % Total Body Fat (BIA-TBF) and Sagittal Abdominal Diameter (SAD) for calculation of visceral fat (kg). Results: A) Males had higher WBC than females (7,394±1,584 vs. 6,995±1,495, p=0.002). B) Smokers had higher WBC than non-smokers in both sexes (males: 7,849±1,566 vs. 7,168±1,548, p=0.001, females: 7,321±1,353 vs. 6,775±1,549, p=0.001). C) Significant correlations: 1) WBC to BMI: non-smoking males: r=0.186, p=0.017, non-smoking females: r=0.306, p=0.000. 2) WBC to BIA-TBF: nonsmoking males: r s =0.156, p=0.045, non-smoking females: r s =0.288, p=0.000 and smoking females: r s =0.180, p=0.037. 3) WBC to WC: non-smoking males: r=0.198, p=0.012, non-smoking females: r=0.291, p=0.000. 4) WBC to SAD: non-smoking males: r=0.177, p=0.025, non-smoking females: r=0.289, p=0.000 and smoking females: r=0.177, p=0.042. 5) WBC to kg of visceral fat: non-smoking males: r=0.164, p=0.038, non smoking females: r=0.288, p=0.000 and smoking females r=0.177, p=0.042. 6) WBC to HOMA-IR: non-smoking females: r s =0.285, p=0.000.
Smoking is important inducer of inflammation as expressed by WBC number, mainly in males. In non-smoking males and in females irrespectively of smoking, WBC are related to obesity, and more importantly to sagittal abdominal diameter and kilograms of visceral fat. S149 T3:PS.71
Druet C, Ong K MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge, UK Introduction: METRIC is an international collaboration of birth cohort studies that aims to identify the optimal infant predictors of later obesity. The current analysis aims to identify which marker of attained infant size (infant weight, BMI or length) best predicts later BMI and obesity risk. Patients and methods: We performed a meta-analysis of data from 4 cohorts (ALSPAC, HAGUENAU, SWEDES and NFBC), totalling 5648 adults (age 17 to 31 years) and 1042 children (age 6 to 8 years). Infant size was expressed as age and sex-adjusted SD scores (SDS) and analyses were adjusted for childhood or adult height. Results: In separate models, infant weight, BMI and length were all positively associated with adult BMI and accordingly each was predictive of adult obesity OR (95% CI) per +1 SDS of infant weight: 1.34 (1.22-1.48) , BMI: 1.29 (1.18-1.40) , and length: 1.11 (0.99-1.25 ). In multivariate models, risk of adult obesity was positively and independently associated with both infant BMI (1.31 [1.20-1.42] ) and infant length (1.13 [1.02-1.26] ). The results were consistent in each cohort, and similarly both infant BMI (p<0.0001) and infant length (p=0.003) contributed independently to childhood BMI. Conclusion: Both larger infant BMI and greater infant length are independent predictors of later BMI and adult obesity. Infant weight, being a composite of infant BMI and length, represents the best single infant size marker of later obesity. Data from 5 further cohorts will be included to assess the predictive abilities of specific thresholds of infant size. The endocannabinoid system has recently emerged as an important regulator of energy homeostasis, involved not only in the control of food intake but also in the regulation of energy metabolism at peripheral level. We have investigated the effect of rimonabant on hepatic mitochondrial function in rats fed a high fat diet. Sprague Dawley rats fed a high fat diet during 13 weeks were treated with rimonabant during the 3 last weeks and matched with pair-fed controls. Body weight and fat mass were decreased in rats treated with rimonabant compared to pair-fed controls. Moreover, adiponectin was increased with rimonabant. An increase of mitochondrial respiration was observed in rats treated with rimonabant. Especially an increase of mitochondrial respiration with palmitoyl CoA compared to respiration with palmitoyl-l-carnitine stating that the entry of fatty acids in mitochondria via the carnitine plamitoyl transferase 1 was increased in rats treated with rimonabant. Moreover rimonabant has caused a reduction in the enzymatic activity of the ATP synthase whereas the quantity of mitochondrial DNA and the activity of the citrate synthase were remained unchanged. That seems to indicate that oxidation of respiratory substrates was increased in order to compensate the reduction of ATP synthesis but without variation of mitochondrial density. The results obtained suggest that rimonabant has a beneficial effect on mitochondrial function by facilitating fatty acids oxidation, thereby reducing fatty liver and so takes part in the increase of insulin sensitivity observed under rimonabant treatment. Results: Mean BMI 5y 0.32SD, 10y 0.51SD. Fasting glucose rose progressively from 5-10y (4.3-4.8 mmol/l, p<0.001). %B was higher, and %S lower, in T3 than T1 throughout. An unexpected switch in direction of disposition occurred in all tertiles (graph). The switch occurred earlier (6-7y), and at lower sensitivity (221%), in T3 compared with T1 (7-8y, 331%). Conclusion: A loop constantly seeks maximum gain to optimise control of its output (glucose). The switch in disposition is a novel observation which demonstrates how the loop reverts to beta cell reserve once insulin sensitivity becomes constrained. BMI appears to be a crucial determinant of the stage at which the inflexion occurs. Disposition mapping may help us better understand the response of the loop to rising obesity in children.
Mirmiran P 1 ± 11.4 cm, p<0 .001) compared with Pre women, while insulin sensitivity and physical activity levels were comparable. After adjustment by centre, BMI was not significantly higher in the Post women. Paradoxically, adiponectin levels were significantly higher in Post women compared with pre women (10.6 μg*ml -1 ± 4.2 vs. 9.7 ± 3.6 μg*ml -1 , p<0.05). However after adjustment for center (F: 2.82, p<0.001), age (F=7.68, p<0.01), BMI (F: 0.38, p=0.53) and waist circumference (F=26.15, p<0.001), menopausal status was not associated with significant differences in adiponectin levels (F=1.68, p=0.19) . Conclusion: Menopausal status is associated with increased adiponectin levels. This finding might indicate an adaptive mechanism involved in the preservation of insulin sensitivity during menopausal transition. Introduction: As childhood obesity increases it also contributes to an increasing incidence of the metabolic syndrome (MS). The aim of the current study was to record the prevalence of these adverse health conditions among Greek preadolescents. Materials and methods: The "Prediabetes, Obesity and Growth Epidemiological Study in Schoolchildren" (PROGRESS) examined a sample of 370 primary schoolchildren (9-13 years old) with complete data on certain anthropometric (weight, height, waist circumference), biochemical (fasting plasma glucose and serum lipids levels) and clinical (blood pressure) indices. The IOTF references were used for the definition of overweight and obesity. MS was diagnosed by abdominal obesity and the presence of two or more other clinical features (ie, elevated triglycerides, low HDL-cholesterol, high blood pressure, or increased plasma glucose) based on the new International Diabetes Foundation definition. Results: The prevalence of overweight and obesity was 31.3% and 11.4%, respectively. Regarding the clinical features of the MS, abdominal adiposity was recorded for 8.9% of the total sample. Furthermore, 2.6% of children were diagnosed with elevated serum triglycerides, 17.4% with low HDL-cholesterol, 8.8% with hypertension and 15% with increased plasma glucose levels. The prevalence of the MS was 3% in the total study population and 21.2% in the obese subjects. Conclusion: The prevalence of overweight, obesity and MS reported by the present study are considerably high and comparable to those reported by similar recent studies conducted with children. Because the number of overweight children is increasing continuously, there is a vital need to develop appropriate screening and prevention strategies. Conflict of Interest: Yannis Manios also works as a part-time scientific consultant for Friesland Foods Hellas. None of the other authors had any potential conflict of interest. Funding: Research relating to this abstract was funded by Friesland Foods Hellas. It is becoming increasingly important in our society to understand the aetiology and to stop the epidemic of obesity and its' related disorders. Metabolic syndrome is a cluster of several risk factors characterised by insulin resistance which can lead to type 2 diabetes. We studied here the impact of the inner quality of food products on metabolic syndrome. Method: 160 men and post-menopausal women aged 18 to 65 years with metabolic syndrome were randomly assigned to a standard diet or a diet containing products naturally rich in omega-3 with similar macronutrients content for 3 month. After the 3-month diet, subjects returned to a free diet but were asked to come back after 2 and 5 months to be measured. 14 subjects from the control group and 14 from the test group also had blood samples taken. Results: no statistical differences were found between the two groups during the 3 month intervention diet. During follow-up, the Body Mass Index (BMI) of the subjects who were in the control group increased significantly more than the BMI of the former test group (+0.58 kg/m² ±0.90 vs. +0.12 ±1.09 respectively, p=0.04). Lipid profile also improved for the 14 subjects in the test group and deteriorated in for the 14 in the former control group. Conclusion: during the 3-month diet, the quantitative impact of the caloric restriction masked the difference between products. During the follow-up, the qualitative aspect predominated and showed that omega-3 fatty acids are potentially beneficial on medium term to help weight management. Funding: Research relating to this abstract was funded by Agence Nationale de la Recherche, Région Bretagne and Eureka.
Skowronska, B, Fichna, P, Majewska, K, Stankiewicz, W
Objectives: The presence of impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) is considered as prediabetes when found in obese children. Its metabolic background comparison to obese children with normal glucose tolerance (NGT) was the aim of study. Methods: 40 IFG/IGT and 308 NGT obese children with the same anthropometric measures (BMI-SDS 3.7±1.6; age 12.3±3.5) underwent IVGTT and OGTT with insulin, proinsulin and C-peptide estimations; HOMA-IR, WBISI were calculated too. Other investigations included: family health history, lipids, fibrinogen, aminotransferases, abdomen ultrasonography. Results: T2DM in family history was in 32.5% of patients with prediabetes and 20.3% of NGT (p<0.01). 42.5% of IFG/IGT and 22.2% of NGT (p<0.0001) had acanthosis nigricans. In OGTT, IFG/IGT vs. NGT patients had higher insulin: AUC 0-120min (p<0.03), 120-0min mean value (p<0.001) and at 120min (p<0.0001); C-peptide 120-0min mean value (p<0.04) and at 120' (p<0.009); proinsulin at 120' (p<0.01). HOMA-IR was higher (4.81±3.76 vs.3.61±2.8; p<0.03) and WBISI was lower (2.81±1.57 vs. 4.4±3.63; p<0.04) in prediabetic children. In IVGTT, patients with IFG/IGT revealed reduced response during the first 3'(171.5±75.5mU/L) and 5'(249.6±99.5mU/L) in comparison to NGT (292.1±151.2 and 431.9±216.5mU/L; p<0.04). NAFLD was more frequent (20% vs.12.9%; p<0.01) and fibrinogen (mg/dl) was higher (417.0±88.6 vs. 363.9±85.7) in prediabetic than NGT patients (p<0.03). Conclusions: Obese children with reduction of the first phase insulin release are close to T2DM, however, there are other advanced disorders caused by insulin resistance too. So, the results suggest to presume an insulin resistance as enough to early diagnosis of prediabetes. Investigations are supported from government sources (MNiSW N407 057 32/2522).
Obesity and its comorbidities in a rural african population. Van Introduction: Obesity, hypertension and diabetes are increasingly common in developing countries. Assuring Health for All in the Free State is a research project aimed at determining how living in rural areas influences the lifestyles of populations, predisposing them to chronic diseases. Methodology: This study forms part of a prospective and longitudinal epidemiological study. Adults aged 25 and 64 years from three rural areas in South Africa were included. Socio-demographic and anthropometric data was collected and medical examination and blood sampling was done. Results: 553 adults (male=163, female=390) were included. In the age groups 25-45 and 46-65 years respectively, 84.1% and 72.0% of males were normal or underweight (BMI < 25). In the younger and older age groups respectively, 66.9% and 64.8% of females were overweight or obese (BMI > 25). Elevated blood pressure (>140/90 mmHg) was measured in 31.2% males and 40.2% females (25-45 years) and 64.7% males and 62.3% females (46-65 years). In the younger group, 46.2% of males and 54.7% of females who reported receiving hypertension treatment, had elevated blood pressure measurements, while in the older group, these percentages were 74.6% and 66.3% for males and females respectively. Blood glucose levels >7.1 mmol/L were measured in 47.5% of patients with diabetes mellitus and in 2.6% of non-diabetics. Conclusion: Most of the females in this population were overweight or obese, while most men were normal or underweight. A large percentage of hypertensive and diabetic patients had elevated blood pressure and blood glucose levels respectively. Obesity is a pathology associated with other considerable health problems, including endometrial hyperplasia and cancer. Objective: to assess the efficacy of orlistat and hormonal therapy in the treatment of the endometrial hyperplasia in obese women. Methods and subjects: we treated 61 obese women with hystologically confirmed endometrial hyperplasia. Group I -simple hyperplasia (32 patients) were treated with levonorgestrel intrauterine device, group IIcomplex hyperplasia with/without atypia (29 patients) were treated with medroxyprogesterone acetate (MPA) 150 -500 mg weekly during 6 month. From each group 15 patients additionally were receiving orlistat 360 mg per day. Results: treatment of endometrial hyperplasia was successful in both groups. In the first group the frequency of hyperplasia recurrence was 2%, in the second one -20%. Side effects of progestins such as increasing of weight and glucose intolerance (II group) were observed in group without orlistat. There were a weight loss and normal results of GTT and lipids after orlistat with progestin. Conclusions: Orlistat combined with progestin was confirmed to improve tolerability and decrease the adverse events in treating the obese women with endometrial hyperplasia.
International Journal of Obesity T3:PS.85
Nazare, J-A 1 *, Normand*,S 1 , De Rougemont, A 1 , Sothier, M 1 , Vinoy, S 2 , Sauvinet, Numerous studies have highlighted the beneficial effect of low-glycemic index (LGI) products on metabolic parameters. Considering that LGI products present by definition a better glycemic profile than high-glycemic index (HGI) ones, we investigated the influence of a medium-term diet enriched with either LGI or HGI products, on the management of the postprandial glycemic profile. In this 5-week randomized study, 38 overweight subjects (BMI 27.3 +/-1.5 kg/m 2 ), replaced their usual starchy foods with either LGI or HGI ones. The GI was significantly different between groups (p<0.0001) with no difference in carbohydrates or caloric content. On Day1 and Day36, glucose metabolism (glycemia, insulinemia, total and exogenous glucose rate of appearance (RaT and RaE), endogenous glucose production (PEG)) was assessed following either a HGI or a LGI 13 C-labeled breakfast. On Day1, the areas under the curve (AUC) of glycemia, RaT, RaE, PEG, and the glycemic peak were significantly lower after the LGI breakfast (p<0.05), but there was no difference in the insulinemic response. No significant diet*time interaction was found for any parameter after 5 weeks. In fact, on Day36, LGI breakfast kinetics were similar to Day1 whereas a trend to a decrease was observed for HGI parameters; as a result, only RaE was lower in the LGI group (p<0.05). The intake of a LGI breakfast improved the short term metabolic tolerance to a meal compared to a HGI breakfast. Interestingly, the LGI beneficial effect was steady but not enhanced by a 5-week LGI diet, whereas the HGI effect remained more variable.
Pacini Giovanni 1 , Sambataro Maria 2 1 Metabolic Unit -ISIB CNR -Padova, Italy ; 2 Ca' Foncello Hospital -Treviso, Italy Insulin sensitivity can be partitioned into basal (hepatic) and peripheral (muscle, adipose tissues) sensitivity. Adipocytokines are important fat mediators for glucose homeostasis in insulin-resistant subjects. However, relationships of abdominal fat with the basal and dynamic components of insulin sensitivity have not been yet elucidated. Aim: was the assessment of possible relationships of adiponectin and leptin with these components of insulin sensitivity in overweight type-2 subjects (T2DM) with plurimetabolic syndrome. Methods: T2DM (5F/11M; 59±2 yr; duration=5±1 yr; HbA1c=6.7±0.1%; BMI=29.5±1.1 kg/m 2 ; waist=104±2 cm; basal glucose=134±5 mg/dl; basal insulin=9.4±1.2 μU/ml; uric acid=5.3±0.3 mg/dl) and 16 matched overweight controls (CTN) underwent a 75g-2h OGTT. Lipid profile was (mg/dl): cholesterol=204±8, HDL=53±3, LDL=119±8, triglycerides(TG)=168±27. Abdominal fat was determined as cardiovascular risk factor LAP [lipid overaccumulation=(waist-k)×TG; k=gender constant]. Basal insulin sensitivity was measured with QUICKI index and the peripheral one with OGIS. Results: LAP was 66±8 cm×mM/L. T2DM and CNT adiponectin (7.4±0.5, 7.8± 0.9 μg/ml), leptin (13±3, 13.3 ng/ml) and QUICKI (0.39±0.01, 0.39±0.01) were not different (p>0.2); OGIS (317±11, 406±12.6 ml min -1 m -2 ) was lower in T2DM, p=0.0001. LAP inversely correlated with OGIS (R=-0.57, p=0.026) and QUICKI (R=-0.56, p=0.022) only in T2DM. Cytokines were normalized to BMI (adiponectin=0.25±0.02; leptin=0.42±0.08). Leptin inversely correlated with QUICKI (R=-0.45, p=0.009), adiponectin directly with OGIS (R=0.43, p=0.015), in all subjects. Conclusions: Lipid overaccumulation plays a major role in insulin sensitivity impairment. Adipocytokines mediate insulin resistance, but have different sites of action: adiponectin operates at peripheral tissues level; leptin is active mainly on fasting (liver) sensitivity and is not relevant in diabetic state.
Puchau, B 1 , Zulet, MA 1 , González de Echávarri, A 1 , Martínez, JA 1 1 Department of Nutrition and Food Sciences, Physiology and Toxicology, University of Navarra, Pamplona, Spain Introduction: Oxidative stress has been related to the development of obesity and other chronic diseases. Furthermore, antioxidant intake has been suggested to protect against oxidative damage and related complications. The objective of this study was to assess the potential association between the total antioxidant dietary capacity (TAC) and several early metabolic syndrome manifestations in healthy young adults. Methods: Anthropometric variables and blood pressure of 101 healthy participants (20.5±2.6 y) included in this study were measured. Dietary intake was assessed by a validated food-frequency questionnaire (SUN), which was used to calculate the TAC and to adjust it by daily energy intake. Fasting blood samples were collected for measuring serum glucose concentrations. Subjects were categorized by the median of body mass index (BMI), whose ranges were: 17.4-21.2 kg/m 2 , 21.2-29.3 kg/m 2 . Results: TAC was inversely correlated with body weight (r=-0.433; p=0.001), BMI (r=-0.294; p=0.028), waist circumference (r=-0.324; p=0.015), serum glucose (r=-0.292; p=0.038) and systolic blood pressure (r=-0.355; p=0.007) in subjects with the highest BMI (percentile 50 and over), whereas HDL-cholesterol (r=0.247) and waist circumference (r=-0.233) showed only a statistical trend (p=0.084). No correlations were found with TAC in subjects with lower values of BMI. Conclusions: These data suggest that TAC, as a measure of antioxidant intake, may be also a potential marker of the risk to develop obesity and metabolic syndrome features in healthy subjects. Background: Alanine aminotransferase (ALT) is a marker of non-alcoholic fatty liver disease (NAFLD), predicts type 2 diabetes mellitus (DM2) as well as coronary events independently of traditional risk factors and the features of the metabolic syndrome. The extent to which left ventricular hypertrophy (LVH), another surrogate marker of cardio-vascular disease (CVD) is associated with ALT levels in morbidly obese (MO) individuals is still unknown.
Cross-sectional pilot-study involving 169 MO asymptomatic young Caucasian participants. Participants disclosing ALT in the upper tertile (ALT > 36 UI/L) were considered to have NAFLD. IR was assessed using the HOMA index. Standard echocardiograms were used to define left ventricular mass (LVM) and interventricular wall thickness (IVWTh). LVH was defined as IVWTh > 12 mm. Results: Age=37.9 ± 0.8 years old. Gender (M45/F124). Body mass index=45.9 ± 0.5 kg.m -2 . NAFLD was found in 30.2% of the participants (M57.8%/F21.2%). As compared with the first tertile, those in the upper tertile disclosed significantly higher HOMA (P=0.003), diabetes (P=0.002) and hypertension (P=0.01) prevalence, LVH prevalence (P<0.0005) and left ventricular mass (P<0.0005). Significant correlations were found between ALT levels and LVM (P<0.0005), IVWTh (P<0.0005), HOMA (P=0.004), gender (P<0.0005) and serum creatinine (P<0.0005). The correlation between ALT and IVWTh persisted after adjustment for the gender, HTN, DM2, HOMA and creatinine levels (P<0.005). Conclusions: NAFLD is very common in MO individuals and appears significantly associated to LVH even after adjustment for the previous confounders. NAFLD stands as a promising surrogate marker for LVH in the morbidly obese. S153 T3:PS.89 The parameters subject to review were Body Mass Index (BMI), blood pressure (BP), fasting glucose and lipid profile.
The population included 220 adolescents, 55% female, mean age:15 years. In the last evaluation only 3.2% were normal weight, 24.1% overweight (P85